ML20082J199
| ML20082J199 | |
| Person / Time | |
|---|---|
| Site: | Clinton  |
| Issue date: | 02/28/1991 |
| From: | ILLINOIS POWER CO. |
| To: | |
| Shared Package | |
| ML20082H991 | List: |
| References | |
| PROC-910228, NUDOCS 9108270237 | |
| Download: ML20082J199 (245) | |
Text
. . . .
CPS-ODCM.
ILLINOIS POWER COMPANY ,,
CLINTON POWER STATION UNIT 1 OFFSITE DOSE CALCULATION MANUAL Docket No. 50-461
't p'
CLINTON-1 Rev.7-2/91 Nk AD P a
I l
CPS-ODCM Illinois Power Company Clinton Power Station OFFSITE DOSE CALCULATION MA1 RIAL Table of Contents Section Title Pace 1.0 PREFACE l-1 1.1 Definitions 1-1 1.2 General Operation Requirements 1-4 1.3 General Surveillance Requiremer.ts 1-4 2.0 LIQUID EFFLUENTS 2-1 2.1 Introduction 2-1 2.2 Liquid Radvaste Discharge Process Radiation 2-1 Monitoring (PRM) System 2.2.1 Method of Representative Sampling 2-1 2.3 10CFR2O Release Rate Limir.s 2-1.
2.3.1 Liquid Effluent Ccncentration - 2-2 Operation and Surveillance Requirements 2.3.2 Liquid Radvaste Discharge PRM 2-6 Setpoints 2.3.3 Plant Service Water Effluent 2-11 PRM Setpoints 2.3.4 Shutdown Service Water (SX) 2-12 Effluent PRM Setpoints 2.3.5 Fuel Pool Heat Exchanger Service 2-12 Water Effluent PRM Satpe,ints 2.4 10CFR50, Appendix I Release Rate Limits 2-13 2.4.1 10CFR50, Appendix I-Release Rate 2-13 Limits - Operation and Surveillance Requirements s
CLINTON-1 i Rev.6-12/89
l CPS-ODCM Illinois Power Company Clinton PoWor Station OFFSITE DOSE CALCULATIOli MA!IVAL
.T11 M a of Centntttu Eection Title Dm
~
2.0 2.4.2 Discussion 2-14 l
l 2.5 Liquid'Radwaste Treatment S/ stem 2-26 2.5.1 Liquid nadwaste Treatment System - 2-26 Operation and Surveillance Requiro.monts 2.5.2 Tenporary Liquid Radwacte 2-27 Hold-up Tanks
~
2.6 Deses From Other Significant Liquid Effluent 2-20 Pathways 2.7 Radioactivo Liquid Effluent Monitoring 2-29 Instrumentation 2.7.1 Radioactive I.iquid Ef fluent 2-29 Monitoring Instrumentation -
s Operation and Surveillanco Requirements ,
3.0 GASEOUS EFFLUEllTS 3-1 3.1 Introduction 3-1 3.2 Gascous Effluent Release Point Monitoring 3-1 3.2 HVAC Stack Process Radiation 3-1 Monitoring (PRM) System 3.2.2 SGTS Stack Process Radiation 3-2 Monitoring (PRM) System 3.3 Main Condenser Off-Gas Monitoring System 3-3 3.3.1 Pre-Treatment Air Ejector Off-Gas 3-3 PRM 3.3.2 Post-Treatment Air Ejector of f-Gas 3-3 PRM 3.4 10CFR20 Release Rato Limits 3-4 CLIllTO!1-1 11 Rev.,6-12/89
e CPS-ODCM Illinois Power company Clinton Power Station !
0FFSITE DOSE CALCULATION MAN'; \L Iable of contents I i
Section Titio Paqo !
3.0 3.4.1 10CFR20 Rolcano Rato Limits - 3-4 [
operation and Surveillance Requirements i
3.4.2 Doso Rato Due to Noblo Gasoc 3-8 ;
~
t 3.4.3 Dono Rato Due to Radiciodinos, 3-A Particulates and Tritium !
3.5 10CFR50, Appendix I Roloaso Rate Limits 3-15 t
3.5.1 Noble Gas Dose - Operation and 3-15 !
Surveillance Requirements !
3.5.2 Iodino-131, Iodino-133, Tritium, 3-16 '
and Radionuclidos in Particulato i Form - operation and Survo111anco i Requirements '
3.533 ;toble Gas Air Doso Equations 3-17 i
3.5.4 Radiciodinos, Particulatos and 3-18 i Tritium Doso Equations 3.6 Gascous Radwasto (offgas) Treatment 3-27 3.6.1 Gaseous Radwasto (Offgna 3-27 l Treatment) System - Operation !
and Survoillanco Requirements !
t 3.7 Vontilation Exhaust Treatment 3-28 l
3.7.1 Ventilation Exhaust Troatment 3-28 ,
t System - operation and j Surveillanco Requirements ;
3.8 Effluent Monitor Sotpoint Calculations 3-29 1 I
- 3.8.1 Total Body Doso Rato Sotpoint 3-29 i
3.S.2 Skin Doso Rato Sotpoint 3-31 l CLINTON-1 lii Rov.6-12/89 f
"+--re-+-- -- = me-mn,-+------->'--+ rpm. --.,-m- e,w .~,--e--,..w--,4 ,. --v-,.---,.,-m,r--s=--
nm --w- w w - e w
- CPS-ODCM Illinois Power Company Clinton Power Station OrrSITE DOSE CALCULATIoll MAltUAL Table of Contents Section T1t1e Mr 3.0 3.9 Radiow:tive Gascous Monitoring Instrumentation 3-33 3.9.1 Offgas Radiation Monitoring 3-33 Instrumentation - operation and Surveillance Requirements 3.9.2 Radioactive Gaseous Effluent 3-39 Monitoring Instrumentation -
Operation and Survoillance
.. Requirements 4.O COMPLIA! ,E WITH 4OCFR190 4-1 4.1 Total Dose - Operation and Surveillance 4-1 Requirements 4.2 4.1.a special Report Requiremonto 4-2 5.O RADIOLOGIb L ElfVIR0!TMEliTAL M0!iITORI!1G PROGRAM 5-1
- 5.1 Monitoring Program - Operation and 5-2 Surveillance Requirements 5.2 Land.Uso Consus - operation and 5-24 Surveillanco Requiremento 5.3 Into'rlaboratory Comparison Program 5-26 5.3.1 Interlaboratory Comparison 5-27 Program - operation and Surve111anco Requiremonte 6.O BASES FOR OPERATIO!1 AND SURVEILIANCE 6-1 REQUIREMENTS
- 6.1 General Operation and Surveillance 6-1 Requirements 6.2 Monitoring Instrumentation 6-2 6.3 Radioactivo Effluents 6-3 6.3.1 Liquid Effluents 6-3 CLINTOH-1 iv Rev,6-12/89
CPS-ODCM Illinoin Power company Clinton Power Station OFFSITE DOSE CALCULATIOtt MAliUAL Table of contento Soction Title Pace 6.0 6.3.2 Gasoous Effluento
, 6-5 6.3.3 Total Dose 6-7 c.4 Radiological Environmental Monitoring 6-8 7.0 REPORTING REQUIREMENTS- 7-1 7.1 Annual Radiological Environmental Operating 7-1 Report 7.2 Semiannual Radioactive Effluent Rolcaco 7-2 Report 8.0 ADJUSTMEN7 OF Tile CPS ODCM METHODOLOGY 8-1 9.0 ATMOSPHERIC TRANSPORT AND DISPERSIO!I MODEL 9-1 9.1 Introduction 9-1 9.2 Concurront Motoorological Data Processing 9-1 9.2.1 Dotormination of Pesquill 9-2 Stability _ Class 9.2.2 Calculation-of Stack Holght 9-2 Wind Spood 9.2.3 Dotormination of Rolcano Mode - 9-3 and the Entrainment Coefficient 9.2.4 Calc 111ation of Vortica) Standard 94 Deviation 9.2.5 Calculation of the Building Wako 9-5 Correction 9.2.6 Calculation of Momentum Plume Riso 9-5 9.2.7 Calculation of Effective Plumo 9-6 Height CLINTON v Rovr6-12/89
Wb aU9CM Illinois Power company Clinton PoWor Station OFFSITE DOSE CALCULATIO!1 MAltUAL Table of Contente -
Section _ ,yltle Pope '
~
9.0 9.2.0 Determinstion of Af fected Sectors 9-7 i CalculatiGA of Deplation and 9.2. 9 '
9-7 Deposition Factore l r
9.2.10 Ground Level X/Q, D2DPXQ, blXQ, 9-12 D/Q Analysis 9.2.11 Elevated X/Q, D2DPXQ, D1XQ, D/Q 9-13 Analysis 4
4p. s l
f
}
e l
l CLIliTOli-1 vi Rev 6-12/89 l'
CPS-0DCM Illinois Power Company Clinton Power Station OFFSITE DOSE CALCULATION MANUAL TilblCli Table Title Pace 1.1-1 Survoillance Frequoney Notation 1-5 2.3-1 Radioactivo' Liquid Wasto Sampling and Analysis Program 2-3 2.4-1 Adult Ingostion Dose Commitment Factors - Ai j 2-16 2.4-2 Bioaccumulation Factors - BFi 2-19 2.4-3 Adult Ingostion Doco Factors - DFi 2-20 2.7-1 Radioactivo Liquid Effluent Monitoring 2-29 Instrumentation 2.7-2 Radioactivo Liquid Effluent Monitoring 2-31 Instrumentation Surveillance Requirements
. 3.4-1 Radioactive Gaseous Waste 7ampling and Analysis Program - -
3-5 3.4-2 Doso Factors For Noble Gases and Daughters 3-10 3.4-3 Inhalation Pathway Doco Rato Factors (Child) - Pij 3-11 3.4-4 Annual Donos in Unrestricted A.eas 3-14 3.9.1-1 Offgas Radiation Monitoring Instrumentation 3-34 3.9.1-2 Offgas Radiation Monitoring Instrumentation 3-37 Surveillanco Requirements 3.9.2-1 Radioactive Gascous Effluent Monitoring Instrumentation 3-40
-3.9.2-2 Radioactive Ganeous Effluent Monitoring 3-43 Instrumentation Surveillanco Requirements 3.5-1 Inhalation Doso Factors For Infant-(DFA1)a 3-48 3.b-;
Inhalation Doso Factors For Child-(DFA1)a -
3-61 CLINTON-1 vii Rev, 6-12/89
~ - . - ._. - ~ _._., ._ - -. - -. - . ..-. - -
CPS-ODCM -
f Illinois Power Company Clinton Power Station !
OFFSITE DOSE CALCULATIoli MAliUAL f
Tables Table Title Paqe
~
3.5-3 Inhalation Dose Factors For Toen~(DFAi )a 3-54 3.5-4 3-57 Inhalation Dose Factors For Adult-(DFA1)a i 3.5-5 Ground Planc Dose Factors-DFGi 3-60 i
3.5-6 Ingestion Dose Factors For Inf ant-(DFL1)a 3-62 3.5-7 Ingestion Dose Factors For Child-(DFL1)a 3-65 3.5-8 Ingestion Dose Factors For Teen ~(DFLi)a 3-68 3.5-9 Ingestion Dose Factors For Adult-(DFLi )a 3-71 C
3.5-10 -Input Parameters For Calculating Raij 3*74 3.5-11 M Input Parameters For Calculating Raij 3-75 V
3.5-12 Input Parameters For Calculating Raij 3-76
- I 3.5-13 Inhalation Pathway Factors - Raij (IIIIAIIT) 3~77 I
3.5-14 Inhalation Pathway Factors - Raij (CHILD) 3-80 I
3.5-15 Inhalation Pathway Factors - Raij (TEE!I) 3-83 '
I 3.5-16 Inhalation Pathway Factors - Raij 3-86
_( ADULT)
C 3.5-17 . Cow Milk Pathway Factors -_Raij (I!JFANT) 3-89 C
3.5-18 Cow Milk Pathway Factors - Raij (CHILD) 3-92 C
3.5-19 Cow Milk Pathway Factors - Raij (TEEN) 3-95 C
3.5-20 . Cow Milk Pathway Factors - Raij (ADULT) 3' '
C 3.5-21 Goat Milk Pathway Factors - Raij (INFANT) 3-101 i C
3.5-22 Goat Milk Pathway Factcra - Raij (CHILD) 3-104 C
3.5-23. Goat Milk Pathway Factors - Raij (TEEN) 3-107 i C
3.5-24 Goat Milk Pathway Factors - Raij 3-110 (ADULT)
CLINTON-1 viii Rev. 5-2/89
,--,e -,c,.. ~
p-p,,,,7-.,-,- ,,pwm.-,- c,,-,g,.y~. w-v. ,,,,,,.,,--....,-.y.-,-.-,,-y.w.,,_m-g ,-,--e,w.,.,,,..,w,ymn
,,m.,,wm.r,y,,,,,,,,,_-.,-,,,-,w,,-,,,,,,.e,-
_ . _ _ _ __-- ____.___.m_______.__._____._____.__ _
i' CPS-0DCM .
Illinois Power company i l
, Clinton Power Station ,
OFFSITE DOSE CALCULATIO11 MAliUAL Tablen Ip@,lo Title PELQ 3.5-25 M Meat Pathway Factors - Raij (CilILD) 3-113 3.5-26 M Meat Pathway Factors - Raij (TEEll) 3-116 3.5-27 M
.- Meat Pathway Factors - Raij (ADULT) 3-119 '-
y 3.5-28 Vogotation Pathway Factors - Raij (Cl!ILD) 3-122 3.5-29 V Vogotation Pathway Factors - Raij (TEEll) 3-125 V ]
3.5-30 Vegetation Pathway Factors - Rali (ADULT) 3-128 3.5-31 G Ground Plane Pathway Factors - Ri 3-129 5.1-1 Radiological Environmental Mogitoring Program 5-4 ,
5.1-2 Reporting Levels for Radioactivity Concentrations 5-16 in Environmental Samplos 5.1-3 Detection capabilition for Environmental Sample 5-17 Analysis Lower Limit of Detection 5.1-4 Environmental Report (Operating Licenso Stage) 5-20 Table 6.1-8 Requirements 9.2-1 Gascous Effluent Releano Point Characteristics 9-15 i
CLIllToll-1 1X Rev,6-12/89
__.-_ _. . ..___. _ __ __.__ _ .- - ~ _ _ . _ _ _ _ _ . . _ _ - _ _ _ _ _
w ro ws n I Illinois Power Company I
Clinton Power Station
[
OFFSITE DOSE CALCULATION MANUAL
}
Finures !
T t
i Timtro Title Pace 2.1-1 Unrestricted Area Boundary For Liquid Effluents 2-10 !
2.5-1 Liquid Radwaste Treatment System t 2-23 !
, 2.5-2 Shutdown and Fuel Pool Heat Exchanger Service 2-24 1 Water Effluent Monitors 2.5-3 Solid Radwanto System Simplified Flow Diagram 2-25 i
3.1-1 CPS Site Boundary For Gaseous Effluents 46 !
3.3-1 Main Condenser Off-Gas Treatment System 3-47 5.0-1 REMP Locations Within 1 Mile of CPS b .
i 5.0-2 i i REMP Locationn 1 2 Miles From CPS 5-29 (
5.0-3 REMP Locations 2-5 Miles From CPS 5-30 .
5.0-4
.s % REMP Locations Greater Than 5 Miles From CPS 5-31 i, i
! I f
6 t
t i,
l i
f l i t
i i i i 6
i i
1 CLINTOH-1 x i Rev.6-12/89 {
i i
.-,_ ,m. _ . , _ - , , - , . _ _ , - . . , - . . . . . . _ _ . . _ . _ _ _ _ _ . _ _ . _ . , , . _ , _ . - . - . - - . . , . _ , _ _ . _ .. ,. ,. _ .-.-- - -,
CPS-ODCM List of Effective Panes Page Revinion Pnne Revir, ion Page Revision Paqo Egvision i 6 3-2 6 3-54 1 3-106 6 11 6 3-3 6 3-55 5 3-107 5 111 6 3-4 6 3-56 5 3-108 5 l iv 6 3-5 7 3-57 v 6 5 3-109 5 3-6 6 3-58 1 3-110 5 vi- 6 3-7 6 3-59 5 3-111 5 vii 6 3-8 6 3-60 5 3-112 5 viii 5 3-9 6 3-61 5 3-113 5 ix 6 3-10 6 3-62 1 3-114 5 x 6 3-11 6 3-63 1 3-115 6 xi 7 3-12 6 3-64 1 3-116 5
+ -
Xii 7 3-13 6 3-65 5 3-117 5 1-1 6 3-14 6 3-66 5 3-118 5 1-2 6 3-15 6 3-67 6 3-119 5 1 6 3-16 6 3-68 1 3-120 5 1-4 6 3-17 6 3-69 5 3-121 5 1-3 6 3-18 6 3-70 1 3-122 5 2-1 6 3-19 6 3-71 1 3-123 5
.2-2 6 3-20 6 3-72 5 3-124 6 l 2-3 6 3-21 3-73 5 1 3-125 5 2-4 6 3-22 5 3-74 1 3-126 5 2-5 6 3-23 6 3-73 1 3-127 5 2's- 6 3-24 1 3-76 1 3-128 5 2-7 6 3-25 3-77 2-0 6 5 3-129 5
? 3-26 1 3-78 5 3-130 5 L 2-9 6 3-27 6 3-79 5 3-131 5 2-10 5 3-28 6 3-80 5 4-1 6 h 2-11 6 3-29 6 3-81 5 4-2 6 L
2-12 6 3-30 6 3-82 S 5-1 6 2-13 6 3-31 6 3-83 5 5-2 6 s-14 6- 3-32 5 3-84 5 5-3 6 2-15 6 3-33 6 3-85 5 5-4 6 16 5 3-34 6 3-86 5 5-5 6 2 5 3-35 6 3-87 5 5-6 6 2-18 5 , 3-36 6 3-88 5 5-7 7 2 5 3-37 6 3-89 5 5-8 6 2-20 5- 3-38 6- 3-90 5 5-9 6 2-21 5 3-39 6 3-91 5 5-10 6 2-22 5 3-40 6 3-92 5 5-11 6 2-23: 6- 3-41 6 3-93 5 5-12 7
[2-24 6 3-42 6 3-94 6 5-13 6 2-25 5 3-43 6 3-95 5 5-14 6 2-26' 6 3-44 6 3-96 5 5-15 6 2-27 6 3-45 6 3-97 5 5-16 6 2 6 3-46 5 3-98 5 5-17 6 2-29 6 3-47 6 3-99 5 5-18 6 2-30 6 3-48 5 3-100- 5 5-19 6 2-31 7 3-49 5 3-101 5 5-20 7 2-32 6 3-50 5 3-102 5 5-21 7 2-33 6 3-51 5 3-103 5 5-22 -7 2-34 6 3-52 1 3-104 5 5-23 6 1 3-1 2 3-53 1 3-105 5 5-24 6 l
lCLINTON-1 xi Rev.7-2/91 r_
. . . . - . .. .- . - = - - - _ . . . . _ . - - - - - . . - . - - - - - . ~ . - . _ . . . - . . . . .
-. .. i f
i t
i List of Effective Paces l r
f.h32 Revision I i
5-25 i 6 '
5-26 6 5 t
5-27 6 -i l5-285-29 7 !
_ 6 I 5-30 7 5-31 7 6-1 6 l 6-2 6 !
6-3 6 6-4 6 fr 6-5 6 L
6-6 6 6-7 6 6-8 6 f*
. 6-9 -6 i
7-1 i 6 ',
7-2 6 ,
7-3 6 '
7-4 6 8-1 6 i 9 6
- i 9-2 6 1 9-3 6
- 9-4 7 i l9 -
6 .
9-6 6 I 9 6 r
9-8 6 '
9-9 6 9 6 3 9-11 6 I 9-12 6
{
9-13 6 i
9-14 6- !
9-15 6 !
f I
f i
l !
u ,
i i
CLINTON-1 xii Rev.7-2/91 e
't
.w-. e n ,- .,,u. ,._w , - .,... . , ...e., , ,,,-,-,r- - , , . - . - ,,- - . + - ,wg m.. ,, - , , , . . , , r, 3 , - - - , .
CPS-0DCM l
1.0 QDJERATION INFORMATION I I
PREFACE The Clinton Power Station OFFSITE DOSE CALCULATION MANUAL (CPS-ODCM)
' provides the methodologies and parameters to be used by Illinois Power Company (IPC) to assure compliance with the radioactivo effluent dose limitations stated in 10CFR20, 10CFRSO Appendix A (GDC60 and 64), 10CFR50 Appendix I, and 40CFR190.
The CPS-ODCM was prepared based on guidance provided in NUREG-0133, PREPARATION OF RADIOLOGICAL EFFLUENT '"ECHNICAL SPECIFICATIONS FOR NUCLEAR POWER PLANTS (October 1978), and NUREG-0473, RADIOLOGICAL EFFLUENT TECHNICAL SPECIFICATIONS FOR BOILING WATER REACTORS (Draft 7, to Revision 3). This manual along with station procedures will be used by CPS personnel to demonstrate compliance with the above reforonced Federal Regulations.
Changes to the CPS-ODCM shall be provided in the SEMIANNUAL RADIOACTIVE RELEASE REPORT.
1.1 Definitions The following terms are defined so that uniform interpretation of requirements of this manual may be achieved. The defined terms appear in capitalized type and shall be applicable throughout this manual.
i CHANNEL _ CALIBRATION '
1.1.1 A CHANNEL CALIBRATION shall be the adjustment, as necessary, l of the channel output such that it responds with the necessary range and accuracy to known values of the parameter which the channel monitors. The CHANNEL CALIBRATION shall encompass the entiro channel including the consor and alarm and/or trip functions, and shall include the CHANNEL FUNCTIONAL TEST. The CHANNEL CALIBRATION may be performed by any series of sequential, overlapping or total 4 channel steps such that the entire channel is calibrated.
CHANNEL CHECK 1.1.2 A CHANNEL CHECK shall be the qualitative assessment of channel behavior during operation by observation. This t
determination shall includo, where possible, comparison of the channel indication and/or status with other indications and/or status derived from independent instrument channels measuring the l same paramotor.
I CLINTON-1 1-1 Rev.6-12/89 L
7 CPS-ODCM CHANNEL FUNCTIONAL TEST 1.1.3 A CHANNEL FUNCTIONAL TEST shall bo:
i
- a. Analog channels - the injection of a simulated signal into the i channel as close to the sensor as practicable to verify li OPERABILITY, including alarm and/or trip functione and cha.onal failure trips. [
- b. Distable channels - the injection of a simulated signal into [
the sensor to verify CPERABILITY including alarm and/or trip i functions. !
The CHANNEL FUNCTIONAL TEST may be performed by any scrics of ,
sequential, overlapping or total channel steps such that the entire f channel is tested. !
FREOUENCY NOTATION fa 1.1.4 The FREQUENCY NOTATION specified for the performance of l surveillanco requirements shall correspond to the intervals defined }
in Table 1.1-1. [
i GASEOUS RADWASTE TREATMENT SYSTEM 1.1.5 A GASEOUS RADWASTE TREATMENT SYSTEM is any system designed !
and installed to reduce radioactive gaseous effluents by collecting ;
primary coolant system offgases from the main condenser evacuation l system and providing for delay or holdup for the purpose of reducing ;
,. the total radioactivity prior to release to tne environment. -
MEMBER (S) OF THE PUBLIC 1.1.6 MEMBER (S) OF THE PUBLIC_shall include all persons who are not ;
occupationally associated with the plant. This category doon not l include employees of the licensee, its contractors or vendors. Also i excluded from this category are persons who enter the site to :
service equipment or to make deliveries. This category does I include persons who uso portions of the oito for recreational, ;
occupational or other purposes not associated with the plant. ;
OPERABLE - OPERABILITY t
1.1.7 A system, subsystem, train, component or device shall be !
OPERABLE or have OPERABILITY when it is capable of performing'its l specified function (s)~and when all necescary attendant !
instrumentation, controls, electrical power, cooling or seal water, I lubrication or other auxiliary equipment that are required for the !
system, subsystem, train, component or device to perform its [
function (s) are also capable of perforning their related support i function (s). j i
I h
i
[
CLINTON-1 1-2 Rov.6-12/89 l t
i
CPS-ODCM ErMEDIAL REOUIREMENT 1.1.8 REMEDIAL REQUIREMENT shall be that part of a requirement which proscribes remodial measures required under designated conditions.
SITE DOUNDARY 2.1.9 The SITE BOUNDARY shall be that line beyond which the land is neither owned, nor leased, nor otherwise controlled by the licensee.
5MRCE CilE.G 1.1.10 A SOURCE CHECK shall be the qualitativo assonsment of channel responso when the channel sensor is exposed to a source of increased radioactivity.
, EFRESTRICTED AREA 1.1.11 An UNRESTRICTED AREA shall be any area at or beyond the SITE DOUNDARY accops to which is not controlled by the licensoo for purposes of protection of individuals from exposure to radiation and e- radioactivo natorials or any area within the SITE B0UNDARY used for residential quarters or for industrial, commercial, institutional, and/or recreational purpocos (sco riguro 2.1-1).
EFTILATION EXHAUST TREATMENT SYSTEM 1.1.12 A VENTILATION EXHAUST TREATMENT SYSTEM is any system designed and installed to reduce gaseous radioiodine or radioactivo material in particulato form in offluents by passing ventilat, ion or vont exhaust gases through charcoal adsorborn and/or HEPA filtors for the purpose of removing lodinos or particulatos from the gaseous exhaust stream prior to the release to the environment. Such a system is not considered to have any offect on noblo gas offluents.
Engincored Safety Teature (ESP) atmosphoric cicanup systems are not considered to be VENTILATION EXRAUST TREATMENT SYSTEM components.
The following systems are designated VENTILATION EXHAUST TREATMENT SYSTEMS:
- 1) Machino Shop HVAC (VJ)
- 2) Laboratory HVAC (VL)
- 3) Drywell purgo (VQ)
- 4) Radwasto Bldg HVAC (VW)
CLINTON-1 1-3 Rev.6-12/89
CPS-ODCM i 1.2 General coeration Renuirements 1.2.1 Compliance with the Operation Requirement contained in tho ;
succeeding requirements is required during the conditions specified ;
thereint except that upon failure to meet the Operation Requirement, !
the associated REMEDIAL REQUIREMENT shall be met. ;
l 1.2.2 Noncompliance with a requirement shall exist when tho ;
requirements of the Operation Requiremont are not mot and the (
associated REMEDIAL REQUIREMENT (s) is not mot within specified tino l limits or inter /als. ;
1.3 General Surveillance Rengirementn l 1.3.1 Surveillanco Requirements shall be met .during the applicabin conditions specified in and for the associated Operation Requireme t l l
unless stated in the individual Surveillance Requirement. i 1.3.2 Each Surveillance Requirement shall be performed within the l specified time interval with: ,
- a. A maximum allowable extension not to exceed 25% of the l; surveillance interval, but i
- b. The combined time interval for any three consecutive !
surveillance intervals shall not exceed 3.25 times the specified survoillance interval. !
1.3.3 Failure to perform a Surveillance Requirement within tho l specified time interval shall constitute a failure to meet the :
OPERABILITY requirements for a Operation Requirement. Surveillance f requirements do not have to be performed on inoperable equipment.
1.3.4 Entry into a specified system operating mode shall not be i made unless the Surveillance Requiremont(s) associated with the !
Operation Requiremont have been performed within the applicable !
surveillance interval or as othorvice specified. ?
i fr ff
.t i
t L
Y i
I r
CLINTON-1 \
1-4 Rev.6-12/89 ;
'I I
- - , . _ - - . ~ _ _ . . . _ _ _ . . _ . . _ , _ . _ , _ . ~ _ , _ . _ . . _ _ . _ . . _ - _ . _ _ _ . - . . . , _ __
CPS-ODCM TABLE 1.1:1 SURVEILI ANCE FREQUEECY NOTATION NOTATION EBEOUENCY S At least onco por 13 hours1.50463e-4 days <br />0.00361 hours <br />2.149471e-5 weeks <br />4.9465e-6 months <br />.
D At least once por 24 hours2.777778e-4 days <br />0.00667 hours <br />3.968254e-5 weeks <br />9.132e-6 months <br />.
W At least on'a por 7 days.
M At least onco por 31 days.
Q At least once por 92 days.
SA At least once por 184 days.
A At least once por 366 days R At least once por 18 months (550 days).
P Prior to each roloaco.
S/U Prior to each reactor startup.
NA Not applicable.
CLINTON-1 1-5 Rev.6-12/89
CPS-ODCM 2.0 LIOUID EFFLUENTg 2.1 Introduction Liquid radwasto offluent relea' sod from CPS will moet 10CFR20 concentration limits at the point of dischargo to the unrestricted area shown in rigure 2.1-1. This design and operation objective will be achieved at all times. Actual dischargos of liquid radwasto effluent _will occur on a batch basis and the averago concontration at tha point of discharge will normally be only a small percentage of the allowed limits. Rofer to Clinton USAR Section 11.5 for a description of radiation monitoring, sampling and effluent control systems.
Cemulativo quarterly doso contributions duo to radioactive offluents released'to the unrestricted area vill be determined onco overy 31 days using NUREG-0133 and Regulatory Guide 1.109 methodology and parametorc.
2.2 Licuid Radwaste pischarco Process Radiation Monitorina (PRM) System _
This monitoring subsystem measures liquid radwante effluent radioactivity prior to the effluent joining plant servico water and circulating water dilution streams. A high radioactivity signal from this gamma scintillation detector automatically terminatos the liquid radwasto offluent release. The liquid radwasto offluent flow, variable from 10-60 GPM or 50-300 GPM, combinos with Plant Servico Water flow (stinimum flow approximately 5000 GPM during plant shutdown periods depo.' ding on system loads) and Plant Circulating Water flow (0-567,000 GiM) in the Seal Well prior to entering the 3.4-mile dicchargo fiume to Lake Clinton (see Figure 2.5-1) .
2.2.1 Method of Representative Samnlina To obtain a representativo sample of the liquid radwaste tank to be discharged, the tank is isolated from all inputs and recirculated a minimum of_two tank volumes at which time a sample is obtained for isotopic analysis.
2.3 10CFR20 Releaso Rate Limits The Operation and Surveillanco Requirements pertaining to discharge i
of liquid radwasto effluent to the unrestricted area are specified in Section 2.3.1 as follows.
l CLINTON-1 2-1 Rev.6-12/89 t
I CPS-0DCM
. i 2.3.1 Liquid Effluent Concentration - Operation and Surveillance Requirements OPERATION REQUIREMENT The concentration of radioactivo material roloaced in liquid offluent to UNRESTRICTED AREAS (soo Figure 2.1-1) shall be limited to the concentrations specified in 10 CFR Part 20, Appendix B, Tablo II, Column 2 for radionuclidos other than dissolved or entrained noble gases. For dissolved or entrained noble gaces, the concontration shall be limited to 2 x 10~
activity. This requiremont applies duringmicrocuries/ml total all releases via this pathway.
REMEDIAL REQUIREMENT:
With the concentration of radioactive material released in liquid offluents to UNRESTRICTED AREAS excooding the abovo limits, l immediately restore the concentration to within the above limits.
i SURVEILIANCE REQUIREMENTS 2.3.1.1 Radioactive liquid vastos shall be sampled and analycod according to the sampling and analysis program of Table 2.3-1.
2.3.1.2 The results of the radioactivity analysos shall be used in y ,s acc7rdance with the methodology and paramotors of Section 2.3.2 to assure that thosconcentrations at the point of release are maintained within the limits of the abovo operation Requirement.
l l
CLINTON-1 2-2 Rev.6-12/89
CPS-CDCl4 ,
I RBLE 2. b ),
i RADIOACTIVE L10VID VASTE SAMPLING AND ANALYSIS PROGRAM I LOWER LIMIT MINIMUM l or DETECTION l LIQUID RELEASE SAMPLING ANALYSIS TYPE TYPE OF ACTIVITY (LLD)a j FREOUENCY FREOUENCY ANALYSIS (uC1/d L.
A. Batch Vaste P P f Releage Each Batch Each Batch Principal camma 5x10*7 Tanks ;
Emitterse t I
i 1 131 1x10 6 P M Dissolved and 1x10-5 l
.. One Batch /M Entrained Cases l (Gamma Emitters) !
i t
P H.3 Q 1x10 5 :
Each Batch Composite d i
Gross Alpha 1x10'7 s f P Sr-89, Sr-90
' Q 5x10*8 Each Batch Composite d Fe 55 1x10-6 [
i i
I I
l!
i i ,
i o
i CLINTON-1 2-3 Rev.6-12/89 [
t t
CPS-0DCM
- TABLE 2.3-1 (Continued) i RADIOACTIVE LIOUID WASTE SAMPLING AND ANALYSIS PROGR13 1 ,
TABLE __ NOTATIONS aT he LLD is defined, for purposes of these requirements, as the smallest concentration of radioactive material in a sample that will i i
yield a net count, above system background, that will be detected ;
with 95% probability with only 5% probability of falsely concluding that a blank observation represents a "real" signal. [
i For a particular measurement system, which may include radiochemical i separation: "
LLD =
4.66 sb '
E x V x 2. 22 x 106 x Y x exp (-Aat' Where: '
LLD is the "a priori" lower limit of detection as defined above, as microcuries per unit mass or volume, !
sb is the standard deviation of the background counting rate or of c
the counting rate of a blank sample as appropriate, as counts per {
=
minute. *
' I E is the counting efficiency, as counts por disintegration, i V is the sample size in units of mass or volume, !
2.22 x 106 is the number of disintegrations per minute per !
microcurie, -
l Y is the fractional radiochemical yield, when applicable, I Ais,}heradioactivedecayconstantfortheparticularradionuclide f (sec ) and at for plant effluents is the elapsed time between the midpoint of !
cample collection and the time of counting (sec). '
Typical values of E, V, Y and' at should be used in the calculation. -I It should be recognized that the LLD is defined as an A priori (before the fact) limit representing the capability of a measurement system and f not as an a posteriori (after the fact) limit for a particular measurement.
i r
l CLINTON-1 2-4 Rev . 6-127 8 9 i
_ . - _. . _ . . . . . . _ _ _ _ , ___.__.___._________-___.._m _ ___
i CPS-ODCM t r
1 TABLE 2.3-1 (Continting), !
RADIOACTIE LIOUID WAS.TE SAMPLIliG AMD AllALYSIS PROGRAM i t
TABIf liOTATIO118 (Continued) !
b I A batch release is the discharge of liquid wastes of a discrete volume. I Prior to sampling for analyses, each batch chall be isolated and then j thoroughly mixed by the method described in Section 2.2.1 to assure representative sampling. ,
c
- The principal gamma emitters for which the LLD requirement applies includeCs-134, Mo-99, the following Cs-137, radionuclides:
and Co-141. Mn-54, Fe-59, Co-58, Co-60, Zn-65, !
with an LLD of 5 x 10~ Co-144 shall also be measu*ed, but Th'is list does not mean that only these nuclides are to be detected and reported. Other gamma peaks that are measurable, together with those of the above nuclides, shall also be analyzed and reported in the Semiannual Radioactive Effluent Release Report pursuant to Technical Specification 6.9.1.7 in a format t outlined in Regulatory Guide 1.21, Appendix B, Revision 1, June 1974. {
d l A composite sample is one in which the quantity of liquid sampled is proportional to the quantity of liquid waste discharged and in which f the method of sampling employed results in a specimen that is ;
representative of the liquids released. ;
i s
{
i I
l s
t i
i i
~!
i f
h CLI!!TOli-1 2-5 Rev.6-12/B9 I I
.f*
CPS-ODCM To comply with the above requirements, setpointo will be calculated to assure that Seal Well concentrations do not exceed 10CFR20, Appendix B, Tablo II, Column 2 values at any time.
2.3.2 Licuid Radwaste Discharce PRM Sotnointo To comply with the Operation Requirements of Section 2.3.1 and Section 2.7.1, the alarm / trip setroints for liquid effluent monitors and flow measurement devices are seg to assure that the following equation is satisfied:
l 4
ef 5 Cgpc F+f (1)
Cgpc =
the effluent concentration limit (Section 2.3.1) implementing 10CFR20 for the site, corresponding to the specific mix of radionuclides in the effluent stream being considered, in pCi/ml c =
the setpoint, in pCi/ml, of the radioactivity monitor measuring the radioactivity concentration in the effluent
' line prior to dilution and subsequent
' reloase; the setpoint is inversely proportional to the volumetric flow of the effluent line and proportional to the volumetric plus the efflu'ont stream.
flow of the dilution stream (s)
F =
the dilution water flow setpoint as determined at the Seal Well, in volume per unit time f =
The liquid radwaste discharge flow setpoint as determined at the liquid radwacte discharge PRM locatien, in volume per unit time (same units as F)
The available dilution water flow (F) should be constant for a given release, and the liquid radwaste tank discharge flow (f) and monitor setpoint (c) are set to meet the condition of equation (1) for a given effluent concentration (CgpC). The method by which tb..s is accomplished is illustrated in sections 2.3.2.1 t o: iugh 2.3.2.5.
CLINTON-1 2-6 Rev.6-12789
._ ~ , . _ , . _ _ _ _ _ . _ _ _ _ _ _ _ _ _ _ _ _ _ . . _ . . _ _ _
_ _ . _ . . _ _ _ _ _ . . _ _ _ _ _ _ _ . _ _ _ . _ . _ . ____m . _ . _ _ _ _ _ _ _ _ _ _ _ _ _ _
t t
CPS-0DCM ,
i t
2.3.2.1 The isotopic concentration for a liquid radwante tanh !
to be discharged is obtained from the sum of the measured concer,trations as determined by the analyses required in Table 2.3-1 !
E1Ci = EggC +IaCa+EcCs+C T +Cre , pCi/ml i
(2) {
, where ECgg i
= The sum of concentrations Cg of each i
' measured gamma emitter g (including I-131) r observed by gamma spectroscopy of the vasto sample, j
. pCi/ml. f IaCa = The sum of concentrations Ca of alpha emitters (a) in liquid radwaste as measured in the most current ;
QUARTERLY composite discharge tank sample, pCi/ml. '
, Isc s = The sum of concentrations Cs of Sr-89/Sr-90 in liquid -
radwaste as observed in the most current QUARTERLY !
composite dischargo tank samplo, 4Ci/ml. !
t CT = The measured concentration of H-3 in liquid radwaste l as determined from analysis of the most current !
QUARTERLY composite discharge tank samplo, 4Ci/ml. l Cro = The measured concentration of Fe-55 in liquid i n.
radwaste as observed in the most current QUARTERLY {
composite dischargo tank campla, 4C1/ml. !
2.3.2.2 r The measured radionuclide concentrations are used to calculate a DILUTION FACTOR (DF) which is equivalent to the ratio of total dilution flow rate to liquid radwasto tank effluent flow rato required to assure {
that the limiting concentrations-of 10CFR20, Appendix ;
B, Table II, Column 2-are met at the point of dischargo to the unrestricted area. {
DF = ), dimensionless
- S F [ ECi (3) e MPC
=
SF [ ICg 4 ECa + ECs + CT + Cre )
9MPC g agpC a MPCs hPCyc MPCT where EC i = The measured concentrations Cg , v C,
a C g, C T'
{
C pe as defined in equation (2), Ci/ml. r f
I i
j CLINTON-1 2-7 Rev.6-12789 :
h L F t
CPS-0DCH MPC i = The limiting concentration of the corresponding radionuclide MPC , MPC , MPC., MPC T' MEC from 10CFR20, Appendik D, T$blo I , Column 2,ropC1/ml.
For dissolved or entrained noble gases, the concentration shall be limited to 2E-04 pC1/ml total activity.
SF = The conservative SAFETY FACTOR normally applied to compensato for statistical fluctuations and measuromont errors, dimensionless.
2.3.2.3 The maximum permissible liquid radwasto tank offluent flow rato, F tank, is calculated by the following equation:
Ftank = 0.9 (Fdil + Itank), volumo/timo (4)
DF where Fdil = Minimum expected dilution water flow rato (Circulating and/or Service Water systems),
volume /timo ftank = Maximum expected 11guld radwaste tank offluent flow rato, volumo/timo 0.9 = Flow rato correction factor to provido a 10% margin i
for variations in flow rates, dimensionless DF = The DILUTION FACTOR calculated by equation (3),
dimensionless Equation (4) is valid only for DF21; for DF<1, the liquid radwasto tank offluent concentration moots the limits of 10CTR20 without dilution and thorofore Ftank may assume any value not to exceed dischargo pump capacity.
2.3.2.4 The liquid radwasto dischargo PRM sotpoint may now be speciflod based on the values of riCi (Eq.2) and F tank (Eq.4) which were determined to provido compliance with the concentration limits of 10CFR20, Appendix B, Tablo II, Column 2. The monitor response is primarily a gamma responso and the actual sotpoint is therefore based on ECaa (Eq.2). The monitor sotpoint, in counts por minQto (cpm), which corresponds to the particular sotpoint concentration, C g, is dotormined based on monitor calibration data or operational data which correlatos monitor response to samplo analyson associated with the actual liquid radwasto discharged.
The second method is considered valid only if the integrity of laboratory methods of determination are proven more accurate than the mci,itor data.
CLINTON-1 2-8 Fav.6-12/89
i CPS-ODCM l
The set point concentration, C g, is obtained by the following equation:
Cg
- (Ftank) ECg g, pCi/ml (S) f act whero fact = The actual liquid radwanto offluent flow rato, volume / time l
If (Ftank/ fact)21, the value obtained for Cg is used to datormino the monitor sotpoint abovo background, ccpm, from either of the two methods described above.
In the case whero (Ftank/ fact)<1, n roloano may be made using the existing diachargo parameter values .
(DF, F tank, fact)*
The sotpoint concentration is conservativo, even if F ta is attainable, since the calculated flow rate conEkains the SAFETY FACTOR, dilution flow rate and liquid radwasto tank effluent flow rato margins, 2.3.2.5 To provent spurious alarms, rovi. . the Plant Service Water Effluent PRM sotpoint to coincido Pith the sotpoint concentration, C calculated by equation (5).
Thisnotpointisvalidon$y,duringperiodsofactual liquid radwasto discharges.
l L
l l
CLINTON-1 2-9 Rev.6-12/89 l
1 CPS-GDCM
,, e . e :' i w$IEIE i 2."E : :
. . :j t e ee :
a.g
- r
- . != = 5
=iar ;; ig;i 2
- : -2;3
!=o .3 -:
a.
'- 4
=!
o
! : "a "i;ge: i IEi ;:
2: n-Eg. :: != s: 0 05".3;t":i' 5e ;"" J E i 5 3 :: g
- ::la:
a2 o o.
- ==
3 E53"U 3.t;$$$ is!!s ,s : -
E 3a iggjj!.E
- [g:3
.~.
-a.m o,. u. ,: .
- Eis05 Og:15E r
C + P E 5 5 e
~
a u 'N s
E 1..:
A ce *
-e c 6 %
6 7 s
< h-= .
o o
5
% +9^ '
EE <
3"; E,.5. _ 3 .
i ." I
. E 3
S 8 C '
!5, :
ic- .
N N
%[' .
i$ I" $Q Nh
\/
3 5 a
l 1
I r
+
s
'l i
CLINTON-1 2-10 :
Rev.5-2/89 :
L E
CPS-0DCM 2.3.3 Plant Service Water Ef fluent PRM Setnoints Plant service water effluent continuously releases to the Seal Well where it mixes with circulating water effluent (if present) prior to entering Lake Clinton via the 3.4 mile discharge flume, i The plant service water effluent is not considered a radioactive discharge pathway unless liquid radwaste discharges are in progress or any service water cooling load heat exchanger has been detected as failed. To ensure that Plan: Service Water intersystem leakage has not occurred, weekly Service Water effluent grah samplos will be obtained (when in service) and analyzed to determine the identity and quantity of principal
, gamma-emitting radionuclides. In addition, a quarterly composite of positive grab samples will be analyzed to determine the quantity of H-3, Sr-89, Sr-90, Fe-55 and gross alpha species released. The analytical Lower Limit of De tection (LLD) for these analyses are specified in Table 2.3-1.
+
If the weekly grab campic analysis indicates the absunce of contamination above background, the Plant Service Water effluent PRM setpoint shoul* be established as close to background as practical to prevent spurious alarms, and yet assure an alarm should an inadvortent release occur, If the weekly grab sample analynis indicates the presence of contamination above background, PRM setpoints wi.1 be .
~
established following section 2.3.2 methodology as follows:
< 2.3.3.1 Pdbform section 2.3.2.2, solving equation (3) for DF using the appropriato values in the concentration term from the grab cample analysis.
2.3.3.2 A modified dilution factor, DF , nmust be determined so that available dilution flows may be apportioned nmong simultaneous discharge pathways. The modified dilution factor is defined as:
DFm = DE (6)
F3 where Fx is an administrativo allocation factor which may be assigned any value between 0 and 1 under the condition that E
n (F3)n 8 1 *
(7) 1 and whero n = the number of liquid discharge pathways for which DF ti and which are planned for simultaneous release. For simplicity, Fg may be assigned the value 1/n. Calculate F in equation (4) by substituting the value of DF forbhnkand perform the calculation specified in section 3.3.2.4 to determine flow rate and PRM setpoints.
CLINTON-1 2-11 Rev.6-12/89
_ _ - - _ _ _ _ _ ~ _ _ _ _ __ _ __ . __ _ ___ _ _ _ __ _ _ __ _ - _ . _ _ _ . _ _ _ _ _ _ . =
CPS-CDCM 2.3.4 Shutdown Service Water (SX) Effluent PRM Sotpoints j
Shutdown Servico Water, when initiated, is a potential i continuous radioactive diccharge pathway to the Ultimate Heat l Sink (UHS) (see Figure 2.5-2). The SX offlucr.t is not ;
considered a radicactive dischargo pathway unless any SX cooling!
load heat exchanger has boon detected as failed. SX effluent t compling, analysis and setpoint establishment will be performed as discussed for the Plant Servico Water system in Section '
2.3.3.
L 2.3.5 Fuel Pool Heat Exchangor Service Water Effluent PRM Setpoints l
The Fuel Pool Heat Exchanger Servico Water is 'ormally supplied by the component Cooling water (CCW) syster
, closed loop system). The CCU system rejects heat loads to th< Plant Service i Water system where intersystem leakage would be de:ected as !
described in section 2.3.3. The Fuel Pool Heat Exchanger '
Service Water offluant is considered a potential radioactive discharge pathway when SX replaces CCW as the heat sink for the j{
fuel pool heat exchangors. To account for a potential batch l release of CCW radioactivity to the Ultimate Heat Sink via SX, ;
CCW will bo sampled and analyced as discussed in section 2.3.3. t The analysis results will then be used to establish Fuel Pool ,
Heat Exchanger Service Water PRM and flow rate setpoints '
following Section 2.3.3.1 and 2.3.3.2 methodology.
+"
Any releases of radioactivity to the environment from the Plant Service Water (except during liquid radwaste dischargos), ;
Shutdown Service Water or Puel Pool Heat Exchanger Service Water i Systens are considered abnormal events. Such events will be '
accounted for as unplanned releases in the SEMIANNUAL ;
RADIOACTIVE EFFLUENT RELEASE REPORT. i P
i i
i L
CLINTON-1 2-12 Rev.6-12/B9
-CPS-ODCM 2.4 10C7RSO, Annendix I Release _ Rate Limits The Operation and Surveillance Requirements concerning 10CFR50, Appendix I Release Limits are specified in section 2.4.1 as fol?.ows.
Dose calculations for ensuring compliance with these limits are discusse~d in section 2.4.2.
2.4.1 10CFR50, Requirements Appendix I Release Rate Limits - Operation and Surveillance OPERATION _ REQUIREMENT
, The dose ar dose commitmbnt to a MEMBER OF THE PU3LIC from radioactive materials 2.1-1) shallin li 11d effluents released to UNRESTRICTED AREAS (see Figure be limited:
a.
- Du;2ng any calendar quarter to less than or equar to 1.5 mrems to the total body and to less than or equal to 5 mrems to any organ, and b.
During any calendar year to less than er equal to 3 mrems to the total body and to less than or equal to 10 mrems to any organ.
This requirement applies at all times.
REMEDIAL REOUIREMEl!T:
a.
With liquidthe calculated effluents dose from excecling any of thethe release aboveoflimits, radioactive materials in prepare and submit-to the Regional Administrator of the Regional Office of the NRC within *
-30 days a Special Report that identifies the cause(s) for exceeding the limit (s) and defines the corrective actions that have been taken to r3 duce the releases and the proposed corrective actions to be taken to aboveassure that subsequent releases will be in compliance with the limits.
_ SURVEILLANCE REOUIREMENTS 2.4.1.1 Cumulative dose contributions from liquid effluents for the current calendar quarter and the current calendar year shall be determined in accordance with the methodology and parameters described in Section 2.4.2 at least once por 31 days.
CLINTON-1 2-13 Rev.6-12/&9 ,
~
CPS-ODCM
-2.4.2 Discussion 2.4.2.1 The dose contribution to the maximum exposed individual from all radionuclides identified in liquid effluenta released to the unrestricted area is calculated as follows:
D3=Ei A i$1]platyC i1F 1, mrem (8) where i
Dj = The' cumulative calendar quarter or yearly dose to any {
organ j from liquid effluent for the total release period, mrem t1 = The length of the lth release time period over which Ciy and F1 are averaged for liquid' releases, hours !
= Liquid Radwaste Tank Volume / Liquid Radwaste Discharge Flow Rate C41' = The averago concentration of nuclide i in undiluted liquid effluent during release period at t for any liquid release, pCi/ml
- 1 = The near field average dilution factor for C 11 during
- '^ any liquid effluent release, dimensionless. Defined as the ratio of the average undiluted liquid radwaste flow
'during the release, to the product of the average flow from the discharge structure (during the reporting period, i.e., quarter or year) to the unrestricted receiving water and Z
= Averace Undiluted Licuid Waste Flow (9)
(Average Discharge Structure Flow)Z Z
= The applicable dilution factor for Lake Clinton, dimensionless
= 1.0 A ij = The composite ingestion dose commitment factor for the total body or critical organ of an ADULT for radionuclide 1, mrem /hr per gCi/ml
=K o U y + U gBF i ' DF i (10)
Uw CLINTON-1 2-14 Rev.6-12/89
'aPS-ODCM '
wherc Ko A units conversion factor, 1.14 E+0S pCi-ml-yr/uCi-liter-hr [
i
=
(1.0E+06 oCi/uCli(1.0E+03 ml/3 iter) ?
8760 hr/yr !
Uw -!
= Annual water consumption by the maximum adult, 0
, liter /yr Dy i
= Dilution factor from the near field area to the nearest ,
potable water intake, 1.0 -
Uf = Adult fish consumption rate, 21 kg/yr (Table E-5 of (
i BF i = Bioaccumulation factor for radionuclide i in fish, '
pCi/kg per pCi/ liter (Table 2.4-2 taken from Table .i A-1 of Regulatory Guide 1.109)
DF i = Adult ingestion dose conversion factor for radionuclide !
i, total body or critical organ, mrom/pci (Table 2.4-3 taken from Table E-11 of Regulatory Guide 1.109) ,
Table (10).
2.4-1 contains values for Ai$ as calculated by equation
- i The quarterly limits specified in the OPERATION REQUIREMENT at '
the beginning of this section represent one-half of the annual design objective of Section II.A of 10CFR50, Appendix I. ;
P i
r
?
i
, i CLINTON-1 2-15 '
Rev . 6-12 / 8-9 l
I i
i
CPS-ODCM TABLE 2.4-1 ADULT INCESTION DOSE COMMITMENT FACTORSt - A j ;
(mrem /hr per pCi/ml)
ISOTOPE BONE LIVER T< BODY Tin?OID KIDNET LUNG GI-LLI H3 NO DATA 2,26E 01 2.26E 01 2.26E-01 2.26E 01 2.26E 01 2.26E 01 C 14 3.12E+04* 6.24E+03 6.24E+03 NA 24 6,24E+03 6.24E403 6,24E+03 6.24E+03 4.06E+02 4.06E+02 4.06E+02 4.06E+02 4.06E+02 4,06E+02 4.06E+02 P 32 1.39E+06 8.62E+04 5.36E+04 NO DATA NO DATA NO DATA 1.56E+05 CR 51 NO DATA NO DATA 1,27E+00 7.60E 01 2.80E 01 1.68E+00 3,20E+02 MN-54 NO DATA 4.37E+03 8,34E+02 NO DATA 1,30E+03 NO DATA 1.34E+04 MN 56 NO DATA 1,10E+02 1,95E+01 NO DATA 1.40E+02 NO DATA 3.51E+03 FE-55 6.57E+02 4.54E+02 1.06E+02 NO DATA NO DATA 2.53E+02 2.60E+02 FE-59 1.04E+03 2.44E+03 9.34E+02 NO DATA NO DATA 6.81E+02 8.13E+03
-CO 58 NO DATA 8,90E+01 2.00E+02 NO DATA NO DATA NO DATA 1.80E+03 CO-60 NO DATA 2.56E+02 5,64E+02 NO DATA NO DATA NO DATA 4.80E+03 NI 63 3.11E+04 2.15E+03 1.04E+03 NO DATA NO DATA NO DATA 4.49E+02
- NI 65 1,26E+02 1.64E+01 7,48E+00 NO DATA CU 64 NO DATA NO DATA 4,16E+02 NO DATA 9.97E+00 4.67E+00 NO DATA Z:4 65 2.51E+01 NO DATA 8.48E+02 2.31E+04 7.36E+04 3.33E+04 NO DATA 4.92E+04 NO DATA 4.64E+04 ZN 69 4,92E+01 9,42E+01 6.55E+00 NO DATA 6.12E+01 NO DATA 1.41E+01 BR-83 NO DATA NO DATA 4.03E+01 NO DATA NO DATA NO DATA 5.81E+01 BR 84 NO DATA NO DATA 5.23E+01 NO DATA NO DATA NO DATA 4.10E-04 BR-85 NO DATA NO DATA 2.15E+00 NO DATA NO DATA NO DATA LT E-15**
RB 86 NO DATA 1,01E+05 4.70E+04 NO DATA NO DATA NO DATA 1.99E+04 RB-88 NO DATA 2.89E+02 1,53E+02 NO DATA NO DATA NO DATA 4,00E 09 RB 89 NO DATA 1,92E+02 1,35E+02 NO DATA NO DATA NO DATA 1,11E 11 SR-89 2.21E+04 NO DATA 6.34E+02 NO DATA NO DATA NO DATA 3.54E+03-
. SR 90 '5.43E+05 NO DATA 1.33E+05 NO DATA NO DATA NO DATA 1.57E+04 SR 91 4.06E+02 NO DATA 1.64E+01- NO DATA NO DATA NO DATA 1.94E+03 SR-92 1.54E+02 NO DATA 6.67E+00 NO DATA NO DATA NO DATA 3.05E+03 Y 90' 5.75E-01 NO DATA- 1.54E-02 NO DATA NO DATA NO DATA -6.10E+03 CLINTON-1 2-16 Rev.S-2/89
. . . . _ _ _ _ . . - - _ . . _ _ . . . _ _ m _ __ . _ __ _ _ _ __- ... _ _
CPS-ODCM
. TABLE 2.4-1 (continuedi ADULT INGESTION DOSE COMMITMENT FACTORS Ai j ,
(mrem /hr per pCi/ml)
ISOTOPE BONE LIVER T. BODY THYROID RIDNEY LUNG GI-LLI
~~
Y-91m- 5.43E-03 NO DATA 2.10E 04 NO DATA NO DATA NO DATA 1.60E-02 Y 8.42E+00 NO DATA 2.25E 01 NO DATA NO-DATA NO DATA 4.64E+03 Y 92 5.05E-02 NO DATA 1.48E-03 NO DATA NO DATA NO DATA 8.84E402 Y-93 1.60E 01 NO DATA 4.42E-03 NO DATA NO DATA NO DATA 5.08E+03 ZR-95 2.40E-01 7,69E 02 5.20E-02 NO DATA 1.21E 01 NO DATA 2.44E+02 ZR 97 1.32E-02 2.67E 03 1.22E 03 NO DATA 4.04E-03 NO DATA 8.28E+02 NB-95 4.46E+02 -2.48E+02 1.33E+02 NO DATA 2.45E+02 NO DATA 1.51E+06 MO-99 NO DATA 1.03E+02 1.96E+01 NO DATA 2.33E+02 NO DATA 2.39E+02 TC 99m 8.86E 03 2.50E 02 3.19E-01 3.80E-01
. NO DATA 1.23E 02 1.48E+01 TC .J1 9.11E 03 1.31E 02 1.29E 01 NO DATA 2.36E-01 6. 70E-03 3,94 E RU-103 4.42E+00 NO DATA 1.90E+00 NO DATA 1.69E+01 NO DATA 5.16E+02 RU-105 3.68E-01 NO DATA 1.45E-01 NO DATA 4.7CE+00 NO DATA 2.25E+02 RU-106 6.57E+01 No DATA 8.32E+00 NO DATA 1.27E+02 NO DATA 4.25E+03
, , , AG-110m NO DATA NO DATA NO DATA NO DATA NO DATA NO DATA NO DATA TE-125m - 2.57E+03 9.28E+02 3.43E+02 7.70E+02 1.04E+04 NO DATA 1.02E+04
'TE-127m 6.47E+03 2.31E+03 7.89E+02 1.65E+03 2.63E+04 NO DATA 2.17E+04 TE 127 1.05E+02 3.77E+01 2.28E+01 7.79E+01 4.28E+02 NO DATA 8.30E+03 TE 129m 1.10E+04 4.10E+03 1.74E+03 3.78E+03 4.59E+04 NO DATA 5.54E+04 TE-129 3.00E+01 1.13E+01 7.31E+00 2.30E+01 1.26E+02 NO DATA 2.26E+01 TE-131m 1.65E+03 :8.09E+02 6.74E+02 1.28E+03 8.19E+03 NO DATA 8.03E+04 TE-131 1.88E+01 7.87E+00 5.95E+00 1.55E+01 8.25E+01 No DATA 2.67E+00 TE 132. 2.41E+03 1.56E+03 1.46E+03 1.72E+03 1.50E+04 NO DATA 7.37E+04 I 130 2.71E+01- - 7 99E+01 3.15E+01 6.78E+03 1.25E402 NO DATA 6.88E+01 I-131 1.49E+02 2.13E+02 1.22E+02- 6.99E+04 3,66E+02 NO DATA 5.63E+01 l I-132 7.28E+00 1.95E+01 6.81E+00 6.81E+02 3.10E+01 NO DATA 3.66E+00 I-133 5.09E+01- 8.85E+01 2,70E+01 1.30E+04 1.54E+02 NO DATA 7.96E+01 I-134 3.80E+00- 1.03E+01 3.69E+00 1.79E+02 1.64E+01 NO DATA 9.00E-03 l
l CLINTON-1 2-17 Rev.5-2/a9
-- - - . - . . - . . - . ~ - - - . - - . - . _
CPS-ODCM.
TABLE 2.4 1 (continued)
ADULT INGESTION DOSE CO!tJ1ITMENT FACTORS i- A j (mrem /hr per 4Ci/ml)
ISOTOPE BONE LIVER T.PODY THYROID MIDNEY LUNG GI LLI I-135 1.59E+01 4.16E+01 1.53E+01 2.74E+03 6.67E+01 NO DATA 4.70E+01 CS-134 2.97E+05 7.07E+05 5.78E+05 NO DATA 2.29E+05 CS 136 3.11E+04 7.60E+04 1.24E+04 1.23E+05 8.84E+04 NO DATA 6.84E+04 9.37E+03 1,40E+04 CS 137 3.81E+05 5.21E+05 3,41E+05 NO DATA 1.77E+05 CS 138 2.64E+02 5.88E+04 1.01E+04 5.21E+02 2.58E+02 NO DATA 3.83E+02 3.78E+01 2.22E 03 BA-139- 9.29E 01 6.60E-04 2.72E 02 NO DATA 6.18E 04 3.75E 04 1.65E+00 BA-140 1.94E+02 2.44E-01 1.27F+01 NO DATA 8.29E-02 EA 141 4.50E 01 1.40E-01 4.00E+02 3.40E 04 1.52 02 NO DATA 3.16E 04 1.93E-04 2.12E 10 BA-142 2.04E 01 2.09E-04 1.28E-02 NO DATA 1.77E-04 1.18E-04 2.89E 19 LA-140 1.49E 01 7.53E 02 1,99E-02 NO DATA NO DATA LA-142 7.65E-03 No DATA 5.53E+03 3.48E-03 8.66E-04 NO DATA NO DATA NO DATA 2.54E+01
'CE 141 2,24E 02 .1.51E-02 1.72E 03 No DATA 7.03E 03 NO DATA 5.78E+01 CE-143 3.94E 03 2.92E+00 3.23E-04 NO DATA 1.28E-03 CE 144 -- 1.17E+00 NO DATA 1.09E+02 4.88E'01 6.26E-02 NO DATA 2.89E NO DATA 3.94E+02 PR-143 5.50E-01 2.20E-01 2.72E-02 NO DATA 1.27E-01 NO DATA 2.41E+03 PR-144 1.80E 03 7.47E-04 9.14E-05 NO DATA 4.21E-04 ND-147 3.76E NO DATA 2.59E-10 4.34E-01 2.60E-02 'NO DATA 2.54E-01 NO DATA 2.08E+03 W-187 2,95E+02 2.47E+02- 8.63E+01 NO DATA NO DATA NO DATA 8.09E+04 NP 239 2.84E-02 2.80E 03 1.54E 03 NO DATA 8.72E-03 NO DATA 5.74E+02
- 3.12 x 104 Less than 10-15 l l
CLINTON-1 2-18 Rev.5-2/89 ;
I
. _ _ . - . . .. .. =- . _ _ . . . _ _ _. - - _ . ._ _ __.;.
CPS-ODCM' '
i i
?
TABLE 2.4-2 f
1 BIOACCUMULATION FACTORS -BF i j (pCi/kg per pCi/ liter)
{
FRESHWATER ELEMENT l
_ FISH H 9.0E-01 C I 4.6E+03 }
Na
- 1.0E+02 ,
P 3.0E+03 Cr 2 OE+02 Mn j 4.0E+02 i Fe 1.0E+02 -!
Co 5.0E+01 Ni l 1.0Z+02 Cu S.0E+01 l Zn 2.0E+03 i Br 4.2E+02 '
Rb 2.0E+03 +
Sr 3.0E+01
- Y 2.5E+01 ;
Zr- 3.3E+00 Nb l 3.0E+04 i Mo 1.0E+01 -l Tc 1.5E+01 Ru x !
s 1.0E+01 )
Rh 1.0E+01 1 Te 4.0E+02 I 1.5E+01 Cs 2.0E+03 Ba i 4.0E+00 !
La 2.5E+01 !
Ce -
1.0E+00 :
Pr 2.5E+01 Nd [
2.5E+01 W 1.2E+03 Np -1.0E+01 l
I i
l t
=
I CLINTON-1 2-19 Rev.5-2/89- !
i
-.. -.. ... . - - . - ~- .. - . . - . . - - , - . . - . - -- . - . _ _ . -
. CPS-ODCM TABLE 2.4-3 ADU1.T INGESTION DOSE FACTORS DFi (mrem /pCi ingested)
NUCl_IDE BONE -LIVER T. BODY THYROID -KIDNEY LUNG CI LLI
'H - 3 NO DATA 1.05E-07 1.05E 07 1.05E 07 1.05E-07 1.05E-07 1.05E 07 C 14 2.84E 06* 5.68E 07 5.68E-07 5.68E 07 5,68E 07 5.68E-07 5.68E 07 NA 24 -1.70E 06 1.70E 06
- 1. 70E- 0,6 1.70E 06 1.70E 06 1.70E 06 1.70E-06 P-32 1.93E-04 1.20E 05 7.46E 06 NO DATA NO DATA NO DATA 2.17E 05 CR 51 NO DATA NO DATA 2.66E 09 1.59E-09 5.86E 10 3.53E 09 6.69E 07 KN-54 NO DATA 4.57E 06 8.72E 07 NO DATA 1.36E-06 NO DATA 1.40E-05 MN-56 .NO DATA 1.15E 07 2.04E 08 FE-55 NO DATA 1.46E 07 NO-DATA 3.67E 06 2.75E 06 1.90E 06 4.43E 07 NO DATA FE 59 NO DATA 1.06E-06 1.09E 06
, 4.34E-06 1.02E 05 3,91E 06 NO DATA NO DATA 2.85E-06 3.40E CO-58 NO DATA 7.45E-07 1.b7E 06 NO DATA NO DATA NO DATA 1.51E 05 C0 60- NO DATA 2.14E 06 4 72E 06 NO DATA NO DATA NO DATA 4.02E 05
-N1 63 1.30E-04 9.01E 06 4,36E 06 NO DATA NO DATA NO DATA 1.88E-06 N1 65 5.28E 07 6.~86E 08 3.13E-08 NO DATA NO DATA NO DATA 1.74E-06 CU 64 NO DATA 8.33E 08 3.91E-08 ZN-65 NO DATA 2.10E 07 NO DATA 7.10E 06 4.84E-06 1.54E-05 6.96E 06 NO DATA 1.03E 05 NO DATA- 9.70E 06 ZN 69 1.03E-08 1.97E 08 1.37E-09 BR-83 NO DATA 1.28E-08 NO DATA 2.96E 09 NO DATA NO DATA 4.02E-08 NO DATA BR-84 NO DATA NO DATA NO DATA 5.79E 08 NO DATA 5.21E 08 NO DATA NO DATA NO DATA- 4,09E 13 '
BR 85 NO DATA NO DATA 2.14E-09 NO DATA NO' DATA NO DATA LT E 24**
RB-86" NO DATA 2.11E 05 9.83E-06 NO DATA NO DATA NO-DATA 4.16E 06 RB-88 NO DATA -6.05E-08 3.21E 08 NO DATA NO DATA NO DATA 8.36E 19 RB 89 NO DATA 4.01E 08 2.82E 08 NO DATA NO DATA NO DATA 2.33E-21 SR 89 3.08E-04 NO DATA 8.84E 06 -NO DATA NO DATA NO DATA 4.94E-05 SR-90 7.58E-03 NO DATA 1.86E-03 NO DATA NO DATA NO DATA 2.19E-04 SR 91 5.67E-06 NO DATA- 2.29E-07 NO DATA NO DATA NO DATA 2.70E-05 SR-92 .2.15E-06 NO DATA 9.30E 08 NO DATA NO DATA NO DATA 4.26E-05 Y-90 9.62E-09 NO DATA 2.58E-10 NO DATA NO DATA NO DATA 1.02E 04
'. CLINTON-1 2-20 Rev.5-2/89
. . 1
- . . - . . _ . - _ - . _ . - - .. - ._. . . _ _- . _ - _ _ ~.~,~ - -. .- .- -
- CPS-0DCM 2
TABLE 2.4 3 (continued)
- ADULT INGESTION DOSE FACTORS DF i (mrem /pCi ingested)
NUCLIDE BONE LIVER T. BODY THYROID }:IDNEY LUNG C1 LLI _
Y-91m 9.09E 11 No DATA 3.52E 12 NO DATA NO DATA NO DATA 2.67E 10 Y 91 1.41E 07 NO DATA- 3.77E-09 NO DATA NO DATA NO DATA 7.76E 05 Y 92- 8.45E-10 NO DATA 2.47E 11 NO DATA NO DATA NO DATA 1.48E 05 Y 93 2.68E-09 NO DATA 7.40E 11 NO DATA -NO DATA NO DATA S.50E 05 4
ZR 95 3.04E-08 9.75E 09 6.60E-09 NO DATA 1.53E 08 NO DATA 3.09E 05 ZR-97 1.68E 09 3.39E-10 1.55E 10 NO DATA 5.12E 10 NO DATA 1.05E-04 NB 95 6.22E-09 3.46E 09 1,86E 09 NO DATA 3.42E-09_ NO DATA 2.10E 05 MO 99- NO DATA 4.31E 06 8.20E-07 No DATA 9.76E-06 NO DATA 9.99E 06 '
TC-99m- 2.47E 10 6.98E-10 F.89E-09 NO DATA 1.06E 08 3.42E 10
. 4.13E 07 TC 101 2.54E-10 3.66E 10 3.59E 09 NO DATA 6.59E-09 1.87E-10 1.10E 21 RU 103 1.85E-07 NO DATA 7.97E 08 NO DATA 7.06E-07 NO DATA 2.16E 05 RU-105 1.54E-08 NO DATA 6.08E-09 NO DATA 1.99E-07 NO DATA 9.42E 06 RU 106- 2.75E-06 NO DATA 3.48E-07 NO DATA 5.31E-06 NO DATA 1.78E 04 A0-110m- 1.60E 07 1.4,8E 07 8.79E-08 NO DATA 2.91E-07 NO DATA 6.04E 05 TE-125m .2.6BE 06 9.71E-07 3.59E 07 8.06E-07 1.09E-05 , NO DATA 1.07E 05
- TE-127m 6.77E 06 2.42E-06 8.25E-07 1.73E 06 2.75E 05 NO DATA 2.27E 05 TE-127 1,10E 07 3.95E 08 2.38E-OS 8.15E-08 4.48E 07 NO DATA 8.68E-06 TE 129m 1.15E-05 4.29E-06 1.82E-06 3.95E-06 4.80E-05 NO DATA 5.79E 05 4
TE-129; 3.14E 08 1.18E 08 7.65E-09 2.41E 08 1.32E-07 NO DATA '2.37E 08 -
TE-131m. 1.73E-06 8.46E 07 7.05E-07 1.34E 06 8.57E-06 NO DATA 8.40E 05 TE-131 1.97E 08- 8.23E-09 6.22E-09 .1,62E 08 8.63E 08 N0' DATA 2.79E-09 TE 132 2.52E-06 ~ 1.63E 06, 1.53E-06 1.80E 06 1.57E-05 NO DATA 7.71E-05 I-130 7.56E 07_ 2.23E-06 8.80E 07 1.89E-04 3.48E 06 NO DATA 1.92E-06 I 131 -4.16E 06- 5.95E 06 3.41E-06 1.95E-03 1.02E 05 NO DATA 1.57E-06 I-132 2.03E-07 5.43E-07 1.90E-07 1.90E-05 8.65E-07 NO DATA 1.02E-07 I-133 1.42E-06 2.47E-06 7.53E-07 3.63E-04 4.31E-06 NO DATA 's2.22E 06 I-134- 1.06E-07 2.88E-07 1,03E 07 4.99E-06 4.58E-07 NO DATA 2.51E-10 l- .
-CLINTON-1 2-21 Rev.Se2/89 3
. . . . . . - . . ..-_- . ~ - = - - - - . . . - . - . _ - . - . . . _ _ - - - ~ . -.
CPS-CDCM .
TABLE 2.4-3 (continuedi ADULT INGESTION DOSE FACTORS DFt
(= rem /pci ingested-)
NUCLIDE BONE LIVrR T. BODY THYROID KIDNEY LUNG O I LL'I *__
1-135 4.43E-07 1.16E 06 4.28E 07 CS-134 7.65E 05 1.86E-06 NO DATA 1.31E 06 6.22E 05 1.48E-04 1.21E-04 1,59E 0$
CS 136 NO DATA 4.79E-05 2.59E 06 6.51E 06 2.57E-05 1.85E 05 NO DATA 1.43E-05 1.96E 06 2.92E 06 CS-137 7.97E 05 1.09E 04 7.14E 05 NO DATA 3.70E 05 1.23E 05 2.11E 06 CS-138 5.52E-08 1.09E-07 5.40E-08 NO DATA 8.01E-08 7.91E 09 4.65E 1.3 BA-139 9.70E 08 6.91E 11 2.84E 09 NO DATA 6.46E 11 3.92F-11 1.72E 07 w
BA-140 2.03E-05 %.55E 08 1.33E-06 NO DATA 8.67E 09 1.46E-08 4.18005 3A-141 4.71E-08 3.56E-11 1.59E 09 No DATA .3,31E 11 2.02E-11 2.22E 17 BA 142 2.13E-08 2.19E-11 1.34E-09 NO DATA 1.85E-11 1: 2' E-11 3.00E 26 LA<140 2.50E 09 1.26E-09 3.33E-10 NO DATA NO DATA NO DATA 9.25E 05 LA-142 1.28E-10 5.82E-11 1.45E 11 NO DATA NO DATA NO DATA 4.25E 07 CE-141 9.36E-09 6.33E-09 7.18E 10 NO DATA 2.94E 09 NO DATA 2.42E 05 CF-143 1.65E-09 1.225 06 1.35E-10 NO DATA 5.37E 10 NO DATA 4.56E-05 CE-144 4.88E-07 2.04E-07 2.62E-08 NO DATA 1.21E 07 NO DATA 1.65E 04 PR-143 9.20E 09' 3.69E 09 4.56E-10 NO DATA 2.13E 09 NO DATA ' 4.03E 05 PR-144 3.01E-11 1.2SE-11 ND 147 1.53E i2 NO DATA 7.05E-l2 NO DATA G.33E 13 6.'29E 09 7.27E-09 4.35E-10 W-187 NO DATA 4.25E 09 NO DATA 3.49E 05 1.03E-07 8.61E-08 3.01E 08 NO DATA NO DATA NO DATA 2.82E 05 NP-239 1.19E 09 1.17E 6.45E 11 NO DATA 3.65E 10 NO DATA 2.40E 05
- 2.84 X 10-06
- Less than 10-24 i
CLINTON-1 2-22 Rev.5-2'/89 l
l
l
~f i
FIGURE 2'. M
( !
t
. LIQUID RADWASTE TREATMENT SYSTEM - -
. i
~
p ~ . . . . 44 1 1 --- y i
- _ y llni '
e% C_ --
l
--P_.
4
~ ~ .
'a 1 :. mev . x .1 i e s owtov
- O 'x $'
+
m , r ' t U*=4==. -. - -n .9(
T j A W ):-
Mo"* i i
g,. as -
i H
\ takrJW
(.
- ^ g/ s ews
.y g
hs"
'~^ y
- ""* d +e,n -- :
l f
,3 .M :
-. er I I - . r a
w 1 -oo--
J v
A i
L p
w@ wm;
.. w O
e m oir ~m-x-"
4.x A
'p;
~cce ""
hig,.!
m; I e i
7 M * ;ma N
_.(
i .-
-y * *
gg , p;
( c.a s6 .
- n
%n i l l '\ '
u N
.? g c. laim
%g w -
l
- Monitors required by Section 2 7 lWF0lS Floor Drain-- OUZ0lP Chem. Ust. 2LT04T Floor Drain 0*JE02TA,B, and C Vaste Evaporator Evap. Tank Pump Evaporator Tank Samp. Tk Pu=ps 2WF0lS Floor Drain .QUE01FA,B und C 07Z01T Che=. Waste 00E0lTA and B Excess Ovaporator Waste Filters Evaporator Tank Water Tanks
'0W201S Chemical- OVE01DA,B, and C IkT04? Fir. Drn. OWE 0lPA and B Excess
'Jaste Evaporator Waste De= ins Evap. Tank Pu=p 7 Water Tank Pu=ps-
! 10F04T Floor Drain 00E02TA,B. and C -2WF04P Fir. Drn. IPR 036' Service l
,vaporator
l l
l CLINTON-1 2-23 Rev.6-12/89 l
CPS-ODCM FIGURE 2.5-2 SHUTDOWN AND FUEL POOL HEAT EXCIL1NGER SERVICE WATER EFFLUENT MONITORS I E *"', c I
= g:,,
11 ::0".,;;:.+
W' -= - m ai -4 ?-
- =,v :::: bm - :. ((
_. na ~ ~
- er t I J ="
r, y
.llllC::= : ^ -L"7' em
.nsa mres
~
=_ _
b :'::"# [
NEY,.
i )W
-e y t __
n=". M'~ -
Y'"
s N
NORMAL COOLING SL'PPLY - COMPONENT COOLING WATER EMERGENCY COOI!rfG SUPPLY - SHUTDOWN SERVICE WATER Monitorc required by Cection 2.7 1PR038 Shutdown rvice 1PR005 Fuel Pool Heat Water Efttuent "A" Exchanger Service Water PRM 1PR039 Shutdown Service 1PR004 Fuel Fool Heat Water Effluent "B" Exchanger Service Water PRM CLINTON-1 2-24 Rev.6-12/89
CPS-ODCl2 s Fiqure 2.5-3 offsite SOLID RADWASTE SYSTEf; Diarlal y i SIMPLIFIED FLOW DIAGRAff Nante Spent Domineralizer > Resin Tank y .
Pre-shipment Monitoring
/ A
/
Phase p Separator Dry ,
Radloactivo Wanto
> Ilydraulic Daler
% Storage A
FP/FD Sludge >
Tank Maste Sludae Tank > p vendor Sol.idificatlon Services Floor Drain Evaporator Bottoms > Concentrate Uaste Chemical > Tank Hasto Evaporator Dottoms CLIf1 Toff-l 2-25 Rev.5-2/89
d a+--n -n+wba--~4-- s> --~-e ~+A- - - 4 m A- -+~4- 0+e- em - -- =J n..b .--
CPS-ODCM l
2.5 Liquid Radwaste Treatment system 2.5.1 Liquid Radwaste Requirements Treatment System - Operation and Surveillance OPERATION REC &LLREMENT The liquid radwaste treatment system shall be OPERABLE. The appropriate portions of the system (Figure 2.5-1) shall be used to reduce the projected Figure 2.1-1) doses due to the liquid effluent to UNRESTRICTE (see organ in a 31-day period.would excebd 0.06 mrem to the total body or 0.2
. This requirement applies at all times. mrem to any REMEDIAL REOUTREMENT:
a.
With radioactive liquid waste being discharged without treatment and in excess of the above limits and any portion of the liquid radwaste _
Administrator of the Regional Office of the NRC within 3 Special Report that includes the following information:
1.
without treatment, Explanation of why liquid radwaste was being disch or subsystems, identification of any inoperable equipment and the reason for the inoperability.
2.
Action OPERABLE (s) taken status, to and restore the inoperable equipment to s
3.
Summary description of action (s) taken to prevent a recurrence.
SURVEILLANCE REOUTREMENTS 2.5.1.1 Doses due to liquid releases to UNRESTRICTED AREAS shall be and parameters described in Section 2.4.2. projected at least once pe 2.5.1.2 meeting the Operation Requirements of Section 2.3.1 and 2.4.1.Th l
2-26 Rev . 6-f2/ 8 9
CPS-ODCM ^
t i
2.5.2 Tenoorary Licuid Radwaste Hold-uc Tankg !
The use of temporary liquid radwaste hold-up tanks may occur at CPS. To comply with Technical Specification 3.7.7, the amount of liquid radwaste .
stored in such tanks shall be limited to 10 curies, excluding tritium and dissolved or entrained noble gases. In lieu of the 10 curie limit, the ;
methodology presented in Appendix B of NURiG-0133 (BWR-RATAFR code) will
. be used to establish the curie limit. !
f I
I i
i I
i 3
l 5
i x I v
i i
s I
i 1
i i
I i
i t
CLINTON-1 i 2-27 Rev.6-12/89 i
r
, , - ~ , .a..-r--. - - . , , ,a e
. . _. _ _ _ - _ _ - _ _ _ _ _ . ~ . _ _ . _ _ _ _ . _ . . _ _ _ _ _ . _ _ _ _ . _ _ - . -
. CPS-ODCM 2.6 Doses From Other Sionificant Licuid Effluent Pathways Section 2.4 of this manual is based upon the aquatic food and potable water exposure pathways only, othar exposure pathways, namely shoreline deposits and irrigated foods, may arise at Clinton Power Station and will be included in the section 2.4 dose contribution if they are likely to provide a significant contribution to the total dose. A pathway is considered significant if a conservative evaluation yields an additional dose increment equal to or more than 10 percent of the total from all l other existing pathways. Methods for calculating doses from other potentially significant liquid offluent pathways are presented in Appendix A to Regulatory Guide 1.109.
When it is determined that other liquid effluent pathways do exist, the Regulatory Guide 1.109 Appendix A equations and parameters will be used in lieu of site-specific data to determine a pathway's significance.
,.s r
CLIllTOli-1 2-28 Rev.6-12/89
CPS-ODCM 2.7 Radioactive Licuid Ef fluent Monitorina Instrumentation 2.7.1 Radioactive Liquid Effluent-Monitoring Instrumentation Operation and Surveilla,nce Requirements OPERATION REQUIRE!iENT ,
The radioactive liquid effluent monitoring instrumentation channels shown
- in Table 2.7-1 chall be OPERABLE with their alarm / trip setpoints set to ensure that the limits of Section 2.3.1 are not exceeded. The alarm / trip setpoints of these channels shall be determined and adjusted in accordance with the methodology and parameters described in Sections 2.3.2 through 2.3.5. This requirement applies during releases via the associated pathway.
REMEDIAL REOUIREMENT: ,
- a. With a radioactive liquid effluent monitoring instrumentation channel alarm / trip setpoint less conservative than required by the I ' above requirement, without delay suspend the release of radioactive liquid e.ffluents monitored by the affected channel, or declare the channel inoperable, or change the setpoint so it is acceptably conservative, b.
With less than the minimum number of radioactive liquid effluent monitoring instrumentation channels OPERABLE, comply with the REMEDIAL REQUIREMENT shown in Table 2.7-1. Restore the inoperable instruments to OPERABLI status within 30 days and, if unsuccessful, gr explain in the n. ext Semiannual Radioactive Effluent Release Report why the inoperability was not corrected in a timely manner.
gj(RVEILLANCE REQUIREMENTS 2.7.1.1 Each radioactive liquid effluent monitoring instrumentation control shall be demonstrated OPERABLE by performance of the CHANNEL CHECK, SOURCE CHECK, CHANNEL CALIBRATION and CHANNEL FUNCTIONAL TEST at the frequencies shown in Table 2.7-2.
l l
CLINTON-1 2-29
- Rev.6-12/89
. . . , . . . , - ~
i.
?
CPS-ODCM TABLE 2.7-l' rat)IOACTIVE LTOUID EFFLUEllT MONITORIliG I llS T R U M E N T A T I Ori
- MIllIMUM Ci!AN!!ELS REMEDIAL i OPERABLE REOUIREMEllT i
- 1. RADIOACTIVITY MONITORS PROVIDING ALARM AND AUTOMATIC ;
TERMINATION OF RELEASE
- a. Liquid Radwaste Disch,arge Process Radiation Monitor 1 (8) 1
- 2. RADIOACTIVITY MONITORS PROVIDING ALARM BUT NOT PROVIDIliG AUTOMATIC TERMINATION OF RELEASE I
a.
Plant Service Water.Effluant Process Radiation Monitor 1 I} 2
- b. Shutdown Service Water Effluent Process Radiation Monitor 1/ Division *I ) 2 t
- c. Fuel Pool Heat Exchanger Service Water Radiation Monitor I I ") 2
- 3. FLOW RATE MEASUREMENT DEVICES
- a. Liquid Radwaste Effluent Line 1 3.
- b. Plant Service Water Effluent Line 1 3
- 4. TANK LEVEL INDICATING DEVICES
- a. Cycled Condensate Storage 1 4 b '. Reactor Core Isolation Cooling Storage 1 4
- Division I and Division II only.
t I
CLINTON-1 2-30 Rev.6-12/89
. __ . , _ _ . . ._. _ _. _ ...,____. _____ . _ .. . _ _ _ - . _ . _ . _ . . . . . - _ _ . _ - - . _ , . _ - . _.._..____ _..___ .~ ___.___ _ . __-._ _ _- ..
urb-vuun TABLE 2.7-1 (Continued)
RADI.OACTIVE LIOUID EFFLUENT MONITORING INSTRUMENTATION TABLE NOTATION (a) . Channel OPERABILITY shall include the capability of either the Main Control Room Central Control Terminal (MCR-CCT) or the Radiation Protection Office Central Control Terminal (RP-CCT) to provide the
, alarm status of the applicable radiation monitor channel (s).
REMEDIAL REOUIREMENT REMEDIAL With the number of channels OPERABL2 less than required by REQUIREMENT the Minimum Channels OPERABLE requirement, effluent 1 releases may continue via this pathway provided that prior to initiating a release:
- a. At least two independent samples are analyzed in accordance with Section 2.3.1.1, and
~
- b. At least two technically qualified members of the Facility Staff independently verify the release rate calculations and discharge line valving:
Otherwise, suspend release of radioactive effluents via this pathway.
REMEDIAL a. With both the MCR-CCT and RP-CCT inoperable perform a REQUIREMENT CHANNEL CHECK using local monitor indication within 8 t-2 hours and at least once per 8 hours9.259259e-5 days <br />0.00222 hours <br />1.322751e-5 weeks <br />3.044e-6 months <br /> thereafter.
- b. With the monitor otherwise inoperable, effluent releases via this pathway may continue provided that at least once per 12 hours1.388889e-4 days <br />0.00333 hours <br />1.984127e-5 weeks <br />4.566e-6 months <br />, grab samples are collected and analyzed for rgdioactivity at a limit of detection of at least 10~ #Ci/ml.
REMEDIAL With the number of channels OPERABLE less than required by REQUIREMENT the Minimum Channe3c OPERABLE requirement, effluent 3 releases via Lhis pathway may continue provided the flow rate is estimated at least once per 4 hours4.62963e-5 days <br />0.00111 hours <br />6.613757e-6 weeks <br />1.522e-6 months <br /> during actual releases. Pump performance curves generated in place may be used to estimate flow '(All flows diverted from Plant Service Water must be taken into account when estimating flow).
REMEDIAL With the number of channels OPERABLE less than required by REQUIREMENT the Minimum Channels OPERABLE requirement, liquid 4 additions to this tank may continue provided the tank liquid level is estimated during all liquid additions to the tank.
CLINTON-1 2-31 Rev.7-2/91
CPS-ODCM TABLE 2.7-2 RADIOACTIVE LIOUID EFFLUE!!T MO!!ITORITIG INSTRUMEllTATIOff SURVEILLANCE REOUIREf1EliTS i
CIIAliNEL CIIANNEL SOURCE CIIANilEL FUNCTIONAL XIISTRUMENT CIIECK Cl!ECK CALIBRATION TEST
- 1. RADIOACTIVITY MONITORS PROVIDING ALARM AND AUTOMATIC TERMINATION OF RELEASE :
- a. Liquid Radwaste Discharge >
Process Radiation Monitor Effluent Line D(5) p p(3) 941)
- 2. RADIOACTIVITY MONITORS PROVIDING ALARM BUT NOT PROVIDING AUTOMATIC TERMINATION OF RELEASE
- a. Plant Service Water Effluent i Process Radiation Monitor- D(5) M R(3) Q(2) [
- b. Shutdown Service Water Effluent Process Radiation
- Monitor D(5) !!
R(3) Q(2) j c. Fuel Pool IIeat Exchanger Service Water Radiation Monitor D(5) M R(3) Q(2) [
- 3. FLOW RIsTE MEASUREMENT DEVICES
- a. Liquid Radwaste Effluent Line D(4) NA R .Q
- b. Plant Service Water
, Effluent Line D(4) NA R Q CLINTON-1 2-32 Rev.6-12/89
L-CPS-ODCM TABLE 2.7-2 (Continued)
RADIOACTIVE LIOUID EFFLUEllT MOfiITORIllG IllSTRUMEllTATIOff SURVEILLAfiCE REOIJIREMEliTS CilAlillEL CllANNEL SOURCE CIIANNEL FUliCTIOtIAL IllSTRUMEriT CIIECK CHECK CALIBRATION TEST
- 4. TANK LEVEL INDICATING DEVICES
- a. Cycled Condensate Storage D* liA R IIA
- b. Reactor Core Isolation Cooling D* liA R NA
- During 11guld additions to the tank..
CLIllTON-1 2-33 Fev.6-12/89
CPS-ODCM TABLE 2.7-2 (Continued)
RADIOACTIVE LIOUID EFFLUENT MONITORING INSTRUMENTATION SURVEILLANCE REOUIREMENTS TABLE NOTATIONS (1) The CHANNEL FUNCTIONAL TEST shall also demonstrate that automatic isolation of this pathway occurs and that the MCR-CCT or RP-CCT provides annunciation and event printout in response to each of uhe following conditions:
- 1. Instrument indicates measured levels above the alarm / trip (HIGH) setpoint.
- 2. Detector failure (LOW FAIL, HI FAIL).
- 3. Sample flow failure (EXTERNAL FAIL) .
4.
Instrument not set in normal operate mode (UNINITIALIZED, CALIBRATE, MAINTENANCE, or STANDBY.)*
(2) The CRANNEL FUNCTIONAL TEST shall also demonstrate that the MCR-CCT or RP-CCT responds with annunciation and event printout to each of the following conditions:
1.
Instrument setpoint. indicates measured levels above the alarm (HIGh:
- 2. Detector failure (LOW FAIL, HI FAIL).
- 3. Sample flow failure (EXTERNAL FAIL).
- 4. Instrument not set in normal operate mode (UNINITIALIZED, CALIBRATE, MAINTENANCE, or STANDBY).
(3) The initial CHANNEL CALIBRATION shall be performed using one or more of the reference standards certified by the National Institute of Standards and Technology (NIST) or using standards that have been obtained from suppliers that participate in measurement assurance activities with NIST. _These standards shall permit calibrating the system over its intended range of energy and measurement range. For subsequent CHANNEL CALIBRATION, sources that have been related to the initial calibration shall be used.
(4) CHANNEL CHECK shall consist of verifying indication of flow during periods of release. CHANNEL CHECK shall be1made at least once per 24 hours2.777778e-4 days <br />0.00667 hours <br />3.968254e-5 weeks <br />9.132e-6 months <br /> on days which continuous, periodic, or batch releases are made.
(5) The CHANNEL CHECK shall also determine that channel communication is established to the MCR-CCT or RP-CCT.
- A demonstration of automatic isolation of the release pathway is not applicable to this condition.
CLINTON-1 2-34 Rev.6-12/89
(
ura vuun i
i I
3.0 GASEOUS EFFLUENTS i 3.1 Introduction i Gaseous effluents from CPS are released on both a batch and continuous k basis. Gaseous effluents are normally discharged on a long term basis. j High volume Continuous Containment Purge and mechanical vacuum pump r discharge may be considered short term releases. ;
e t l'
There are two gaseous effluent release points to the environment: the !
Common Station HVAC Stack and the Standby Gas Treatment System (SGTS)
Stack. The height of these stacks is such that all gaseous effluents are l treated as mixed-mode releases (reference Table 9.2-1). The SGTS is an i Engineered Safety Feature filter system utilized following an accident to i reduce iodine and particulate activity in gases leaking from the primary containment and which are potentially present in the secondary I containment. The Common Station HVAC Stack ("HVAC Stack") receives l process and ventilation exhaust from the following inputs: 7 i) Continuous Containment Purge (CCP)
J. ) Containment Building Ventilation :
- 3) Turbine Building Ventilation !
- 4) Radwaste Building Ventilation
}
- 5) Auxiliary Building Ventilation
[
- 6) Fuel Building Ventilation ;
- 7) Auxiliary _ Building Refrigerant Purge ;
- 8) Laboratory Ventilation System i
- 9) Counting / Equipment Decon Rooms Ventilation
.e
- 10) Steam Packing Exhauster '
- 11) Mechanical Vacuum Pump !
the combined inputs to the HVAC stack are monitored at the HVAC stack. .
All inputs to the HVAC Stack, with the exception of input numbers 7 -
through 10, can be monitored prior to entering the stack. !
, Figure 3.1-1 delineates the CPS site boundary for implementation of [
l gaseous effluent 10CFR20 and 10CFR50, Appendix I Release Rate Limits.
t 3.2 Gaseous Effluent Pelease Point Monitoring
- 3.2.1 RVAC Stack Process Radiation Monitorina (PRM) System e
The HVAC Stack inputs are monitored for radioactivity prior to .
discharge to the environment by the HVAC Stack PRM. The PRM j detector en-fagurttion provides e ffluent monitoring using i seven (7) ch5nnels as follows: [
- 1) Beta scintillator for particulates
[
i CLINTON-1 3-1 Rev.2-10/86 i
CPS-ODCM
- 2) Alpha surface barrier detector to account for the radon / thoron contribution to the beta particulate measurement
- 3) Gamma scintillator for iodine
- 4) Iodine background subtraction
- 5) Beta scintillator for low range noble gas
- 6) Energy-compensated Geiger-Mueller (G-M) detector for high range noble gas
- 7) Encryy-compensated G-M detGctor for gamma area subtraction This monitor has no control function but annunciates in the Main Control Room and the Radiation Protection Office where proper response actions will be initiated in accordance with CPS procedures.
3.2.2 SGTS Staq'llrocess Radiation Monitorine (PRM) System As discussed in section 3.1, the SGTS is used to reduce post-accident concentrations of radioactivity in the primary and secondary containment via filter trains. The SGTS Stack PRM monitors the gaseous effluent of the filter trains at the SGTS
^' Stack prior to release to the environment. The PRM detector configuration utilizes nine (9) channels as follows:
- 1) Beta scintillator for particulates
- 2) Gamma scintillator for iodine
- 3) Iodinn background subtraction -
- 4) Beta scintillator for low range noble gas
- 5) Energy-compensated G-M detector for intermediate range noble gan
- 6) Energy-compensated G-M detector for gamma area subtraction
- 7) Alpha surface barrier detactor to account for the radon / thoron contribution to the beta particulate measurement CLINTON-1 3-2 Rev.6-12/89 l
t
~
1 CPS-ODCM
- 9) ,
Sample flow-rate through the SGTS PRM This monitor has no control function but annunciates in the Main Control Room and the Radiation Pro ection Office where proper response actions will be initiated in accordance with CPS procedures.
3.3 Main Condenser Off-Gas Monitorina System 3.3.1 Pre-Treatment Air Eiector Off-Gas Process Radiation Monitor (PRM)
The Pre-Treatment Off-Gas PRM monitors hydrogen recombiner effluent for gross noble gas radioactivity. This effluent is then routed to the charcoal adsorbers for eventual release to the environment via the station HVAC Stack (see Figure 3.3-1).
~
The PRM detector configuration consists of a single energy-compensated G-M detector mounted in a gas volunc.
The monitor has no control function but annunciates in the Main Control Room and the Radiation Protection Office where proper response actions will be initiated in accordance with CPS procedures.
3.3.2 Post-Treatment Air Eiector Off-Gas Process Radiation McDittr (PRM)
-+ ,
The Post-Treatment Off-Gas PRM monitors the gaserus radioactivity at upstream, intermediate or downstream actions of the charcoal adsorber. beds prior to tne afflucnt e ring the station HVAC Stack for release to the environment ee Figure 3.3-1). The PRM detector configuration is as .escribed for the HVAC Stack PRM (Section 3.2.1) with the exception of two additional channels which measure sample press.ure at the PRM and sample flow-rate through the monitor.
The monitor has two control functions. Upon detection of noble gas activity in excess of the ALERT setpoint, the charcoal adsorber bypass valves shut _(if in the charcoal bypass mode) and the off-gas is routed through L 2 adsorbers.
Should noble gas activity exceed the HIGH setpoint, or upon PRM failure, the off-gas system is automatically isolated from the HVAC Stack and a reactor scram may occur if loss of condenser vacuum occurs.
The Main Condenser Off-Gas Treatment System is shown in Figure 3.3-1.
CLINTON-1 3-3 Rev.6-12/89
CPS-ODCM 3.4 10CFR20 Release Rate Limits The Operation and Surveillance Requirements concerning 10CFR20 Release Rate Limits are specified in Section 3.4.1 as follows. Dose Rate calculations for ensuring compliance with these limits are discussed in Sections 3.4.2 and 3.4.3.
3.4.1 10CFR20 Release Rate Limits - Operation and Surveillance Requirements OPERATION REOUTREMENT The dose rate due to radioactive materials released in gaseous effluents from the site to areas at and beyond the SITE BOUNDARY (see Figure 3.1-1) shall be limited to the following:
- a. For noble gases: Less than or equal to 500 mrem /yr to the total body and less than or equal to 3000 mrem /yr to the skin, and
- b. For iodine-131, for iodine-133, for tritium, and for all radionuclides in particulate form with half lives greater than 8 days: Less than or equal to 1500-mrem /yr to any organ.
This requirement applies at all times.
REMEDIAL REOUIREMENT:
With the dose rate (s) exceeding the above limits, immediately restore the release rate to within the above limit (s).
SURVEILLANCE REOUIREMENTS 3.4.1.1- The dose rate due to noble gases in gaseous effluents shall be determined to be within the above limits in accordance with the methodology and parameters in Section 3.4.3 by obtaining representative samples and performing analyses in accordance with the sampling and analysis program specified in Table 3.4-1.
3.4.1.2 The dose rate due to iodine-131, iodine-133, tritium, and all radionuclides in particulate form with half lives greater than 8 days in gaseous-effluents shall be determined to be within the above limits in accordance with the methodology and parameters in Section 3.4.4 by l obtaining representative samples and performing analyses in accordance with the sampling and analysis program specified in Table 3.4-1.
i l
l CLINTON-1 3-4 Rev.6-12/89 L
i L .m
. t CPS-ODCM' TABLE 3.4-1 RADIOACTIVE GASEOUS WASTE SAMPLING AND ANALYSIS PROGRAM MINIMUM LOWER LIMIT OF SAMPLING ANALYSIS TYPE OF DETECTION (LLD)
GASEOUS RELEASE TYPE FREOUENCY FREOUENCY ACTIVITY ANALYSIS (nCi/ml)
A. Station IIVAC Wc,e gc,e Principal Gamma Emitters D '1x10-4 Exhaust Grab Sample II-3 1x10 -6 B. Standby Gas W Principal Gamma EmitLers D 1x10 -4 Treatment System Grab Sample W Exhaust, when flow exists H-3 1x10 -6
- c. All release Types Continuous f W9 I-131 1x10 -12 as Listed in A and Charcoal B above Sample I-133 1x10 -10 Continuous f W9 Principal Gamma Emitters b 1x10 -11 Particulate (I-131, others)
Sample -
Continuous f M Gross Alpha 1x10 -11 Composite Particulate Sample Continuous f Q Sr-89, Sr-90 1x10 ~11 Composite Particulate Sample CLINTON-1 3-5 Rev.7-2/91
. .. _ _ _ _ . . _ _ _ _ . . _ _ _ ~ _ . . _ - ___ ._ . . _ . . . _ _ . . _ . _. . . _ . _ . . - . __
CPS-ODCM TABLE 3.4-1 (Continued)
RADIOACTIVE GASEOUS WASTE SAMPLING AND ANALYSIS PROGRAM TABLE NOTATIONS aT he LLD is defined, for purposes of these specifications, as the smallest concentration of radioactive material in a sample that will yield a net count, above system backgtound, that will be detected with 95% probability with only 5% prosability of falsely concluding that a blank observation represents a "real" signal.
For a particular measurement system, ahich may nclude radiochemical separation:
LLD =
4.66 sb E x V x 2.22 x 106 x y x ogp (-Aat)
Where:
LLD is the "a' priori" lower limit of detection as defined above, as microcuries por unit mass or volume, sb is the standard deviation of the background counting rate or of the counting rate of a blank sample as appropriate, as counts per minute, E is the counting efficiency, as counts per disintegration, V is the sample size in units of mass or volume, 2.22 x 10 6 is the number of disintegrations per minute per microcurie, Y is the fractional radiochemical yield, when applicable, Ais,gheradioactivedecayconstantfortheparticularradionuclide (sec ) and at for plant effluents is the elapsed time between the midpoint of sample collection and the time of counting (sec).
Typical values of E, V, Y, and at should be used in the calculation.
It should be recognized that the LLD is defined as an a priori (before the fact) limit representing the capability of a measurement system and not as an JL nosteriori (after the fact) limit for a particular measurement.
CLINTON-1 3-6 Rev.6-12/89
cps-0DCM TABLE 3.4-1 (Contintimi).
RADIO \CTIVE GASE00S WASTE _ SAMPLI?{Q, AND ANALYSIS PROGR&B c
TABLE NOTATIONS (Continued) b The principal gamma emitters for which the LLD specification applies
, include the following radioDdclidost Kr-87, Kr-08, Xo-133, Xo-133m, Xo-135, and Xo-139 in noble gas releases and Mn~54, Fe-59, Co-58, Co-GO, 2n-65, Mo-99, I-131, Cs-134, Co-137, Co-141 and Co-144 in iodino and pr?ticulato releases. -This list d.os not mean that only thoso nucijnca are to be considorod. Other gamma peaks that are identifiab) , together with those of the above nuclidos, shall also be analyze 6 and reported in the Semiannual Radioactivo Effluent Roloaso Report pursuant to Specification 6.9.1.7 in the format outlinod in Regulatory Guido 2.21, Appondix B, Revision 1, June 1974.
C Sampling and analysis shall also be performed following shutdown, startup, or a THERHAL POWER chango exceeding 15% of RATED THERMAL POWER within a 1-hour period.
d Not applicable.
" Tritium grab samplos shall bo taken at loast once por 7 days from the ventilation exhaust from the spent fuel pool area, whenever spent fuel is in the spent fuel pool.
f The ratio of the camplo flow rato to the sampled stroem flow rate shall be known for the timo period covered by each dose or dose rato calculation mado in accordance with Sections 3.4.1, 3.5.1 and 3.5.2.
9samplos shall be changed at least onco per 7 days and analysis shall be completed within 48 hours5.555556e-4 days <br />0.0133 hours <br />7.936508e-5 weeks <br />1.8264e-5 months <br /> after changing, or after removal from sampler.
Sampling shall also bo performed at least once por 24 hours2.777778e-4 days <br />0.00667 hours <br />3.968254e-5 weeks <br />9.132e-6 months <br /> for at least 7 days following each shutdown, startup, or THERMAL POWER change exceeding 15% of RATED THERMAL POWER in 1-hour period and analysos shall be comp).eted within 48 hours5.555556e-4 days <br />0.0133 hours <br />7.936508e-5 weeks <br />1.8264e-5 months <br /> of changing. When samplos collected for 24 hours2.777778e-4 days <br />0.00667 hours <br />3.968254e-5 weeks <br />9.132e-6 months <br /> are analyzed,.the corresponding LLDs may bo increased by a factor
) of 10. This requirement does apply ift (1) analysis shows that the DOSE EQUIVALENT I-131 concentration in the primary coulant has increased more than a , factor of 3, and (2) the noblo gas monitor shows that offluent activity has increased more than a factor of 3.
CLINTON-1 3-7 Rev.6-12/89
dh3-ODCM 3.4.2 Dose Pste Due to Noble Gagga In ordor to comply with Section 3.4.1.(a), the donu rato at or beyond the site boundary due to nobio gases shall be calculated as follows:
Dt "EiKi[(X/Q)mQim) (1)
= total body doso rato at timo of release, mrom/ year Da =Ei(Li+1.1Mi) ( (X/Q)mQim) (2)
= skin donc rato at timo of release, mrom/yoar The terms in the abovo equations are defined in section 3.4.3.
3.4.3 Dose Rato Duo To Radiciodines. Particulates and Tritium 4
In order to comply with Section 3.4.1(b), organ doso ratos duo to radiciodinos (1-131, I-133), particulates with half-li't a
> 8 days and tritium shall be calculated as follows:
Do =riPij (X/Q)m im (3)
= organ coso rato at time of
.... releaso, mrom/yr
~
The terms used in equations (1) through (3) are defined as follows:
Ki = The total body dono factor duo to gamma omissionsforeachidentifiednobgogas radionuclido 1, mrom/yr por pCi/m Li = The skin dose factor due to bota emissions for each-identified goble gas radionuclido 1, mrom/yr por pCi/n e
Mi = The air doso factor due to gamma' emissions for each identified gobio gas radionuclido 1, mrad /yr por pCi/m (1.1 mrom/ mrad converts air doso to skin doso)
CLINTON-1 3-8 Rev.o-12/89 l
- _~ _- . - - - . - .. - - - - - . - - - - - _ _ - _ - . - . . .
CPS-ODCM l
Pij = The dose factor for non-noblo gas l
radionuclide i and organ j which includes pathway transport paremoters, receptor usage factors and the dosimetry of tho exposure. The dono factors fgr the inhalation, mrem /yr per pCi/m , pathway are
! listed in Table 3.4-3 (CHILD) . Deso factors are based on NUREG-0133, Section 5.2.1.1 assumptions unions otherwise ;
stated.
l Qin = The releano rate of noblo gas radionuclido 1 in gaseous offluent from mixed-mode rolosso points, pCi/sec Qin = The release rate of non-noble-gas-radionuclide i in gaseous offluent from mixed-modo releaso points, uci/sec (X/Q)m = The highest calculated averago relative concentration for any area at or beyond the sitogoundaryfrommixed-modereleases, sec/m
.Do is calculated for each of six organs and the total body; the maximum Do value is then used to determino compliance with section 3.4.1(b).=
^
The factors Ki, L i, and Mi relate the radionuclido airborno concentrations to various dose ratos assuming a semi-infinito cloud.
These factors are listed in Table 3.4-2 and were obtained from Table B-1ofRegulagoryGuide1.109aftermultiplyingthevaluesbythe conversion 10 pC1/pC1.
10CPR20 organ dose rato calculations are limited to the inhalation pathway only. Section 3.4.1(a) is annlicable to the unrestricted area location characterized by the (X/Q)m valuu which results in the maximur, total body or skin doso commitment. Should the total body and P%in locations differ, the selected location shall La that which minimizos allowablo release rates.
There are unrestricted areas within the CPS site boundary which are utilized by members of the public for residences, farming, recroation and camping. These areas are identified in Table 3.4-4.
Table 3.4-4 will be revised to remain consistent with the most recont land use consus.
f CLINTON-1 3-9 Rev.6-12/89
CPS-ODCM TABLE 3.4-2 DOSE FACTORS FOR fiOBLE GASES AfiD DAUGitTERS*
Total Body Gamma Air Beta Air Dose Factor Skin Dose Factor Dose Factor Dose Factor Radionur-lide (nrem/yr per pCi/m") (mremfyr per pCi/m") (nrad/yr per pCi/m 3) (mrad /yr per ACi/m 3)
Kr-85m 1.17E+03 1.46E+03 1.23E+03 Kr-85 1.61E+01 1.97E+03 1.34E+03 1.72E+01 1.95E+03 Kr-87 5.92E+03 9.73E+0' 6.17E+03 Kr-88 1.03E+04 1.47E+04 2.37E+03 1.52E+04 2.93E+03 Kr-89 1.66E+04 1.01E+04 1.73E+04 Kr-90 1.56E+04 1.06E+04 7.29E+03 1.63E+04 7.83E+03 Xe-131m 9.15E+01 4.76E+02 1.56E+02 Xe-133m 1.11E+03 2.51E+02 9.94E+02 3.27E+02 1.48E+03 Xe-133 2.94E+02 3.06E+02 3.53E+02 Xe-135m 1.05E+03 3.12E+03 7.11ESO2 3.36E+03 Xe-135 7.39E+02 1.81E+03 1.86E+03 1.92E+03 2.46E+03 Xe-137 1.42E+03 1.22E+04 1.51E+03 Xe-138 1.27E+04 8.03E+03 4.13E+03 9.21E+03 4.75E+03 Ar-41 8.84E+03 2.69E+03 9.30E+03 3.28E+03
- The listed dose factors are for radionuclides that may be detected in gaseous effluents.
l r
OLINTOV-1 3-19 Rev.6-12/89
. - - . - - - ~_.
3 CPS-ODCM TABLE 3.4-3
' It01ALATIO!1 PATINAY DOSE RATE TACTgRS (CHILD) -P i$
(mrem /yr por pCi/n )
ORGAN LCE LIVER T. BODY IlnTOI!2 1;IN:EY IEG 01 LLI 190 TOPE l
)
l H3 NO DATA 1.12E+03* 1.12E+03 1.12E403 1.12E+03 1.12E+03 1.12E+03 c 14 3.59E+04 6.73E+03 6.73E+03 6.73E+03 6.73E+03 6.73E403 6.73E+03
'NA 24 1.61E+04 1.61E404 1.61E+04 1.61E+04 1.61E+04 1.61E+04 1.61E+04
~
P 32 2.60E+06 1.14EA05 9.88E+04 NO DATA NO DATA NO DATA 4.22E+04 CR 51 NO DATA NO DATA 1. 54 E+ 02 8.55E+01 2.43+01 1.70E+04 1.08E+03 MN 54 NO DATA 4.29E 04 9.51E+03 NO DATA 1.00E+04 1.58E+06 2.29E+04 i MN 56 NO DATA 1.66E+00 3.12E 01 NO DATA 1.67E+00 1.31E404 1.23E+05 FE 55 4.74E+04 2.52E+04 7.77E+03 NO DATA NO DATA 1.11E+05 2.87E+03 FE 59 2.07E+04 3.34E+04 1.67E+04 NO DATA NO DATA 1.27E+06 7.07E+04 co 58 NO DATA 1.77E+03 3.16E+03 NO DATA NO DATA 1.11E+06 3.44E404 Co 60. NO DATA 1.31E+04- 2.26E+04 lio DATA NO DATA 7.07E406 9.62E+04
. - NI 63 8.21E+05 4.63E404 2.80E+04 NO DATA NO DATA 2.75E+05 6.33E+03
, NI 65 2.9 3400 2.96E 01 1.64E 01 NO DATA NO DATA 8.18E+03 8.40E+04 CU 64 110 DA7/ 1.99E+00 1.07E+00 NO DATA 6.03E+00 9.58E+03 3.67E+04 ZN 65 4.26E+04 1.13E+05 7.03E+04 !!O DATA 7.14E+04 9.95E+05 1.63E+04 ZN 69 6.70E 02 9.66E 02 8.92E 03 NO DATA 5.85E 02 1.42E+03 1.02E+04 ;
BR-83 NO DATA NO DATA 4.74E+02 NO DATA NO DATA NO DATA LT 3.70E 1$**
BR 84 NO DATA NO DATA 5.48E+02 NO DATA NO DATA NO DATA LT 3.70E 15 BR 8$ NO DATA NO DATA' 2.53E+01 NO DATA NO DATA NO DATA LT 3.70E 15 RB 86 NO DATA 1.98E+05 1.14E+05 NO DATA NO DATA NO DATA 7.99E+03 RB 88 NO DATA 5,62E+02 3.66E+02 NO DATA NO DATA NO DATA 1.72E+01 RB 89 NO DATA 3.45E+02 2.90E402 NO DATA NO DATA NO DATA 1.89E+00-SR 89 5.99E405 NO DATA 1.72E+04 NO DATA NO DATA 2.16E+06 1.67E+05 SR 90 1.01E+08 NO DATA 6.49E406 NO DATA NO DATA 1.4BE+07 3.43E+05 SR 91 1,21E+02 NO DATA 4.59E+00 NO DATA NO DATA 5.33E+04 1.74E+05 SR 92- 1.31E+01 NO DATA 5.2SE 01 NO DATA NO DATA 2.40E+04 2.42E+05 Y 90 4.11E+03 _NO DATA 1.11E+02 NO DATA NO DATA 2.62E+05 2.68E+05 i CLINTON-1 3-11 Rev.6-12/89
I l
CPS-ODCH I l
TABLE 3.4-3 (cont'd) i s
l IliHALATIONPATHWAYDOSERATEFACTgRS (CHILD) -P i$
(mrom/yr per #Ci/m )
OPMil EE LIVER T. BODY TlfYROID TINiEY
-liqTOPE Ll'}{Q {llfjll g i
Y 91m 5.07E 01 110 DATA 1.84E 02 NO DATA tio DATA
- 2.81E+03 1.72+03 Y 91 9.14E+05 110 DATA 2.44E+04 NO DATA 2.63+06 NO DATA 1.84E+05 Y 92 2.04E+01 NO DATA 5.81E 01 NO DATA No DATA 2.39E+04 2.39E+05 l.
Y 93 1.87E+02 NO DATA 5.11E+00 NO SATA NO DATA 7.44 E4 04 3.89E+05 ZR 95 1.90E+05 4.18E+04 3.70E+04- NO LATA 5.96E+04 2.23E+06 6.11E404 ZR 97 1.88E+02 2.72E+01 1.60E+01 @ D.TA 3.89E+01 1.13E+05 3.51E+05 l 1
NB 95 2.35E+04 9.18E+03 6.55E+03 No ar, 8.62E+03 6.14E+05 3.70E404 MO 99 NO DATA 1.72E+02 4.26E+01 NC P.7/ 3.92E+02 1.35E+05 1.27E+05 TC 99m 1.78E 03 3.48E 03 E.77E 02 NO DATA 5.07E 02 9.51E+02 4.81E+03 TC 101 8.10E 05 8.51E 05 1.08E 03 NO DATA 1.45E 03 $.82E+02 1.63E+01 RU 103 2.79E+03 NO DATA 1.07E+03 7.03E+03 NO DATA 6.62E+05 4.48E+04 RU 105 1.53E+00 NO DATA 5.55E 01 No DATA 1. 34EK)D 1.59E404 9.95E+04 RU 106 1.36E+05 NO DATA 1.69E+04 NO DATA 1.84E+05 1.43E+07 4.29E+05 AG 110m 1.69E+04 1.14E+04 9.14E+03 NO DATA 2.12E+04 5.48E+06 1.00E+05 i TE 125m 6.73E+03 2.33E+03 9.14E+02 1.92E+03 NO DATA 4.77E+05 3.38E+04 i i
TE 127m 2.49E+04 8.56E+03 3.03E+03 6.07E+03 6.36E+04 1.48E+06 7.14E+04 TE-127- 2.77E+00 9.51E 01 6.11E 01 1.96E+00 7,07E+00 1.00E+04 5.62E+04 i TE 129m 1.92E+04. 6.85E+03 6.33E+03 3.04E+03_ 5.03E+04 1.76E+06 1.82E+05 !
i i
TE 129 9.77E 02 3.50E 02 2.38E 02 7.14E 02 2.57E 01 2.93E+03 2.55E+04 l TE 131m 1.34E+02 5.92E+01 5.07E+01 9.77E+01 4.00E+02 2.06E+05 3.08E+05 !
TE 131 2.17E 02 8.44E 03- 6.59E 03 1.70E 03 5.88E 02 2.05E+03 1.33E+03 I i
TE 132 4,81E+02 2.72E+02 2.63E+02 3.18E+02 1,77E+03 3.77E+05 1.38E+05 j I 130 8.18E+03 1.64E+04 8.44E+03 1.85E+06 2.45E404 NO DATA 5.11E+03 !
1 131 4.81E+04 4.81E+04 2.73E+04 1.62E+07 7.88E+04 NO DATA 2.84E+03
?
1 132 2.12E+03 4.07E+03 1,88E+03 1.94E+05 6.25E+03 .NO DATA 3.20E+03-I 133 1.66E+04 2.03E+04 7.70E+03 3.85E+06 3.38EdO4 NO DATA 5.48E+03 I 134 1.17E+03 2.16E+03 9.95E+02 5.07E+04 3 . 3 0'. + 0 3 NO DATA ~ 9.55E+0.
i i
I 1
CLINTON-1 3-12 Roy.G 12/89
CPS-ODCM TA11Li' 3.4-3 (cont'd)
IlillALATIOll PATIIWAY DOSE RATE FACTgRS (CilILD) -P i3 (mrem /yr per NCi/m )
OPEANI LIVEP. TmT01D KIMEY ISOTOPE E0fiE T.PODY IJ3G Gl.dll
, 1 135 4.92E+03 8.73E+03 4.14E+03 7,92E405 1.34E404 !;O DATA 4.44E+03 CS.134 6.51E+05 1.01E+06 2.25E405 tio DATA 3.30E+05 1.21E+05 3.84E403 CS.136 6.51E+04 1.71E+05 - 1.16E+05 110 DATA 9.55E+04 1.45E+04 4.18E+03 CS.137 9.07t+05 8.25E405 1.28E+05 !40 DATA 2.82EiO5 1.04E+05 3.62E+03 CS.138 6.33E+02 8.u0E+02 5.55E402 NO DATA 6.21E+02 6.81E+01 2.70E+02 EA.139 1.84E400 9,84E.04 5.37E.02 NO DATA 8.62E.04 5.77E+03 5.77t+04 BA.140 7,40E>04 448E+01 4.33E403 !!O DATA 2.11E+01 1.74E+06 1.02E+05
~
BA.141 1.96E.01 1.09E.04 6.36E 03 110 DATA 9.47E 05 2.92E+03 2.75E+02 EA.142 5.00E 02 3.60E.05 2.79E 03 110 DATA 2.91E.05 1.64E+03 2.74E400
_ _1A.140 6.44E402- 2.25E+02 7.55E+01 !;0 DATA !0 DATA- 1.83E+05 2.26E405 LA 142 1.30E+00 4.11E.01 1.29E 01 NO DATA NO DATA 8.70E+03 7.59E+04 CE.141 3.92E+04 1.95E+04 2.90E+03 NO DATA 8.$5E403 5.44E+05 5.66t+04
, CE.143_ 3.66E+02 1.99E+02 2.88E+01 tio DATA 8.36E401 1.15E+05 1.27E+05 CE.144 6.77E+06 2.12E+06 3.62E+05 NO DATA 1.17E+06 1.20E+07 3.89E+05 PR 143 1.85E404 5.55E+03 9.14E+02 NO DATA 3.00E+03 4.33E+05 9.73E+04 PR 144 5.96E.02 1.85E 02 3.00E.03 NO DATA 9.77E.03 1.57E403 1.97E+02 ND.147 1.08E404 8.73E+03 6.81E+02 NO DATA 4.81E+03 3.28E+05 8.21E+04 W 167 1.63E+01 9.66E+00 4.33E+00 NO DATA 4,11E+04 NO DATA 9.10E404 HP 239 4.66E002 3.35E+01 2.35E+01 NO DATA 9.73E401 5.81E+04 6.40E404
- 1.12 x 10J
- Less than 3.70 x 10 15 s
s CLINTON-1 3-13 Rev.6-12/89
CPS-0DCM
, TABLE 3.4-4 IhCATION OF MEMBERS OF Tile PUBLIC VITit!N Tile CPS SITE BOUNDARY AND TilEIR ASSOCIATED OCCUPANC*l FACTORS
- Distanco Occupancy Location (milo/moter) Sector (hrs /ylj.
Road 0.3/495 SE 243(1)
Agri-cultural '
Acrongo (2) 0.9/1372 SSW 964(3)
Clinton Lake 0.2/335 NW 22 08 ( t. )
Department of Consor-vation Rocroation Area 0.8/1287 ESE 2208(5)
Residenco 0.8/1219 SW 8760 Residence 1.5/2414 WSW 8760 Residence 1.7/2736 SSE 8760 (1) Assumos travel on road for forty minutos por day.
(2) Maximum farm acrongo (276) within sito boundary.
(3) Assumes 3.5 hours5.787037e-5 days <br />0.00139 hours <br />8.267196e-6 weeks <br />1.9025e-6 months <br /> in field por acro firmed.
l Assumes continuous occupation on Clinton Lake for the months (4) of-June, July, and August.
(5) Assumos continuous occupation on Department of Conservation camping areas for the months of Juno, July, and August.
- Dosos for such MEMBERS OF THE PUBLIC are provided in tho Somiannual Radioactive Effluent Release Report as given in Section 6.3.2.
CLINTON-1 3-14 Rev.6-12/89
-. . _ - . _ _ _ . _ _ _ . _ _ _.___ ._,-_ ___._ _.._ _,_.,_ _ _ __ .~
_ _ . - _ _ _ _ _ - . _ _ . _ _ _ . _ . ._ m . .._.m _ _ _ . - -
CPS-ODCM f
3.5 10CPR50_._ APPENDIX 7 RELEASE RATE LIMITS The Operation and Surveillance Requirements concerning l 10CFR50 (Appendix I) Releano Rate Limits are specified in !
Sections 3.5.1 and 3.5.2 as follows. Dose calculations '
for ensuring compliance with these limits are discussed !
in Sections 3.5.3 and 3.5.4. }
3.5.1 Noble Gas Dose - Operation and Surveillance Requirements I OPERATION REOUIRFMENT I The air dose due to noble gases released in gaseous effluents, from each reactor unit, to areas at and beyond the SITE DOUNDARY (see rigure 3.1-1) shall be limited to the following: '
l
- a. During any calendar quarter: Less than or equal to 5 mrad for gamma !
radiation and less than or equal to 10 mrad for beta radiation, and i
- b. During any calendar year: Less than or equal to 10 mrads for gamma r i
radiation and less than or equal to 20 mrad for beta radiation. !
t This requirement applies at all times.
REMEDIAL REOUIREMENT:
i
- a. With the calculated air dose from radioactive noble gasas in gaseous s
i effluents exceeding any of the above limits, in lieu of a Licensee l Event Report, prepare and submit to the Regional Administrator of ;
the Regional Office of the NRC within 30 days a Special Report that t identifies the cause(s) for exceeding the limit (s) and defines the .
corrective actions that have been taken to reduce the releases and !
the proposed corrective actions to be taken to assure that !
subsequent releases will be in compliance with the above limits. !
SURVEILLANCE PEOUTREMENTS
- i 3.5.1.1 Cumulativo dose contributions for the current calendar quarter '
and current calendar year for noble gases shall be determined in accordance with the methodology and parameters described in Section 3.5.3 i at least once per 31 days.
i i
i 1
t l
t i
CLINTON-1 3-15 Rev.6-12/89 l l
, , .- ._ e., . - - - , _ . . _ . - - - - , - - -
CPS-CDCM 3.5.2 Iodine-131, Iodine-133, Tritium, and Radionuclides in Particulate Form - Operation and Surveillance Requirements OPERATTON PEOUTPEMENT The dose to a MEMBER OF THE PUBLIC from iodine-131, iodine-133, tritium, and all radionuclides in particulate form with half-lives greater than 8 days in gaseous offluents released to areas at and beyond the SITE 3 i
BOUNDARY (see Figure 3.1-1) shall be limited to the following: l
- a. During any calendar quarter: Less than or equal to 7.5 mroms to any organ, and
- b. During any calendar years Less than or equal to 15 mremo to any organ.
This requirement applies at all times.
REMEDIAL REOUIREMENT:
- a. With the calculated dose from the release of iodine-131, iodine-133, tritium, and radionuclides in particulate form with half lives greater than 8 days, in gaseous effluents exceeding any of the above limits prepare and submit to the Regional Administrator of the Regional Office of the NRC within 30 days a Special Report that identifies the cause(s) for exceeding the limit and defines the corrective actions that have been taken to reduce the releases and the proposed corrective actions to be taken to ascura that subsequent releases will be in compliance with the above limits.
SURVEILLANCE PEOUIREMENTS 3.S.2.1 Cumulative dose contributions for the current calendar quarter and current calendar year for iodine-131, iodine-133, tritium, and radionuclides in particulate form with half lives greater than 8 days shall be determined in accordance with the methodology and parameters in Section 3.5.4 at least once per 31 days.
CLINTON-1 3-16 Rev.6-12/89
CPS-ODCM 3.5.3 Noble Gas Air Dose Ecuationn The air dose at or beyond the site boundary due to noble gases released in gaseous effluent will be determined using the following equations.
3.5.3.1 During any calendar quarter or calendar year, for gamma -
radiation:
D7 = 3.17 x 10~8 EMii (X/Q) , Qim (4) 3.5.3.2 During any calendar quarter or calendar year, for beta radiation:
Dp = 3.17 x 10~8 ENi i (X/Q)mQim (5)
Where Mi.= The gamma air dose factor for each identified noble gas radionuclide i, mrad / gear per yCi/m (Mi values are listed in Table 3.4-2).
" Ni= The beta air-dose facter for each identified noble gas r'dionuclide mrad / year per yCi/m a i,3 (Ni values are listed in Table 3.4-2).
(X/Q)m = The highest calculated average relative concentration from mixed-mode release points for areas at or beygnd the site boundary, sec/m Qim = The average release of noble gas radionuclide i for long-term releases from mixed-modo release points, yCi. Releases shall be cumulative over the calendar quarter or year, as appropriate.
3.17 x 10-8 = The inverse of the number of seconds in a year.
l l
CLINTON-1 3-17 Rev.6-12/89 l
CPS-ODCM Section 3.5.1 noble gas doso calculations are ovaluated at the site boundary location where maximum air dosos prevail. Should the bota and gamma locations differ, the selected location shall be that which minimizos allowablo roloaso ratos due to the gamma component.
3.5.4 Radiolodines. Particulates and Tritium Dose Equations The dose to an individual at or beyond the sito boundary due to radiolodinos (I-131, I-133), tritium and particulates with half-lives > 8 days, will be dotormined using the following equation:
for any calendar quarter or calendar year, Dp = 3.17 x 10-8 3iap ij Wm im (6) where Dim = The releason-of radionuclido i (I-131, I-133, tritium and particulatos) for releases from mixed-modo release points, pCi. Roloanos shall be cumulativo over the calendar quarter or year, as appropriato.
(D/Q) ,= The relativo deposition from mixed-modo release pojntsforareasatorbeyondthesitoboundary, m
Wm =
The dispersion parameter for estimating the dose to an individual at a controlling location for mixed-mode releases.
3
=
(X/Q) ,, soc /m , for the inhalation pathway
=
(D/Q)m, m -2, for the-food and ground plano pathways 3.17 x 10-8 = The invorse of the number of seconds in a year.
R aij =
The doce 1, age factor group (a) for andeach identi{iod organ j, radionuclido mrem /yoar por pCi/sec or mrem / year por #Ci/m CLINTON-1 3-18 Rev.6-12/89
{-
?
I CPS-ODCM f,
Section 3.5.2 is applicable to the location at or j beyond the sito boundary where the combination of existing pathways and receptor ago groups indicates the maximum potential exposure. The inhalation and ground plano exposure pathways exist at all locations; other pathways exist as datormined by the most curront land !
use connus. !
f 3.5.4.1 Dono Factor For Radionuclide i (R i l at j The R aij values used to calculate D in equation '
(6) are datormined separately for oSch of the potential exposure pathways, namely
- Inhalation (I) ,
- Ground Plane contamination (G) *
- Grass-Cow / Goat-Milk (C)
- Grass-Cow-Moat (M)
Vogotation (V)
The R313 paramotor is independent of the i duration of'gascous relonson and is calculated i using the methodology discussed in the remaindor !
of this section. t 3.5.4.1.1 Calculation of the Inhalation Pathway Factor, R .
I a17 (
R aij" 3 E#(UE)a (DFA 1)a, mrom/ year per uCi/m (7) where K' = A units conversion constant, 10 6 [
pCi/pci [
r e of the receptor (DR)a=Thebroathingrag/
age group (a), m year, f
. j i
= 1400 (infant) !
= 3700 (child) i
= 8000 (toen and adult) [
i values for (BR)a are obtained from 17UREG-0133, l p.32. ;
(DPA1 )a= The organ inhalation doso factor for receptor of ago group (a) for radionuclido 1, mrom/pci. Values ,
for (DFA voro obtained from [
Tables Ei)a7 through E-10 of ->
Regulatory Guido 1.109 and aro l proconted in Tables 3.S-1 through !
3.5-4 of this manual. !
I r
CLINTON-1 3-19 Rev.6-12/89 i
, I l !
I.- - _ _ _ . - . - . . , _ - . . - - _ - _ - , . .
--..-,-,.-..-)
CPS-ODCM 3.5.4.1.2 Calculation of the Ground Plano G
Pathway Factor R ,
i RU = K'K" (SF) (DFG i ) (1-e 'Al )j3i, (3) t m2 -mrem / year per uCi/sec where K' = A units conversion constant, 10 6 peijggi X" = A units conversion constant, 8760 hour0.101 days <br />2.433 hours <br />0.0145 weeks <br />0.00333 months <br /> / year SP = The shielding factor, dimensionless ,
= 0.7 as suggested in Table E-15 of Regulatory Guide 1.109 ,
DFGi= The ground plano dose conversion factor fo radienuclido 1, mrom/ hour porpCi/m{. Values for DFGi were ,
obtained from Table E-6 of Regulatory Guide 1.109 and are proconted in Tablo 3.5-5 of this
.. w manual.
t Ai= The i, see decgy constant for radionuclide t= The exposure time, sec
= 6.31E+08 soc (20 years) i 3.5.4.1.3 Calculation of The Grass-Cow / Goat-Milk I
Pathway Factor, R ..
az)
C R g = K' Qp(Unp) Im (r) (DFL1)a (9)
Ai+Av !
ffp3 (1-fp3f )o'Al t3 3-Ait y,
+
Y Y p 3 m 2 -mrom/yr por pCi/coc t
I i
CLINToti-1 3-20 Rev.6-12/89 !
t
CPS-oDCM where K' = A units conversion constant, 10 6 pci/pci Qp = The cow / goat feed consumption rate, kg(wet)/ day U ap = The receptor's milk consumption rate for age group (a), liters / year Yp = The agricultural productivity by unit,a ea of pasture feed grass, kg/m' Ya
=Theagriculturalproductivitygy unit area of stored feed, kg/m Fm = The stable element transfer coefficients, days / liter r = Froction of deposited activity retained on feed grass, dimensionless (DFLi )a = The organ ingestion dose factor for radionut ide i and the receptor in age group (a), mrem /pci. Values for (DFL were obtained from Tables Ei)a 11 through E-14 of Regulatory Guide 1.109 and are presented in Table 3.5-6 through 3.5-9 of this manual.
A i = The i, see decgy constant for radionuclide Ay= The decay constant for removal of activity on leaf an byweathering,secgplantsurfaces
= 5.73 x 10-7 sec -1 (corresponding to a 14-day half-life) tg = The transport time from pasture to animal, to milk, to receptor, see t The transport time from pasture to h = harvest, to animal, to receptor, sec CLINTON-1 3-21 Rev.5-2/89 ,
-i
CPS-ODCM f Fraction of the year that the E = cow / goat is on pasture, dimensionless f3 = Fraction of the cow / goat feed that is pasture grass while the cow / goat is on pasture, dimensionless Tgeinputparametersforcalculating R
aij are listed in Table 3.5-10.
Tritium The concentration of tritium in milk is based on its airborno concentration rather than the deposition.
C RT = K'K"F O Um F ap(DFLi )a (0.75(0.5/H)],
mrom/yr per pCi/m 3 (10) where K" = A unite convgrsion constant, 10 gm/kg H = The absolute atmospheric humidity
= 8 gm/m 3 (liUREG-013 3, p. 34) 0.75 = The fraction of total feed that is water, dmansionless i
O.5 = The ratio of the specific activity of the feed grass water to the atmospheric water, dimensionless The other parameters arg as defined in the calculation of R f3
~CLINTON-1 3-22 Rev.5-2/89 ,
CPS-ODCM :
Carbon - 14 Following the development of equation C-8 on page 1.109-26 of Regulatory Guide 1.109, carbon-14 is assumed to be released as an oxide, either C14 0 or C 14 0 2 The concentration of carton-14 in milk is therefore based upon its airborne concentration assuming that the vegetation C 14 /C ratio is the same as the local atmospheric C 14 /C ratio.
RC , g,K"F nQgUap(DFL1 ) a p(0.11/0.16) , mrem /yr per pCi/m3(11) where
.p = Fractional equilibrium ratio, dimensionless
= Ratio of the total annual C-14 atmosheric release
, time to the total annual photosynthesis time (4400 hours0.0509 days <br />1.222 hours <br />0.00728 weeks <br />0.00167 months <br />) not to exceed unity
= 1.0 0.11 = !!atural carbon fraction of total plant mass, dimensionless s .,
0.16 = Atmogheric gm/m natural carbon concentration, The other parameters are as defined in the calculation of R C 3.5.4.1.4 Calculation of The Grass-Cov-Mrrat Pathway Factor, RM 3fg Raij = K'Qp(Uap) Ff(r) (DFLg)3 ff pg (1-fp3f ) e~Ai t3 [e-Aits),
Ai+Ay Y p Y o
2 m -mrem /yr per pCi/sec (12) where K' = A units conversion D constant, 10 pCi/#Ci U ap = The receptor's meat consumption rate for age group (a), kg/ year I Fg = The stable element transfer l coefficient, days /kg 1 CLINTCN-1 3-23 Rev.6-12/89
i CPS-ODCM tg = The transport time from slaughter of meat animal to receptor, seconds th = The transport time from crop field to receptor, ,
seconda 1 (DFLg)a= The organ ingestion dose j factor for radionuclide i )
and the receptor in age ;
group (a), mrem por pci.
Values are tabulated in Table 3.5-6 through 3.5-9 of this Manual.
The input parameters necessary for calculating R are listed in Table 3.5-11. Allokkertermsareas defined for equations (9) and (10).
Tritium:
The concentration of tritium in meat is based on its airborne concentration rather than the deposition.
M RT= K'K"FfQpU ap(DFL i )a (0.75(0.5/11)) , mrom/yr per
- Ci/m 3 (13)
The terms in equation (13) are as defined in equations (10) and (12).
Carbon - 14 Following the development of equation C-8 on page 1.109-26 of Regulatory Guide 1.109, carbon-1g4 1s aggumed to be released as an oxide, either C 0 or C 02 The concentration of carbon-14 in meat is therefo.e based upon its airbo assum'.ng that the vegetgtion C{ne /C ratioconcentration is the same as-the 'ocal atmospheric C /C ratio.
Ry4= K'K"Fg QgU ap (DFL i ) a p(0.11/0.16) , mrem /yr per 4Ci/m 3 (14)
The terms in equation (14) are as defined in equations (11) and (13).
CLINTON-1 3-24 Rev.1-11/85
CPS-ODCM Calculation of the Venetation Pathway Factor, Rv 3.5.4.1.5 aij {
R = K' '
U"f t t g3 (DTL1 )a aL ""AI b
- U agf e-Afh, Yv( Ai+Aw) ;
i m 2 -mrem /yr per pCi/oce (15) i there j K' = A units conversion D
I constant, 10 pCi/pCi '
L Ua = The consumption rate of .
fresh leafy vegetation by !
the receptor in age group !
(a), kg/yr l
l 5 '
Ua = The consumption rate of {
stored vegetation by the i receptor in age group (a), l kg/yr j
= The fraction of the annual f
t I intake of fresh leafy p vegetation grown locally,
- dimensionlesr,
, l
=
f 9 The fraction of the annual i intake of stored vegetation (
grown locally, ;
dimensionless [
tn = The average time'between {
harvest of Icafy vegetation f
.nd its consumption, i seconds j th = The average time between i
harvest of stored i
! vegetation and its !
consumption, seconde Yy =
The vegetatiog areal density, kg/m ,
r -
k I
f i
1 i CLINTON-1 3-25 Rev.6-12/89-l
._ . _ , _ _ _ .. . _ , _ , . . . . - _ - . , - . _ . ._. _ _ , . . _ ~ . - - . .._ _ . . .._ _.. - I
CPS-ODCM (DFLi )a a T.io organ ingestion doso factor for radionuclide i and the receptor in ago group (a), mrom por pC1.
Valuon are tabulated in Tablo 3.5-6 through 3.5-9 of this Manual.
The input paramotors necessary for calculatingRfigarelistedinTablo 3.5-12. All other terms are as defined for equations (9) through (14).
Tritiumt The concentration of tritium in vogotation is based on its airborno concentration rather than the deposition.
R
= K'K"(U faL+Uf' (DFI9g ) a ( 0. 7.5 (0. 5/11) ] ,
mrom/yr por 4Ci/m 3 (16)
The terms in ot A ica (16) are as defined in equhtions. (',0) *M 115).
Ca rbott-,11 FMiowing the development of equation C-8 on p.go 1.109-26 of Regulatory Guido 1.109, carbona 1
C{[OorCs ausgod to be roloased as an oxide, oithe::
02 The concentration of carbon-14 in vogotation is therefore based upon its airborno vogotation C congntration assuming that the atmospheric C1fCratioisthesameasthelocal
/c ratio.
R
= K'K"(U fa L + Uffg) (DFLi ) a p(0.11/0.16) , (17) mrem /yr por 4Ci/m 3 The terms in equation (17) are as defined in equations (11)~and (15).
The I C V M athway dono rato factors (Raij' Raij, Raij' faij' R), by ago group, are listed in Table 3.5-13 through 3.5-31.
CLI!1 Toll-1 3-26 Rev.1-11/85
CPS-ODCM-3.6 Gaseoun Radwaste (Offcas Treatmenti !
3.6.1 Gaseous Radwaste (Offgas Treatment) System - Operation and Surveillance Requirements OPERATION REOUIREMTNT The GASEOUS RADWASTE (OFF%ji; TREATMENT SYSTEM shall be in operation. This requiespur, r:cylics whenever the main condenser steam jet air ejector c4n W 3e p1 operation. ;
REMEDIAL REOUIREMENT:
- a. With gaseous radwacC3 titIO 'the rain condenser air ejector '
system being discharged without treatment for more than 7 days, prepare and submit to the Regional Administrator of the Regional Office of the NRC within 30 days a Special Report that includes the following information:
- 1. Identification of any inoperabic equipment or subsystems, and the reason for the inoperability.
- 2. Action (s) taken to restore the inoperable equipment to OPERABLI status, and ;
- 3. Summary description of action (s) taken to prevent a recurrence.
SURVEILLANCE REOUIREMENTS 3.6.1.1 .The GASEOUS RADWASTE (OFFGAS verified to be in operation once every) TREATMENT SYSTEM 12 hours1.388889e-4 days <br />0.00333 hours <br />1.984127e-5 weeks <br />4.566e-6 months <br /> when shall be the main condenser air ejector is in use to ensure that the main condenser offgas treatment system is functioning.
NOTE Prior to placing the Offgas Treatment System in the charcoal bypass mode, the alarm setpoints for the Station KVAC Exhaust and the ,
Post-Treatment Offgas radiation monitors shall be calculated to account for the increased fractions of short-lived noble gases.
The noble gas release fractions shall be based either on actual measured values or on design basis noble gas concentration fractions (30-minute delay) in the primary coolant offgas.
l l
l I
l i
CLINTON-1 3-27 Rev.6-12/89 ,
CPS-ODCM 3.7 Ventilation Exhaust Treatment 3.7.1 Ventilation Exhaust Treatment System - Operation and Surveillance Requirement OPERATION REOUTPEMENT The VENTILATION EXHAUST TREATMENT SYSTEM (VETS) shall be used to reduce radioactive materials in gaseous waste prior to their discharge when the projected doses due to gaseous effluent releases to areas at and beyond the SITE BOUNDARY (coe Figure 3.1-1) would exceed 0.3 mrem to any organ in a 31-day period. This requirement applies at all times other than when the VETS is undergoing routine maintenance.
- REMEDIAL REOUIREMENT
- a. With gaseous waste being discharged without treatment and in excess of the above limit, prepare and submit to the Regional Administrator of the Regional Office of the-NRC1vithin 30 days a Special-Report that includes the following information:
- 1. Explanation of why gaseous radwaste was being discharged without treatment, identification of any inoperable equipment or subsystems, and the reason for the inoparability,
. . . . 2. Action (s) taken to restore the inoperable equipment to OPERABLE status, and
- 3. Summary description of action (s) taken to prevent a recurrence.
SURVEILIANCE REOUTREMENTS 3.7.1.1 Doses due to gaseous releases from the site shall be projected at least once per 31 days in accordance with this manual ;
when the ventilation exhaust treatment system is not in use.*
3.7.1.2 The installed VENTILATloN EXHAUST TREATMENT SYSTEM shall be considered OPERABLE by meeting the Operation Requirements of {
Sections 3.4, 3.5.1, and 3.5.2.
{
l
- The projected doses resulting from such releases will be calculated using Section 3.5.4 methodology. If the doce impact resulting from the projected 31-day release exceeds 0.3 mrom and the VETS.is capable of reducing the projected impact to less than 0.3 mrom, the VETS shall be used.
CLINTON-1 i
3-28 Rev.6-12/89 i
_ , _ _ __ _ . ~ . - -- - - ~ ~ - - - - ~ ' - - - - ~ ~ - - " ~ ~ ~ ~ ' ~ ~ ~ ~ - ~ ~
i CPS-ODCM !
I t
3.8 Effluent Monitor S_etnoint Calculations l
\
Gaseous effluent Process Radiation Monitor (PRM) alarm setpoints !
shall be calculated to ensure that the donc rate in unrestricted -
areas due to nobic gases released do not exceed 500 mrem / year to !
the total body and 3000 mrom/ year to the skin. The initial '
setpoints were calculated using the DRR-GALE code radionuclide mix obtained for CPS; when the actual radionuclide mix can be i determined, it will be used for cetpoint calculations. The PRM setpoints are based on the instantaneous nobic gas dose rates and l are applied at the point of which the effluent enters an i unrestricted area.
l Due to PRM limitations, non-noble gas setpoints will not be I implemented to demonstrate compliance with Section 3.4.1(b). t compliance with the organ dore rate limitation is demonstrated l during performance of sampling and analysis activities required by l Table 3.4-1.
l Both total body and skin dose setpoints will be calculated and the
~
more restrictive limit applied to the respective PRM. The actual !
setpoint used may be lower than the restrictive limit since the two i release points will be partitioned such that their sum does not exceed 100 percent of the restrictive limit. The percentages used [
to partition the release points could vary at plant discretion to l accommodate plant operational conditions. In no case will the i combined releases due to variations in the PRM setpoints result in i effluent limits being exceeded. !
, 3.8.1 Total Body Dose Rate Setnoint The fraction of the total gaseous radioactivity in each (
gaseous effluent release path j for each noble gas j radionuclide i shall be determined using the following t relationsnip:
f i$=Cj i , dimensionless (18)
EC i ig ;
i wherc !
=
Cji The measured concentration of l identified noble gas radionuclide i }
in gaseous effluent release path j, ;
C1/cc j The maximum acceptable release rate of all noble h gases in release path j to comply with section 3.4.1 is calculated by using the equation:
Qj=T 500 Fj , pCi/sec (19) i (X/Q)$ri(Kiif j) {
?
CLINTON-1 3-29 .v.6-12/89 [
i l
CPS-0DCM where Qj= T The maximum acceptable release rate of all noble gases in release path j, pC1/sec Fj = Total dose rate allocation factor assigned to release path j (varying between 0.0 and 1.0), dimensionless 500 = Total body dose rate limit specified in Section 3.4.1(a), mrom/ year The highest calculated 4 (X/Q) $ = average relative concentration of release
, path j at the site boundary Ki= The total body dose factor due to gamma emissions of noble gas radionuclide i as listed in Table B-1 of Regulatory Guide 1.109 and Table 3.4-2ofthjsmanual, mrem /yr per pC1/m f The fraction as defined by
'#^ i$ = equation (18) ,
dimensionless The total maximum acceptable concentration setpoint of noble gas radionuclides in release path j is calculated using the following equation:
Cj=
T Tj, yCi/cc (20)
"j where CjT
= The total maximum acceptable concentration f setpoint of all noble gases in release path j, #Ci/cc 1
l i
i i
CLINTON-1 3-30 Rev.6-12/89
i' CPS-0DCM Qj=T The maximum acceptable !
release rate of all noble gases in release path j determined from equation (19), 4C1/sec l l
R The effluent release rate
$= of release point j, cc/sec !
t t
3.8.2 Skin Dose Pate Setnoint c To ensure compliance with the Section 3.4.1(a) skin dose rate limit, PRM setpoints shall be calculated !
using the methodology presented in section 3.8.1 and by !
substituting the following equation for equation (19): j Qg$ = 3000 Fj , #Ci/sec (21) f (X/Q) 3ri(Li +1.1Mi ) fi j j where ,
Q33
= The maximum acceptable release rate f of all noble gases in release path i j, 4Ci/sec !
t F = Total dose rate allocation factor :
assigned to release path j (varying between 0.0 and 1.0), dimensionless i
'r, ?
3000 = Skin dose rate limit specified in !
Section 3.4.1(a), mrom/ year j (X/Q)$ = The highest calculated average l relative concentration of release !
path j at the site-boundary j r
Li = The skin dose factor due to gamma j emissions for each identified noble !'
gas rgdionuclide i, mrem /yr per
- C1/m , as listed in Table 3.4-2 of
{
this Manual.
1.1 = An air dose to skin dose equivalent {
conversion factor, mrem / mrad 1
Mi = The air dose factor due to gamma emissions for each identified noble gas rgdionuclide 1, mrad /yr per 4Ci/m , as listed in Table 3.4-2 of
! l this Manual ,
1
?
I I
L ;
I
?
CLINTON-1 3-31 Rev.6-12/89 {
L :
l -
f L -
[
cps-ODCN fj i = The fraction defined by equation (18)
The calculated total body and skin maximum acceptablo concentration setpoints are compared and the more rostrictivo setpoint used. A safety factor may also be applied to the concentration sotpoint calculated by aquation (20) to compensate for statistical fluctuations and measurement errors.
1, i
l l
l i
I' 1
- CLINTON-1 3-32 Rev.5-2/89
._2._ . - - . - - - . _ _ . .
- . - _ . . . - - - - - - - . . - . - . . - - - ~ _ - - _ _ . . -
I i
i CPS-ODCH 3.9 Radioactivo Gaseous Monitorina Instrumenta. tion i
3.9.1 Offgas Radiation Monitoring Instrumentation - Operation and j Survoillance Requirements !
OPERATION REOUIREMENT !
The offgas radiation monitoring instrumentation channels shown in !
Table 3.9.1-1 shall be OPERABLE, with their alarm / trip setpoints I within the specified limits. This requirement applios during j operation of the main condenser air ejector (s).
REMEDIAL REOUIREMENT:
- a. With a radiation monitoring instrumentation channel alarm / trip ;
setpoint exceeding the value shown in Table 3.9.1-1, adjust the j sotpoint to within the limit within 4 hours4.62963e-5 days <br />0.00111 hours <br />6.613757e-6 weeks <br />1.522e-6 months <br /> or declaro the !
channel inoperablo. i I
- b. With one or more radiatien monitoring channels inoperable, '
comply with the REMEDIAL REQUIREMENT specified by Tablo 3.9.1-1.
SURVEILLANCE REQUIREMENTS l 1
3.9.1.1 Each of the above required radiation monitoring instrumentation channels shall be demonstrated OPERABLE by the performance of the CHANNEL CHECK, SOURCE CHECK, CHANNEL FUNCTIONAL TEST and CHANNEL CALIBRATION at the frequencies shown in l Table 3.9.1-2. i
+ !
I i
I l,
l r
h
.i, I
l i
CLINTON-1 3-33 Rev.6-12/89 1
i
...-:-..~m. . . . ,,,,,...-.,,-.,m....
. . . , . - . - _ . , - - - - - - . . _ . - - . _.-,---.~.--.--,U.-~--.--, '
I-CPS-ODCM TABLE 3.9.1-1 OFFGA$ RADIATIOli MONITORING INSTRUMENTATIOli MINIMUM CIIANNELS ALARM / TRIP REMEDIAL If3STRUMENTATION OPERABLE! SETPOINT REOUIREMENT
- 1. Pre-treatment.Off gas 1(D) $ 50 pCi/cc***O 5 PRM - Noble Gas Activity Monitor
/
- 2. Post-treatment Of f-gas PRM
- a. liigh-Range Noble l IDI $ 7.06 pCi/ccbb 6 Gas' Activity Monitor Providing Alarm and i
Automatic Termina-i tion of Release 5
- b. Effluent System !
1 NA 7 I Flow Rate Measuring i Device
- c. Sample Flow Rate 1 NA 7 Measuring Device CLINTON-1 3-34 Rev.6-12/89
CPS-ODCM TABLE 3.9.1-1 (Continuedl L
OFFGAS LADIATION_MONITORTNG INSTRUMEETATION
, TABLE NOTATIONE
- Alarm only,
~
f A channel- nay be placed in an inoperable status for up to 1 hour1.157407e-5 days <br />2.777778e-4 hours <br />1.653439e-6 weeks <br />3.805e-7 months <br /> for the pur;ose of performing surveillances.
$ Reactivity concentration expected at the monitor location is a noble gas mix with a 2.9-minute decay.
$$ Radioactivity concentration expected at the monitor location is a noble gas mix released from the off-gas treatment system.
(b) Channel OPERABILITY shall include the capabi)ity of either
) ~
the Main Control Room Central Control Termin.1 (MCR-CCT) or the Radiation Protection Office Central Contr -1 Terminal (RP-CCT) to provide the alarm status of the applicable radiation monitor channel (s).
REMEDI f, 7EOUIREMENT REMEDIAL REQUIREMENT a. With both th, MCR-CCT and RP-CCT 5 inoperable,
- 1. Perform a CHANNEL CHECK using local monitor indication within 8 hours9.259259e-5 days <br />0.00222 hours <br />1.322751e-5 weeks <br />3.044e-6 months <br /> and at least once i per 8 hours9.259259e-5 days <br />0.00222 hours <br />1.322751e-5 weeks <br />3.044e-6 months <br /> thereafter, and
- 2. Restore the MCR-CCT or RP-CCT to OPERABLE 1 status for the applicable channel (s) within the next 30 days, and if unsuccessful, prepare and submit to the Regional' Administrator of the Regional Office of the NRC within the next 10 days a Speci-1 Report outlining the cause of the CCT failure or malfunction and the action taken to restore the inoperable equipment to OPERABLE status,
- b. With the Pre-treatment Off gas PRM - Noble Gas Activity Monitor otherwise inoperable, gases from the main condenser off-gas treatment system may be released to the environment providod:
- 1. The off-gas treatment system is not bypassed, and CLINTON-1 3-35 Rev.6-12/89
CPS-ODCM TABLE 3.9.1-1 (Contintiqdi OFFGAS PADIATION MONITORING INSTRUMENTATION TABLE NOTATIONS
- 2. The post-treatment air ejector off-gas PRM high rango noblo gas activity monitor is OPERABLE, or the provisions of REMEDIAL REQUIREMENT 6-b are in offect, and
- 3. Grab samplos are taken at least enco por 8 hours9.259259e-5 days <br />0.00222 hours <br />1.322751e-5 weeks <br />3.044e-6 months <br /> and analyzed for gross noble gas activity within 4 hours4.62963e-5 days <br />0.00111 hours <br />6.613757e-6 weeks <br />1.522e-6 months <br />.
RIMEDIAL REQUIREMENT a. With both the MCR-CCT and RP-CCT inoperable, C
- 1. Perform a CHANNEL CHECK using local monitor indication within 8 hours9.259259e-5 days <br />0.00222 hours <br />1.322751e-5 weeks <br />3.044e-6 months <br /> and at least once por 8 hours9.259259e-5 days <br />0.00222 hours <br />1.322751e-5 weeks <br />3.044e-6 months <br /> thoroafter, and
- 2. Rostoro the MCR-CCT or RP-CCT to OPERADLE status for the applicable channol(s) within the next 30 days, and if unsuccessful, preparo and submit to the Regional Administrator of the Regional Offico of the NRC within the next 10 days a Special Report outlining the cauco of the CCT failuro or malfunction and the action taken to rostore the inoperable equipment to OPERABLE status,
- b. With the Post-treatment Off-gan PRM High Range Noblo Gas Activity Monitor otherwise inoperablo, offluent roloasos via this pathway may continuo provided grab samplos are tahon at least once por 8 hours9.259259e-5 days <br />0.00222 hours <br />1.322751e-5 weeks <br />3.044e-6 months <br /> and analycod for gross noble gas activity within 24 hours2.777778e-4 days <br />0.00667 hours <br />3.968254e-5 weeks <br />9.132e-6 months <br />.
REMEDIAL REQUIREMENT With the number of channels OPERABLE loss than 7
required by the Minimum Channels OPERABLE requiro-mont, offluent releason via this pathway may continuo provided the flow rato is estimated at
, least onco por 8 hours9.259259e-5 days <br />0.00222 hours <br />1.322751e-5 weeks <br />3.044e-6 months <br />.
CLINTON-1 3-36 Rev.6-12/89
A TABLE 3.9.1-2 OFFGAS RADIATION MONITORING' INSTRUME!!TATIOff SURVEILLANCE REOUIREMENTS CIIANNEL CilANNEL CIIAliNEL SOURCE FUNCTIONAL CIIANNEL IllSTRUMENTATION CllECK CIIECK TEST CALIBRATION ,
- 1. Pre-Treatment Off-gas D(3) M Q(1)
PRM-Noble Gas R(2)
Activity Monitor -
l
- 2. Post-Treatment Off gas PRM
- a. High Range Noble D(3) D Gas Activity Monitor Q(1) R(2)b Providing Alarm and Automatic, Termination of Release
- b. Effluent Systen D NA Q R Flow-Rate Measuring
, Device
- c. Sample Flow-Rate D NA Measuring Device Q R
?
CLINTON-1 3-37 Rev.6-12/89 L. . . _ . . - - - _. . __ . . _
s CPS-ODCM TABLE 3.9.1-2 (Continued)
OFFGAS RADIATION MONITORING INSTRUMENTATION SURVEILLANCE REOUIREMEllTS TABLE NOTATIQH
$ Automatic isolation of valve IN66-F060 shall be demonstrated during the CHANNEL CALIBRATION.
(1) The CHANNEL FUNCTIONAL TEST shall also demonstrate that the MCR-CCT or RP-CCT responds with annunciation and event printout to each of the following conditions:
- 1. Instrument indicates measured levels above the alarm / trip (HIGH) setpoint.
- 2. Detector failure (LOW FAIL, HI FAIL) .
- 3. Sample flow failure (EXTERNAL FAIL) .
- 4. Instrument not set in normal operate mode (UNINITIALIZED, CALIBRATE, MAINTENANCE, or STANDBY).
(2) The initial CRANNEL CALIBRATION shall be performed using one or more of the reference standards certified by the National Institute of Standards and Technology (NIST) or using standards that have been obtained from suppliers that participate in measurement assurance activities with NIST.
These standards shall permit calibrating the system over its intended energy range and measurement range. Subsequent CHANNEL CALIBRATION shall be performed using the initial radioactive standards or other standards of equivalent quality or radioactive sources that have been related to the initial'calibrati'n. o (3) The CHANNEL CHECK shall also determine that channel communication is established to the MCR-CCT or RP-CCT, CLINTON-1 3-38 Rev.6-12/89
E i
-CPS-ODCM ;
3.9.2 Radioactive Gaseous Effluent Monitoring Instrumentation -
Operation and Surveillance Requirements OPERATION REQUIREMENT The radioactive gaseous effluent monitoring instrumentation channels shown in Table 3.9.2-1 shall be OPERABLE with their alarm / trip sccpoints set to ensure that the limits of Section 3.4 1 and Technical Specification 3.7.8.2 are not exceeded. The alarm / trip setpoints of these channels shall be determined and adjusted in accordance with the methodology and parameters in the this manual. This requirement applies as shown in Table 3.9.2-1.
REMEDIAL REOUIREMENT:
- a. With a radioactive gaseous effluent monitoring instrumentation channel alarm / trip setpoint less conservative than required by the above requirement, immediately suspend the release of radioactive gaseous effluents monitored by the affected channel, or declare the channel inoperable.
- b. With less than the minimum number of radioactive gaseous effluent monitoring instrumentation channels OPERABLE, comply with the REMEDIAL REQUIREMENT specified in Table 3.9.2-1.
Restore the inoperable instrumentation to OPERABLE status within 30 days and, if unsuccessful, explain in the next Semiannual Radioactive Effluent Release Report pursuant to Technical Specification 6.9.1.7 why this inoperability was not corrected in a timely manner.
~-
SURVEILLANCE REOUTREMENTS 3.9.2.1 Each radioactive gaseous effluent monitoring instrumentation channel shall be demonstrated OPERABLE by performance of the CHANNEL CHECK, SOURCE CHECK, CHANNEL CALIBRATION and CHANNEL FUNCTIONAL TEST operations at the frequencies shown in Table 3.9.2-2.
i CLINTON-1 3-39 Rev.6-12/89
4 CPS-ODCM '
TABLE 3.9.2-1 RADIOACTIVE GASEOUS EFFIJJEtiT MOllITORII!G IllSTRUMEtiTATIOli MIllIMUM g REMEDIAL ITI S T R U M Ell T CifA!!!iELS OPERABLE APPLICABILITY REOUIREMEliT
- 1. Station liVAC Exhaust PRM
- a. High-Range lloble Gas 1(a) . g Activity Monitor /
- b. Low-Range floble Gas 1(a) , , g Activity Monitor
- c. Iodine Sampler 1
- 9
- d. Particulate Sampler 1
- 9
- c. Sample Flow-Rate 1
- 10 Measuring Device
- f. Effluent System Flow 1
- 10 Rate Measuring Device
- 2. S,tandby Gas Treatment Systen Exhaust PRM
- a. High-Range lioble Gas 1(a) ,, g Activity Monitor
., r
- b. Low-Range lloble Gas 1(a) ** 8 Activity Monitor i i
l i
CLIliTON-1 3-40 Rev.6-12/89
% 1 s
CPS-ODCM TABLE 3.9.2-1-(Continued)
RADIOACTIVE GASEOUS EFFLUEliT MOflITORIliG IllSTRUMEliTATIOli MIllIMUM g REMEDIAL IllSTRUMEllT CHAll!IELS OPERABLE APPLICABILITY '
REOUIREME!!T
- 2. Standby Gas Treatment System Exhaust PRM (Continued) f
- c. Iodine Sampler 1 ** 9
- d. Particulate Sampler 1 ** 9
- e. Sample Flow-Rate 1 ** 10 Measuring Device
- f. Effluent System Flow- 1 ** 10 Rate Measuring Device t
+
i I >
CLIIITOll-1 3-41 Rev.6-12/89
CPS-ODCM TABLE 3.9.2-1 (Continued)
RADIOACTIVE GASEOUS EFFLUENT MONITORING INSTRUMENTATION TABLE NOTATIOt1H
- At all times.
During standby gas treatment system operation.
A channel may be pl' aced in an inoperable status for up to 1 hour1.157407e-5 days <br />2.777778e-4 hours <br />1.653439e-6 weeks <br />3.805e-7 months <br /> for the purpose of performing surveillances.
(a) Chat- 1 OPERADILITY shall include the capability of either the Ma3 atrol Room Central Control Terminal (MCR-CCT) or the ti 1
.deProtection the alarmOffice statusCentral of the Control Terminal applicable (RP-CCT) radiation tv
. tor channel (s).
REMEDIAL REOUIREMENT REMEDIAL a.
REQUIREMENT With both the MCR-CCT and RP-CCT inoperable, 8
perform a CHANNEL CHECK using local monitot indication within 8 hours9.259259e-5 days <br />0.00222 hours <br />1.322751e-5 weeks <br />3.044e-6 months <br /> and at least once per 8 hours9.259259e-5 days <br />0.00222 hours <br />1.322751e-5 weeks <br />3.044e-6 months <br /> thereafter.
- b. With the noble gas activity monitor w channel (s) otherwise inoperable, effluent releases via this pathway may continue provided grab samples are taken at least once per a hours and analyzed for gross noble gas activity within 24 hours2.777778e-4 days <br />0.00667 hours <br />3.968254e-5 weeks <br />9.132e-6 months <br />.
REMEDIAL REQUIREMENT With the number of channels OPERABLE less than required by the Minimum Channels OPERABLE 9
requirement, effluent releases via this pathway may continue provided that, within 4 hours4.62963e-5 days <br />0.00111 hours <br />6.613757e-6 weeks <br />1.522e-6 months <br /> after the channel has been declared inoperable, samples are continuously collected with auxiliary sampling equipment as required in Table 3.4-1.
REMEDIAL REQUIREMANT With the-number of channels OPERABLE less than required by the Minimum Channels OPERABLE 10 requirement, effluent releases via this pathway may continue provided the flow rate-is estimated at least once per 4 hours4.62963e-5 days <br />0.00111 hours <br />6.613757e-6 weeks <br />1.522e-6 months <br />.
CLINTON-1 3-4; Rev.6-12/89
CPS-ODCN '
i TABLE 3.9.2-2 RADIOACTIVE GASEOUS EFFLUEliT MO!!ITORIliG IllSTRUffErlTATIOff SURVEILIAfiCE REOUIREMEtiTS CIIAlillEL CIIAlillEL SOURCE CIIAlltiEL FUllCTIOfiAL INSTRUMENT CIIECK CIIECK CALIBRATIOli TEST APPLICABILITY *
- 1. Station IIVAC Exhaust PRM
- a. Ifigh-Range Noble D(3) !! / R(2) Q(1)
- Gas Activity 1 Monitor .
- b. Low-Range lloble D(3) M R(2) Q(1)
- Gas Activity Monitor ,,
- c. Iodine Samplek W NA NA liA
- I
- d. Particulate W fiA NA NA *
! Sampler ..
- e. Sample Flow Rate D NA R Q *
, Measuring Device l f. Effluent System D NA R Q * '
Flow Rate Measuring Device
- 2. Standby Gas Treatment System Exhaust PRM j f
- a. Iligh-Range Noble D(3) NA R(2) Q(1) **
Gas Activity i
Monitor
- b. Low-Range Noble D(3} M R(2) Q(1) **
- Gas Activity Monitcr CLIllTON-1 3-43 Rev.6-12/89 l
3 CPS-ODCM TABLE 3,9.2-2 (Continued)
RADIOACTIVE GASEOUS - EFFLUEllT MOllITORI!IG IllSTRUMEllTATIOli SURVEILLA! ICE REOUIREMEliTS ~ :
CilAlillEL CllAllllEL SOURCE CIIAllNEL FUllCTIOllAL IllSTRUMEllT CllECK CIIECK CALIBRATIOli TEST APPLICABILITY-
- c. Iodine Sampler W NA 13A liA -
- d. Particulate W liA !
Sampler f liA flA ** *
- e. Sample Flow- D liA R Rate Measuring Q **
Device
- f. Effluent System D flA R Flow-Rate Q **
Measuring Device i 4
i CLIliTON-1 3-44 Rev.6-12/89
CPS-ODCM TABLE 3.9.2-2 (Continuedl RADIOACTIVE GASEOUS EFFLUENT MONITORING INSTRUMENTATION SURVEILLANCE REOUIREMENTS TABLE NOTATIONS At all times.
During operation of the standby gas treatment system.
(1)
The CHANNEL FUNCTIONAL TEST shall also demonstrate that the MCR-CCT or RP-CCT rbsponds with annunciation and event printout to each of the following conditions:
1.
Instrument indicates measured levels above the alarm (HI.GH) setpoint.
2.
Detector failure (LOW FAIL, HI FAIL).
3.
Sample flow failure (EXTERNAL FAIL) .
4.
Instrument not set in normal operate mode (UNINITIALIZED, CALIBRATE, MAINTENANCE, or STANDBY).
(2) The initial CHANNEL CALIBRATION shall be performed using one or more of the reference standards certified by the National Institute of Standards and Technology (NIST) or using standards that have been obtained from suppliers that participate in measurement assurance activities with NIST.
These standards shall permit calibrating the system over its intended range of energy and measurement range. Subsequent
' CHANNEL CALIBRATION shall be-performed using the initial radioactive standards or other standards of eauivalent quality or radioactive sources that have been relat'.a to the initial calibration.
(3)
The CHANNEL CHECK shall also determine that channel communication is established to the MCR-CCT or RP-CCT.
CLINTON-1 3-45 Rev.6-12/89
CPS-ODCM O
, d a- C*
- ee - w w 0
> W$ ) $ $ "
O #- o o .! O '
- J ma" s s >
sfe G"wo e e a 0
3 S
= EEE5 -u 5 3:53 %
- 5 -2n~ 2., 2:a a ;
, 3 : *o 03== e wo* =
. a = ~ ~= g - a o.
e * .Iw
w o Be e ese s 2 o g .- 2 e
= = _s -~
- : "3 au .e*
- o- 3e o *<
m .: .~ =z,wer
<=e = = -.
- u. = G
<:=a n==E a:
d-
- 6
.2-w M
-o _ ;s.go.=, _-=2 u o m o .2 ,
wa a*4<*am CQw d ;g t
- z3= a.3C*CAO=o- o -- a3"c*-
$s 5 E p *5320$.$t$.5!!
-~=g-= *
=< .
sa,..
.s .
== . -
=a'- a u-
% won
===o qu,, =g d:o .s
- *<sutomd6,==*g. d*
o
- a aA 4 4 m . S u D 4 =,
m 2 m : -
d u.
N 8 w 2 e *3 m
C
= E Y<
w a
- m i <
m o
e O x g_ -
.s 5
w(
.=
==
-o e
a a w 3,
- I . *
^ .
y -3 M
3 M
.s g.;$ $ x ,!
o
=
< N a, c o3 55 < s
-av= y N
=
=
o N ea A y ,
h' )). 26 -
/ .
m g m
% o s s
~
D N. N x
\
W
'\ /
\i .
W
- =
0 -
a o
=
CLINTON-1 3-46 Rev.5-2/89
[ __
ODCM ,
FIGURE 3.3-1 r
MAIN CONDENSER OFF-GAS TREATMENT SYSTEM
"!fS!ff . Peace;i ~
l ) 1 /\
l INb6Zoc'A ] ,N ,-
/
he , ii d'7,_,. ,_
~ *
- ; uc
/ s 1 ?C ( # pw".. I
.-- m
~ t
] 7 O 44 :-
,i /M4pa. 6 @
y -
( I
^
vv ll '""4 l'
4A i
J ll @A 1 }R ,
p4 i
/ **
l M #' % i-
>++ H11 i i i
i%
T n b.
I ,
1* oen 7i ""* f4aut s ooa 3,,a
, t Y l CuatTA l ,
l l tI
[ CNc5 yV a
[~
um cuctn 'j
- ' ij ,-+- SCS Q 1Coc1 A }---
~ ~
M* "
urs * **ack 0 : o Pm " i I
Pr:L.ary/Seconda:7 '
co ntairnen t Exhausi
- Monitors required by Sections 3.9.1 and 3.9.2 1CD01A Main OCA01TA CV IN66B010B Cooler 1U66D013 1PR035 Off-cas Condenser Separator Tank A Condenser B Charcoal Adsorber Post Treatment PPJi 1CA01AA Steam Jet OCA0lTB CV 1N66Z003A IN66D016 HEPA 1PR041 Off Gas Air Ejector A Separator Tank B Dessicant Dryer A Filter Post Treatment PPJi 1CA01AB Steam Jet 1N66D005A IN66Z003B OPR001 HVAC OPR003 Standby Cas Air Ejector B Recombiner A Dessicant Dryer B Stack PRM v1 Treatment PRM OCA0lPA Condenser 1N66D005B 1U66B511Cas OPR002 HVAC OPR004 Standby Cas Vacuum (CV) Pu=p A Recombiner B Cooler Stack PRM #2 Treatment PPJ1 OCA0lPB CV Pump B IN66B010A Cooler 1N66D012 1PR034 Off-Gas Condenser A Charcoal Adsorber Pretreatment PPli i
i CLINTON-1 3-47 Rev.6-12/89
1 CPS 0DCM Table 3.5-1 IN1!ALATION DOSE FACTORS FOR INFAliT - (DFA1 )a (mrem per pCi inhaled)
NUCLIDE BONE LIVER T. BODY THYROID KIDNEY LUNC GI LT.I H3 NO DATA 4.62E 07 4.62E-07 4.62E 07 4.62E 07 4.62E 07 4.62E 07 C 14 1.89E 05* 3.79E 06 3.79E 06 3.79E OL 3.79E 06 3.79E-06 3.79E 06 NA 24 7.54E 06 7.54E 06 7,54E 06 7.54E-06 7.54E 06 7.54E 06 7.54E 06 P 32 1.45E 03' 8.03E 05 5,53E 05 NO DATA NO DATA NO DATA 1.15E 05 CR 51 NO DATA NO DATA 6.39E 08 4.11E-08 9.45E 09 9.17E 06 2.55E-07 '
MN 54 NO DATA 1.81E-05 3.56E 06 NO DATA 3.56E 06 7.14E 04 5.04E 06 !
t 101 56 NO DATA 1.10E-09 1.58E 10 7.86E 10 8.95E 06 NO DATA 5.12E 05 [
FE 55 1.41E 05 8.39E-06 2.38E-06 NO DATA NO DATA 6.21E 05 7.82E 07 l FE 59 9.69E 06 1.68E 05 6.77E-06 NO DATA NO DATA 7.25E 04 1.77E-05 !
CO 58 NO DATA 8.71E-07 1.30E 06 NO DATA NO DATA 5,55E-04 7.95E 06 '
CO 60 NO DATA 5.73E 06 8.41E 06 NO DATA .;0 DATA -3.22E 03 2.28E-05 i NI 63 2.42E 04 1.46E 05 8.29E 06 NO DATA NO DATA 1.49E 04 1.73E 06 )
a i
NI 65 1.71E-09 2.03E 10 8.79E-11 NO DATA NO DATA 5.80E 06 3.58E-05 !
CU 64- NO DATA 1,34E 09 5.53E 10 2.84E 09 NO DATA 6.64E 06 1.07E 05 ;
ZN 65 1.38E 05 4.47E-05 2.22E 05 N0' DATA 2.32E 05 4.62E 04 3.67E 05 ;
'l ZN 69 3.85E 11 6.91E-11 '5,13E 12 NO DATA 2.87E 11 1.05E-06 9.44E 06 BR 83 NO DATA NO DATA 2.72E-07 NO DATA NO DATA NO DATA LT E 24** l BR 84 .NO DATA NO DATA 2.86E 07 NO DATA NO DATA NO DATA LT'E 24 '
t BR 85 NO DATA- NO DATA .1.46E-08 NO DATA l
NO DATA NO DATA LT E 24 i RB 86 NO DATA 1.36E 04 6.30E 05 NO DATA- NO DATA NO DATA 2.17E 06 !
RB 88 NO DATA 3.98E 07 2.05E 07 NO DATA NO DATA NO DATA 2.42E 07 -
I RB 89 NO DATA 2.29E 07 1.47E-07 NO DATA NO DATA NO DATA 4.87E 08 SR 89 2.84E 04 NO DATA 8.15E-06 NO DATA NO DATA 1.45E 03 4.57E 05 SR 90 2.92E-02 NO DATA 1.85E-03 NO DATA NO DATA 8.03E 03 9.36E 05 '
SR-91 6.83E-08 NO DATA 2.47E 09 NO DATA NO DATA 3.76E 5.24E 05 !
SR 92 7.50E 09 NO DATA 2.79E-10 NO DATA NO DATA 1.70E-05 1.00E-04 Y 90' 2.3SE-06 NO DATA 6.30E-08 1.92E 04 NO DATA No DATA 7.43E 05 l j
i l
t t CLINTON 1 3-48 Rev.5-2/89 ;
L
CPS-ODCM i f
Table 3.5-1 (continued 1 ;
i INHALATION DOSE FACTORS FOR INFANT - (DFA1 )a ,
(nrem per pCi inhaled) I KUCLIDE BONE LIVER T. BODY TRYROID KIDNEY LUNC C I - LLI'
~
Y 91m 2.91E-10 NO DATA 9.90E-12 NO DATA NO DATA 1.99E-06 1.68E-06 Y 91 4.20E 04 NO DATA 1.12E-05 NO DATA NO DATA 1.75E 03 5.02E 05 [
Y-92 1.17E-08 NO DATA 3.29E-10 NO DATA NO DATA 1.75E-05 9.04E 05 }
l Y-93 $
1.07E-07 NO DATA 2.91E-09 NO DATA NO DATA 5.46E-05 1.19E 04 j ZR 95 8.24E-05 1.99E-05 1.45E-05 NO DATA 2.22E 05 1.25E-03 1.55E-05
-ZR-97 1.07E-07 1.83E-08 l 8.36E-09 NO DATA 1.85E 08 7.88E-05 1.00E 04 ,
. -NB 95 1.12E 05 4.59E-06 2.70E 06 NO DATA 3.37E 06 3.42E-04 9.05E 06 MO-99 !
NO DATA 1.18E-07 2.31E-08 NO DATA 1.89E-07 9.63E-05 3.48E-05 TC 99m 9.98E-13 2.06E-12 2,66E-11 NO DATA 2.22E-11 5.79E-07 1.45E 06 TC-101 \
4.65E-14 5,88E-14 5.80E-13 NO DATA 6.99E 13 4.17E-07 6.03E 07 '
RU-103 1.44E-06 NO DATA 4,85E-07 NO DATA 3.03E-06 3.94E-04 1.15E-05 :
RU-105 8.74E-10 NO DATA 2.93E-10 NO DATA 6.42E 10 1.12E-05 3.46E-05 ;
i t
RU+106- 6.20E-05 NO DATA 7.77E-06 NO DATA 7.61E-05 8.26E-03 1.17E-04 AG-110m 7.13E-06 5.16E-06 3.57E-06 NO DATA 7.80E-06 2.62E-03 2.36E 05 i TE 125m 3.40E-06 1.42E-06 4.70E-07 1,16E-06 NO DATA 3.19E-04 9.22E-06 !
TE 127m 1.19E 05 4.93E-06 1.48E-06 3.48E-06 2.68E-05 9.37E 04 1.95E 05 !
TE 127 1.59E-09 6.81E-10 3.49E-10 1.32E-09 3.47E-09 7.39E-06 1.74E 05 TE 129m 1.01E-05 4.35E-06 1.59E-06 3.91E-06 2.27E-05 1.20E-03 4.93E 05 TE 129 5.63E-11 2,48E-11 1.34E 11 4.82E-11 1.25E-10 2.14E-06 1.88E 05 !
TE 131m 7.62E-08 3.93E-08 2.59E-08 6.38E-08 1.89E 07 1.42E-04 8.51E-05 TE-131 1.24E-11 5.87E-12 3.57E-12 1.13E 11 2.85E-11 1.47E-06 5.87E-06 TE-132 2.66E-07 1.69E-07 1.26E-07 1.99E-07 7.39E-07 2.43E-04 3.15E 05 I-130 4.54E-06 9.91E-06 3.98E 06 1.14E-03 1.09E 05 NO DATA 1.42E-06 I-131 2.71E-05 3.17E-05 1.40E-05 1.06E-02 3.70E-05 NO DATA 7.56E I-132 1.21E-06 2.53E-06 8.99E-07 1.21E-04 2.82E-06 NO DATA 1.36E 06 L
r I-133 9.46E-06 1.37E-05 4.00E-06 2.54E-03 1.60E-05 NO DATA 1.54E-06 ;
I-134 6.58E 07 1.34E-06 4.75E 07 3.18E 05 1.49E-06 NO DATA 9.21E-07 i 3
)
CLINTON-1 3-49 Rev.5-2/89 [
- - e --
- . ~_ . _
-. ,_- -. - __ - . -- - . . - ~. -. - . _ .
l CPS-ODCM ,
l l
l Table 3.-5-1 (continued)
INHALATION DOSE FACTORS FOR INFANT - (DFA1)a
.(mrem per pCi inhaled)
NUCLIDE BONE' LIVER T. BODY TRYFOID KIDNEY LUNG GI-LLI I-135 2.76E-06 5.43E 06 1.98E 06 4.97E-04 6.05E-06 NO DATA 1.31E 06 CS-134 2.83E 04 5.02E-04 5.32E 05 NO DATA 1.36E-04 5.69E-05 9.53E-07 CS 136 3.45E-05 9,61E 05 3.78E-05 4.03E-05 NO DATA 8.40E 06--- 1.02E 06 CS-137. 3.92E-04 4.37E-04 3.25E-05 NO DATA 1.23E-04 5.09E-05 9.53E 07 CS-138- 3.61E-07 5.58E 07 2.84E-07 2.93E-07 NO DATA 4.67E 08 6.26F 07 BA-139 1.06E-09 7.03E-13 3.07E 11 NO DATA 4.23E 13 4.25E 06 3.64E-05 BA 140 4.00E-05 4.00E-08 2.07E 06 9,59E-09 1.14E-03 NO DATA 2.74E 05 BA 141 1.12E-10 7.70E 14 3.55E-12 NO DATA 4,64E-14 2.12E-06 3.39E-06 BA 142 2.84E-11 2.36E 14 1.40E-12 1.36E-14 NO DATA 1.11E 06 4.95E 07 IA-140 3.61E-07 1.43E-07 3.68E-08 1.20E 04 NO DATA NO DATA 6.06E-05 1A-142 7.36E-10 2.69E 10 6.46E NO DATA NO DATA 5.87E-06 4.25E 05 CE 141 1.98E-05 1.19E 05- 1.42E 06 3.75E 06 NO-DATA 3.69E 04 1.54E-05'
- n CE-143 2.09E-07 1.38E 07 1.58E 08 4.03E-08 NO DATA -8.30E-05 3.55E-05 CE 144 2.28E 03 8.65E 04 1.26E-04 NO DATA 3.84E-04 7 03E 1.06E 04 PR 143 1,00E-05 3.74E-06 4.99E 07 1.41E-06
-NO DATA 3.00i 04 2.66E 05 PR-144 3,42E-11 1.32E 11 1.72E 12- NO DATA 4.80E-12 -1.15E 06 3.06E-06 ND 147-- 5.67E-06 5.81E-06 3.57E-07 NO DATA 2. 25 E-- 06 2.30E-04 2.23E 05 V-187- -9.26E-09 6.44E 2,23E 09 2.83E 05
.NO DATA NO DATA- 2.54E NP 239: 2.65E-07 1.34E 08 4.73E-08
- 2. 3 7 E- 08_ - NO DATA 4.25E-05 1.78E 05-
- 1.89 X 10-05
- Less than 10 -
CLINTON-1 3-50 Rev.5-2/89
.ur.> vuun I
Table 3.5-2 INHALATION DOSE FACTORS FOR CHILD - (DFAi)a (mrem per pCi inhaled)
NUCLIDE BONE LIVER T. BODY THYROID KIDNEY LUNG GT-LLI 4 H 3. NO DATA 3.04E-07 3.04E-07 3.04E-07 3.04E-07 3.04E 07 3.04E-07 I C-14 9.70E-06* 1.82E-06 1.82E-06 1.82E 06 1.82E-06 1.82E-06 1.82E 06 NA 24 4.35E-06 4.35E-06 4.35E-06 4.35E-06 4.35E-06 4.35E 06 4.35E 06 P-32 7.04E-04 3.09E-05 2.67E-05 NO DATA NO DATA NO DATA '1.14E 05 CR 51 NO DATA NO DATA 4.17E-08 2.31E-OS 6.57E-09 4.59E-06 2.93E 07
- MN 54 NO DATA 1.16E 05 2.57E-06 2.71E 06 4.26E 04 NO DATA 6.19E 06 l
MN NO DATA 4.48E 8.43E-11 4.52E-10 3.55E-06 NO DATA 3.33E-05 .
FE 55 1.28E-05 6.80E 06 2.10E-06 3.00E-05 NO DATA NO DATA 7.75E-07 I FE 59 5,59E-06 9.04E-06 4.51E-06 NO DATA 3.43E-04 NO DATA 1.91E-05 CO-58 NO DATA 4.79E 07 8.55E-07 NO DATA NO DATA 2.99E 04 9.29E-06 CO-60 NO DATA 3.55E-06 6.12E-06 NO DATA NO DATA 1.91E-03. 2.60E-05 NI-63 2.22E 04 -1.25E-05 7.56E-06 NO DATA NO DATA 7.43E-05 1.71E 06
-4 NI-65 8.08E-10 7.99E-11 4.44E-11 NO DATA NO DATA 2.21E-06 2.27E-05 CU 64 NO DATA 5.39E-10 2.90E-10 1.63E-09 NO DATA 2.59E-06 9.92E 06 .
ZN-65 1.15E-05 3.06E-05 1.90E-05 1.93E 05 2.69E 04 NO DATA 4.41E-06 ;
ZN-69 1.81E-11 2.61E 2.41E-12 1.58E-11 3.84E-07 NO DATA 2.75E-06 ,
BR-83 NO DATA NO DATA -1.28E-07 NO DATA NO DATA NO DATA LT E-24** l BR-84 NO DATA NO DATA 1.48E-07 NO DATA NO DATA NO DATA LT E-24 .
I BR 85 NO DATA .
NO DATA 6.84E-09 NO DATA 'NO DATA NO DATA LT E 24 .
RB-86 NO DATA 5.36E-05 3.09E-05 NO DATA NO DATA NO DATA 2.16E-06 f RB 88 NO DATA 1.52E-07 9.90E-08 NO DATA NO DATA NO DATA 4.66E j RB-89 NO DATA 9.33E-08 7.83E-08 NO DATA NO DATA NO DATA 5.11E-10 f SR-89 1.62E 04 NO DATA 4.66E-06 5.83E-04 NO DATA NO DATA 4.52E-05 i 8R-90 2.73E-02 NO DATA 1.74E 03 3.99E-03 NO DATA NO DATA 9.28E-05 '
i h
i CLINTON-1 3-51 Rev.5-2/89 [
I
i CPS-ODCM i
Table 3.5-2 (continued) ,
INHALATION DOSE FACTORS FOR CHILD - (DFAi)a (nrem per pCi inhaled)
NUCLIDE BONE LIVER T. BODY THYROID KIDNEY LUNG GI LLI h SR-91 3.28E-08 NO DATA 1.24E 09 1.44E 05 NO DATA NO DATA 4.70E 05 SR-92 3.54E 09 NO DATA 1.42E-10 NO DATA NO DATA 6.49E 06 6.55E 05 Y-90 1.11E 06 NO DATA 2.99E-08 NO DATA 7.07E 05 NO DATA 7.24E 05
- Y 91m 1.37E-10 NO DATA 4.98E-12 NO DATA NO DATA 7.60E-07 4.64E-07 l Y-91 2.47E 04 NO DATA 6.59E 06 7.10E-04 '
NO DATA NO DATA 4.97E 05 Y-92 5,50E 09 NO DATA 1.57E-10 6.46E 06 NO DATA NO DATA 6.46E-05 i
Y 93 5.04E 08 NO DATA 1.38E-09 2.01E 05 NO DATA NO DATA 1.05E 04 ZR-95 5.13E 05 1.13E-05 1.00E-05 1.61E-05 6.03E-04 NO DATA 1.65E-05 !
ZR-97 5.07E-08 7.34E 09 4.32E-09 1.05E-08 NO DATA 3.06E 05 9.49E 05 ._
t NB-95 6.35E-06 2.48E-06 1.77E 06 2.33E 06 1.66E-04 NO DATA 1.00E 05 MO 99 30 DATA 4.66E-08 1.15E-08 1.06E-07 NO DATA 3.66E-05 3.42E 05 TC 99m 4.81E-13 9.41E-13 1.56E-11 1.37E 11 NO DATA 2.57E 07 1.30E-06
- TC 101 2.19 E-14 2.30E-14 2.91E-13 3.92E 13 1.58E 07 NO DATA 4.41E 09 RU 103 7.55E 07 NO DATA 2.90E-07 NO DATA 1.90E-06 1.79E-04 1.21E 05 RU-105- 4.13E 10 NO DATA 1.50E-10 3.63E 10 NO DATA 4.30E-06 2.69E 05 RU-106 3.68E-05 NO DATA 4.57E-06 NO DATA 4.97E 05 3.87E-03 1,16E-04 AC 110m 4.56E 06 3.08E 06 2.47E-06 5.74E-06 NO DATA 1.48E-03 2.71E 05 TE-125m 1.82E-06 6.29E-07 2.47E-07 5.20E 07 NO DATA 1.29E-04 9.13E 06 !
TE-127m 6.72E 06 2.31E-06 8.18E-07 1.64E-06 1.72E 05 4.00E-04 1.93E-05 ,
TE 127 7.49E-10 2.57E-10 1.65E-10 5.30E-10 1.91E-09 2.71E-06 1.52E 05 TE-129m 5~.19E-06 1.85E-06 8.22E-07 1.71E 06 1.36E 05 4.76E-04 4.91E-05 TE 129 2.64E-11 9.45E-12 6.44E-12 1.93E-11 6.94E-11 7.93E-07 6.89E TE-131m 3.63E-08 1.60E-08 1.37E 08 2.64E 08 1.08E-07 '
5.56E 05 8.32E-05 TE-131 5.87E-12 2.28E-12 1.78E-12 4.59E 12 1.59E 11 5.55E-07 3.60E-07 TE-132 1.30E-07 7.36E-08 7.12E-0S 8.58E-08 4.79E-07 1.02E 04 I-130 3.72E-05 2.21E-06 4.43E-06 2.28E-06 4.99E-04 6.61E 06 NO DATA 1.38E-06 :
1 131 1.30E 05 1.30E-05 7.37E-06 4.39E-03 2.13E-05 NO DATA 7.68E-07 .
CLINTON-1 3-52 Rev.1-11/85 L . ._ ,_ _
CPS-ODCM ,
Table ?.5-2 (continued) !
INHALATION DOSE FACTORS FOR CHILD - (DFAi)a i (mrem per pCi inhaled)
NUCLIDE i
BONE LIVER T. BODY THYPOID KIDNEY LUNG GI-LLI f
I 132 5.72E-07 1.10E 06 5.07E 07 S.23E-05 1.69E-06 NO DATA 8.65E-07 1-133 4.48E-06 5.49E-06 2.0BE 06 1.04E-03 9.13E-06 NO DATA 1.48E-0A '
I-134 3.17E 07 5.84E-07 2.69E 07 1.37E-05 8.92E-07 NO DATA 2.556-07 i
f I-135 1.33E-06 2.36E 06 1.12E 06 2.14E-04 3.62E 06 NO DATA 1.20E-06 CS-134 1.76E-04 2.74E-04 6.07E 05 8.93E 05
'f NO DATA 3.27E 05 1.04E 06 l CS-136 1.76E-05 4.62E-05 3.14E-05 NO DATA 2.58E-05 3.93E-06 1.13E 06 ;
CS-137 h 2.45E 04 2.23E 04 3.47E 05 NO DATA 7.63E 05 2.81E-05 9.78E-07 !
CS-138 1.71E 07 2.27E 07 1.50E 07 NO DATA 1.68E 07 1.84E 08 7.29E-08 BA-139 4.98E 10 [
2.66E 13 1.45E 11 NO DATA 2.33E 13 1.56E-06 1.56E 05 l l
t BA-140 2.00E-05 1.75E 08 1.17E 06 NO DATA 5.71E-09 4.71E 04 2.75E-05 I BA-141 5.29E-11 2.95E-14 1.72E 12 NO DATA 2.56E-14 7.89E 07 7.44E 08 >
BA-142 1.35E-11 9.73E 15 7.54E-13 NO DATA 7.87E-15 4.44E-07 7.41E-10 _j f
4" LA-140 1.74E-07 6,08E-08 2.04E-08 NO DATA NO DATA 4.94E 05 6.10r f5 LA-142 3.50E-10 1.11E-10 3.49E 11 NO DATA NO DATA 2.35E 06 2.0' CE-141 1.06E-05 '{
-5.28E-06 7.83E 07 NO DATA 2.31E 06 1.47E 04 1.53 s !
CE-143 9.89E-08 5.37E-08 7.77E 09 2.26E-08 3.12E-05 NO DATA 3.44E-05 CE-144 1.83E-03 5.72E-04 9.77E 05 NO DATA 3.17E-04 3.23E-03 1.05E-04 i
' PR-143 4.99E-06 1.50E-06 2.47E-07 No DATA 8.11E 07 -1.17E-04 2.63E-05 PR-144 1.61E-11 4.99E-12 8.10E 13 NO DATA 2.64E-12 4,23E 07 5.32E-08 !
ND-147 2.92E-06 2.36E-06 1.84E 07 NO DATA 1.30E-06 -8.87E-05 2.22E-05 )
V-187 4.41E 2.61E-09 1.17E-09 NO DATA NO DATA 1.11F-05 2.46E-05 i
NP-239 1.26E-07 9.04E-09 6.35E-09 NO DATA 2.63E-08 1.57E-05 1.13E-05 .
t i
- 9.70 X 10 -06
- Less than 10-24 {
t F
CLINTON-1 3-53 Rev.1-11/85 [
CPS-ODCM
. Table 3.5-3 INHALATION DOSE FACTORS FOR TEEN - (DFA1)a (mrem per pCi inhaled)
NUCLIDE BONE LIVER T. BODY THYROID KIDNEY QJNG GI-LLI H-3 NO DATA 1.59E 07 1.59E 07 1.59E 07 1.59E 07 1.59E 07 1.59E 07 C-14 3.25E 06* 6.09L 07 6.09E 07 6.09E 07 6.09E 07 6.09E 07 6.09E 07 NA 24 1.72E 06 1.72E 06 1.72E-06 1.72E 06 1.72E-06 1.72E 06 1.72E 06 P 32 2.36E 04 1.37E 05 8.95E 06 NO DATA NO DATA NO DATA 1.16E-05 CR 51 NO DATA NO DATA 1,69E 08 9.37E 09 3.84E 09 2.62E 06 3.75E-07 MN 54 NO DATA 6.39E 06 1.05E 06 NO DATA 1.59E 06 2.48E-04 8.35E 06 MN 56 NO DATA 2.12E-10 3.15E-11 NO DATA 2.24E 10 1.90E 06 7.18E 06 FE 55 4.18E 06 2.98E 06 6.93E-07 NO DATA NO DATA 1,55E 05 7.99E 07 FE 59 1.99E 06 4.62E 06 1.79E-06 NO DATA 1,91E-04 NO DATA 2.23E 05 CO 58 NO DATA 2.59E 07 3.47E 07 NO DATA NO DATA 1.68E-04 1.19E 05 C0 60 NO DATA 1.89E-06 2.48E 06 NO DATA NO DATA 1.09E 03 3.24E-05 NI 63 7.25E 05 5.43E-06 2.47E 06 NO DATA 3.84E-05 NO DATA 1.77E-06 NI-65. 2.73E-10 3.66E-11 1.59E-11 NODATk 1.17E-06 CU-64 NO DATA 4.59E 06 ;
No DATA 2.54E-10 1.06E-10 NO DATA 8.01E 10 1.39E-06 7.68E 06
- ZN-65 4.82E 06 1.67E-05 7.80E 06 NO DATA 1.08E-05 1.55E-04 5.83E 06 ;
5 ZN-69 6.04E-12 1.15E-11 8.07E-13 'NO DATA 7.53E 12 1.98E-07 3.56E-08 I BR-83 NO DATA NO DATA 4.30E 08 - NO DATA BR-84 NO DATA NO DATA LT E-24** ;
NO DATA NO DATA 5.41E 08 NO DATA NO DATA NO DATA LT E-24 i l
BR NO DATA NO DATA 2.29E i RB-86 NO DATA NO DATA NO DATA LT E 24 '
NO DATA 2.38E 05 1.05E-05 NO DATA NO DATA NO DATA 2.21E-06 RS-88 NO DATA 6.82E-08 3.40E 08 ;
NO DATA NO DATA NO DATA 3.65E-15 ,
8 RB-89 NO DATA 4.40E-08 -2.91E 08 NO DATA NO DATA NO DATA 4.22E-17 :
SR-89 5.43E-05 NO DATA 1.56E-06 SR 90 NO DATA NO DATA 3.02E-04 4.64E-05 't 1.35E-02 NO DATA 8.35E-04 NO DATA NO DATA 2.06E-03 9.56E 05 i i
CLINTON-1 3-54 Rev.1-11/85 t
, l
CPS-ODCM Table ?.5-3 (continued)
INHAIATION DOSE FACTORS FOR TEEN - (DFA1 )a (mrem per pCi inhaled) t'UCLT DE BnNE LIVER T. BODY THYROID MIDNEY LUNG GI-LLI
^
SR 91 1.10E 08 NO DATA 4.39E-10 NO DATA NO DATA 7.59E-06 3.24E 05 SR 92 1.19E-09 NO DATA 5.08E-11 NO DATA NO DATA 3.43E 06 1.49E 05 Y-90 3.73E-07 NO DATA 1.00E-08 NO DATA NO DATA 3.66E 05 6.99E 05 Y-91m 4.63E-11 NO DATA 1.77E-12 NO DATA NO DATA 4.00E 07 3.77E-09 Y-91 8.26E-05 NO DATA 2.21E-06 NO DATA NO DATA 3.67E-04 5.llE-05 Y-92 1.84E 09 NO DATA 5.36E-11 NO DATA NO DATA 3.35E 06 2.06E-05 Y 93 1.69E-08 NO DATA 4.65E-10 NO DATA NO DATA 1.04E-05 7.24E-05
~
ZR-95 1.82E-05 5.73E-06 3.94E-06 NO DATA 8.42E-06 3.36E-04 1.86E-05 ZR-97 1.72E-OS 3.40E-09 1.57E-09 NO DATA 5,15E-09 1.62t 05 7.88E 05 NB-95 2.32E-06 1.29E 06 7.08E-07 NO DATA 1.25E-06 9.39E-05 1.21E-05 MO-99 NO DATA 2.llE-08 4.03E-09 NO DATA 5.14E-08 1.92E 05 3.36E-05 TC-99m 1.73E 13 4.83E-13 6.24E-12 NO DATA 7.20E-12 1.44E-07 7.66E 07 TC-101 7.40E-15 1.05E-14 1.03E-13 NO DATA 1.90E-13 8.34E-08 1.09E 16 RU-103 2.63E-07 NO DATA 1.12E-07 NO DATA 9.29E-07 9.79E-05 1.36E-05 RU-105 1.40E-10 NO DATA 5.42E-11 NO DATA 1.76E-10 2.27E 06 1.13E-05 RU 106 -1.23E-05 NO DATA 1.55E NO DATA 2.38E-05 2.01E-03 1.20E-04 ACl 10m 1.73E 06 1.64E-06 9.99E-07 NO DATA 3.13E-06 8.44E-04 3.41E-05 TE-125m 6.10E-07 2.80E-07 8.34E-08 1.75E 07 NO DATA- 6.70E-05 9.38E 06 TE-12em 2.25E-06 1.02E 06 2.73E-07 5.48E-07 8.17E-06 2.07E-04 1.99E-05 TE-127 2.51E-10 1.14E-10 5.52E-ll 1.77E-10 9.10E-10 1.40E-06 1.01E-05 TE-129m 1.74E-06 8.23E-07 2.81E-07 5.72E-07 6.49E-06 2.47E-04 5.06E 05 TE-129 8.87E-12 4.22E-12 2.20E-12 6.48E-12 3.32E-ll 4.12E-07 2.02E-07 TE-131m 1.23E-08 7.51E-09 5.03E-09 9.06E-09 5.49E-08 2.97E 05 7.76E 05 TE-131 1.97E-12 1.04E-12 6.30E-13 1.55E-12 7.72E-12 2.92E-07 1.89E-09 i
CLINTON-1 3-55 Rev.5-2/89 J
. CPS-ODCM _-
Table 3.5-3 (continued)
INHALATION DOSE FACTORS FOR TEEN - (DFAi)a (mrom per pCi- inhaled)
NUCLIDE BONE LIVER T. BODY THYROID KIDNEY LUNG GI-LLI TE 132 4.50E 08 3.63E-08 2.74E-08 3.07E 08 2.44E-07 1-130 5.61E 05 5.79E-05 7.80E-07 2.24E 06 8.96E 07 1.86E-04 3.44E 06 I 131 NO DATA 1.14E 06 4.43E-06 6.14E-06 3.30E-06 1.83E-03 1.05E-05 NO DATA 8.11E 07 I-132- 1.99E-07 5.47E-07 1.97E-07 1.89E-05 8.65E 07 I-133 NO DATA 1.59E-07 1.52E-06 2.56E-06 7.78E-07 3.65E-04 4.49E 06 I-134 NO DATA 1.29E-06 1.11E-07 2.90E 07 1.05E-07 4.94E 06 4.58E-07 NO DATA 2.55E 09 I-135 4.62E-07 1.18E-06 4.36E-07 7.76E-05 1,86E 06 CS 134 NO DATA 8.69E-07 6.28E-05 1.41E 04 6.86E-05 NO DATA 4.69E 05 1.83E-05 1.22E-06 CS-136 '6.44E 2.42E-05 1.71E-05 NO DATA 1.38E 05 2.22E-06 1.36E 06 C5 137 8.38E 05 1.06E 04 3.89E 05 NO DATA 3.80E-05 1.51E 05 1,06E 06 CS-138 5.82E-08 1.07E-07 5.58E 08 NO DATA 8.28E-08 9.84E-09 3.38E 11 BA 139 1.67E-10 1.18E 13 4.87E 12 NO DATA 1.11E-13 8.08E 07 8.06E 07 4
BA 140 6.84E-06 8.38E-09 4.40E-07 NO DATA 2.85E-09 2.54E 04 2.86E 05 BA 141 1.78E 11 1.32E-14 5.93E-13 NO DATA 1.23E-14 4.11E 07 9.33E-14 BA-142 4.62E-12 4.63E-15 2.84E-13 NO DATA 3.92E-15 2.39E-07 5.99E-20 LA-140 5.99E-08 2.95E-08 7.82E-09 1A-142 NO DATA NO DATA 2.68E-05 6.09E-05 1.20E-10 5.31E-11 1.32E 11 NO DATA NO DATA 1.27E-06 CE-141 1.50E 06 3.55E-06 2.37E-06 2.71E-07 NO DATA 1.11E-06 7.67E-05 1.58E-05 CE 143 3.32E 08 2.42E 08 2.70E-09 CE 144 NO DATA- 1.08E-08 1.63E 05 3.19E 05 6.11E-04 2.53E-04 3.28E 05 NO DATA 1.51E-04 1.67E-03 PR-143 1.08E-04 1.67E-06 6.64E-07 8.28E 08 NO DATA 3.86E 07 6.04E-05 2.'67E-05 I PR-144 5.37E 12 2.20E-12 2.72E-13 NO DATA 1.26E-12 2.19E-07 2.94E 14
. ND-147 9.83E-07 1.07E 06 6.41E-08 W-187 NO DATA 6.28E-07 4.65E-05 2.28E 05 1
1.50E-09 1.22E-09 4.29E-10 NO DATA 5.92E-06 NO DATA 2.21E 05
- NP-239 4.23E-08 3.99E-09 2.21E-09 NO DATA 1.25E 08 8.11E-06 1.65E 05 3 52 X 10-06
! ** Less than 10-24 CLINTON-1 3-56 Rev 5-2/89 v
CPS-ODCM Table 3.5-4 INHALATION DOSE FACTORS FOR ADULT - (DFAi)a
~
(mrem per pCi inhaled)
NUCLIDE BONE LIVER T. BODY THYROID MIDNEY LUNG GT-LLI H3 NO DATA 1.58E 07 1.58E-07 1.58E 07 1.58E 07 1.58E 07 1.58E 07 C 14 2.27E-06* 4.26E-07 4.26E-07 4.26E 07 4.26E 07 4.26E-07 4.26E-07 NA 24 1.28E-06 1.28E-06 1.28E-06 1.28E 06 1.28E-06 1.28E-06 1.28E-06 P-32. 1.65E 04 9.64E-06 6.26E-06 NO DATA NO DATA NO DATA 1.08E 05 CR 51 NO DATA NO DATA 1.25E-08 7.44E-09 2.85E 09 1.80E-06 4.15E-07 KN-54 NO DATA 4.95E-06 7.87E-07 NO DATA 1.23E-06 1.75E-04 9.67E 06
~
MN 56 NO DATA 1.55E-10 2.29E-11 NO DATA 1.63E-10 1.18E-06 2.53E-06 FE 55 3.07E 06 2.12E-06 4.93E-07 NO DATA NO DATA 9.01E-06 7.54E 07 FE-59 1.47E 06 3.47E-06 1.32E-06 NO DATA NO DATA 1.27E-04 2.35E 05 C0 58 NO DATA 1.98E 07 2.59E-07 NO DATA NO DATA 1.16E-04 1.33E 05 CO 60 NO DATA 1.44E-06 1.85E-06 NO DATA NO DATA 7.46E-04 3.56E 05 NI-63 3.40E-05 3.93E-06 1.81E-06 NO DATA NO DATA 2.23E-05 1.67E-06
'^
N1-65 1.92E-10 2.62E-11 1.14E-11 NO DATA NO DATA 7.00E-07 1.54E-06 CU-64 NO DATA 1.83E-10 7.69E-11 NO DATA 5.78E 10 8.48E-07 6.128-06 ZN-65 4.05E 06 '1.29E-05 5.82E-06 NO DATA 8.62E-06 1.08E-04 6.68E-06 ZN-69 4.23E 12 8.14E-12 5.65E-13 NO DATA 5.27E-12 1.15E 07 2.04E-09
.BR-83 NO DATA NO DATA 3.01E-08 NO DATA NO DATA NO DATA 2.90E-08 BR-84 NO DATA NO DATA 3.91E-08 NO DATA. NO DATA NO DATA 2.05E-13 BR 85 NO DATA NO DATA 1.60E-09 NO DATA NO DATA NO DATA LT E 24**
RB-86 .NO DATA 1.69E 05 7.37E-06 NO DATA NO DATA NO DATA 2,08E-06 RB-88 NO DATA 4.84E-08 2.41E-08 NO DATA NO DATA NO DATA 4.1SE-19 RB 89 NO DATA 3.20E-08 2.12E-08 NO DATA NO DATA NO DATA 1.16E-21 SR-89 3.80E-05 NO DATA 1.09E-06 NO DATA NO DATA 1.75E-04 4.37E-05 SR-90 1.24E 02 NO DATA 7.62E-04 NO DATA NO DATA 1.20E-03 9.02E-05 l
i I
CLINTON-1 3-57 Rev.5-2/89 l
l ;
-CPS-CDCM' Table 3.5-4 (continued)
INHALATION DOSE FACTORS FOR ADULT - (DFAi )a (mrem per pci inhaled) s NUCLIDE BONE LIVER THYROID T. BODY KIDNEY LUNG GI-LLI SR 91 7. 74 E-09 NO DATA 3.13E-10 NO DATA NO DATA 4.56E-06 2.39E-05 SR-92 8.43E-10 NO DATA 3.64E-11 Y-90 NO DATA No DATA 2.06E-06 5.38E-06 2.61E-07 NO DATA 7.01E 09 NO DATA NO DATA 2.12E-05 6.32E-05
'Y-91m 3.26E-11 NO DATA 1.27E-12 NO DATA NO DATA 2.40E-07 1.66E-10 Y-91 5.78E-05 NO DATA 1.55E 06 2.13E-04 Y-92 NO DATA NO DATA 4.81E-05 1.29E-09 NO DATA 3.77E-11 NO DATA NO DATA 1.96E-06 9.19E-06 Y-93 1.18E-08 NO DATA 3.26E-10 ZR-95 NO DATA NO DATA 6.06E-06 5.27E 05 1.34E 05 4.30E-06 2,91E-06 NO DATA 6.77E-06 2.21E-04 1.88E-05 ZR-97 1.21E 08 2.45E-09 1.13E-09 NO DATA 3.71E-09 9.84E 06 6.54E-05 NB 95 1.76E-06 9.77E-07 5.26E 07 NO DATA 9.67E-07 6.31E 05 1.30E-05 MD 99 NO DATA 1.51E 08 2.87E-09 NO DATA 3.64E-08 1.14E-05 3.10E-05 TC 99m 1.29E-13 3.64E-13 4.63E 12 NO DATA -5.52E-12 9,55E-08 5.20E 07 4
TC-101 5.22E-15 '7.52E-15 7.38E-14 1.35E-13 NO DATA 4.99E-08 1.36E-21 RU-103 1.91E-07 NO DATA 8.23E 08 NO DATA 7.29E-07 6.31E-05 1.38E-05 RU-105 9.88E-ll NO DATA 3.89E 11 NO DATA 1.27E 10 1.37E.06 6.02E-06 RU 106 8.64E-06 NO .3ATA- 1.09E-06 NO DATA 1.67E 05 1.17E-03 1.14E-04 AG-110m 1.35E 06 1.25E-06 7.43E-07 NO DATA 2.46E-06 5.79E 04 3.78E-05 TE-125m 4.27E-07 1.98E-07 5.84E 08 1.31E-07 1.55E-06 3.92E-05 8.83E-06 TE 127m 1.58E-06 7.21E 07 1.96E-07 4.11E-07 5.72E 06 1.20E-04 1.87E-05 TE-127 1.75E-10 8.03E-ll 3.87E-11 1.32E-10 6.37E-10 8.14E-07 7.17E-06 TE 129m 1.22E 5.84E-07 1.98E-07 4.30E 07 4.57E 06 1.45E-04 4.79E-05 TE-129 6.22E-12 2.99E-12 1.55E-12 4.87E-12 2.34E-11 2.42E-07 1.96E-08 TE-131m 8.74E-09 5.45E-09 3.63E 09 6.88E 09 3.86E 08 1.82E-05 6-95E-05 TE-131 1.39E-12 7.44E 13 4.49E-13 1.17E-12 5.46E-12 1.74E-07 2.30E-09 TE-132 3.25E-08 2.69E-08 -2.02E-08 2.37E-08 1.82E-07 3.60E-05 6.37E-05 1 130 5.72E-07 1.68E-06 6.60E-07 1.42E-04 2.61E-06 1-131 NO DATh . 9.61E-07 3.15E-06 4.47E-06 2.56E 06 1.49E 03 7.66E 06 NO DATA 7.85E-07 CLINTON-1 3-58
'_ Rev.1-11/85 l A
LTS-OUCM Table 3.5-4 (continued)
INHALATION DOSE FACTORS FOR ADULT - (DFA1)a (mrem per pCi inhaled)
NUCLTDE BONE LIVER T. BODY THYROID KIDNEY LUNO GI-LLI I-132 1.45E-07 4.07E-07 1.45E-07 1.43E-05 6.48E 07 NO DATA 5.08E-08 I-133 1.08E-06 1.85E-06 5.65E-07 2.69E 04 3.23E-06 NO DATA 1.11E-06 I 134 8.05E-08 2.16E-07 7.69E 08 3.73E-06 3.44E 07 NO DATA 1.26E 10 I-135 3.35E-07 8.73E 07 3.21E-07 5.60E-05 1.39E-06 NO DATA 6.56E 07 CS-134 4.66E-05 1.06E-04 9.10E-05 NO DATA 3.59E-05 1.22E 05 1,30E-06 CS-136 4.88E-06 1.83E-05 1.38E 05 NO DATA 1.07E 05 1.50E-06 1.46E-06 CS-137 5.98E-05 7.76E-05 5.35E-05 NO DATA 2.78E-05 9.40E-06 1.05E-06 ;
CS-138 4.14E-08 7.76E-08 4.05E 08 NO DATA 6.00E OS 6.07E-09 2.33E 13 l BA 139 1.17E 10 8.32E-14 3.42E-12 NO DATA 7.78E 14 4.70E-07 1.12E 07 i BA 140 4.88E-06 6.13E-09 3,21E-07 NO DATA 2.09E-09 1.59E 04 2.73E-05 BA-141 1.25E-11 9.41E-15 4.20E 13 NO DATA 8.75E-15 2.42E-07 1.45E 17 BA 142 l 3.29E-12 3.38E-15 2.07E-13 NO DATA 2.86E-15 1.49E-07 1.96E-26 t
>J LA 140 4.30E-08 2.17E-08 5.73E-09 NO DATA .NO DATA 1.70E-05 5.73E 05 [
LA-142 8.54E-11 3.88E-ll 9.65E-12 NO DATA NO DATA 7.91E-07 2,64E 07 ;
CE 141 2.49E-06 1.69E-06 1.91E 07 NO DATA 7.83E 07 4.52E-05 1,50E-05 CE-143 2.33E-08 1.72E-08 1.91E-09 NO DATA 7.60E 09 9.97E-06 2.83E 05 !
CE-144 4.29E-04 1.79E-04 2.30E-05 NO DATA 1.06E-04 1.02E 04 9.72E 04 . [
PR-143 1.17E 06 4.69E-07 5.80E-08 NO DATA 2.70E 07 3.51E-05 2.50E 05_ ;
' )
PR-144. 3.76E-12 1.56E-12 1.91E-13 NO DATA 8.81E-13 1.27E-07 2.69E 18 ND-147 {
6.59E 07 7.62E-07 4.56E 08 NO DATA 4,45E 07 2.76E-05 2.16E-15
- U-187 1.06E-09 B.85E-10 3.10E-10 NO DATA NO DATA 3.63E-06 '1.94E 05 1
NP-239 2.87E-08 2.82E-09 1.55E 09 NO DATA 8.75E 09 4.70E-06 1.49E-05
- 2.27 X 10-06 l
- Less than 10-24 CLINTON-1 3-59 Rev.5-2/89
CPS-ODCM TABLE 3.5-5 GROUND PLANE DOSE FACTORS - DFGi (mrem /hr per pCi/m 2)
ELEMENT TOTAL BODY SKIN H3 0.0 0.0-C-14 0.0 0.0 Na 24 2.50E 08* 2.90E 08 P-32 0.0 0.0 Cr 51 2.20E 10 2.60E 10 m Mn-54 5,80E-09 6.80E 09 Mn 56 1.10E 08 1.30E 08 Fe-55 0. 0 _ 0.0 Fe-59 8,00E 09 9.40E-09 Co-58 -7.00E-09 8.20E 09 Co 60 1.70E-08 2.00E 08 Ni-63 0.0 0.0 Ni-65 3.70E-09 4.30E-09.
Cu-64 1.50E 1.70E-09 Zn-65 4.00E 09 4.60E-09 2n-69 0.0 0.0 Br 83 6.40E 11 9.30E-11 sm Br-84 1.,20E-08 1.40E-08 Br-85 0.0 0.0 Rb-86 6.30E-10 7.20E-10 Rb-88 3.50E 09 4.00E-09 Rb-89 1.50E 08 1.80E 08 Sr 89 5.60E-13 6.50E-13 Sr-91 . 7.10E-09 8,30E-09 Sr 92 9.00E-09 1.00E-08 Y-90 2.20E-12 2.60E-12 Y-91m 3.80E-09 4.40E-09 Y-91 2.40E-11 2.70E-11 Y-92 1.60E-09 1.90E-09
'Y-93 5.70E-10 7.80E-10 Zr-95 5.00E-09 5.80E 09 2r-97 5.50E-09 6.40E-09 Nb-95 5.10E 09 6.00E-09 Mo 99 1.90E-09 2.20E Tc-99m 9.60E-10 1.10E 09 Te-101 2.70E-09 3.00E-09 Ru-103' 3.60E-09 4.20E 09 Ru-105 4.50E-09 5.10E-09 Ru-106 1.50E-09 1.80E-09 An-110m 1.80E-08 2.10E-08 CLINTON-1 3-60 Rev.5-2/89 l
n ]_;
. un-uuun i
l Table 3.5-5 (Continued)
GROUND PLANE DOSE FACTORS - DFGi (mrom/hr per pCi/m 2)
ELEMENT- TOTAL BODY SKIN Te-125m 3.50E-11 4.80E 11 Te-127m 1.10E-12 1.30E 12 Te-127 1.00E 11 1,10E 11 Te-1?9m 7.70E-10 9.00E-10 Te-129 7,10E 10 8.40E 10 Te-131m 8,40E 09 9.90E 09 Te-131 2,20E 09 2,60E 06 Te-132 1.70E 09 2.00E 09 I-130 1.40E-08 1.70E 08 I 131 2,80E-09 3.40E 09 I 132 1.70E 08 2,00E 08 T-133 3.70'E 09 4.50E 09
+ -
I-134 1.60E-08 1.90E 08 I-135 1.20E 08 1.40E 08 Cs-134 1.20E 08 1.40E 08 Cs-136 1.50E-08 1.70E-08 Cs-137 4,20E 4.90E-09 Cs-138 2.10E 08 2.40E-08 Ba-139 2,40E-09 2.70E 09 Ba-140 7.10E-09 2.40E-09 Ba 141 4,30E-09 4.90E 09 m*- Ba-142 7.90E 09 9.00E 09 La-140 1.50E 08 1.70E 08 La-142 1.50E-0B 1.80E-08 Cc-141 5,50E 10 6.20E-10 ce-143 2.20E-09 2.50E 09 Ce-144 3.20E-10 3,70E 10 Pr-143 0.0 0.0 Pr-144 2.00E-10 2.30E 10 Nd-147 1.00E 09 1,20E-09 W-187 3.10E-09 3.60E 09 Np-239-- 9.50E 10 1.10E-09 o
- 2.'50-X.10-08 s
4 CLINTON-1 3-61 Rev.5-2/89 y ,,
.w,y - -iw,
.i +- - v- , m ~ ,..--.,_e.- -.s- - y .
CPS-ODCM TABLE 3.5-6 INGESTION DOSE FACTORS FOR INFANT - (DFL1)a (mrem per pCi ingested)
NUCL1DE $0Nf5 LLVf2 T. BODY THYROID KIDNEY LIEQ CI - LL1_
H3 NO DATA 3.08E 07 3.08E 07 3.08E-07 3.08E-07 C 14 3.08E-07 3.08E-07 2.37E-05* 5.06E 06 5,06E-06 5.06E-06 5.06E-06 5.06E-06 5.06E 06 NA-24 1.01E-05 1.01E 05 1.01E 05 1.01E-05 1.01E-05 1.01E-05 1.01E 05 P 32 1.70E 03 1.00E 04 6.59E 05 NO DATA.
CR 51 NO DATA NO DATA 2.30E 05 NO DATA NO DATA 1.41E 08 9.20E 09 2.01E-09 1.79E-08 MN 54 4.11E 07 NO DATA 1.99E 05 4.51E-06 NO DATA 4.41E-06 NO DATA 7.31E 06 MN 56 NO DATA 8.18E 07 1.41E 07 NO DATA 7.03E-07 NO DATA 7.43E 05 FE 55 1 39E-05 8.98E-06 2.40E 06 FE-59 NO DATA NO DATA 4.39E 1.14E-06 3.08E-05 5.38E 05 2.12E 05 NO DATA NO DATA 1.59E-05 2.57E 05 CO 58 NO DATA 3.60E-06 8.98E 06 CO-60 NO DA.TA NO DATA NO DATA 8.97E 06 NO DATA 1.08E 05 2.55E-05 NO DATA NO DATA NO DATA 2.57E 05 NI 63 6.34E-04 3.92E 05 2.20E-05 NO DATA NO DATA NO DATA 1.95E 06 NT-63 4.70E 06 5.32E 07 2.42E-07 NO DATA CU-64 NO DATA NO DATA 4.05E 05 NO DATA 6.09E-07 2.82E-07 NO DATA 1.03E-06 NO DATA 1.2SE-05 ZU-65 1.84E 05 6.31E-05 2.91E 05 NO DATA 3.06E-05 NO DATA 5.33E-05 ZN-69 9.33E 08 1.68E-07 1.25E-08 NO DATA 6.98E-08 NO DATA 1.37E-05 BR 83 NO DATA NO DATA 3.63E-07 BR-84 NO DATA NO DATA NO DATA LT E 24**
NO DATA NO DATA 3.82E 07 NO DATA NO DATA NO DATA LT E 24 BR 85' NO DATA NO DATA 1.94E-08 NO DATA RB 86 NO DATA NO DATA LT E-24 NO DATA 1.70E-04 8.40E 05 NO DATA NO DATA NO DATA 4.34E-06 RB-88 NO DATA 4.98E-07 2.73E 07 NO DATA NO DATA NO DATA 4.85E 07 RB-89 NO DATA 2.86E 07 1.97E 07 N^ DATA SR NO DATA NO DATA 9.74E 08 2.51E-03 NO DATA 7.20E-05 NO DATA NO DATA NO DATA 5.16E-05 SR-90 1.85E-02 NO DATA 4.71E-03 NO DATA NO DATA NO DATA 2.31E 04 SR-91 5.00E-05 NO DATA 1.81E-06 NO DATA NO DATA NO DATA 5.92E 05 SR-92 1.92E-05 NO DATA 7.13E-07 NO DATA NO DATA NO DATA 2.07E-04 Y-90 8.69E-08 NO DATA 2.33E-09 NO DATA NO DATA NO DATA 1.20E 04 CLINTON-1 3-62 Rev 1-11/85 L: -
( , . - _ -- --
{
CPS"0DCM TArLE 3.5-6 (continued)
IllGESTIO!1 DOSE PACTORS FOR Il1FAliT - (DFL1 )a (mrem per pci ingested) "
!NCLIDE $0.N1 LIVER I.10DY THYROID 111Elly llEG EL,]11 t
Y.91m 8.10E.10 NO DATA 2.76E.11 NO DATA 110 DATA !!O DATA 2.70E.06 Y.91 1.13E.06 NO DATA 3.01E 08 NO DATA NO DATA tiO DATA 8.10E 05 Y.92 7.65E.09 110 DATA 2.15E.10 NO DATA NO DATA NO DATA 1.46E.04 Y.93 2.43E.08 NO DATA 6.62E.10 NO DATA NO DATA NO DATA 1.92E 04 ZR.95 2.06E.07 5.02E.08 '.56E.08 s 110 DATA 5.41E 08 110 DATA 2.50E.05
- 'P
.. 97 1.481. 08 2.54E 09 1.192 09 110 DATA 2.56E.09 NO DATA 1.62E.04 t
NB.95 4.20E.08 1.73t.08 1.00E.08 40 DATA 1.24E.08~ .NO DATA 1.46E.05-H0 99 NO DATA 3.iOE.05 6.63E.06 NO DATA 5.08E 05 NO DATA 1.12E.05 TC.99m 1.92E 09 3.9CE 09 5,10E.08 NO DATA 4.26E.08 2.07E.09 1.15E.06 TC.101 2.27E.09 2.86E 09 2.83E.08 NO DATA 3.40E.08 1.56E.09 4.8bE.07- -
Rb.103 1.48E.06 NO DATA 4.95E.07 NO DATA 3.08E 06 -110 DATA 1.80E 05 RU 105 1.36E.07 NO DATA 4 $8E.08 NO DATA 1.00E.06 NO DATA 5.41E 05
" "~
f RU.106 2.41E 05 DATA 3.01E+06 NO DATA 2.85E.05 NO DATA 1.83E.04 AG*110m 9.96E 07 7E 07 4.81E 07 NO DATA 1.04E.06 110 DATA 3.77E 05 TE.125m 2.33E 05 't.06 3.15E 06 7.84E.06 NO DATA NO DATA 1.11E.05 TE.127m 5.85E 05 1.94E.05 7.08E.06 1.69E.05 1 44E.04 NO DATA 2.36E.05 TE.127 1.00E.06 3.35E 07 2.15E.07 8.14E.07 2.44E*06 NO DATA 2.10E.05 TE.129m 1.00E 04 3.43E.05 1.54E.05 3.84E.05 2.50E 04 NO DATA 5.97E.05 TE.h9 2.84E 07 9.79E 08 6.63E 08 2.38E.07 7.07E.07 NO DATA 2.27E.05 TE.131m 1.52E.05 6.12E 06 5.05E 06 1.24E.05 4.21E.05 NO DATA 1.03E.04 TE 131 1.76E 07 6.50E 08 4.94E.08 1.57E.07 4.50E.07 No DATA 7.11E.06 TE.132 2.08E.05 1.03E.05 9.61E.06 1.51E.05 6.44E.05 NO DATA 3,81E 05 I.130 6.00E.06- 1.32E.05 5.30E.06 1.48E.03 1.45E.05 NO DATA 2.83E.06 1 131 3.59E 05 4.23E 05 1.86E.05 1.39E.02 4.94E.05 NO DATA 1.51E.06 1 132 1.66E.06 3.37E.06 1.?0E.06 1.5BE.04 3.76E.06 NO DATA 2.73E.06 1*133 1.25E.05 1.82E.05 5,33E.06 3.31E.03 2.14E.05 NO DATA- 3.0BE.06 I.134 S.69E.07 1.78E.06 6.33E.07 4.15E.05 1.99E.06 NO DATA 1.84E.06 CLINTON-1 3-63 Rev.1-11/85
. _ . _ _ _ _ _ _ _ _ _ _ _ _ _ _ . _ _ . _ _ _ . _ _ _ _ _ _ _ _ _ _.. _ . _ _ _ _ .__..__.2
CPS-0DCM TABLE 3.5-6 (continued)
IllGESTION DOSE FACTORS FOR IllFANT - (DFLi )a (mrom por pci ingested)
LTCLIDE anE LIVER I,JQQ,Y TliYROID EIDNEY L*1% GI.LLL I.135 3.64E.06 7.24E 06 2.64E.06 6.49E.04 8.07E 06 !;0 DATA 2.62E.06 CS.134 3.77E.04 7.03r :4 7.10E.05 NO DATA 1.81E.04 7.42E 05 1.91E 06 CS 136 4.59E 05 1.35E.04 5.04E 05 5.38E.05 1.10E.05 NO DATA 2.05E 06 CS .1.17 5.22E.04 6.11E.04 4.33E 05 NO DATA 1.64E.04 6.64E.05 1.91E 06 CS.138 4.81E.07 7.82E.07 3.79E.07 NO DATA 3.90E.07 6.09E 08 1.25E.06 BA 139 8.81E.07 5.84E.10 2.55E 08 110 DATA 3.51E.10 3.54E.10 5.58E.05
'BA 140 1.71E.04 1.71E.07 8.81E+06 110 DATA 4.06E 08 1.05E.07 4.20E.05 BA 141 4.25E.07 2.91E.10 1.34E 08 NO DATA 1.75E.10 1.77E.10 5.19E.06 Er.142 1.84E.07 1.53E.10 9.06E.09 NO DATA 8.81E.11 9.26E.11 7.59E 07 1A 140 2.11E.08 8.32E 09 2.14E.09 110 DATA No DA11. !!O DATA 9.77E.05 1A 142 1.10E.09 4.04E.10 9.67E.11 NO DATA !!O DATA NO DATA 6.86E.05 CE.141 7.87E.08 4.80E.08 5.65E 09 NO DATA 1.48E 08 NO DATA 2.48E.05 CE.143 1.48E 08 9.82E.06 1.12E 09 2.86E.09 NO DATA NO DATA 5.73E.05 CE.144 2.98E.06 1.22E.06 1.67E 07 NO DATA 4.93E.07 NO DATA 1.71E.04 PR 143 8.13E.08 3.04E.08 4.03E.09 1.13E.08 NO DATA NO DATA 4.29E 05 PR.144 2.74E.10 1.06E.10 1.38E.11 3.84E.11 NO DATA NO DATA 4.93E.06 ND.147 5.53E.08 5.68E.08 3.48E 09 2.19E 08 NO DATA 110 DATA 3.60E.05 V.187 9.03E.07 6.28E.07 2.17E 07 NO DATA NO DATA NO DATA 3.69E 05 NP.239 1.11E.08 9.93E.10 5.61E.10 NO DATA 1.98E.09 NO DATA 2.87E 05
- 2.37 X 10-05
- Less-than 10-24 Cf.TitToti-1 t-64 rov.1-11/85 N. .
i r
CPS-ODCM TABLE 3.5-7 INGESTION DOSE TA0 TORS FOR CHILD - (DFLg)a (mrom per pCi ingested) ;
i NUCLIDE i
_ffdE LIYEf; T.IODY TmTOID }',1 DN EY IJ111q Elf,Q.1 [
I
.H.3 NO DATA 2.03E.07 2.03E.07 2.03E 07 2.03E.07 2.03E 07 2.03E.07 i C 14 1.21E.0$* 2.42E.06 2.42E.06 2.42E.00 2.42E 06 2.42E.06 2.42E.06 NA 24 5.80E.06 5.80E.06 5.80E.06 5.80E.06 5.80E 00 5.80E 06 5.80E.06 P 32 8.25E.04 3.86E.05 3.16E.05 NO DATA NO DATA 110 DATA 2.28E 0$ l CR 51 NO DATA NO DATA 8.90E.09 4.94E.09 1.35E 09 9.02E.09 4.72E.07 j MN.54 NO DATA 1.07E.05 2.85E.06 NO DATA 3.00E.06 No DATA 8.98E.06 l i
I MN 56 NO DATA 3.34E.07 7.54E 08 NO DATA 4.04E 07 NO DATA 4.84E+05 i FE.55 1.15E.05 6.10E 06 1.89E.06 NO DATA NO DATA 3.45E 06 1,13E.06 FE.59 l
1.65E.05 2.67E 05 1.33E.05 NO DATA NO DATA 7.74E 06 2.78E.0!: [
Co.58 10 DATA 1.80E 06 5.$1E.06 No DATA 110 DATA No DATA 1.0$E.05 Co.60 NO DATA 5.29E 06 1.56E.05 NO DATA NO DATA No DATA 2.93E 05 NI 63 5.38E 04- 2.88E.05 1.83E.05 NO DATA 110 DATA NO DATA 1.94E 06 -
NI 65 2.22E.06 2.09E.07 1.22E.07 NO DATA NO DATA NO DATA 2.56E.05 CU.64 l
NO DATA 2.45E.07 1.48E.07 No DATA 5.92E 07 HO DATA 1.15E.05 ?
2N 65- 1.37E.05 3.65E 05 2,27E.05 NO DATA 2.30E.05 NO DATA 6.41E.06 i 7.N.69 4.38E.08 6.33E 08 -5.85E.09 NO DATA 3.84E.08 NO DATA 3.99E.06 [
BR+83 NO DATA NO DATA 1.71E.07 NO DATA NO DATA NO DATA LT E.24**
BR.84 NO DATA NO DAT!. 1.9PE 07 NO DATA NO DATA NO DATA LT E.24 i
. BR 85 NO DATA NO DATA 9.12E.09 NO DATA NO DATA NO DATA LT E.24 ;
RB 86 NO DATA 6.70E.05 4.12E 05 NO DATA No DATA NO DATA 4.31E.06 RB 88 1.32E 07 NO DATA 1. 90E 07 - NO DATA NO DATA NO DATA 9.32E 09 i RB.89 NO DATA 1.17E.07 1.04E.07 NO DATA NO DATA NO DATA 1.02E.09 SR 89 1.32E.03 NO DATA 3.77E.05 No DATA NO DATA No DATA 5.11E.05 f SR.90 1.70E 02 NO DATA 4.31E.03 NO DATA NO DATA NO DATA 2.29E.04 }
r SR.91 2.40E.05 NO DATA 9.06E 07 No DATA No DATA No DATA 5.30E.05 l SR.92 9.03E 06: NO DATA 3.62E 07 NO DATA- Ur DATA NO DATA 1.71E 04 -
Y.90 4.11E.08 NO DATA 1.10E 09 NO DATA NO DATA NO DATA 1,17E.04_ [
i i's CLINTON-1 3-65 Rev.5-2/89
CPS-0DCM TADLE 3.5-7 (contin 11cD.
INGr.STION DOSE FACTORS FOR CHILD - (DFL 1 ) a (mrom por pCi ingested) i WCL1DE E LIVER T. BODY THYRotD PIDNEY M GI LLI
. Y.91m 3.82E.10 NO DATA 1.39E.11 NO DATA Y.91 NO DATA NO DATA 7.48E.07 6.02E.07 NO DATA 1.61E 08 NO DATA NO DATA Y.92 NO DATA 8.02E 05 3.60E.09 NO DATA 1.03E.10 NO DATA No DATA NO DATA 1.04E 04 Y.93 1.14E.08 NO DATA 3.13E.10 NO DATA NO DATA NO DATA 1.70E.04 7.R 95 1.16E.07 2.55E 08 2.27E 08 NO DATA 3.65E.08 No DATA 2.66E.0$
ZR 97 6.99E.09 1.01E.09 5.96E.10 NO DATA 1.45E 09 NO DATA 1.53E.04 NB.95 2.25E.08 8.76E 09 6.26E.09 M0 99 NO DATA 8.23E 09 NO DATA 1.62E.05 H0 DATA 1.33E.05 3.29E.06 NO DATA 2.84E.05 TC 99m NO DATA 1.10E.05 9.23E.10 1.81E.09 3.00E.08 HO DATA 2.63E.08 9.19E.10 1.03E.06 TC 101 1.07E.09 1.12E.09 1.42E.08 NO DATA 1.91E-08 5.92E.10 3.56E.09 RU 103 1.31E.07 NO DATA 2.81E.07 NO DATA 1.84E.06 NO DATA 1.89E.05 RU 105 6.45E.08 NO DATA 2.34E.08 NO DATA 5.67E.07 NO DATA 4.21E.05 RU 106 1.17E.05 NO DATA 1.46E.05 AG.110m NO DATA 1.58E.05 NO DATA 1.82E.04 5.39E.07 3.64E.07 2.91E.07 NO DATA 6.78E.07 TE.125m 1.14E.05 NO DATA 4.33E.05 3.09E.06 1.52E.06 3.20E.06 NO DATA NO DATA 1.10E.05 TE.127m 2.89E.05 7.78E.06 3.43E 06 6.91E.06 8.24E 05 NO DATA 2.34E.05 TE.127 4.71E.07 1.27E.07 1.01E 07 3.26E.07 1.34E.06 NO DATA -1.84E 05 TE.129m 4.87E.05 1.36E.05 7.56E.06 1.57E.05 1.43E.04 NO DATA 5.94E.05 TE.129 1.34E.07 3.74E 08 3.18E.08 9.56E.08 3.92E 07 NO DATA- 8.34E.06 TE.131m 7.20E.06 2.49E.06 2.65E 06 5.12E.06 2.41E-05 NO DATA- 1.01E 04 TE.131 8.30E.08 2.53E 08 2.47E 08 6.35E 08 2.51E.07 50 DATA 4.36E.07 TE.132 1.01E.05 4.47E.06' 5.40E.06 6.51E.06 4.15E 05 NO DATA 4.50E.05 ,
1 130_- 2.92E 06 5.90E.06 3.04E.06 6.50E.04 8.82E.06 I.131 1.72E.05 NO DATA 2.76E.06 1.73E.05 9.83E.06 5.72E-03 2.84E 05 NO DATA 1.54E.06 1 132 8.00E.07 1.47E.06 6.76E.07 I.133 6.82E.05 2.25E.06 NO DATA 1.73E 06 5.92E.06 7.32E 06 2.77E.06 1.36E.03 1.22E.05 1 134- 4.19E.07 NO DATA 2.95E.06
- 7.78E 07 3,58E.07 1.79E 05 1.19E.06 NO DATA 5.16E 07 CLINTON-1 3-66 Rev.5-2/89 J
CPS-ODCM l
T12LE 3 J-71c.M11111edi I
IliGESTIOli DOST FACTORS FOR Cl!ILD - (DFL 1) 3 (mrem per pCi ingested)
L1DJLI E01iE 1.T VEn I S DY I1DZQlD l'1211[.Y LCiG 01 .111 1 135 1.75E 06 3.15E 06 1.49E 06 2.79E 04 4.83E 06 110 DATA 2.400 06 CS 134 2.34E 04 3.84E 04 8.10E 05 NO DATA 1.19E-04 4.27E 05 0.07E 06 CS 136 2.35E 05 6.46E 05 4.18E 05 110 DATA 3.44E 05 5.13E 06 0.27E 06 CS 137 3.27E 04 3.13E 04 4.62E 05 NO DATA 1.02E 04 3.67E 05 1.96E 06 CS 138 2.28E 07 3 17E 07 2.01E 07 No DATA 2.23E 07 2.40E 08 1.46E 07 EA 139 4.14E 07 2.21E 10 1.20E 08 NO DATA 1.93E 10 1.30E 10 2.39E 05 BA 140 S.31E 05 7.28E 08 4.85E 06 140 DATA 2.37E 08 4.34E 00 4.21E 05 BA 141 2.00E 07 1.120 10 6.51E 09 NO DATA 9.69E 11 6.58E-10 1.14E 07 BA 142 8.74E 08 6.29E 11 4.88E 09 NO DATA 5.09E 11 3.70E 11 1.14E 09 1A 140 1.01E 08 3.53E-09 1.10E 09 NO DATA NO DATA 110 DATA 9.84E 05 1A 142 5.24E 10 1.67E 10 5.23E 11 NO DATA 110 DATA !!O DATA 3.31E 05 CE 141 8.97E 08 1.98E 08 2.94E 09 140 DATA 8.68E 09 NO DATA 2.47E 05 CE 143 6.99E 09 3.79E 06 5.49E 10 110 DATA 1.59E 09 NO DATA 5.55E 05 CE 144 2.08E 06 6.52E-07 1.11E 07 110 DATA 3.61E 07 NO DATA 1.70E 04 PR 143 3.93E 08 1.18E 08 1.95E 09 NO DATA 6.39E 09 NO DATA 4.24E 05 ER 144 1.29E 10 3.99E 11 6.49E 12 NO DATA 2.11E 11 NO DATA 8.59E 08 ND-147 2.79E 08 2.26E 08 1.75E 09 NO DATA 1.24E 08 NO DATA 3.58E 05 V 187 4.29E 07 2.54E 07 1.14E 07 NO DATA NO DATA NO DATA 3.57E 05 NP 239 5.25E 09 3.77E 10 2.65E 10 NO DATA 1.09E 09 140 DATA 2.79E 05
- 1.21 X 10-05
- Less than 10-24 CLINToli-1 3-67 Rev.6-12/89
a CPS-ODCM l
TABLE 3.5-8 INGESTIO!1 DOSE FACTORS FOR TEEN - (DFLi )a (mrom per pci ingosted)
{
f
@ CLIDE E LIVER T. BODY TinTOID l'IDNEY M GI LLI f H3 i NO DATA 1.06E.07 1.06E.07 1.06E 07 1.06E 07 1.06E 07 1.06E.07 [
C 14 4.06E 06* 8.12E.07 8. lie.07 8.12E 07 8.12E 07 8.12E.07 8.12E 07 i NA.24 2.30E 06 2,30E 06 2.30E 06 2.30E 06 2.30E 06 2.30E.06 2.30E 06 i P.32 2.76E.04 1.71E.05 1.07E 05 NO DATA NO DATA NO DATA 2.32E.05 ..
CR.51 NO DATA NO DATA 3.60E.09 2.00E 09 7.89E.10 5.14E.09 6.0$E 07 !
MM 54 NO DATA 5.90E 06 1.17E 06 110 DATA 1.76E 06 NO DATA 1.21E.05 MN 56 NO DATA 1.58E 07 2.81E.08 NO DATA 2.00E 07 NO DATA 1.04E.05 TE.55 3.78E.06 2.68E.06 6.25E.07 NO DATA NO DATA 1.70E 06 1.16E.06 TE.59 5.87E 06 1.37E.05
(
5.29E.06 NO DATA NO DATA 4.32E.06 3.24E 05 l
C0 58 NO DATA 9.72E.07 2.24E.06 NO DATA NO DATA NO DATA 1.34E.05 CO.60 NO DATA 2.81E 06 6.33E 06 NO DATA NO DATA NO DATA 3.66E 05 l NI 63 1.77E 04 1.25E.05 6.00E.06 NO DATA NO DATA NO DATA 1.99E 06 i
[
" t NI 65 7.49E 07 9.57E.08 4.36E.08 NO DATA NO DATA NO DATA 5.19E.06 j CU.64 NO DATA 1.15E 07 5.41E-08 NO DATA 2.91E.07 No DATA 8.92E.06 '
ZN 65 5.76E.06 2.00E 05 9.33E 06 NO DATA 1.28E.05 NO DATA 8.47E 06 ZN 69 1.47E.08 2.80E 08 1.96E 09 NO DATA 1.83E.08 NO DATA 5.16E 08 I BR.83 NO DATA No DATA 5.74E.08 NO DATA NO DATA NO DATA LT E.24** !
BR-84 NO DATA NO DATA 7.22E.08 NO DATA NO DATA 110 DATA LT E.24 !
I k
BR 85 No DATA NO DATA 3.05E.09 NO DATA NO DATA NO DATA LT E.24 !
RB-86 No DATA 2.98E 05 1.40E 05 NO DATA NO DATA NO DATA 4.41E 06 !
RB 88 NO DATA 8.52E.08 4.54E.08 NO DATA NO DATA NO DATA 7.30E.15 l PJ 89 NO DATA 5.50E 08 3.89E.08 NO DATA NO DATA NO DATA 8.43E.17 <
SR 89 4.40E-04 NO DATA 1.26E 05 NO DATA NO DATA NO DATA 5.24E-05 SR 90 8.30E.03 NO DATA 2.05E.03 NO DATA
- NO DATA NO DATA 2.33E.04 SR-91 8.07E 06 NO DATA ". 21E 07 NO DATA NO DAT/. No DATA 3.66E.05 SR 92 3.05E.06
{
NO DATA . 30E 07 NO DATA NO DATA NO DATA 7.77E 05 ,
Y.90 1.37E.08 No DATA 3,69E.10 NO DATA NO DATA NO DATA 1.13E.04 j l
1 i
CLINTON-1 3-68 Rev.1-11/85 i
____ _ _ . __ _ . _ . _ . m.-.- - - _ -
' l CPS-ODCM I TABLE 3.5-8 (continued)
IllGESTIOli DOSE PACTORS FOR TEEN - (DFLi )a (mrom per pCi ingested) [
r
!!UCLI D" $31.E LIVER T PODY THYROID }'IDNEY LDJ.Q 01 Ll1 Y.91m 1.29E.10 NO DATA 4.93E.12 NO DATA 110 DATA NO DAT/> 6.09E.09 Y.91 2.01E.07 140 DATA 5.39E 09 N0 mTA NO DATA NO DATA 8.24E 05 l Y 92 1.21E 09 140 DATA 3.50E 11 No DnTA NO DATA NO DATA 3.32E.05 i Y.93 3.83E.09 NO DATA 1.0$E.10 NO DATA NO DATA NO DATA 1.17E 04 !
ZR.95 4.12E.08 1.30E 08 8.94E 09 HO DATA 1.91E.08 NO DATA 3.00E 05 f ER.97 2.37E 09 4.69E.10 2.16E.10 NO DATA 7.11E.10 110 DATA 1.27E.04
{
.7 NB.95 8.22E.09 4.56E.09 2.51E.09 NO DATA 4.42E 09 HO DATA 1.95E.05 [
M0 99 NO DATA 6.03E.06 1.15E.06 NO DATA 1.38E.05 NO DAT/s 1.08E 05 '
TC 99m 3.32E.10 9.26E.10 1.20E.08 NO DATA 1.38E.08 5.14E 10 6.08E 07 L
TC.101 3.60E.10 5.12E.10 5.03E.09 HO DATA 9.26E.09 3.12E 10 6.75E.17 i RU.103 2.55E 07 No DATA 1.09E+07 NO DATA 8.99E 07 110 DATA 2.13E.05 I RU 105 2.18E.08 NO DATA 8.46E.09 NO DATA 2.'5E.07 110 DATA 1.76E 05 l RU-106 3.92E.06 110 DATA 4.94E 07 NO DATA 7.56E.06 NO DATA 1.88E.04 AG 110m 2.05E 07 1.94E.07 1.18E 07 NO DATA 3.70E.07 110 DATA 5.45E.05 TE.125m 3.83E.06 1,.38E.06 5.12E.07 1.07E.06 !!O DATA 110 DATA 1.135 05 f
i TE.127m 9.67E.06 3.43E 06 1.15E.06 2.30E 06 3.92E.05 tio DATA 2.41E 05 h TE 127 1.58E.07 5.60E.08 3.40E 08 1.09E 07 6.40E 07 No DATA 1.22E.05 TE.129m 1.63E.05 6.0$E 06 2.58E.06 5.26E.06 6.82E 05 110 DATA 6.12E.05
[
TE.li9 4.48E.08 1.67E.08 1.09E.08 3.20E 08 1.8BE 07 NO DATA 2.45E.07 TE.131m 2.44E 06 1.17E.06 9.76E.07 1476E 06 1.22E.05 110 DATA 9.39E.05 TE 131 2.79E-08 1.15E.08 8.72E 09 2.15E.08 1.22E.07 110 DATA 2.29E 09 TE 132 3.49E.06 2.21E.06 2.08E 06 2.33E 06 2.12E.05 No DATA 7.00E.05 I.130 1.03E.06 2.98E 06 1.19E.06 2.43E.04 4.59E.06 No DATA 2.29E.06 1 131 5.85E 06 -8.19E.06 4.40E 06 2.39E.03 1.41E 05 NO DATA 1.62E 06 I.132 2,79E.07 7.30E.07 2.62E 07 2.46E 05 1,15E.06 NO DATA 3.18E.07 1 133 2.01E.06 3.41E.06 1.04E 06 4.76E.04 5.98E 06 NO DATA 2.58E.06 1 134 1.46E-07 ,
3.87E 07 1.39E-07 6.45E.06 6.10E.07 NO DATA 5.10E.09 I
l CLINTON-1 3-69 Rev.5-2/89 my.<,r4-, ,gy .9 3 w a- w - -, v- y-, ,%- ww,.,,,,, y ,ew m .% _ - w. -.cm,wwem*.ne.,yw,m.e.-,,-,swwv,, mr-w%w.__ _* e- w v.
l CPS-ODCM TABLE 3.5-8 (continued) j IllGESTIO!! DOSE PACTORS FOR TEEli - (DFLi )3 (mrom por pCi ingested)
NUCLIDE MJ'iE LIVER T. BODY Tlrm01D }ilDi'.L/ LMtiQ GI LLI I.135 6.10E.07 1.57E.06 5.82E 07 1.01E.04 2.48E.06 NO DATA 1.74E.06 CS 134 8.37E.05 1.97E.04 9.14E.05 NO DATA 6.26E.05 2.39E.05 2.45E.06 C3 136 8.59E.06 3.38E-05 2.27E.05 110 DATA 1.84E 05 2.90E 06 1
2.72E.06 l CS.137 1.12E.04 1.49E.04 5.19E.05 5.07E.0$
NO DATA 1.97E.05 2.12E.06 i CS.138 7.76E.08 1.49E 07 7.45E 08 1.10E.07 NO DATA 1.28E.08 6.76E.11 BA.139 1.39E.07 9.78E.11 4.05E.09 NO DATA 9.22E.11 6.74E.11 1.24E.06 BA.140 2.84E.05 3,48E.08 1.83E 06 1.18E.08 NO DATA 2.34E.08 4.38E.05 BA.141 6.71E.08 5.01E.11 2.24E 09 4.65E.11 NO DATA 3.43E.11 1.43E.13 BA.142 2.99E.08 2.99E.11 1.84E.09 NO DATA 2.53E.11~ 1.99E.11 9.18E 20 LA.140 3.48E.09 1.71E.09 4.55E.10 NO DATA LA.142 NO DATA NO DATA 9.82E 05 1.79E.10 7.95E.11 1.98E.11 NO DATA NO DATA NO DATA 2.42E.06 CE.141 1.33E.08 8.88E 09 1.02E.09 NO DATA 4.18E 09 NO DATA 2.54E.05 t CE.143 2.35E.09 1.71E.06 1.91E.10 NO DATA 7.67E.10 NO DATA 5.14E.05 CE.144 6.96E.07 2.88E.07 3.74E.08 NO DATA 1.72E.07 No DATA 1.758 04 PR.143 1.31E.08 S.23E.09 6.52E.10 No DATA 3.04E.09 NO DATA 4.31E.05 PR 144 4.30E.11 1.76E.11 2.18E.12 NO DATA 1.01E.11 NO DATA 4. 74 E.14 ND 147 9.38E.09 1.02E.08 6.11E.10 NO DATA 5.99E.09 NO DATA 3.68E.05 '
W.187 1.46E.07 1.19E 07 4.17E.08 NO DATA NO DATA NO DATA 3.22E 05 NP.239 1.76E.09 1.66E.10 9.22E.11 NO DATA 5.21E.10 NO DATA 2.67E.05
- 4.06 X 10-06
- Loss than 10-24 t
CLIliTON-1 3 70 Roy.1-11/85
l CPS-0DCH l l
W TABLE 3.5,f.
INGESTION DOSE FACTORS FOR ADULT - (DFLi )a 1
. (arem per poi ingested)
NUCLIDE I?Q]if, LIVER T. BODY IHYROID }'IDNEY 11tgg gL.L(I H3 NO DATA 1.05E.07 1.05E 07 1.05E.07 1.05E.07 1.05E 07 1.05E.07 C 14 2.84E 06* 5,68E.07 5.68E 07 5.68E 07 5.68E 07 5.68E.07 5.6SE.07 NA 24 1.70E.06 1.70E 06 1.70E 06 1.70E.06 1.70E 06 1.70E 06 1.70E 06 i i
P 32 1.93E.04 1.20E 05 7.46E.06 NO DATA NO DATA NO DATA 2.17E.05 CR 51 NO DATA NO DATA 2.66E 09 1.59E.09 5.86E.10 3.53E+09 6.69E 07 MN 54 NO DATA 4.57E.06 8.72E 07 HO DATA 1.36E.06 NO DATA 1.40E 05 e
HN 56 NO DATA 1.15E.07 2.04E 08 NO DATA 1.46E 07 NO DATA 3.67E.06 FE.55 2.75E.06 1.90E.06 4.43E*07 NO DATA NO DATA 1.06E 06 1.09E 06 FE.59
, 4.34E 06 1.02E.05 3.91E 06 NO DATA NO DATA 2.85E 06 3.40E 05 CO.58 NO DATA 7.45E 07 1.67E 06 NO DATA NO DATA NO DATA 1.51E 05 C0 60 NO DATA 2.14E 06 4.72E 06 NO DATA NO DATA NO DATA 4.02E 05 -
NI 63- 1.30E-04 9.01E 06 4.36E.06 NO DATA NO DATA NO DATA 1.88E 06 NI 65 5.28E.07 6.86E 08 3.13E.08 NO LATA NO DATA NO DATA 1.74E.06 CU.64 NO DATA 8.33E.08 3.91E 08 NO DATA 2.10E.07 NO DATA 7.10E 06 -
ZN 65 4.84E 06 1.54E.05 6.96E 06 No DAM 1.03E 05 NO DATA 9.70E 06 ZN 69-- 1.03E 08 1.97E 08 1.37E.09 NO DATA 1.28E 08 NO DATA 2.96E.09 BR 83 NO DATA NO DATA 4.02E 08 NO DATA NO DATA NO DATA 5.79E.08 BR 84 NO DATA NO DATA 5.21E 08 NO DATA NO DATA NO-DATA 4.09E.13 BR 85 NO DATA NO DATA 2.14E.09 NO DATA NO DATA NO DATA LT E 24**
- RB.86 NO DATA 2.11E.05 9.83E 06 NO DATA NO DATA NO DATA 4.16E 06 RB-88 NO DATA 6.05E.08 3.21E.08 NO DATA NO DATA NO DATA 8.36E 19 i RB 89 NO DATA 4.01E.08 2.82E 08 NO DATA NO DATA NO DATA 2.33E.21 SR 89 3.08E 04 NO DATA 8.84E 06 NO DATA NO DATA NO DATA 4.94E-05 i SR.90 7.58E 03 NO DATA 1.86E.03 NO DATA NO DATA NO DATA 2.19E 04
- SR 91 5.67E.06 NO DATA 2.29E.07 NO DATA NO DATA NO DATA 2.70E 05 SR.92 2.15E 06 NO DATA 9.30E 08 NO DATA NO DATA NO DATA 4.26E.05 i Y.90' 9.62E 09 NO DATA 2.5BE.10 NO DATA NO DATA NO DATA 1.02E-04 i
CLINTON-1 3-71 Rev.1-11/85 f
, i
.--m,,_.-. ...-....-..-.__.,-_.,,,__,-_.~.,_.;.-....-.-.,,.-..u-.-.-_- - - - . . , - -
l CPS-ODCM l
1 TABLE 3.5-9 (continued) '
INGESTION DOSE FACTORS FOR ADULT - (DFLi )a (nrem por pCi ingested) l NUCLIDE E0l!E LIVER T. BODY THYROID KIDNEY L131G GI LLI Y.91m 9.09E.11 NO DATA 3.52E.12
' NO DATA NO DATA NO DATA 2.67E.10 Y 91 1.41E-07 NO DATA 3.77E 09 NO DATA NO DATA NO DATA 7.76E 05 !
Y.92 8.45E 10 NO DATA 2.47E 11 NO DATA NO DATA NO DATA 1.48E 05 Y.93 2.68E 09 NO DATA 7.40E 11 NO DATA NO DATA NO DATA 8.50E.05 ZR 95 3.04E 08 9.75E.09 6.60E 09 NO DATA 1.53E 08 NO DATA 3.09E 05 ER 97 1.68E.09 3.39E.10 1.55E 10 NO DATA 5.12E.10 NO DATA 1.0$E 04 NS 95 6.22E 09 3.46E-09 1.86E.09 NO DATA 3.42E 09 NO DATA 2.10E 05 M0 99 NO DATA 4.31E 06 8.20E 07 NO DATA 9.76E 06 NO DATA 9.99E.06 TC.99m 2.47E-10 6.98E.10 8.89E.09 NO DATA 1.06E.08 3.42E.10 4.13E 07 TC 101 2.54E.10 3.66E-10 3.59E 09 No DATA 6.59E 09 1.87E 10 1.10E.21 RU.103 1.85E 07 NO DATA 7.97E.08 NO DATA 7.06E 07 NO DATA 2.16E.05 RU 105 1.54E 08 NO DATA 6.08E 09 NO DATA 1.99E.07 NO DATA 9.42E.06 RU 106 2.75E.06 NO DATA 3.48E.07 NO DATA 5.31E 06 NO DATA 1.78E.04 ,
AG.110m 1.60E-07 1.48E 07 8.79E-08 NO DATA 2.91E 07 NO DATA 6.04E 05 TE 125m 2.68E.06 9.71E.07 3.59E.07 8.06E.07 1.09E.05 NO DATA 1.07E.05 TF 127m 6.77E.06 2.42E 06 8.25E.07 1.73E.06 2.75E.05 NO DATA 2.27E.05 TE-127- 1.10E.07 3.95E.08 2.38E.08 -8.15E.08 4.48E.07 NO DATA 8.68E 06 TE.129m 1.15E 05 4.29E-06 1.82E 06 3.95E.06 4.80E.05 NO DATA 5.79E 05 TE.129 3.14E 08 1.18E 08 7.65E-09 2.41E.08 1.32E 07 NO DATA 2.37E 08 !
TE 131m 1.73E-06 8.46E 07 7.05E.07 1.34E 06 8.57E.06 NO DATA 8.40E.05 TE.131 1.97E 08 8.23E-09 6.22E.09 1.62E.08 8.63E 08 NO DATA 2.79E 09 i TE 132 2.52E 06 1.63E.06 1.53E 06 1.80E 06 1.57E 05 NO DATA 7.71E.05 1 130 7.56E.07 2.23E 06 8.80E 07 1.89E.04 3.4eE 06 NO DATA- 1.92E 06 1 131 4.16E 06 5.95F.06 3.41E.06 1.95E.03 1.02E.05 NO DATA 1.57E.06 I 132 2.03E 07 5.43E.07 1.90E.07. 1,90E.05 8.65E 07 NO DATA 1.02E 07 i 1 133 1.42E 06 2.47E 06 7.53E-07 3.63E-04 4.31E 06 NO DATA 2.22E.06 I 134 1.06E 07 2.88E.07 1.03E-07 4.99E.06 4.58E-07 NO DATh 2.51E.10 i
(
I M.TNTM-1 "t-72 Rev.5-2/89 [
- ,..- - - - - .- . - . = . - . - - - . - . - . . _ . - _ . - -. l
I CPS-ODCM
{
TABLE 3.5-9 (continuedi !
' INGESTION DOSE FACTORS FOR ADULT - ( DF.Li ) a I
(nrem per pCi ingested)
{
l fMCLID.E E31 LIVER T. BODY THYPOID MIDNEY 1171Q CI LLI l 1
I 135 4.43E 07 1.16E 06 4.28E 07 7.65E 05 1.86E 06 NO DATA 1.31E 06 i CS 134 6.22E 05 1.48E 04 1.21E 04 NO DATA 4.79E 05 1.59E-05 2.59E 06 I CS 136 6.51E 06 2.57E 05 1.85E 05 NO DATA 1.43E 05 1.96E-06 2.92E 06 l l
I CS 137 7.97E 05 1.09E 04 7.14E-05 NO DATA 3.70E 05 1.23E 05 2.11E-06 i CS 138 5.52E 08 1.09E 07 5.40E-08 NO DATA 8.01E 08 7.91E 09 4.65E 13 !
BA 139 9.70E 08 6.91E 11 2.84E 09 NO DATA 6.46E 11 3.92E-11 1.72E 07
{
BA 140 2.03E 05 2.55E 08 1.33E 06 NO DATA 8.67E 09 1.46E 08 4.18E 05 i BA 141 4.71E 08 3.56E 11 1.59E 09 NO DATA 3.31E-11 2.02E 11 2.22E 17 l BA 142 2.13E-08 2.19E 11 1.34E 09 NO DATA 1.85E 11 1.24E 11 3.00E 26 1A 140 2.50E 09 1.26E 09 3.33E 10 NO DATA NO DATA NO DATA 9.25E 05 i 1A 142 1.28E 10 5.82E 11 1.45E 11 NO DATA NO DATA NO DATA 4.25E 07 j CE 141 9.36E 09 6.33E-09 7.18E-10 NO DATA 2.94E 09 NO DATA 2.42E 05 !
l
\
CE 143 1.65E 09 1.22E 06 1.35E 10 NO DATA 5.37E 10 NO DATA 4.56E 05 !
CE 144 4.88E 07 2.04E 07 2.62E-08 NO DATA 1.21E 07 NO DATA 1.65E 04 i PR 143 .9.20E 09 3.69E-09 4.56E-10 NO DATA 2.13E 09 NO DATA 4.03E 05 !
PR 144~ 3.01E 11 1.25E-11 1.53E-12 NO DATA 7.05E-12 NO DATA 4.33E 18 l ND 147 6.29E 09 7.27E 09 4.35E 10 NO DATA 4.25E-09 NO DATA 3.49E 05 !
W187 1.03E 07 8.61E 08 3.01E-08 NO DATA NO DATA NO DATA 2.82E-05 l i
NP-239 1.19E 09 -1.17E 10 6.45E 11 NO DATA 3.65E 10 NO DATA 2.40E 05 1
- 2.84 X 10-06
- Less than 10-24 i
i
{
i r
f CLINTON-1 3-73 Rev.1-11/85 l I
- - _ . _ . _ - , , _ _ _ _ _ . _ _ . , _ _ _ . _ . _ . _ ._.____._ _ ___._ _.-__._-._ _ _a
CPS-ODCM TABLE 3.5-10 INPUT PARAMETERS FOR CTLCUIATING Raij Parameter Value Table
- i QF (kg/ day) 50 for cow E3 6 for goat E3
+
Uap (liters /yr) - Infant 330 E5 Child 330 E5
- Teen 400 E5 Adult 310 E5 Yp (kg/m2 ) 0.7 E 15 Y, (kg/m2) 2.0 E 15 Fm (days / liter) Each stable element for cow E1 Each stable element for goat E2 r-(dimensionless) 1.0 for radioiodine E 15 '
O.2 for particulates E 15 tg (seconds) 1.73 x 105 (2 days) E 15 th (seconds) 7.78 x 106 (90 days) E 15 fs (dimensionless)
~
1.0 for cow NUREG 1.0 for goat 0133 Section -
5.3.1.3 fp (dimensionless) 1 0 for cow NUREG 1.0 for goat 0133 Section 5.3.1.3 i
- of Regulatory Guide 1.109 unless otherwise stated I f CLINTON-1 3-74 Rev.1-11/85 l
l CPS-ODCM TABLE 3.5-11 INPUT PARAMETERS POF CALCULATING R"4 Parnerer Value Table
- Uap (kg/yr) . Infant 0 E5 Child 51 E.5 Teen 65 E.5
. Adult 110 E.5 ,
Tt (days /kg) Each stable E.1 element ts (eeconds) 1.73E+06 E.15 (20 days)
' th (seconds) 7.78E+06 E*15 i
(90 days)
~
Yp (kg/m2) o,7 g.13
{
. Ys (kg/m2 ) 2.0 E 15 i
r (dimensionless) 1.0 for radiciodine E.15
, 0.2 for particulates E 15 Qt (kg/ day) 50 E3
,s...
- *of Regulatory Guide 1,109 i
CLINTON-1 3-75 Rev.1-11/05
I CPS-ODCM j
1 TABLE 3.5-12 V
INPUT PARAMETERS FOR CALCUIJsTING R aij Pa ran e te r Value Table
- L Ua (kg/yr) Infant 0 i
. Child E5 I 26 E5 !
. Teen 42 E.5 Adult 64 E5 '
S Va (kg/yr) Infant .0 E5 I
Child '520 {
E5 l
. Teen 630 E5 l Adult $20 E5 f t.(dimensionless) 1.0 E 15 ;
fg (dimensionless) 0.76 E 15 tt (seconda 8.6 x 104 (1 day) E 15 th (seconds) 5.18 x 106 (60 days) E 15 Yv (kg/m*) 2.0 E 15-
. .. e I
l l-
- of Regulatory Guide 1,109 CLINTON-1 3-76 Rev.1-11/85
CPS-ODCM f
i l
TABLE 3.5-13 4 I !
INHALATION PAT!IWAY FACTORS - R aij (IN NJT) l (mrom/yr per 4Ci/m 3) f I
f ORGANI EQ!!E LIVER T . !;0DY THYROID VIDNEY IfliG GI LLI l' ISOTOPE ,
H3 NO DATA 6.47E+02* 6.47E+02* 6.47E+02* 6.47E+02* 6.47E+02 6.47t+02* !
C.14 2.65E+04 5.31E+03 5.32E+03 5.31E+03 5.31E+03 5.31E+03 5.31E+03 l NA.24 1.06E+04 1.06E+04 1.06E+04 1.06E+04 1.06E+04 1.06E+04 1.06E+04 !
I P
P 32 2.03E+06 1.12E+05 7.74E+04 NO DATA NO DATA NO DATA 1.61E+04 i CR 51 NO DATA NO DATA 8.95E+01 5.75E+01 1.32E+01 1.28E+04 3.57E+02 !
MN.54 NO DATA 2.53E+04 4.98E+03 NO DATA 4.98E+03 1.00E+06 7.06E+03 !
l
~
MN.56 NO DATA 1.54E+00 2.21E.01 NO DATA 1.10E+00 1.25E+04 7.17t+04 l TE.$$ 1.97E+04 1.17E+04 3.33E+03 NO DATA NO DAT/. 8.69E404 1.09E+03 l FE.59 1.36E404 2.35E+04 9.48E+03 NO DATA NO DATA 1.02E406 2.48E+04 ;
CO.58 NO DATA 1.22E+03 1.82E+03 NO DATA NO DATA 7.77E+05 1.11E+04 i CO.60 NO DATA 8.02E+03 1.186+04 NO DATA NO DATA 4.51E+06 3.19E+04 !
NI.63 3.39E+05 2.04E+04 1.16E+04 NO DATA NO DATA 2.09E+05 2.42E+03 NI 65 2.39E+00 -2.84E+01 1.23E 01 No DATA NO DATA 8.12E+03 5.01E+04 l CU.64 NO DATA 1.88E+00 7.74E 01 NO DATA 3.98E+00 9.30E+03 1.50E+04 {
ZN 65 1.93E+04 6.26E+04 3.11E+04 NO DATA 3.25E+04 6,47E+05 5.14E+04 i i
I ZN 69 5.39E.02 9.67E 0' 7.18E.0S NO DATA 4.02E.02 1.47E+03 1.32E+04 l BR.83 NO DATA NO DATA 3.81E+02 NO DATA NO DATA No DATA LT1.4E 15**
BR.84 NO DATA NO DATA 4.00E+02 NO DATA NO DATA NO DATA LT1.4E.15 BR 65 NO DATA NO DATA 2.04E+01 NO DATA- NO DATA NO DATA LT1.4E.15 RB 86 NO DATA 1.90E+05 8.82E+04 -NO DATA NO DATA NO DATA 3.04E+03 l RB.88 NO DATA 5.57E+02 2.87E+02 NO DATA NO DATA NO DATA 3.39E+02 l t
RB.89 NO DATA 3.21E+02 2.06E+02 NO DATA NO DATA NO DATA 6.82E+01 l SR.89 3.98E+05 NO DATA 1.14E+04 NO DATA NO DATA 2.03E+06 6.40E+04 SR.90 4.09E+07 NO DATA 2.59E+06 NO DATA NO DATA 1.12E+07 1.31E+05 l
1 i
t i
CLINTON-1 3-77 Rev.5-2/89 l
[
. ,_. _ . _ . _ ,- _ - _ , _ _ . _ _ _ _ _ , _ . _ . ~ . _ _ . .__. . _ _ _ _ , _ _- _ _ _ _ . - _ . - -
= . _ - . . . - . - _ - . - - - - . - . - . . . - . - . . -
CPS-ODCM TABLE 3.5-13,(continued)
INHALATION PATINAY FACTORS - R aij (INFANT)
(mrem /yr por 4Ci/m 3)
ORGAN! Elig LIVER T. BODY THYF01D KIDNEY LEG G1 LLI ISOTOPE SR 91 9.56E+01 NO DATA 3.46E+00 NO DATA NO DATA 5,26E+04 7.34E+04
$R 92 1.05E+01 NO DATA 3.91E 01 NO DATA NO DATA 2.38E+04 1.40E+05 Y+90 3.29E+03 NO DATA 8.82E+01 NO DATA NO DATA 2.69E+05 1.04E+05 Y 91m 4.07E 01 NO DATA 1.39E 02 NO DATA No DATA 2.79E+03 2.35E+03 Y 91 5.88E+05 NO DATA 1.57E+04 NO DATA NO DATA 2.45E+06 7,03E404 Y 92 1.64E+01 NO DATA 4.61E 01 NO DATA NO DATA 2.45E+04 1.27E+05 Y 93 1.50E+02 NO DATA 4.07E+00 NO DATA NO DATA 7.64E+04 1.67E+05 i ZR 95 1.15E+05 2.79E+04 2.03E+04 NO DATA 3.11E+04 1.75E+06 2.17E+04 ZR 97 1.50E+02 2.56E+01 1.17E+01 NO DATA 2.59E+01 1.10E+05 1.40E+05 NB 95 1.57E+04 6.43E+03 3.78E+03 NO DATA 4.72E+03 4.79E+05 1.27E+04 MO 99 NO DATA 1.65E+02 3.23E+01 2.65E+02 NO DATA 1.35E+05 4.87E+04 TC 99m 1.40E 03 2.88E 03 3.72E 02 NO DATA 3.11E 02 8.11E+02 2.03E+03 TC 101 6.51E 05 8.23E 05 8.12E 04 NO DATA 9.79E-04 % 84E+02 8.44E+02 RU 103 2.02E+03 NO DATA 6.79E+02 NO DATA 4.24E+03 s.52E+05 1.61E+04 RU 105 1.22E+00 NO DATA 4.10E 01 NO DATA 8.99E 01 1.57E+04 4.84E+04 RU 106 8.68E+04 NO DATA 1.09E404 NO DATA 1.07E+05 1.16E+07 1.64E+05 AG 110m S.98E+03 7.22E+03 5.00E+03 NO DATA 1.09E+04 3.67E+06 3.30E+04. l TE 125m 4.76E+03 1.99E+03 6.58E+02 1.62E+03 NO DATA 4.47E+05 1.29E+04 TE 127m 1.67E+04 6.90E+03 2.07E+03 4.87E+03 3.75E+04 1.31E+06 2.73E+04 TE 127 2.23E+00 9.53E-01 4.89E 01 1.85E+00 4.86E+00 1.03E+04 2.44E+04 TE-129m 1.41E+04 6.09E+03 2.23E+03 5.47E+03 3.18E+04 1.68E+06 6.90E+04 TE 129 7.88E-02 3.47E+02 1.88E 02 6.75E 02 1.75E 01 3.00E+03 2.63E+04 TE 131m 1. 0 */E+02 5.50E+01 3.63E+01 8.93E+01 2.65E+02 1.99E+05 1.19E+05 )
TE 131 1.74E 02 8.22E 03 5.00E 03 1.50E 02 3.99E-02 2.06E+03 8.22E+03 TE 132 3.72E+02 2.37E+02 1 76E+02
. 2.79E+02 1.03E+03 3,40E+05 4,41E+04 L 130 6.39E+03 1.39E+04 5.57E+03 1.60E+06 1.53E+04 NO DATA 1.99E+03 I-131 3.79E+04 4.44E+04 1.96E+04 1.48E+07 5.18E+04 NO DATA 1 06E+03 CLINTON-l' 3-78 Rev.5-2/89
_m _ . _. . _. - _ ._ _ _,. _ _ _ _ -_ _ .._ _. _ _ _ _ . _ _ . -. _ _ _ _ . _ ._ - __
CPS-ODCM
[
TABLE 3.5-13 (continued) l I
INHALATION PATHWAY FACTORS - R aij (IMANT) !
(mren/yr por 4Ci/m 3)
I i
M i
OPGAN* LIVER ISOTOPE T.P.0DY T1NROID 1*IDNEY M CI LLI l l
I.132 1.69E+03 3.54E+03 1.26E+03 1.69E+05 3.95E+03 NO DATA 1.90E+03 I.133 1.32E+04 {
1.92E+04 5.60E+03 3.56E+06 2.24E+04 NO DATA 2.16E+03 t I 134 9.21E+02 1.88E+03 6.65E+02 4.45E+04 2.09E+03 NO DATA 3.29E+03 i
[
I.135 3.86E+03 7.60E+03 2.77E+03 6.96E+05 8.47E+03 NO DATA 1.83E+03 [
CS 134 3.96E+05 7.03E+05 7.45E+04 NO DATA 1.90E+05 7.97E+04 1,33E+03 i CS.136 4.83E+04 1.35E+05 5.29E+04 NO DATA 5.64E+0, 1.18E+04 1.43E+03 j CS.137 5.49E+05 6.12E+05 4.55E+04 NO DATA 1.71r<05 7.13E+04 1.33E+03 CS.138 5.05E+02 7.81E+02 3.98E+02 NO DATA 4.1C +02 6.54E+01 8.76E+02 EA 139 1.48E+00 1.84E 04 4.30E 02 NO DATA 5.92E.04 5.95F+03 5.10E+04 ;
[
. I BA 140 5.60E+04 5.60E+01 2.90E+03 NO DATA 1.34E+01 1.60E+06 3.84E+04 BA.141 1.57E.01 1.08E 04 4.97E.03 NO DATA 6,50E 05 2.97E+03 4.75E+03 >
BA 142 3.98E 02 3.30E 05 1.96E 03 NO DATA 1.90E.05 1.55E+03 6.93E+02 l l
"+ 1A.140 5.05E+02 2.00E+02 5.15E+01 NO DATA NO DATA 1.68E+05 8,48E404 IA 142 1.03E+00 3.77E.01 9.04E.02 NO DATA NO DATA 6.22E+03 5.95E+04 I CE.141 2.77E+04 1.67E+04 1.99E+03 NO DATA 5.25E+03 5.17E+05 2.16E+04 f CE.143 2.93E+02 1.93E+02 2.21E+01 NO DATA 5.64E+01 1.16E+05 4.97E+04 I CE.144 3.19E+06 1.21E+06 1.76E+05 NO DATA 5.38t+05 9.84E+06 1.48R+05 j PR 143 1.40E+04 5.24E+03 6.99E+02 NO DATA 1.97E+03 4.33E+05 3.72E+04 !
PR.144 4.79E 02 1.85E 02 2.41E.03 NO DATA 6.72E.03 1.61E+0? 4.28E+03 ND 147 7.94E+03 8.13E+03 5.00E+02 NO DATA 3.15E+03 3.22E+05 3.12E+04 '
V.187 WE+01 9.02E+00 3.12E+00 NO DATA NO DATA 3.96E+04 3,56E+04 ;
NP.239 3.71E+02 3.32E+01 1.88E+01 NO DATA 6.62E+01 5.95E+04 2.49E+04
- 6.47 x 102
- Loss than 1.40 x 10~10 c
4 I
i CLINTON-1 3-79 Rev.5-2/89 ;
i
. . _ . _ -. _ _ _ _ . ___ .. ... m . . - _ _ _ _ _ . . _ . _ . _ _ . - _ _ - _ . _ _ _ . . __ . . . _ . _
4 CPS-ODCM TABLE 3.5-14 INHALATION PATitWAY FACTORS - R 13 (CllILD)
(mrom/yr per pC1/m 3)
ORGAN- EEE LIVER T. BODY THYROID FID$EY 113iG GI LLI ISOTOPE H3 NO DATA 1.12E+03* 1.12E+03 1.12E+03 1.12E+03 1 uE+03 1.12E+03 C 14 3.58E+04 6.73E+03 6. 73E403 6.73E403 6.73E+03 6.73E+03 6.73E+03 NA 24 1.61E+04 1.61E+04 1.61E+04 1.61E+04 1.61E+04 1.61E+04 1.61E+04 P 32 2.60E+06 1.14E+05 9.87E+04 110 DATA NO DATA NO DATA 4.21E+04 CR-51 NO DATA NO DATA 1.54E+02 8.54E+01 2.43E+01 1.70E+04 1.08E+03 101 54 NO DATA 4.29E+04 9.51E+03 NO DATA 1.00E+04 1.58E+06 2.29E+04 MN 56 NO DATA 1.66E+00 3.12E 01 NO DATA 1.67E+00 1.31E+04 1.23E+05 FE 55 4.74E+04 2.52E+04 7.77E+03 NO DATA 1.11E405 NO DATA 2.87E+03 FE 59 2.07E+04 3.34E+04 1.67E+04 NO DATA NO DATA 1.27E+06 7.07E+04 CO 58 NO DATA 1.77E+03 3.16E+03 NO DATA 1.11E+06 NO DATA 3.44E+04 CO 60 NO DATA 1.31E+04 2.26E+04 NO DATA NO DATA 7.07E+06 9.62E+04 ,
NI 63 8.21E+05 4.63E+04 2.80E+04 NO DATA No DATA 2.73E+05 6.33E+03 ;
NI-65 2.99E+00 2.96E-01 1.64E 01 NO SATA NO DATA 8.18E+03 8.40E+04 CU 64 NO DATA 1.99E+00 1.07E+00 6.03E+00 NO DATA 9.58E+03 3.67E+04 ZN 65 4.26E+04 1.13E+05 7.03E+04 NO DATA 7.14E+04 9.95E+05 1.63E+04 i ZN 69 6.70E 02 9.66E 02 8.92E 03 NO DATA 5.-85E 02 1.42E+03 1.02E+04
'BR 83 NO DATA NO DATA 4.74E+02 NO DATA NO DATA NO DATA LT3.70E 15** '
PR-84 NO DATA NO DATA 5.48E+02 NO DATA NO DATA NO DATA LT3.70E 15 BR-85 NO DATA NO DATA 2.53E+01- NO DATA NO DATA NO DATA LT3.70E 15 RB 86 NO DATA 1.98E+05 1.14E+05 NO DATA NO DATA NO DATA 7.99E+03 RB-88 NO DATA 5.62E+02 3.66E+02 NO DATA NO DATA NO DATA 1.72E+01 RB 89 NO DATA 3.45E+02 2.89E+02 NO DATA NO DATA NO DATA -1.89E+00 SR-89 5.99E+05 NO DATA 1.72E+04 NO DATA NO DATA 2.16E+06 1.67E+05 SR 90 1.01E+08 NO DATA 6.44E+06 NO DATA NO DATA 1.48E+07 3.43E+05 i
SR-91 1.21E+02 NO DATA 4.59E+00 NO DATA NO DATA 5.33E+04 1,74E+05 SR 92 1.31E+01 NO DATA 5.25E 01 NO DATA NO DATA 2.40E+04 2.42E+05 Y-90 4.11E+03 NO DATA 1.11E+02 NO DATA NO DATA 2.62E+05 2.66E+05 t
CLINTON-1 3-80 Rev.5-2/89
- ~ . . . ~ _ - _ . - . , - - _ _ _ - _ - . _ _ - - - - _ . _ . . ~ . - - . - - - . - . -
h CPS-ODCM f
i TABLE 3.5-14 (continuedi I INHAIATION PATHWAY FACTORS - Raij (CHI @
(mrem /yr per #Ci/m 3)
OPCAN- f.QfiE LIVER T. BODY THYPOID KIDNEY LUl;L ML1 ISOTOPE
[
' l Y 91m 5.07E-01 NO DATA 1.84E 02 NO DATA NO DATA 2.81E+03 1.72E+03 !
Y 91 9.14E+05 NO DATA 2.44E+04 NO DATA NO DATA 2.63E406 1.84E+05 l Y 92 2.04E+01 NO DATA 5.81E 01 NO DATA NO DATA 2.39E+04 2.39E+05 I i
l Y-93 1.86E+02 NO DATA 5.11E+00 NO DATA NO DATA 7.44E+04 3.89E+05 I ZR 95 1.90E+05 4.18E+04 3.70E+04 NO DATA 5.96E+04 2.23E+06 6.11E+04 !
ZR 97 1.88E+02 2.72E+01 1.60E+01 NO DATA 3.89E+01 1.13E+05 3.51E+05 i I
NB 95 2.35E+04 9.18E+03 6.55E+03 NO DATA 8.62E+03 6.14E+05 3.70E+04 MO 99 NO DATA 1.72E+02 4.26E+01 NO DATA 3.92E+02 1.35E+05 1.27E+05 70 99m 1.78E 03 3.48E 03 {
5.77E 02 NO DATA 5.07E 02 9.51E+02 4.81E+03 i t
TC 101 8.10E 05 8.51E-05 1.08E 03 NO DATA 1.45E 03 5.84E+02 1.63E+01 RU 103 2.79E+03 NO DATA 1.07E+03 NO DATA 7.03E+03 6.62E+05 4.48E+04 ;
RU 105 1.53E+00 NO DATA 5.55E 01 NO DATA 1.34E+00 1.59E+04 9.95E+04 t RU 106 1.36E+05 NO DATA 1.69E+04 NO DATA 1.84E+05 1.43E+07 4.20E+05 AG-110m 1.69E+04 1.14E+04 9.14E+03 NO DATA 2.12E+04 5.48E+06 1.00E+05 i TE 125m 6.73E+03 '2.33E+03 9.14E&O2 1.92E+03 NO DATA 4.77E+05 3.38E+04 !
i l
TE-127m 2.49E+04 8.55E+03 3.02E+03 6.07E+03 6.36E+04 1.48E+06 7.14E+04 TE 127 2.77E+00 9.51E 01 6.11E 01 1.96E+00 7.07E+00 1.00E+04 5.62E+04 )
TE 129m 1.92E+04 6.85E+03 3.04E+03 6.33E+03 5.03E+04 1.76E+06 1.82E+05 !
[
TE 129 9.77E 02 3.50E 02 2.38E 02 7.14E-02 2.57E 01 2.93E+03 2.55E+04 TE 131m 1.34E+02 5.92E+01 f
5.07E+01 9.77E+01 4.00E+02 2.06E+05 3.08E+05 !
TE-131 2.17E 02 8.44E 03 6~59E 03
. 1.70E-02 5,88E-02 2.05E+03 1.33E+03 j!
i TE 132 4.81E+02 2.72E+02 2.63E+02 3.17E+02 1.77E+03 3.77E+05 1.38E+05 I I 130- 8.18E+03 -1.64E+04 8.44E+03 1.85E+06 2.45E+04 NO DATA 5.11E+03 .
1-131 4.81E+04 4.81E+04 2.73E+04 1.62E+07 7.88E+04 NO DATA 2.84E+03 l
- l. h l I 132 2.12E+03 4.07E+03 1.88E+03 1.94E+05 6.25E+03 NO DATA 3.20E+03 I 133 1.66E+04 2.03E+04 7.70E+03 3.85E+06 3.38E+04 NO DATA 5.48E+03 i I-134 1.17E+03 2.16E+03 9.95E+02 5.07E+04 3.30E+03 NO DATA 9.54E+02 l
i t _CLINTON-1 3-81 Rev.5-2/89 f
[
. ..--_-- -.__--.- .- --- - - - - . _ . . ~ --- -- -. ...~_-
CPS-ODCM TABLE 3.5-14 (continued)
INHALATION PATHWAY FACTORS - R aij (CHILD)
(crem/yr per 4Ci/m 3) I ORGAN- EiE LIVER T. BODY THYFOID }'Jfl{EY L!Jl{G GI LLI ISOTOPE I 135 4.92E+03 8.73E+03 4.14E+03 7.92E+05 1.34E+04 NO DATA 4.44E+03 CS 134 6.51E+05 1.01E+06 2.25E+05 NO DATA 3.30E+05 1.21E+05 3.85E+03 CS 136 6.51E+04 1.71E+05 1.16E+05 NO DATA 9.55E+04 1.45E+04 4.18E+03 CS 137 9.70E+05 8.2$E+05 1.28E+05 NO DATA 2.82E+05 1.04E+05 3.62E+03 CS 138 6.33E+02 8.40E+02 5.55E+02 NO DATA 6.22E+02 6.81E+01 2.70E+02 BA 139 1.84E+00 9.84E 04 5.37E 02 NO DATA 8.62E 04 5.77E+03 5.77E+04 BA 140 7.40E+04 6.48E+01 4.33E+03 NO DATA 2.11E+01 1.74E+06 1.02E+05 BA 141 1.96E 01 1.09E 04 6.36E 03 NO DATA 9.47E 05 2,92E+03 2.75E+02 BA 142 5.00E 02 3.60E 05 2.79E 03 NO DATA 2 91E 05 1.64E+03 2.74E+00 LA 140 6.44E+02 2.25E+02 7.55E+01 NO DATA 1.83E+05 NO DATA 2.26E+05 LA 142 1.30E+00 4.11E 01 1.29E 01 NO DATA NO DATA 8.70Et03 7.59E+04 CE 141 3.92E+04 1.95E+05 2.90E+03 NO DATA 8.55E+03 5.44E+05 5.66E+04 ,
CE 143 3.66E+02 1.99E+42 2.87E+01 8,36E+01 NO DATA 1.15E+05 1.27E+05 CE-144 6.77E+06 2.12E+06 3.61E+05 NO DATA 1.17E+06 1.20E+07 3.89E+05 PR 143 1.85E+04 5.55E+03 9.14E+02 3.00E+03 NO DATA 4.33E+05 9.73E+04 PR 144 5.96E 02 1.85E-02 3.00E 03 NO DATA 9.77E-03 1.37E+03 1.97E+02 ND 147 1.08E+04 8.73E+03 6.81E+02 NO DATA 4.81E+03 3.28E+05 8.21E+04 u-187 1.63E+01 9.66E+00 4.33E+00 NO DATA NO DATA 4.11E+04 9.10E+04 NP-239 4.66E+02 3.34E+01 2.35E+01 No DATA 9.73E+01 5.81E+04 6.40E+04 1.12 x 103
- Less than 3.70 X 10-15 CLINTON-1 3-82 Rev.5-2/89
CPS-ODCA
- I TABLE 3.5-15 4
f INHALATIONPATHWAYFACTORS-Rfig(TEEN) j (nrem/yr per pCi/m 3) 1 i
j ORGAN: LGliI LIVER T. BODY THYPOID 12DfiU LlWTG 01 LLI l ISOTOPE
]
H3 NO DATA 1.27E+03* 1.27E+03 1.27E+03 1.27E403 1.27E+03 1. 27 E403 C-14 2.60E+04 4.87E+03 4.873+03 4.67E+03 4.87E+03 4.87E+03 4.87E+03 i NA 24 1.38E+04 1.38E+04 1.38E+04 1.38E+04 1.38E+04 1.38E+04 1.38E+04 P 32 1.89E+06 1.10E+05 7.16E+04 NO DATA NO DATA NO DATA 9.28E+04 CR-51 NO DATA NO DATA 1.35E+02 7.50E+01 3.07E+01 2.10E+04 3.00E+03 i
_- MN 54 NO DATA 5.11E+04 8.40E+03 No DATA 1.27E+04 1.98E+06 6.68E+04 i
MN 56 NO DATA 1.70E+00 -2.52E 01 NO DATA 1.79E+00 1.52E+04 5.74E+04 FE 55 3.34E+04 2.38E+04 5.54E+03 NO DATA NO DATA 1.24E+05 6.39E+03 FE 59 1.59E+04 3.70E+04 1.43E+04 NO DATA NO DATA 1.53E+06 1.78E+05 CO.58 NO DATA 2.07E+03 2.78E+03 NO DATA NO DATA 1.34E+06 9.52E+04 CO.60 NO DATA 1.51E+04 1.98E+04 NO DATA NO DATA 8.72E406 2.59E+05 NI 63 5.80E+05 4.34E+04 1.98E+04 NO DATA NO DATA 3.07E+05 1.42E+04 NI-65 -2.18E+00 2.93E.01 1.27E 01 NO DATA NO DATA 9.36E+03 3.67E+04 CU 64 NO DATA 2.03E+00 8.48E.01 NO DATA 6.41E+00 1.11E+04 6.14E+04 EN 65 3.86E+04 1,34E+05 6.24E+04 NO DATA 8.64E+04 1.24E+06 4 6E+04 1
ZN 69 4.83E 02 9.20E 02 6.46E 03 NO DATA 6.02E 02 1.58E+03 2.85E+02 BR-83 NO DATA NO DATA 3.44E+02 NO DATA NO DATA _ N0_ DATA- LT8E.15**
BR.84 NO DATA NO DATA 4.33E+02 NO DATA NO DATA NO DATA LT8E-15 BR-85 NO LATA NO DATA 1.83E+01 NO DATA No DATA NO DATA LT8E 15 RB 86- NO DATA 1.90E+05 8.40E+04 NO DATA NO DATA NO DATA 1.77E+04 RB-88 NO DATA 5.46E+02 2.72E+02 NO DATA NO DATA NO DATA 2.92E 05 RB 89 NO DATA 3.52E+02 2.33E+02 NO DATA NO DATA NO DATA 3.38E 07 SR 4.34E+05 NO DATA -1.25E+04 -NO DATA NO DATA 2,42E+06 3.71E+05 SR 90- 1.08E+08 NO DATA 6.68E+06 NO DATA NO DATA 1.65E+07 7.65E+05 SR-91 8.80E+01 NO DATA 3.51E+00 NO DATA NO DATA 6.07E404 2.59E+05 SR 92 9.52E+00 NO DATA 4.06E.01 NO DATA NO DATA 2.74E+04 1.19E+05 Y-90 2.98E+03 NO DATA 8 00E+01 NO DATA NO DATA 2.93E+05 5.59E+05 CLINTON-1 3-83 Rev.5-2/89
- - - - - ~ . - . _ - - - - - ._-
CPS-ODCM TABLE 3.5-15 (continuedl IN!!ALATION PATl!WAY FACTORS - R aij (TEEN)
(mrom/yr por pCi/m 3)
OROAN: DE LET2 T.It0DY TilYROID KIDNEY LWG GI LLI ISOTOPE i
Y 91m 3.70E 01 NO DATA 1.42E 02 NO DATA NO DATA 3.20E403 3.02E401 :
Y 91 6.61E+05 NO DATA 1.77E+04 NO DATA NO DATA 2.94E+06 4,09E+05 i Y 92 1.47E+01 NO DATA 4.29E 01 NO DATA NO DATA 2.68E404 1.65E+05 Y 93 1.35E+02 NO DATA 3.72E400 NO DATA NO DATA 8.32E404 5.79E405 ZR 95 1.46E+05 4.58E+04 3.15E+04 NO DATA 6.74E+04 2.69E+06 1.49E405 ZR 97 1.38E+02 2.72E401 1.26E+01 NO DATA 4.12E+01 1.30E+05 6.30E+05 NB 95 1.86E+04 1.03E+04 5.66E+03 NO DATA 1.00E+04 7.51E405 9.68E404 MO 99 NO DATA 1.69E+02 3.22E+01 NO DATA 4.11E+02 1.54E+05 2.69E+05 TC 99m 1.38E 03 3.86E 03 4.99E 02 NO DATA 5.76E 02 1.15E403 6.13E+03 TC 101 5.92E 05 8.40E 05 8.24E 04 NO DATA 1.52E 03 6.67E+02 8.72E 07 RU 103 2.10E+03 NO DATA 8.96E+02 NO DATA 7.43E+03 7.83E+05 1.09E+05 RU 105 1.12E+00 NO DATA' 4.34E 01 NO DATA 1.41E400 1.82E404 9.04E+04
.RU 106 9.84E+04 NO DATA 1.24E+04 NO DATA 1.90E+05 1.61E+07 9.60E+05 A0 110m 1.38E+04 1.31E&O4 7.99E403 NO DATA 2.50E404 6.75E+06 2.73E405 TE 125m 4.88E+03 2.24E+03 6.67E+02 1.40E+03 NO DATA 5.36E+05 7,50E+04 TE 127m 1.80E+04 8.16E+03 2.18E403 4.38E+03 6.54E+04 1.66E+06 1.59E+05 TE 127 2.01E+00 9.12E 01 4.42E 01 1.42E+00 7.28E+00 1.12E+04 8.08E+04 TE 129m 1.39E+04 6.58E+03 2.25E+03 4.58E+03 5.19E+04 1.98E406 4.05E+05 IE 129 7.10E 02 3.38E 02- 1.76E 02 5.18E-02 2.66E 01 3.30E+03 1.62E+03 TE 131m 9,84E+01 6,01E+01 4.02E+01 7.25E+01 4.39E402 2.38E+05 6.21E+05 TE 131- 1.58E 02 8.32E 03 5.04E 03 1.24E 02 6.18E 02 2.34E+03 1.51E+01 TE 132 3.60E+02 2.90E+02 2.19E+02 2.46E402 1.95E+03 4.49E405 4.63E+05 l I 130 6.24E+03 1.78E+04 7.17E+03 1.49E+06 2.75E+04 NO DATA 9.12E+03 I 131 3.54E+04 4.91E+04 2.64E404 1.46E+07 8.40E+04 NO DATA 6.49E+03 2
1 132 1,59E+03 4.38E+03 1.58E+03 1.51E+05 6.92E+03 NO DATA 1.27E+03 I 133 1.22E+04 2.05E+04 6.22E+03 2.92E406 3.59E+04 NO DATA 1.03E+04 1 134 8.88E+02 2.32E+03 8.40E+02 3,95E+04 3.66E+03- NO DATA 2.04E+01 CLINTON-1 3-84 Rev.5-2/89
- _ , . . _ m,._
.. . _ _ _ _ - - e.... . . . . . _ . _ - - _ . _ . _ _ _ _ _ _ . _ . - - _
CPS-ODCM TABLE 3.5-15 (continued)
INHALATION PATHWAY FACTORS - Raij (T U.N) ,
(mrom/yr por pCi/m 3)
ORGAN: E21!E LIVER T. BODY TIWROID ElpliEX L131G 01-LLI
, ISOTOPE I 135 3.70E+03 9.44E+03 3.49E403 6.21E+05 1.49E+04 NO DATA 6.95E+03 CS 134 5.02E+05 1.12E+06 5.49E+05 NO DATA 3.75E+05 1.46E+05 9.76E+03 CS 136 5.15E+04 1.94E+05 1.37E+05 NO DATA 1.10E405 1.78E404 1.09E+04 ,
CS 137 6.70E+05 8.48E+05 3.11E+05 NO DATA 3.04E+05 1.21E405 8.48E+03 CS 138 4.66E+02 8.56E+02 4.46E+02 NO DATA 6.62E+02 7.87E+01 2.70E 01 BA 139 1.34E+00 9.44E 04 3.90E 02 NO DATA 8.88E 04 6.46E+03 6.45E403 BA 140 5.47E+04 6.70E+01 3.52E403 NO DATA 2.28E+01 2.03E+06 2.29E+05 BA 141 1.42E 01 1.06E 04 4,74E 03 NO DATA 9.84E 05 3.29E+03 7.46E 04 BA 142 3.70E 02 3.70E 05 2.27E 03 NO DATA 3.14E 05 1.91E+03 4.79E 10 LA 140 4.79E+02 2.36E+02 6.26E+01 NO DATA NO DATA 2.14 E4 05 4.87E+05 1A 142 9.60E 01 4.25E 01 1.06E-01 NO DATA NO DATA 1.02E+04 1. 20E+ 04 CE 141 2.84E404 1.90E+04 2.17E+03 NO DATA 8.88E+03 6.1 '4 E4 05 1.26E+05 '
1 CE 143 2.66E+02 1.94E402 2.16E+01 NO DATA 8.64E+01 1.30E+05 2.55E+05 CE 144 4.89E+06 2.02E+06 2,62E+05 NO DATA 1.21E+06 1.34E+07 8. 64 E+ 05 .
PR 143 1 34E+04 5,31E403 6.62E+02 NO DATA 3.09E+03 4.83E+05 2.14E+05 !
PR 144 4.30E 02 1.76E 02 2.18E-03 NO DATA 1.01E 02 1.75E+03 2.35E 04 !
ND 147 7. 8 6 E+ 03 -- 8.56E+03 5.13E+02 NO DATA 5.02E+03 3.72E+05 1.82E+05 f W 187 1.20E+01 9.76E+00 3.43E+00 NO DATA NO DATA 4.74E+04 1.77E+05 i i
NP 239 3.38E+02 3.19E+01 1.77E401 NO DATA 1.00E+02 6.49E+04 1.32E+05 i
- 1.27 x 10 3 l
- Less than 8.00 x 10-15 j i
l t
i I
I t
CLINTON-1 3-85 Rev.5-2/89 [
-l
CPS-ODCM TABLE 3.5-16 INilALATION PATINAY FACTORS - R y (ADULT)
(mrom/yr por 4Ci/m 3)
ORGAN: fe{!jlE LIVER TlWROID Tm BODY FIDNEY 11 LEI GI-LLI ISOTOPE H3 NO DATA 1.26E+03* 1.26E+03 1.26E+03 1.26E+03 1.26E403 1.26E+03 C-14 1.82E+04 3.41E+03 3.41E+03 3.41F+03 3.41E+03 3.41E+03 3.41E403
!!A 24 1.02E+04 1.02E+04 1.02E+04 1.02E+04 1.02E+04 1.02E+04 1.02E+04 P 32 1.32E+06 7.71E+04 5.01E+04 NO DATA NO DATA NO DATA 8.64E+04 CR 51 NO DATA N0 DATA 1.00E+02 5.95E+01 7.28E+01 1.44E+04 3.32E+03 101 54 NO DATA 3,96E+04 6.30E+03 NO DATA 9.84E+03 1.40E+06 7.74E+04 101 56 NO DATA 1.24E+00 1.83E 01 NO DATA 1.30E+00 9.44E+03 2.02E+04 I FE 55 2.46E+04 1.70E+04 3.94E+03 NO DATA NO DATA 7.21E+04 6.03E+03 FE 59 1.18E+04 2.78E+04 1.06E+04 NO DATA NO DATA 'E+06 1.88E+05 {
CO 58 NO DATA 1.58E+03 2.07E+03 NO DATA NO DATA 9.28E+05 1.06E+05 CO-60 NO DATA 1.15E+04 1.4 8 E+04 NO DATA NO DATA 5.97E+06 2.85E+05 {
NI 63 4.32E+05 3.14E+64 1.45E+04 NO DATA NO DATA 1.7EE+05 1.34E+04 l
I NI 65 1.54E+00 2.10E 01 9.12E 02 NO DATA NO DATA 5.60E+03 1.23E+04 [
CU 64 NO DATA 1.46E+00 6.15E 01 NO DATA 4.62E+00 6.78E+03 4.90E+04 ZN 65 3.24E+04 1.03E+05 4.66E+04 NO DATA 6.90E+04 8.64E+05' $.34E+04 i
ZN 69 3.38 02 6.51E 02 4.52E 03 NO DATA 4.22E 02 9.20E+02 1.63E+01 [
BR 83 NO DATA NO DATA 2.41E+02 NO DATA NO DATA NO DATA 2.32E+02 BR 84 NO DATA l
NO DATA 3.13E+02 NO DATA NO DATA NO DATA 1.64E 03 BR 85 No DATA NO DATA 1.28E+01 NO DATA NO DATA NO DATA LT8E 15**
j RB 86 NO DATA 1.35E+05 5.90E+04 NO DATA NO DATA NO DATA 1,66E+04 i RB 88 NO DATA 3.87E+02 1.93E+02 NO DATA NO DATA NO DATA 3.34E 09 i l
RB 89 NO DATA 2.56E+02 1.70E+02- No' DATA NO DATA- NO DATA- 9.28E SR 89 3.04E+05 NO DATA 8.72E+03 3.50E+05-NO DATA NO DATA 1.40E+06 SR 90 .9.92E407 NO DATA '6.10E+06 NO DATA NO DATA 9.60E+06 7.22E+05
[
SR 91 6,19E+01 NO DATA 2.50E+00 NO DATA No DATA 3.65E+04 1.91E+0*
SR-92 6.74E+00 NO DATA 2.91E-01 NO DATA NO DATA 1.65E+04 4.30E+04 Y 2.09E+03 NO DATA 5.61E+01 NO DATA NO DATA 1.70E405 5.06E+05 CLINTON-1 3-86 Rev.5-2/89
l !
CPS-0DCM t
i' TABLE 3.5-16 (continued)
INHALATION PATHWAY FACTORS - R aij (ADULT) 3 (mren/yr per pCi/m ) f l
I ORCAN: EEE LIVER T. BODY THYROID KIDNEY LlE GI LLI i ISOTOPE t Y 91m 2.61E.01 NO DATA 1.02E 02 NO DATA NO DATA 1.92E+03 1.33E400 Y.91 4.62E+05 NO DATA 1.24E+04 NO DATA NO EATA 1.70E+06 3.85E+05 [
Y 92 1.03E+01 NO DATA 3.02E 01 NO DATA NO DATA 1.57E+04 7.35E+04 l l
i Y.93 9.44E+01 NO DATA 2.61E+00 NO DATA NO DATA 4.85E+04 4.22E+05 !
ZR 95 1.07E+05 3.44E+04 2.33E+04 NO DATA 5.42E+04 1.77E+06 1.50E+05 j ZR 97 9.68E+01 1.96E+01 9.04E+00 NO DATA 2.97E+01 7.87E+04 5.23E+05 t t
~
NB 95 1.41E+04 7.82E+03 4.21E403 NO DATA 7.74E+03 5.0$E+05 1.04E+05 I MO 99 NO DATA 1.21E+02 2.30E+01 NO DATA 2.91E+02 9.12E+04 2.48E+05 :
TC 99m 1.03E-03 2.91E 03 3.70E 02 NO DATA 4.42E 02 7.64E+02 4.16E+03
{
t i'
101 4.18L 05 6.02E.05 5.90E.04 NO DATA 1.08E 03 3.99E+02 1.09E.11 RU 103 1.53E+03 NO MTA 6.58E+02 NO DATA 5.83E+03 5.05E+05 1.10E+05 [
RU 105 7.90E.01 NO DATA 3.11E 01 NO DATA 1.02E+00 1.10E+04 4.82E+04 :
RU-106 6.91E+04 NO DATA 8.72E+03 NO DATA 1.34E+05 9.36E+06 9.12E+05 AC 110m 1.08E+04 1.00E+04 5.94E+03 NO DATA 1.97E+04 4.63E+06 3.02E+05 !
TE 125m 3.42E+03 '1.58E+03 4.67E+02 1.05E+03 1.24E+04 3.14E+05 7.06E+04 i I
I TE 127m 1.26E+04 5.77E+03 1.57E+03 3.29E+03 4.58E404 9.60E+05 1.50E+05 :
TE-127 1.40E+00 6.42E.01 3.10E.01 1.06E+00 5.10E+00 6.51E+03 5.74E+04 j TE.129m 9.76E+03 4.67E+03 1.58E+03 3.44E+03 S.66E+04 1.16E+06 3.83E+05 ) i TE 129 4.98E 02 2.39E 02 1.24E.02 3.90E 02 1.87E 01 1.94E+03 1.57E402 I TE 131m 6.99E+01 4.36E+01 2.90E+01 5.50E+01 3.09E+02 1.46E+05 5.56E+05 i TE-131 1.11E-02 5 95E 03
. 3.59E 03 9.36E 03 4.37E.02 1.39E+03 1.84E+01 r
l TE 132- -2.60E+02 2.15E+02 1.62E+02 1.90E+02 1.46E+03 2.88E+05 5.10E+05 i I.130 4.58E+03 1.34E+04 5.28E+03 1.14E+06 2.09 E+ 04 NO DATA 7.69E+03 [
I 131 2.52E+04 3.58E+04 2.05E+04 1,19E+07 6.13E+04 NO DATA 6.28E+03 }
f s ;
I 132 1.16E+03 3.26E+03 1,16E+03 1.14E+05 5.18E+03 NO DATA 4.06E+02 !
I-133 8.64E+03 1.48E+04 4.52E+03 2.15E+06 2.58E+04 NO DATA 8.88E+03 I-134 6.44E+02 1.73E+03 6.15E+02 2.98E+04 2.75E+03 NO DATA 1.01E+00- ;
i i
CLINTON-1 3-87 Rev.5-2/89 f I
CPS-ODCM TABLE 3.5-16 (continued)
INHALATIOli PATHWAY FACTORS - R aij (ADET)
(mrcm/yr por pCi/n 3)
ORGAN: 101{E IJ,yIB T. BODY THYROID M1DNEY IJJEG GI-LLI ISOTOPE I 135 2.68E+03 6.98E+03 2.57E+03 4.48E405 1.11E404 NO DATA 5.25E+03 CS 134 3,73E+05 8.48E+0$ 7.28E+05 NO DATA 2.87E&05 9.76E+04 1.04E+04 CS 136 3.90E+04 1.46E+05 1.10E+ 05 NO DATA 8.56E+04 1.20E404 1.17E+04 CS 137 4.78E+05 6.21E+05 4.28E+05 NO DATA 2.22E+05 7.52E+04 8.40E+03 CS 138 3.31E602 6.21E+02 3.24E+02 NO DATA 4.80E+02 4.86E+01 1.86E 03 BA 139 9.36E 01 6.66E 04 2.74E 02 NO DATA 6.22E 04 3.76E+03 8.96E+02 BA 140 3.90E+04 4.90E+01 2.57E+03 NO DATA 1.67E&O1 1.27E+06 2.18E+05 BA 141 1.00E 01 7.53E 05 3.36E 03 NO DATA 7.00E 05 1.94E+03 1.16E 07 BA 142 2.63E 02 2.70E 05 1.66E 03 2.29E 05 NO DATA 1.19E+03 1.57E 16 LA 140 3.44E+02 1.74E+02 4.58E+01 NO DATA NO DATA 1.36E+05 4.58E+05 LA 142 6.83E 01 3.10E 01 7.72E 02 NO DATA NO DATA 6.33E+03 2,11E+03 CE 141 1.99E+04 1.35E+04 1.53E+03 NO DATA 6.26E+03 3.62E+05 1.20E+05
.y.4 CE 143 1.86E+02 1.38E+02 1.53E+01 NO DATA 6.08E+01 7.98E+04 2.26E+05 CE-144 3.43E+06 1.43E+06 1.84E+05 8.48E+05 NO DATA 7.78E+06 8.16E+05 PR 143 9.36E+03 3.75E+03 4.64E+02 2.16E+03 NO DATA 2.81E+05 2.00E+05 PR 144 3.01E 02 1.25E 02 1.53E 03 7.0$E 03 NO DATA 1.02E+03 2.15E 08 ND-147 5.27E+03 6.10E+03 3.65E+02 NO DATA 3.56E+03 2.21E+05 1.73E+05 W 187 8.48E+00 7.08E+00 2.48E+00 NO DATA NO DATA 2.90E+04 1.55E+05 NP 239 2.30E+02 2.26E+01 1. 24EM)1 NO DATA 7.00E+01 3.76E+04 1.19E+05
'* .1.26 x 103
- Less than 8.00 x 10-15 CLTirrott-1 3-8a Rev.5-2/89
CPS-ODCM '
TABLE 3.5-17 COW HILK PATHWAY FACTORS - Raij (INFANT) I (m2 mrom/yr por 4Ci/sec)
\
ORGANt LQHE' LIVER T.P.0DY THYPOID EIDNEY L12iG GI LLI ISOTOPE
' H3 NO DATA 2.38E+03* 2.38E+03* 2.38E+03* 2.38E+03* 2. 38E+03* 2. 38E+03*
C 14 3.23E+06* 6.89E+0$* 6.89E+0$* 6.89E+0$* 6.89E+0$* 6. 89E405* 6.89E+05*
NA 24 1.55E+07** 1.55E+07 1.55E+07 1.55E+07 1.55E+07 1.55E+07 1.55E+07 P 32 1.60E+11 9.41E+09 6.20E+09 NO DATA NO DATA NO DATA 2.16E+09 CR 51 NO DATA NO DATA 1.61E+05 1.05E+05 2.29E+04 2.04E+05 4.69E+06 MN $4 NO DATA .3.90E+07 8.84E+06 NO DATA 8.64E+06 NO DATA 1.43E+07 -
i t
MN 56 NO DATA 3.12E 02 5.39E 03 NO DATA 2.69E 02 NO DATA 2.84E+00 FE 55 1.35E+08 8.72E+07 2.33E+07 NO DATA NO DATA 4.26E+07 1.11E+07 FE 59 2.25E+08 3.92+08 1.55E+08 NO DATA NO DATA 1.16E+08 1.87E+0S ,
CO 58 NO DATA 2.43E+07 6.06E+07 NO DATA NO DATA NO DATA 6.0$E+07 CO 60 NO DATA 8.82E+07 2. 08 E+ 08 NO DATA NO DATA NO DAT/ 2.10E+08 NI-63 3.50E+10 2.16E+09 1.21E+09 NO DATA NO DATA NO DATA 1.08E+08 NI 65 3.52E+00 3.98E 01 1.81E 01 NO DATA NO DATA No DATA 3.03E+01 CU 64 NO DATA -1.84E405 8.52E+04 NO DATA 3.11E+05 NO DATA 3.78E+06 ZN 65 5.55E+09 1.91E+10 8.78E+09 NO DATA 9.23E+09 NO-DATA 1.61E+10 ZN 69 1.94E 11 3.49E 11 2.60E 12 NO DATA 1.45E 11 NO DATA 2.85E 09 BR 83 NO DATA NO DATA NO DATA NO DATA. NO DATA NO DATA NO DATA ER-84 .NO DATA NO DATA NO DATA NO DATA NO DATA NO DATA NO DATA BR 85 NO DATA NO DATA NO DATA NO DATA NO DATA No DATA NO DATA RB 86 NO DATA 2.23E+10 1.10E+10 NO DATA NO DATA NO DATA 5.70E+0B RB 88 NO DATA 1.88E 44 1.03E 44 NO DATA NO DATA NO DATA 1.83E 44 RB-89 NO DATA 3.43E 52 2.36E 52 NO DATA NO DATA NO DATA 1.17E-52 SR-89 1.26E+10 NO DATA 3.61E+08 NO DATA NO DATA NO DATA 2.59E+08 SR 90 1.22E+11 NO DATA 3.10E+10 NO DATA NO DATA NO DATA 1.52E+09 SR 91 2.71E+05 ~ NO DATA 9.76E+03 NO DATA NO DATA NO DATA 3.20E+05 SR 92 4.6BE+00 NO DATA 1.74E 01 NO DATA NO DATA NO DATA -5.05E+01 Y-90 6.83E+02 NO DATA 1.83E+01 NO DATA NO DATA NO DATA 9.43E+05
'CLINTON-1 3-89 Rev.5-2/89 l
_ _ _ _ . - . _ . . _ _ . _ _ _ _ _ _ _ .__._._ _ _ . _ _ _ _ m. _ _
CPS-ODCM TABLE 3.5-17 (continued)
COW MIIE PATHWAY FACTORS - R aij (IN F,WT)
(m2 mrem /yr por 4Ci/ cec) !
ORGAN' D.0E LIVEPs T. BODY THYPOID MIDNEY GI LLI Ll!1LG ISOTOPP Y 91m 6.09E 19 NO DATA 2.08E 20 NO DATA NO DATA NO DATA 2.03E 15 Y 91 7.33E404 NO DATA 1.95E+03 NO DATA NO DATA NO DATA 5.26E+06 Y 92 5.35E 04 NO DATA 1.50E 05 NO DATA NO DATA NO DATA 1.02E+01 Y 93 2.14E+00 NO DATA 5.83E 02 NO DATA NO DATA NO DATA 1.69E+04 IR 95 6.82E+03 1. 66 E+ ')3 1.18E+03 NO DATA 1.79E+03 NO DATA 8.28E+05 ZR 97 4.03E+00 6.96E 01 3.16E 01 NO 1 sTA 7.01E 01 NO DATA 4.41E+04 NB 95 5.93E+05 2.44E+05 1.41E+05 NO DATA 1.75E+05 NO DATA 2.06E+08 MO 99 NO DATA 2.07E+0S 4.04E+07 NO DATA 3.10E+08 NO DATA 6.83E+07 TC 99m 2.75E+01 5.66E+01 7.29E402 NO DATA 6.09E402 2.96E+01 1.64E+04 TC 101 2.72E 59 3.42E-59 '.39E 58 NO DATA 4.07E 58 1.87E 59 5.81E 57 RU 103 8.67E+03 NO DATA 2.92E+03 NO DATA 1.81E+04 NO DATA 1.06E+05 RU 105 8.002 03 NO DATA 2.70E 03 NO DATA 5.88E 02 NO DATA 3.18E+00
.w RU 106 1.91E+05 NO DATA 2.38E+04 NO DATA 2.26E+05 NO DATA 1.45E+06 AC 110m 3.85E+08 2.81E+08 1.86E+08 NO DATA 4.02E+08 NO DATA 1.46E+10 TE 125m 1.51E+08 5.0$E+07 2.04E+07 5.08E+07 NO DATA NO DATA 7.19E+07 TE 127m 4.22E+08 1.40E+08 5.10E+07 1.22E+08 1.04E+09 NO DATA 1.70E+08 TE 127 6.31E+03 2.11E+03 1.39E+03 5.13E+03 1,58E+04 NO DATA 1.36E+05 TE 129m 5.56E+08 1.91E+08 8.56E+07 2.14E+08 1.39E+09 NO DATA 3.32E+08 i
TE 129 2.71E 09 9.34E-10 6.33E 10 2.27E 09 6.75E 09 NO DATA 2.17E-07 TE 131m 3.37E+06 1.36E+06 1.12E+06 2.75E+06 9.35E+06 NO DATA 2.29E+07 TE 131 3.48E 32 1.29E 32 9.78E 33 3.11E 32 8.91E 32 NO DATA 1.41E 30 TE 132 2.12E+07 1.05E+07 9.80E+06 1.55E+07 6.57E+07 NO DATA 3.89E+07 1 130 3.53E+06 7.76E+06 3.12E+06 8.70E+08 8.53E+06 NO DATA 1.66E+06 I 131 2.71E+09 3.19E+09 1.40E+09 1.05E+12 3.73E+09 NO DATA 1.14E+08-I-132 1.43E+00 2.90E+00 1.03E+00 1.36E+02 3.24E+00 NO DATA 2.35E+00 I 133 3.63E+07 5.28E+07 1.55E+07 9.60E+09 6.21E+07 NO DATA 8.93E+06 I 134 1.64E 11 3.36E-11 1.208 11 7.86E 10 3.76E 11 NO DATA 3.48E-11 l
l CLINTON-1 3-90 Rev.5-2/89 i
l
CPS-ODCM ,
TABLE 3 E17 (continued)
COW MILK PATHWAY FACTORS - Raij (IN N T)
(mE mrem /yr per pCi/sec)
ORCAN' }.D.ti.E L1,'Q LEQ.Dl' THYROID KIDNEY C1-LLI LUl!.G ISOTOPE
~
I 135 1.13E+05 2.24E+05 8.18E+04 2.01E+07 2.50E+05 NO DATA 8.12E+04 CS 134 3.65E+10 6.81E+10 6.8BE+09 NO DATA 1.75E+10 7.19E+09 1.85E+08 CS+136 1.97E+09 5.F1E+09 2.17E+09 NO DATA 2.31E+09 4.73E+08 8.82E+07 CS-137 f.15E+10 6.0JE+10 4.27E+09 NO DATA 1.62E+10 6.55+09 1.89E+0S CS-138 8.06E 23 1.31E.22 6.35E 23 NO DATA 6.53E 23 1.02E 22 2.09E 22 BA-139 4.29E 07 2.84E 10 1.'24E 08 NO DATA 1.71E.10 1.72E-10 2.72E 05 BA 140 2.45E+08 2.45E+05 1.26E+07 NO DATA 5.72E+04 1.50E+05 5.92E+07 BA 141 4.16E 45 2.85E 48 1.31E 46 NO DATA 1.71E-48 1.73E 48 5.08E-44 BA-142 2.32E 79 1.93E-82 1.14E 60 NO DI,TA 1.11E 82 1.17E 82 9.56E 79 LA-140 4.05E+01 1.60E+01 4.11E+00 NO DATA NO DATA NO DATA 1.8BE+05 1A.142 1.73E 10 6.34E 11 1.52E-11 NO DATA NO DATA NO DATA 1.08E 05 CE-141 4.34E+04 2.65E+04 3.12E+03 NO DATA 8.17E+03 NO DATA 1.37E&O7
+ CE 143 3.98E+02 2,64E+05 3.01E+01 NO DATA 7.69E+01 NO DATA 1.54E+06.
CE-144 2.34E+06 9.56E+05 1.31E+05 F0 DATA 3.87E+05 NO DATA 1.34E+08 Pbl43 1.49E+02 5.56E+02 7.37E+01 NO DATA 2.07E+02 NO DATA 7.85E+05 PR-144 d.27E-53 2.43E-53 3.16E 54 NO DATA 8.79E 54 NO DATA 1.13E-48 ND 147 8.79E+02 9.03E+02 5.53E+01 NO DATA 3.48E+02 NO DATA 5.72E+05 W-187 6.10E+04 4.24E+04 1.46E+04 NO DATA NO DATA NO DATA 2.49E+06 NP 239 3.64E el 3.26E+00 1.84E+00 NO DATA 6.49E+00 NO DATA 9.41E+04 p.
s
- Mrem /yr per pCi/m 3
)_ .,
M ** 1.55 x 10' d
~
O CLINTON-1 3-91 Rev.5-2/89
CPS-ODCM TABLE 3.5-18 CCW MILK PATHWAY FACTORS - Rai-j (CHILD)
(m2 mrem /yr por pci/sec)
ORGAN' ffQ1E IdV.EE T. BODY THYROID KIDNEY IM{q GI LLI ISOTOPE H3 NO DATA 1.57E+03* 1.57E+03* 1.57E+03* 1.57E+03* 1. 57E+03* 1. 57E+03*
C-14 1.65E+06* 3.29E+05* 3.29E+05* 3.29E+05* 3.29E+05* 3. 29E+05* 3. 29E+05*
NA-24 8.93E+06** 8.93E+06 8.93E+06 8.93E+06 8.93E+06 8.93E+06 8.39E+06 P-32 '.79E+10 3.64E+09 3.00E+09 NO DATA NO DATA NO DATA 2.15E+09 CR-51 NO DATA NO DATA 1.01E+05 5.63E+04 1.54E+04 1,03E+05 5.38E+06 MN 54 NO DATA 2.10E+0? 5.59E+06 NO DATA 5.88E+06 NO DATA 1.76E+07 MN 56 NO DATA 1.2,E-02 2.88E-03 NO DATA 1.54E-02 NO DATA 1.85E+00 FE-55 1.12E+08 5.94E+07 1.84E+07 NO DATA NO DATA 3.36E+07 1.10E+07 FE-59 1.20E+08 1.95E+08 9.71E+07 NU DATA NO DATA 5.65E+07 2.03E+08 00-58 NO DATA 1.21E+07 3.71E+07 NO DATA NO DATA NO DATA 7,08E+07 Co 60 NO DATA 4.32E+07 . 27E+08 NO DATA NO DATA NO DATA 2.39E+08 N1 63 2.97E+10 1.59E+09 1.01E+09 NO DATA NO DATA NO DATA 1.07E+08 NI-65 1.65E+00 1.56E-01 9.10E-02 NO DATA NO DATA NO DATA 1.91E+01 CU-64 NO DATA 7.40E+04 4.47E+04 NO DATA 1.79E+05 NO DATA 3.47E+06 ZN 6. 4.13E+09 1.10E+10 6.83E+09 NO DATA 6.92E+09 NO DATA 1.93E409 ZN-69 9.11E-12 1.32E-11 1.22E-12 NO DATA 7.99E-12 NO DATA 8.30E-10 BR-83 NO DATA NO DATA NO DATA NO DATA NO DATA NO DATA NO DATA BR-84 NO DATA NO DATA NO DATA NO DATA NO DATA NO DATA NO DATA BR-85 NO DATA NO DATA NO DATA NO DATA NO DATA NO DATA NO DATA RB 86 NO DATA 8.78E+09 5.40E+09 NO DATA NO DATA NO DATA 5.65E+08 RB-88 NO DATA 7.16E-45 4.98E-45 NO DATA NO DATA NO DATA 3.51E 46 RB 89 NO DATA 1.40E-52 1.25E-52 NO DATA NO DATA NO DATA 1.22E 54 SR-89 6.63E+09 NO DATA 1.89E+08 NO DATA NO DATA NO DATA 2.57E+08 SR-90 1.12E+11 NO DATA 2.84E+10 NO DATA NO DATA NO DATA 1.51E+09 cT.TM'mu-1 1-42 Rev 5-2/89
- . - . - - . - - - - _ - - _ . ~ - . - - . _ - . - . . -
i CPS-ODCM i I
i TABLE 3.5-18 (continued)
COW MILK PATHWAY FACTORS -
R aij (CHILD) ;
2 (m mrem /yr otr 4Ci/sec) l I
OPGAm E.QE LIVER T. BODY
' T1NR010 FID!?EY REQ 01-LLI }
ISOTOPE
^
SR 91 1.30E+05 NO DATA 4.89E+03 NJ DATA NO DATA No DATA 2.86E+05 j SR 92- 2.20E+00 NO DATA 8.83E-02 NO DATA NO DATA NO DATA 4.17E+01 !
Y-90 3.23E+02 NO DATA S.65E+00 NO DATA NO DATA NO DATA 9.20E+05 l i
Y-91m 2.88E 19 NO DATA 1.05E 20 NO DATA NO DATA NO DATA 5.63E 16 l Y-91 3.90E+04 NO DATA 1.04E+03 NO DATA NO DATA NO DATA 5.20E+06 Y-92 2.53E-04 NO DATA 7.23E-06 {
NO DATA NO DATA NO DATA 7.30E+00 j i
Y-93 1.01E+00 NO DATA 2.76E 02 NO DATA NO DATA NO DATA 1.50E+04
~
ZR 95 I 3.84E+03 8,44E+02 7.51E+02 NO DATA 1.21E+03 NO DATA 8,80E+05 ZR 97 1.92E+00 2.78E-01 l 1.64E-01 NO DATA 3.99E 01 NO DATA 4.21E+04 j
- i NB-95 3.18E+05 1.24E+05 8.84E+04 NO DATA 1.16E+05 NO DATA 2.29E+08 MO 99 f NO DATA 8.15E+07 2.02E+07 NO DATA 1.74E+08 NO DATA 6,74E+07 ;
TC-99m 1.32E+01 2.58E+01 4.2;E+02 No DATA 3.75E+02 1.31E+01 1.47E+04 i l
TC-101 1.28E-59 1.34E-59 1.70E-58 NO DATA 2.29E-58 7.08E-60 4.26E 59 {
RU-103 4.29E+03 NO DATA 1.65E+03 NO DATA 1.08E+04 NO DATA 1.11E+05 !
RU-105 3.80E 03 -NO DATA 1.38E-03 NO DATA 3.34E-02 NO DATA 2.48E+00 !,
RU 106 9.25E+04 NO DATA 1.15E.34 NO DATA 1.25E+05 NO DATA 1.44E+06 !
AG-110m 2.09E+08 1.41E+08 1,13E+08 NO DATA 2.63E+08 No DATA 1.68E+10 !
TE-125m 7.39E+07 2.00E+07 9.85E+06 2.07E407 NO DATA NO DATA 7.13E+07 :
l
)
TE 127m 2.08E+08 5.61E+07 2.47E+07 4.98E+07 5.94E+08 NO DATA 1.69E+08 TE 127 2.97E+03 8.01E+02 f
6.37E+02 2.06E+03 8.45E+03 NO DATA 1.16E+05 i TE-129m -2.71E+08 7.58E+07 4.21E+07 8.74E+07 7.97E+08 NO DATA 3.31E+08 ,
t
'i TE 129 1.28E-09 3.57E-10 3,04E 10 9.12E 10 3,74E 09 NO DATA 7.96E-08 i TE 131m 1.60E+06 5.53E+05 5.88E+05 1.14E+06 5.35E+06 NO DATA 2.24E+07 [
TE-131 1.64E-32 5.01E-33 4.89E-33 1.26E-32. 4.97E-32 NO DATA 8.63E 32 !
(
TE-132 1.03E+07 4.56E+06 5.51E+06 6.64E+06 4.23E+07 NO DATA 4.59E+07 l I 130 1.72E+06 3.47E+06 1.79E+06 3.82E+08 5.19E+06 NO DATA 1.62E+06 [
I 131 1.30E+09 1.31E+09 7.44E+08 4.33E+11 2.15E+09 NO DATA 1.17E+08
[
l CLINTON-1 3-93 Rev.5-2/89 !
[
CPS 0DCM J
TABLE 3.5-18 fcontinufdu C
COW MILK PATHWAY FACTORS - R aij (CHRD)
(m2 mremfyr per yCi/sec)
QRGAN: HQf,{g Llyfa T. BODY THYPOID KIDNEY MR{G El,,L,LI, ISOTOPE I-132 6.91E 01 1.27E+00 5.84E 01 5.89E+01 1.94E+00 NO DATA 1 49E+00 1 133 1.72E+07 2.12E+07 8.03E+06 3.94E+09 3,54E+07 NO DATA 8.56E+06 I 134 7.92E-12 1.47E 11 6.77E-12 3.38E-10 2.25E 11 NO DATA 9.75E-12 1-135 5.43E+04 9.77E+04 4.62E+04 8.56E+06 1.50E+03 NO DATA 7.44E+04
_CS 134 2.27E+10 3.72E+10 7.85E+09 NO DATA 1.15E+10 4.14 E+09 2.01E+08 CS 136 1.01E+09 2.78E+09 1.80E+09 NO DATA 1.48E+09 2.21E+08 9.76E+07 CS-137 3.23E+10 3,09E+10 4.56E+09 NO DATA 1.01E+10 3.63E+09 1.94E+08 CS-138 3.82E 23 5.31E 23 3.37E-23 NO DATA 3.74E-23 4.02E-24 2.45E 23 BA-139 2.01E 07 1.08E-10 5.84E-09 NO DATA 9.39E-11 6.33E-11 1.16E 05 BA 140 1.18E+08 1.03E+05 6.84E+06 NO DATA 3.37E+04 6.12E+04 5,94r.+07 BA-141 1.96E-45 1.10E-48 6.38E 47 NO DATA 9.50E 49 6.45E 48 1.12E 45' BA 142' 1.10E 79 7.93E 83 6.15E 81 NO DATA 6.41E 83 4.66E 83 1.44E.81 LA-140 1.94E+01 6.78E+00 2.11E+00 NO DATA NO DATA NO DATA 1.89E+05 LA-142 8.23E-11 2.62E-11 8.21E 12 NO DATA NO DATA NO DATA 5.20E-06 CE-141 2.19E+04 1.09E+04 1.62E+03 NO DATA 4.78E+03 NO DATA 1.36E+07 CE 143 1.87E+02 1.02E+05 1.47E+01 NO DATA 4.26E+01 NO DATA 1.49E+06 CE 144 1.63E+06 5.10E+05 8.68E+04 NO DATA 2.82E+05 NO DATA 1,33E+08 PR-143 7.19E+02 2.16E+02 3.57E+01 NO DATA 1.17E+02 NO DATA 7.76E+05 PR-144- 2.94E-53 9,10E-54 1.48E-54 NO DATA 4.81E 54 NO DATA 1.96E 50 ND-147 4.44E+02 3.59E+02 2.78E+01 NO DATA 1.97E+02 NO DATA 5.69E+05 W 187 2.88E+04 1.71E+04 7.66E+03 NO DATA NO DATA NO DATA 2,40E+06 NP-239 1.72E+01 1.24E+00 8.69E-01 NO DATA 3.58E+00 NO DATA 9.15E+04
- mrem /yr per pCi/m 3
- B 9 3 x 3.0 6 cf Temu 1 1 44 Rev.6 12/89
CPS 0DCM-TABLE 3.5-19 COW MILK PATHWAY FACTORS - Raij (TEEN) 2 (m mrom/yr per #Ci/sec)
ORGl_- E0jlg LTVER T BODY THYF01D ElDNEY 11319, CI.LLI ISOTOPE H3 NO DATA 9.92E+02* 9.92E+02* 9.92E+02* 9.92E+02* 9.92E+02* 9.92E+02*
C 14 6.70E+05* 1.34E+05* 1.34E+05* 1.34E+0$* 1.34E+05* 1.34E+05* 1.34E+05*
NA 24 4.29E+06* 4.29E+06 4.29E+06 4.29E+06 4.29E+06 4.29E+06 4.29E+06 P 32 3.15E+10 1.95E+09 1.22E+09 NO DATA NO DATA NO DATA 2.64E+09 CR-51 NO DATA NO DATA 5.00E+04 2.78E+04 1.10E+04 7.14E+04 8.41E+06 MN 54 NO DATA 1.40E+07 2.78E+06 NO DATA 4.19E+06 NO DATA 2.88E+07 MN 56 NO DATA 7.32E-03 1.30E 03 NO DATA 9.26E-03 NO DATA 4.82E-01 FE 55 4.46E+07 3.16E+07 7.38E+06 NO DATA NO DATA 2.01E+07 1.37E+07 FE-59 5.18E+07 1.21E+08 4.67E+07 NO DATA NO DATA 3.81E+07 2.86E+08 CO-58 NO DATA 7.98E+06 1.84E+07 NO DATA NO DATA NO DATA 1.10E+08 CO-60 NO DATA 2.18E+07 6.26E+07 NO DATA NO DATA NO DATA 3.62E+08 NI-63 1.18E+10 8.34E+08 4.00E+08 NO DATA NO DATA NO DATA 1.33E+08 Ni-65 6.79E-01 8.67E-02 3.95E 02 NO DATA NO DATA NO DATA 4.70E+00 Cu-64 NO DATA 4.20E+04 1.97E+04 NO DATA 1.06E+05 NO DATA 3.26E+06 Zn 65 2.11E+09 7.32E+09 3.41E+09 NO DATA 4.68E+09 NO DATA 3.10E+09 ZN 69 3.70E-12 7.06E 12 4.94E-13 NO DATA 4.61E-12 NO DATA 1.30E-11 BR-83 NO DATA NO DATA NO DATA NO DATA NO DAT* NO DATA NO DATA ER-84 NO DATA NO DATA NO DATA NO DATA NO DATA NO DATA NO DATA BR-85 NO DATA NO DATA NO DATA NO DATA NO DATA NO DATA NO DATA-RB 86 NO DATA 4.74E+09 2.23E+09 NO DATA NO DATA NO DATA RB 88 _7.01E+08 NO DATA 3.90E-45 2.0BE 45 NO DATA NO DATA NO DATA 3.34E 52 RB-89 NO DATA 7.98E-53 5.64E-53 NO DATA NO DATA NO DATA 1.22E-61 SR-89 2.68Et09 NO DATA 7.67E+07 NO DATA NO DATA NO DATA 3.19E+08 SR 90 6.62E+10 NO DATA 1.64E+10 NO DATA NO DATA NO DATA 1.86E+09 SR 91 5.27E+04 NO DATA 2.10E+03 NO DATA NO DATA NO DATA 2.39E+05 SR-92 9,03E-01 NO DATA 3.85E 02 NO DATA- NO DATA NO DATA 2,30E+01 Y 90 1.31E+02 NO DATA 3.53E+00 NO DATA NO DATA NO DATA l'.08E+06 CLINTON-1 3-95 Rev.5-2/89
_ . _ - .- -- ~ . . - . _ . - - . - - . . . --- . - . . - - -
CPS 0DCM i
TABI;E 3.5-19 (cont inuec')
I COW MILK PATHWAY FACTORS --R aij (TEEW (m2 mrom/yr per 4Ci/sec) .
l ORGAN f.$]E LIVER T. BODY KIDNEY THYR 012 LklLG GI-LLI ISOTOPE Y-91m 1.18E-19 NO DATA 4.49E 21 NO DATA NO DATA NO DATA 5.55E-18 !
Y 91 1.58E+04 NO DATA 4.24E+02 NO DATA NO DATA NO DATA 6.48E+06 Y-92 1.03E-04 NO DATA 2.97E 06 NO DATA NO DATA NO DATA 2.82+00 l
[
Y-93 4.10E 01 NO DATA 1.12E 02 NO DATA NO DATA NO DATA 1.25E+04 !
ZR-95 1.65E+03 5.20E+02 3.58E+02 No DATA 7.65E+02 -NO DATA 1.20E+06 .
ZR 97 7.87E-01 1.56E 01 7.17 E 02 NO DATA 2.36E-01 NO DATA 4.22E+04 [
NB-95 1.41E+05 7.81E+04 4.30E+04 NO DATA 7.57E+04 NO DATA 3.34E+08 MO 99 NO DATA 4.46E+07 8.50E+06 NO DATA 1.02E+08 NO DATA 7.98E+07 [
TC-99m. 5.74E+00 1.60E+01 2.08E+02 NO DATA 2.39E+02 8.89E+00 1.05E+04 <
TC 101 5.22E-60 7.42E-60 7,29E-59 NO DATA 1.34E 58 4.52E 60 1.27E 66 RU-103 1.81E+03 NO DATA 7.73E+02 NO DATA 6.37E+03 NO DATA 1.51E+05 !
RU-105 1.56E 03 NO DATA 6.06E-04 NO DATA 1.97E 02 NC DATA 1.26E+00 [
t i
t RU-106 3.75E+04 NO DATA 4.73E+03 NO DATA 7.23E+04 NO DATA 1.80E+06 AG-110m [
9.64E+07 9.12E+07 5,55E+07 NO DATA 1.74E+08 NO DATA 2.56E+10 t TE-125m 3,01E+07 1.08E+07 4.02E+06 8.41E+06 NO DATA NO DATA 8.88E+07 jt t'
TE-127m 8.43E+07 2.99E+07 1.00E+07 2.01E+07 3.42E+08 NO DATA 2.10E+08 TE-127 1.21E+03 4.28E+02 2.60E+02 8.33E+02 4.89E+03 NO DATA 9.33E+04 >
TE-129m 1.10E+08 4.09E+07 1.74E+07 3.56E+07 4.61E+08 NO DATA 4.14E+08 ,
I r
TE-129 5.18E-10 1.93E 10 1.26E-10 3.70E-10 2.17E 09 NO DATA 2.83E 09 TE-131m 6.56E405 3.15E+05 2.63E+05 4.73E+05 3.28E+06 NO DATA 2.53E+07 TE 131 6.70E-33 2.76E 33 2.09E-33 5.16E 33 2.93E-32 NO DATA '5.50E-34 ;
'i TE-132 4.29E+06 -2.72E+06 2.56E+06 2. 87E< 06 2.61E+07 No DATA 8.61E+07 I-130- .7.33E+05 2.12E+06 8.47E+05 1.73E+08 3.27E+06 No DATA 1.63E+06 I-131 5.36E+08 7.50E+08 4.03E+08 2.19E+11 1.29E+09 NO DATA 1.48E+08 l I-132 2.90E-01 7.59E-01 2.72E-01 2.56E+01 1.20E+00 No DATA 3.31E-01 1-133 7.06E+06 1.20E+07 3.65E+06 1.67E+09 2.10E+07 NO DATA 9.06E+06 +
I-134 3.34E-12 8.86E-12 3.18E-12 1.48E-10 1.40E-11 NO DATA 1.17E-13 .,
t P
i CLINTON-1 3-96 Rev.5-2/89 ;
. . - -~ . . - - - _ - . - - . ~ . - - . ._. - - - -..
L CPS-0DCM TABLE 3.5-19 (continuedi COW MILK PATHWAY FACTORS - R ai-j (TEEN)
(m2 mrcm/*cr per pCi/sec) {
ORGAN: E02 LlyIB T . P.0DY THYROID KIDNEY LUNG ghtLI !
ISOTOPE I s ,
I-135 2.29E+04 5.90E+04 2.19E+04 3.80E+06 9.32E+04 NO DATA 6.54E+04 .
CS-134 9.79E+09 2.30E+10 1.07E+10 NO DATA 7.32E+09 2,80E+09 2.87E+08 I CS-136 4.48E+08 1.76E+09 1.18E+09 NO DATA 9.59E+0B 1.51E+08 1.42E+08 l l
CS 137 1,33E+10 1.77E+10 6.18E+09 NO DATA 6.03E+09 2.34E+09 2.52E+08 I CS-138 1.58E-23 3.03E 23 1.51E 23 NO DATA 2.23E 23 2.60E-24 1.37E-26 f
- +
BA-139 8.20E 08 5.77E-11 2.39E-09 NO DATA 5.44E 11 3.98E 11 7.31E-07 i f
. BA-140 4.85E+07 5.95E+04 3.13E+06 NO DATA 2.02E+04 4.00E+04 7.49E+07 i BA 141 7.98E 46 5.96E-49 2.67E 47 5.53E 49 4.08E-49 1.70E 51 NO DATA BA 142 4.54E-80 4.54E 83 2.80E-81 NO DATA 3.85E-83 3.02E-83 1.40E 91 l
t LA 140 8.11E+00 3.98E+00 1.06E+00 NO DATA NO DATA NO DATA 2.29E+05 !
LA 142 3.42E-11 1.52E-11 3.78E 12 NO DATA NO DATA NO DATA 4.62E-07 CE 141 8.88E+03 5.93E+03 6.81E+02 NO DATA 2.79E+03 NO DATA 1.70E+07 l
r CE 143 7 64E+01 5.55E+04 6.21E+00 NO DATA 2.49E+01 NO DATA 1.67E406 ;
CE-144 6.61E+05 2.73E+05 3.55E+04 NO DATA 1.63E+05 NO DATA 1.66E+08 i PR-143 2.91E+02 1.16E+02 1.4 5 E+01 NO DATA 6.75E+01 NO DATA 9.57E+05 i f
PR 144 1.19E-53 4.88E-54 6.04E-55 NO DATA 2.80E-54 NO DATA 1.31E-56 .
ND 147 1.81E+02 1.97E+02 1.18E+01 NO DATA 1.16E+02 NO DATA 7.10E+05 ;
U 187 1.19E+04 9.72E+03 3.41E+03 NO DATA NO DATA NO DATA -2.63E+06 ;
NP-239 6.99E+00 6.59E-01 3.66E-01 NO DATA 2.07E+00 NO DATA 1.06E+05 l
- mrem /yr per pCi/m 3 f
- 4.29 x 10 6 i
i t
1 I
CLINTON-1 3 97 Rev.5-2/89 ;
-- - . - . . - - , - . - , , a._.- . -- .-
CPS-0DCM TAAELE 3.5-20 COW MILK PATHWAY FACTORS - RC (ADULT)
(m2 mrom/yr por pCi/sec)
ORGAN- hg1]E LIVER T. BODY THWOID MIDNEY GI-LLI M31Q ISOTOPE H3 NO DATA 7.62E+02* 7.62E+02* 7.62E+02* 7.62E+02* 7.62E+02* 7.62E+02+
C 14 3.63E+05* 7.26E+04* 7.26E+04* 7.26E+04* 7.26E+04* 7.26E+04* 7.26E+04*
NA 24 2.46E+06** 2.46E+06 2.46E+06 2.46E+06 2.46E+06 2.46E+06 2.46E+06 P 32 1.71E+10 1.06E+09 6.61E+08 NO DATA NO DATA NO DATA 1.92E+09 CR 51 NO DATA NO DATA 2.85E+04 1.70E+04 6.27E+03 3.78E+04 7.16E+06
-MN 54 NO DATA 8.41E+06 1.60E+06 NO DATA 2.50E+06 NO DATA 2.58E+07 MN 56 NO DATA 4.14E 03 7.34E 04 NO DATA 5.26E 03 NO DATA 1.32E 01 FE-55 2.51E+07 1.73E+07 4.04E+06 NO DATA NO DATA 9.68E+06 9.95E+06 FE 59 2.97E+07 6.99E+07 2.68E+07 NO DATA NO DATA 1.95E+07 2.33E+08 CO 58 NO DATA 4.72E+06 1.06E+07 NO DATA NO DATA NO DATA 9.57E+07 CO 60 NO DATA 1.64E+07 3.62E+07 NO DATA NO DATA NO DATA 3.08E+08 NI-63 6.73E+09 4.67E+02 2.26E+08 NO DATA NO DATA NO DATA 9.74E+07 NI-65 3.70E 01- 4.81E-02 2.19E 02 NO DATA NO DATA NO DATA 1.22E+00 CU 64 NO DATA 2.36E+04 1.11E+04 NO DATA 5.94E+04 NO DATA 2.01E+06
- 2N 6 5 - 1,37E+09 4.37E+09 1.98E+09 NO DATA 2.93E+09 NO DATA 2.75E+09 ZN 69 2.01E-12 3.84E-12 2.67E 13 NO DATA 2.50E-12 NO DATA 5.77E 13 BR-83 NO DATA NO DATA NO DATA NO DATA NO DATA NC DATA NO DATA BR-84 NO DATA NO DATA NO DATA- NO DATA NO DATA NO DATA NO DATA BR-85 NO DATA NO DATA NO DATA NO DATA NO DATA NO DATA -NO DATA
-RB-86 NO DATA 2.60E+09 1.21E+09 NO DATA NO DATA NO DATA 5.12E+08 RB-88 NO DATA 2.15E-45 1.14E 45 NO DATA NO DATA NO DATA 2,97E-56 RB 89 NO DATA 4.49E-53 3.16E 53 NO DATA NO DATA NO DATA 2.61E-66 SR-89 1.45E+09 NO DATA 4.16E+07 NO DATA NO DATA NO DATA 2.33E+08 SR-90 4.68E+10 NO DATA 1.15E+10 NO DATA NO DATA NO DATA 1.35E+09 SR-91 2.87E+04 NO DATA 1.16E+03 NO DATA NO DATA NO DATA 1.37E+05 SR 92 4.92E-01 NO DATA 2.13E 02 NO DATA NO DAIA NO DATA 9.76E+00 Y-90 7.10E+01 NO DATA 1.90E+00- NO DATA NO DATA NO DATA 7.53E+05 CLINTON-1 3 98 Rev.S-2/89
CPS 0DCM-TABLE 3.5-20 (continued)
C COI MILE PATINAY FACTORS - R (ADULT)
(m2 mrem /yr per pCi/ soc)
OBQA,Ni EE LIVER T P.0DY THYROID l'IDNEY .l.UNG GI-LLI ISOTOPE Y-91m 6.42E-20 NO DATA 2.49E-21 NO DATA NO DATA NO DATA 1.89E-19 Y-91 8.60E+03 NO DATA 2.30E+02 NO DATA NO DATA NO DATA 4.73E+06 Y 92 5.57E-05 NO DATA 1.63E-06 NO DATA NO DATA NO DATA 9.75E 01 Y 93 2.22E-01 NO DATA 6.12E 03 NO DATA. NO DATA NO DATA 7. 03 E+ 03 ZR-95 9.45E+02 3.03E+02 2.05E4 02 NO DATA 4.76E+02 NO DATA 9.61E+05
-ZR 97 4.32E-01 8.71E 02 3.98E 02 NO DATA 1.32E-01 NO DATA 2.70E+04 NB 95 8.25E+04 4.59E+04 2.47E+04 NO DATA 4.54E+04 NO DATA 2.79E+0S MO 99 NO DATA 2.48E+07 4.72E+06 NO DATA 5.61E+07 NO DATA 5.74E+07 TC 99m 3.31E+00 9.35E+00 1.19E+02 NO DATA 1.42E+02 4.58E+00 '5.53E+03 TC 101 2.85E 60 4.11E-60 4.03E-59 NO DATA 7.41E-59 2.10E 60 1.24E-71 RU 103 1.02E+03 NO DATA 4.39E+02 NO DATA 3,89E+03 NO DATA 1.19E+05 RU 105 8.52E-04 NO DATA 3.36E 04 NO DATA 1.10E 02 NO DATA 5.21E-01 RU-106 2.04E+04 NO DATA 2.58Et03 NO DATA 3.94E+04 NO DATA 1.32E+06 AG-110m 5.82E+07 5.39E+07 3.20E+07 NO DATA 1.06E+08 NO DATA 2.20E+10 TE-125m 1.63E+07 5.91E+06 2.19Et06 4.91E+06 6.64E+07 NO DATA 6.52E+07 TE-127m 4.58E+07 1.64E+07 5.58E+06 1.17E+07 1.66E+08 NO DATA 1.53E+0S TE-127 6.52E+02 2.34E+02 1.41E+02 4. 83 E -02 2,65E+03 NO DATA 5.14E+04 TE 129m 6.01E+07 2.24E+07 9.52E+06 2.07E+07 2.51E+08 NO DATA 3.03E+0B TE-129 2.82E-10 1.06E-10 6.86E-11 2.16E-10 1.18E 09 NO DATA 2.12E-10 TE-131m 3.60E+05 1.76E+05 1.47E+05 2.79E+05 1.78E+06 NO DATA 1.75E+07 TE 131
- s. 1.54E-33 1.16E-33 3.03E-33 1.61E-32 NO DATA 5.22E-34 TE 132 2.41E+06 1.56E+06 1.46E+06 1.72E+06 1.50E+07 NO DATA 7.36E+07 I-130 4.16E+05 1.23E+06 4,84E+05 1.04E+08 1.91E+06 NO DATA 1,06E+06 I-131 2.97E+0E 4.24E+08 2.43E+08 1.39E+11 7.27E+08 NO DATA 1.12E+08 I-132 1.65E-01 4.40E 1.54E-01 1.54E+01 7.02E-01 NO DATA _ 8.27E I-133 3.86E+06 6.72E+06 2.05E+06 9.87E+08 1.17E+07 NO DATA 6.04E+06 1-134 1.89E-12 5.13E-12 1.83E-12 8.88E-11 8.15E-12 NO DATA 4.47E-15 CLINTON-1 3 99 Rev.5-2/89
.- . -__ _ . ~ . - .. .- . _- . . . . - . . . . . - . . . . .
CPS-0DCM TABLE 3.5-20 (continued)
COR MILK PAtr a W FACTORS - RCaij(ADULT) 2 (m mrom/yr por pCi/sec)
ORGAN: S2iE LIVER T. BODY THYROID E'.DNEY IE(G GI-LLI ISOTOPE I 135 1.29E+04 3.39E+04 1.25E+04 2.23E+06 5.43E+04 NO DATA 3.83E+04 CS-134 5.67E+09 1.35E+10 1.10E+10 -NO DATA 4.37E+09 1.45E+09 2.36E+08 CS 136 2.64E+08 1.04E+09 7.49E+08 NO DATA 5.79E+08 7.94E+07 1.18E+08 CS 137 7.39E+09 1.01E+10 6.62E+09 NO DATA 3.43E+09 1.14E+09 1.96E+08 CS-138 8.69E-24 1.72E 23 8,50E-24 NO DATA 1.26E-23 1.24E 24 7.32E-29 BA-139 4.43E 08 3.16E 11 1.30E-09 NO DATA 2.95E-11 1.79E-11 7.86E 08 BA-140 2.72E+07 3.42E+04 1.78E-06 NO DATA 1.16E+04 1.96E+04- 5.60E+07 BA-141 4.33E-46 3.27E-49 1.46E 47 NO DATA 3.04E-49 1.86E 49 2.04E 55 BA 142 2.51E 80 2.58E 83 1.58E-81 NO DATA 2.18E 83 1.46E-83 3.54E 98 LA-140 4.53E+00 2.28E+00 6.03E 01 NO DATA NO DATA NO DATA 1.67E+05 1A-142 1.89E 11 8.61E-12 2,15E-12 NO DATA NO DATA NO DATA 6.29E-08 CE 141 4,84E+03 3.27E+03 3.71E+02 NO DATA 1.52E+03 NO DATA 1.25E+07 CE 143 4.16E+01' 3.07E+04 3.40E+00 NO DATA 1.35E+01 NO DATA 1.15E+06 CE 144 3.58E+05 1.50E+05 1.92E+04 NO DATA 8.87E+04 NO DATA 1.21E+08 PR-143 1.58E+02 6.35E+01 7.84E+00 NO DATA 3.66E+01 NO DATA 6.93E+05 PR-144 6.47E 54 2.69E 54 3.29E-55 NO DATA 1.52E NO DATA 9.31E-61 ND-147 9.44E+01 1.09E+02 6.53E+00 NO DATA 6.38E+01 NO DATA 5.24E+05 W-187 6.50E+03 5.43E+03 1.90E+03 NO DATA NO DATA NO DATA 1.78E+06 NP-239 3.67E+00 3.60E-01 1.99E NO DATA 1.12E+00 NO DATA 7.39E+04
- mrem /yr per 4Ci/m 3
- 2.46 x 106 CLINTON-1 3-100 Rev.5-2/89
Utb-UUGH
- l TABLE 3.5-21 [
GOAT MILK PATHWAY FACTORS - R Caij(INFANT) l (m2 mrom/yr per #Ci/sec)
{
f f
ORGAN; EqtiE LIVER T. BODY THYROID FIDNE1 gig GI-LLI t ISOTOPE a !
H+3 NO DATA 4.86E+03* 4.86E+03* 4.86E+03* 4.86E+03* 4.86E+03* 4.86E+03* !
C 14 3.23E+06* 6.89E+05* 6.89E+05* 6 89E+05* 6.89E+05* 6.89E+05* 6.89E+05* I NA-24 1.87E+06** 1.87E+06 1.87E+06 1.87E+06 1.87E+06 1.87E+06 1.87E+06 i
l P-32 1.90E+11 1.12E+10 7.46E+09 NO DATA NO DATA NO DATA 2.58E+09 CR 51 NO DATA NO DATA 1.93E+04 1.26E+04 2.75E+03 2.45E+04 5.63E+05 j MN-54 NO DATA 4.68E+06 1.06E+06 NO DATA 1.04E+06 NO DATA 1.72E+06 l i
MN 56 NO DATA 3.75E 03 6.46E-04 NO DATA 3.22E-03 NO DATA 3.40E-01 l FE 55 1.75E+06 1.13E+06 3.02E+05 NO DATA NO DATA 5.53E+05 1.44E+05 ;
FE-59 2.91E+06 5.08E+06 2.00E+06 NO DATA NO DATA 1.50E+06 2.43E+06 l
t i
CO 58 NO DATA 2.90E+06 7.24E+06 NO DATA NO DATA NO DATA 7.23E+06 ;
CO-60 NO DATA 1.06E+07 2,49E+07 NO DATA NO DATA NO DATA 2.51E+07 ;
NI-63 4.19E+09 2.59E+08 1.45E+08 NO DATA NO DATA NO DATA 1.29E+07
{
NI-65 4.20E-01 4.76E 02 2.16E-02 NO DATA NO DATA NO DATA 3.62E+00 !
CU-64 NO DATA 2.04E+04 9.45E+03 NO DATA 3.45E+04 NO DATA 4.19E+05 i ZN-65 6.64E+08 2.28E+09 1,05E+09 NO DATA 1.10E+09 NO DATA 1.92E+09 l ZN-69 2.32E-12 4.18E 12 3.11E-13 NO DATA 1.74E-12 NO DATA 3.41E 10 j BR-83 NO DATA NO DATA NO DATA NO DATA NO DATA NO DATA NO DATA j BR-84 NO DATA NO DATA NO DATA NO DATA NO DATA NO DATA- NO DATA 1 I
.BR 85 NO DATA NO DATA. NO DATA NO DATA NO DATA NO DATA NO DATA l RB 86 NO DATA 2.65E+09 1.31E+09 NO DATA NO DATA NO DATA 6.79E+07 RB-88 NO DATA 2.25E 45 1.23E-45 NO DATA NO DATA NO DATA 2.19E-45 PIc89 NO DATA 4.09E-53 2.82E-53 NO DATA NO DATA NO DATA 1.39E-53 SR 89 2.64E+10 NO D AT!. 7.56E+08 NO dab NO DATA NO DATA 5.42E+08 5 5".-90 2.55E+11 NO DATA 6.50E+10 NO DATA NO DATA NO DATA 3.19E+09 l l
SR 91 5.65E+05 NO DATA 2.05E+04 NO DATA NO DATA NO DATA 6.69E+05 5 SR 92 '
9.83E+00 NO DATA 3.65E-01 NO DATA NO DATA NO DATA 1.06E+02 Y-90 8.19E+01 NO DATA 2.19E+00 NO DATA NO DATA NO DATA 1.13E+05 i
e CLINTON-1 3-101 Rev.5-2/89
. _ -- -_ _ . . _ ._ . _ . . ~ . , , _ . . . , _ .
CPS-0DC!t TABLE 3.5-2_1 (continued)
GOAT MIIE PATHWAY FACTORS - RC aij(INFANT) 2 (m mrom/yr per 4Ci/sec)
ORGA!h 10FI LIVER T. BODY THYROID ISOTOPE KIDNEY IM{Q GI-LLI Y-91m
- 29E 20 NO DATA 2.48E-21 NO DATA NO DATA NO DATA 2.43E-16 Y-91 8.78E+03 NO DATA 2.34E+02 NO DATA NO DATA NO DATA 6.29E+05 Y-92 6.40E 05 NO DATA 1.80E-06 NO DATA NO DATA NO DATA 1.22E+00 Y-93 2.55E-01 NO DATA 6.95E 03 NO DATA NO DATA NO DATA 2.02E+03 ZR-95 8.16E+02 1.99E+02 1.41E+02 NO DATA 2.14E+02 NO DATA 9.90E+04 ZR-97 4.85E-01 8.33E-02 3.80E-02 NO DATA 8.40E-02 NO DATA 5.31E+03 NB-95 7.12E+04 2.93E+04 1.69E+04 NO DATA 2.10E+04 NO DATA 2.47E+07 tiO 99 NO DATA 2.48E+07 4.84E+06 NO DATA 3.71E+07 NO DATA 8.18E+06 TC 99m 3.26E+00 6.73E+00 8.67E+01 NO DATA 7.24E+01 3.52E+00 1.96E+03 TC-101 3.?6E-60 4.11E-60 4.06E-59 NO DATA 4.88E-59 2.24E-60 6.98E 58 RU-103 1.04E+03 NO DATA 3.47E+02 NO DATA 2.16E+03 NO DATA 1.26E+04 RU-105 9.60E--04 NO DATA 3.23E-04 NO DATA 7.06E 03
, NO DATA 3.82E-01 RU-106 2.28E+04 NO DATA 2.84E+03 NO DATA 2.69E+04
' NO DATA 1.73E+05 AG-110m 4.62E+07 3.37E+07 2.23E+07 NO DATA 4.83E+07 NO DATA 1.75E+09 TE-125m- 1.80E+07 6.02E+06 2.43E+06 6.06E+06 NO DATA NO DATA 8.58E+06 TE-127m 5.04E+07 1.67E+07 6.10E+06 1.46E+07 1.24E+08 NO DATA 2.03E+07 TE-127 7.57E+02 2.54E+02 1.63E+02 6.16E+02 1.85E+03 NO DATA 1.59E+04 TE-129m 6.68E+07 2.29E+07 1.03E+07 2.57E+07 1.67E+08 NO DATA 3.99E+07 TE-129. 3.25E-10 1.12E-10 7.59E-11 2.73E-10 8.10E-10 NO DATA 2.60E 08
.TE-131m -4.04E+05 1.63E+05 1.34E+05 3.30E+05 1.12E+06 NO DATA 2.74E+06 TE-131 4.19E 33 1.55E-33 1.18E-33 3.74E 33 1.07E-32 NO DATA 1.69E-31
-TE-132 2.54E+06 1.26E+06 1.17E+06 1.85E+06 7.86E+06 NO DATA 4.65E+06 3
I-130 4.22E+06 9.28E+06 3.73E+06 1.04E+09 1.02E+07 NO DATA 1.99E+06
- I-131 3.25E+09 3.83E+09 1.69E+09 1.26E+12 4.48E+09 NO DATA 1.37E+08 I-132 1.73E+00 3.50E+00 1.25E+00 1.64E+02 3.91E+00 NO DATA 2.84E+00 l I 133 4.34E+07 6.32E+07 1.85E+07 1.15E+10 7.43E+07 NO DATA 1.07E+07 4 I-134 1.97E-11 4.04E-11 1.44E-11 9.42E-10 4.52E-11 NO DATA 4.18E-11 CLINTON-1 3-102
] Rev.5-2/89
Gr>*UUUn TABLE 3.5-21 (continued)
GOAT MILK PATHWAY FACTORS - R C (INFANT)
(m2 mrem /yr per gCi/sec)
ORGAN: 0 D_01{E LTVER T. BODY THYROID MIDNEY IELQ GI LLI ISOTOPE I 135 1.36E+05 2.70E+05 9.85E+04 2.42E+07 3.01E+05 NO DATA 9.77E+04 CS-134 1.09E+11 2.04E+11 2.06E+10 NO DATA 5.25E+10 2.15E+10 5.54E+08 CS-136 5.92E+09 1.74E+10 6.50E+09 NO DATA 6.94E+09 1.42E+09 2.64E+08 CS-137 1.54E+11 1.80E+11 1.28E+10 NO DATA 4.84E+10 1.96E+10 5.63E+08 CS-138 2.42E-22 3.93E-22 1.90E 22 NO DATA 1.96E 22 3.06E 23 6.28E 22 BA-139 5.14E-08 3.41E-11 1.49E-09 NO DATA 2.05E 11 2.07E-11 3.26E 06 BA-140 2.87E+07 2.87E+04 1.48E+06 NO DATA 6.82E+03 1.76E+04 7.06E+06 BA-141 4.97E-46 3.40E 49 1.57E-47 NO DATA 2.05E-49 2.07E 49 6.07E 45 BA-142 2.76E-80 2.30E 83 1.36E 81 No DATA 1.32E 83 1.39E-83 1.14E-79 1A 140 4.83E+00 1.91E+00 4.90E-01 NO DATA NO DAT!. NO DATA 2.24E+04 LA-142 2.07E-11 7.60E-12 1.82E-12 NO DATA NO DATA NO D/>TA 1.29E-06 CE-141 5.20E+03 3.17E+03 3.73E+02 NO DATA 9.78E+02 NO DATA 1.64E+06
~CE-143 4.75E+01 3.15E+04 3.60E+00 NO DATA 9.18E+00 NO DATA 1.84E+05 CE-144 2.79E+05 1.14E+05 1.56E+04 NO DATA 4.61E+04 NO DATA 1.60E+07 PR-143 1.78E+02 6,66E+01 8.83E+00 NO DATA 2.47E+01 NO DATA 9.40E+04 PR 144 7.51E-54 2.90E-54 3.78E-55 NO DATA 1.05E-54 NO DATA 1.35E-49 ND-147 1.06E+02 1.08E+02 6.65E+00 NO DATA 4.18E+01 NO DATA 6.88E+04 U 187 7.27E+03 5.06E+03 1.75E+03 NO DATA NO DATA NO DATA 2.97E+05 NP-239 4.37E+00 3.91E-01 2.21E-01 NO DATA 7.80E-01 NO DATA 1.13E+04
- mrem /yr per pCi/m 3
- -1.87 x 10 6 CLINTON-1 3-103 Rev.5-2/89 i
k
CPS 0DCM TABLE 3.5-22 GOAT MILK PATHWAY FACTORS - RC aij (CHILD) 2 (m mrem /yr per pCi/sec)
CaGAN- 10fg LIVER T. BODY THYROID FIDNEY Lip 1q GI LLI ISOTOPE H-3 NO DATA 3.20E+03* 3.20E+03* 3.20E+03* 3.20E+03* 3.20E+03*- 3.20E+03*
C-14 1.65E+06* 3.29E+05* 3.29E+05* 3.29E+05* 3,29F'05* 3.29E+05* 3.29E+05*
NA-24 1.07E+06** 1.07E+06 1.07E+06 1.07E+06 1.07E+06 1.07E+06 1.07E+06 P-32 9.32E+10 4.36E+09 3.59E+09 NO DATA NO DATA NO DATA 2.58E+09 CR 51 No DATA NO DATA 1.22E+04 6.77E+03 1.85E+03 1.24E+04 6.47E+05 MN 54 NO DATA 2.51E+06 6.70E+05 NO DATA 7.05E+05 NO DATA 2.11E+06 MN 56 No DATA 1.53E-03 3.45E 04 NO DATA 1.85E-03 NO DATA 2.21E-01 FE 55- 1.45E+06 7.65E+05 2.38E+05 NO DATA NO DATA 4.35E+05 1.42E+05 FE-59 1.55E+06 2.52E+06 1.25E+06 NO DATA NO DATA 7.29E+05 2.62E+06 CO 58 NO DATA 1.46E+06 4.46E+06 NO DATA NO DATA NO DATA 8.49E+06 CD 60 NO DATA 5.16E+06 1.52E+07 NO DATA NO UATA NO DATA 2.86E+07 NI 63 3.55E+09 1.90E+08 1.21E+08 NO DATA 3 NO DATA NO DATA 1.28E+07 NI 65 1.99E-01 1.87E-02 1,09E-02 NO DATA CU 64 NO DATA NO DATA 2.29E+00 NO DATA 8.23E+03 4.97E+03 NO DATA 1.99E+04 NO DATA- 3.86E+05 ZN-65 4.96E+08 1.32E+09 8.22E+08 NO DATA 8. 3'lE+08 NO DATA 2.32E+08 ZN-69 1.09E-12 1.58E-12 1.46E 13 NO DATA 9.56E-13 NO DATA 9.94E-11 BR-83 NO DATA NO DATA NO DATA NO DATA NO DATA NO DATA NO DATA BR 84 NO DATA NO DATA NO DATA NO DATA ' ) DATA NO DATA NO DATA ,
BR-85 NO DATA NO DATA NO DATA NO DATA NO DATA NO DATA NO D/.fA RB 86 NO DATA 1.05E+09. 6.47E+08 NO DATA NO DATA NO DATA 6.7'E+07-RB 88 NO DATA 8.59E-46 -5.97E 46 NO DATA NO DATA NO DATA 4 21E 47 RB 89 NO DATA 1.67E-53 1.49E-53 NO DATA NO DATA NO DATA 1.46E-55 SR-89 1.39E+10 NO DATA 3 e6E+08 NO DATA NO DATA NO DATA 5.37E+08 SR-90 2.35E+11 NO DATA 5.95E+10 No DATA NO DATA NO DATA 3.16E+09 SR-91 2.71E+05 NO DATA 1.02E+04 NO DATA NO DATA NO DATA 5.99E+05 SR-92 4.61E+00 NO DATA 1.85E-01 NO DATA NO DATA NO DATA 8.74E+01 Y-90 3.86E+01 NO DATA 1.03E+00 NO DATA NO DATA NO DATA 1 *0E+05 CLINTON-1 3-104 Rev.5-2/89
. . _ _ _m . . . _ _ _ ._ _. _ __ ___ __ _ _ . ._
vro vuun
?
TABLE 3.5-22 (continued) !
GOAT MILK PATHWAY FACTORS - RC aij (CHILD) !
(m2 mrem /yr per 4Ci/sec)
ORGAN
- LIVEP T.P0DY TFnTOID ISOTOPE EQ.MI KIDNEY LUNO GI-LLI )
a Y-91m 3.44E 20 NO DATA 1.25E 21 NO DATA NO DATA NO DATA 6.73E 17 Y-91 4.67E+03 NO DATA 1.25E+02 NO DATA NO DATA NO DATA 6.22E+05
- Y-92 3.02E-05 NO DATA 8.64E-07 NO DATA No DATA NO DATA 8.73E 01 i i
1 Y-93 1.20E-01 NO DATA 3.29E-03 NO DATA NO DATA NO DATA 1.79E+03 ,
~~
ZR 95 4.58E+02 1.01E+02 8.97E+01 NO DATA 1.44E+02 NO DATA 1,05E+05 !
ZR-97 2.29E-01 3.31E-02 1.95E-02 NO DATA 4.76E-02 NO DATA 5.02E+03 f NB 95 3.81E+04 1.48E+04 1.06E+04 NO DATA 1.39E+04 NO DATA 2.75E+07 i MD 99 No DATA 9.74E+06 2.41E+06 NO DATA 2.08E+07 NO DATA 8.05E+06 TC-99m 1.58E+00 3.10E+00 5.13E+01 NO DATA 4.50E+01 1.57E+00 1.76E+03 !
i i
TC-101 1.54E-60 1.61E-60 2.04E-59 NO DATA 2.74E-59 8.50E 61 5.11E-60 :
RU-103 5.10E+02 NO DATA 1.96E+02 NO DATA 1.28E+03 NO DATA 1.32E+04 i RU-105 4.53E 04 No DATA 1.65E-04 NO DATA 3.99E 03 NO DATA 2.96E-01 RU-106 1.11E404 NO DATA 1.38E+03 NO DATA 1.49E+04 NO DATA 1.72E+05 AG-110m f
2.50E+07 1.69E+07 1.35E+07 NO DATA 3.15E+07 NO DATA 2.01E+09 TE-125m 8.84E+06 2.39E+06 1.18E+06 2.48E+06 NO DATA NO DATA 8,53E+06 l.
TE-127m 2.'49E+07 6.71E+06 2.96E+06 5.96E+06 7.10E+07 NO DATA 2.02E+07 i TE-127 3.57E+02 9.61E+01 7.65E+01 2.47E+02 1.01E+03 NO DATA 1.39E+04 l TE-129m 3.24E+07 9.06E+06 5.03E+06 1.05E+07 9.52E+07 NO DATA 3.96E+07 y TE-129 1.53E-10 4.28E-11 3.64E 11 1.09E 10 4.49E 10 NO DATA 9.55E-09 TE-131m 1.91E+05 6.60E+04 7.02E+04 1.36E+05 6.39E+05 NO DATA 2.68E+06 ,
TE 131 1.96E-33 5.97E-34 5.83E-34 1.50E-33 5.92E-33 NO DATA 1.03E 32 TE-132 1.23E+06- 5.45E+05 6.59E+05 7.94E+05 5.06E+06 NO DATA 5.49E+06 i 1-130 2.06E+06 4.17E+06 2.15E+06 4.59E+0B 6.23E+06 NO DATA 1.95E+06 I-131 1.56E+09 1.57E+09 8.94E+08 5.20E+11 2.58E+09 NO DATA 1.40E+08 i l
I-132 8.32E-01 1.52E+00 7.03E-01 7.09E+01 2.34E+00 NO DATA 1.80E+00 I-133 2.06E+07 2.55E+07 9.64E+06 4.73E+09 4.25E+07 NO DATA 1.03E+07 I-134 9.51E-12 1.77E-11 8.13E-12 4.06E-10 2.70E-11 NO DATA 1.17E 11 l >
l CLINTON-1 3 105 Rev.5-2/89 ,
_ - . .~. -- .- _. . - - _ - - _ . - . .-. -
TABLE 3.5-22 (continued)
GOAT MILK PATHWAY FACTORS - RC (CHILD) 2 (m mrem /yr per yCi/sec)
. ORGAN: aQJ!g LIVER T. BODY THYPOID KIDNEY LIH{Q GI - LLI_
ISOTOPE I 135 6.53E+04 1.17E+05 5.56E+04 1.04E#)7 1.80E+05 NO DATA 8.95E+04 CS 134 6.76E+10 1.11E+11 2.34E+10 NO DATA 3.44E+10 1.23E+10 5.98E+08
.CS 136 3.03E+09 8.33E+09 5.39E+09 NO DATA- 4.44E+09 6.62E+08 2.93E+08 CS-137 9.65E+10 9.23E+10 1.36E+10 NO DATA 3,01E+10 1.08E+10 5.78E+08 CS 138 1.15E-22 1.59E 22 1.10E 22 NO DATA 1.12E 22 1.21E-23 7.34E-23 BA-139- 2.42E 08 1.29E-11 7.01E 10 NO DATA 1.13E 11 7.59E-12 1.40E 06 BA-140 1.40E+07 1.22E+04 8.15E+05 NO DATA 3.98E+03 7.29E+03 7.07E+06 >
-BA-141 2,34E-46 1.31E-49 7.62E 48 NO DATA 1.13E 49 7,70E 49 1.33E-46 BA-142 1.31E 80 9.44E-84 7.32E-82. NO DATA 7.64E 84 5.55E-84 1.71E 82 LA-140 2.32E+00 8.12E-01 2.53E 01 NO DATA NO DATA NO DATA 2.26E+04 LA-142 9.85E-12 3.14E 12 9.83E 13 NO DATA CE-141 NO DATA NO DATA 6.22E 07
,, 2.62E+03 1.31E+03 1.94E+02 NO DATA 5.73E+02 NO DATA 1.63E+06 CE 143 2.24E+01- 1.22E+04 1.76E+00 NO DATA 5.10E+00 NO DATA 1.78E+05 CE-144- 1.94E+05 6.10E+04 1.04E+04 NO DATA 3.38E+04 NO DATA 1.59E+07 PR-143 8.61E+01 2.58E+01 4.27E+00 NO DATA 1.40E+01 NO DATA 9.29E+04 PR 144 3.53E-54 1.09E-54 1.78E-55 NO DATA 5.78E-55 NO DATA 2.35E 51 ND 147 5.33E+01 4.32E+01 3.34E+00 NO DATA 2.37E+01 NO DATA 6.84E+04 U-187 3.46E+03 2.05E+03 9.20E+02 NO DATA NO DATA NO DATA 2.88E+05 NP-239 2.07E+00 1.49E-01 1.04E-01 NO DATA 4.29E-01 NO DATA 1.10E+04-
- mrem /yr per #Ci/m3
- 1.07 x 106 l
I CLINTON-1 3-106 Rev.6-12/89
.. . - ~ . - - - - _ . - . . - . - . - . . . .- _ .- - . -
i TABLE 3.5-23 GOAT MILK PATHWAY FACTORS - RU aij(TEEN) 2 (m mrem /yr per yci/sec) !
ORGAN: EDHE LIVER T. BODY THYROID MIDNEY LEEg CI-LLI !
ISOTOPE
^
l H3 NO DATA 2.02E+03* 2.02E+03* 2.02E+03* 2.02E+03* 2.02E+03*
C-14 2.02+03*
6.70E+05* 1.34E+05* 1.34E+05* 1.34E+05* 1.34E+05* 1.34E+05* 1.34E+05*
NA 24 5.15E+05** 5.15E+05 5.15E+05 5.15E+05
(
5.15E+05 5.15E+05 5.15E+05 l l
P 32 3.78E+10 2,34E+09 1.47E+09 NO DATA NO DATA NO DATA 3.18E+09 CR 51 NO DATA NO DATA 5.94E+03 3.30E+03
- 1.30E+03 8,48E+03 9.98E+05 i KN 54 NO DATA 1.68E+06 3.32E+05 NO DATA 5.00E+05 NO DATA 3.44E+06 l 1
MN 56 NO DATA 8.770-04 1.56E-04 i NO DATA 1.11E-03 NO DATA 5.77E-02 l FE 55 5,79E+05 4.llE+05 9.57E+04 NO DATA NO DATA 2.60E+05 1.78E+05 i FE 59 6.75E+05 1.58E+06 6.08E+05 NO DATA NO DATA 4.97E+05 3.73E+06 !
l 5
CO 58 NO DATA 9.51E+05 2.19E+06 NO DATA NO DATA NO DATA 1.31E+07 !
CO-60_ NO DATA 3.32E+06 7.47E+06 NO DATA NO DATA NO DATA 6.32E+07 NI 63 1.42E+09 1.00E+08 4.81E+07 NO DATA
{
NO DATA NO DATA 1.60E+07 i
~ i NI-65 8.09E-02 1.03E-02 4.71E-03 NO DATA t
CU-64 NO DATA NO DATA 5.61E 01 1 NO DATA 4.68E+03 2,20E+03 NO DATA 1.18E+04 NO DATA 3.63E+05 ;
ZN-65 2.52E+0C 8.76E+08 4,09E+08 NO DATA 5.61E+08 NO DATA 3.71E+08 ;
ZN-69 4.44E-13 8.46E 13 5.92E-14 NO DATA 5.53E-13 NO DATA' l.56E 12 j BR 83 NO DATA NO DATA NO DATA NO DATA NO DATA NO DATA NO DATA BR 84 NO DATA l NO DATA NO DATA NO DATA NO DATA NO DATA NO DATA !
BR 85 NO DATA NO DATA NO DATA NO DATA l
NO DATA NO DATA NO DATA l RB 86- NO DATA 5.66E+08 2.66E+08 NO DATA NO DATA NO DATA 8.38E+07 i RB 88 NO DATA 4.66E 46 2.48E-46 NO DATA NO DATA NO DATA 3.99E-53 I 1
RS-89 NO DATA 9.52E-54 6.73E-54 SR-89 NO DATA NO DATA NO DATA 1.46E 62 (
5.59E+09 NO DATA 1.60E+08 NO DATA NO DATA NO DATA 6.65E+08 SR 90 1.38E+11 NO DATA 3.40E+10 NO DATA- NO DATA NO DATA 3.87E+09 i SR-91 1.11E+05 NO DATA 4.40E+03 NO DATA NO DATA NO DATA 5.01E+05 SR-92 1.89E+00 NO DATA 8.05E-02 NO DATA NO DATA NO DATA 4.81E+01 !
Y 90 1.56E+01 NO DATA 4.21E-01 NO DATA NO DATA NO DATA 1.29E+05 I l
i CLINTON-1 3-107 Rev.5-2/89
TABLE 3.5-23 (continued)
GOAT MILK PATHWAY FACTORS - RC aij(TEEN) 2 (m nrem/yr per 4Ci/ soc)
ORGAN: E@J LIVER T. BODY THYROID MIDNEY Ltyqq CI.LLI ISOTOPE Y 91m 1.41E 20 NO DATA 5.37E-22 NO DATA NO DATA NO DATA- 6.64E-19 Y 91 1.89E+03 NO DATA 5.07E+01 NO DATA NO DATA NO DATA 7.75E+05 Y 92 1.23E 05 NO DATA 3.57E 07 NO DATA NO DATA NO DATA 3.39E 01 Y 93 4.86E 02 NO DATA 1.33E-03 PO DATA NO DATA NO DATA 1.49E+03 2R-95 1.98E+02 6.24E+01 4.29E+01 NO DATA 9.17E+01 NO DATA 1.44E+05 ZR-97= 9.43E 02 1.87E-02 8.60E 03 No DATA 2.83E-02 NO DATA 5.05E+03
'NB-95 1.69E+04 9.37E+03 5.16E+03 NO DATA 9.08E+03 NO DATA 4.01E+07 MO-99 NO DATA 5.33E+06 1.02E+06 NO DATA 1.22E+07 NO DATA 9.55E+06 TC-99m 6.87E-01 1.92E+00 2.48E+01 NO DATA 2.86E+01 1.06E+00 1.26E+03 TC 101 6.26E 61 8.91E-61 8,75E-60 NO DATA 1.61E-55 5,43E 61 1.52E-67 RU-103 2.17E+02 NO DATA 9.27E+01 NO DATA 7.64E+02 NO DATA 1.81E+04 RU-105 1.86E-04 NO DATA 7.21E-05 2.35E 03 NO DATA NO DATA 1.50E 01 RU-106 4.47E+03 i
NO DATA 5.63E+02 NO DATA 8.62E+03 NO DATA 2.14E+05 AG-110m 1.15E+07 1.09E+07 6.62E+06 NO DATA 2,08E+07 NO DATA 3.06E+09 TE-125m 3.59E+06 1.29E+06 4.80E+05 1.00E+06 NO DATA NO DATA 1.06E+07 1
TE-127m 1.01E+07 3 . 571'+06 1.20E+06 2.39E+06 4.08E+07 NO DATA 2.51E+07 TE-127 1.48E+02 5.14E401 3.18E+01 1.02E+02 5.87E+02 NO DATA 1.14E+04 TE-129m 1.32E+07 4.89E+06 2.08E+06 4.25E+06 5.51E+07 NO DATA 4.94E+07 TE-129: 6.22E-11 2.32E-11 1.51E-11 4.44E 11. 2.61E-10 NO DATA 3.40E-10 TE 131m 7.86E+04 3.77E+04 3.14E+04 5.67E+04 3.93E+03 NO DATA 3.02E+06 TE 131 8.04E-34 3.31E-34 1.51E 34 6.19E-34 3.51E 33 NO DATA 6.60E 35 TE-132 5.13E+05 3.25E+05 3.06E+05 3.43E+05 3.12E+06 NO DATA 1.03E+07-I-130 8.82E+05 2.55E+06 1.02E+06 2.08E+08 3.93E+06 NO DATA 1.96E+06 I-131 6.44E+08 9.01E+08 4.84E+08 2,63E+11 1.55E+09 NO DATA 1.78E+08 I-132 3.52E-01 9.20E-01 3.30E-01 3.10E+01 1.45E+00 NO DATA 4.01E-01 1-133 8.48E+06 1.44E+07 4.39E+06 2.01E+09 2.52E+07 NO DATA 1.09E+07 I-134 4.03E-12 1.07E-11 3.84E-12 1.78E-10 1.68E-11 NO DATA 1.41E 13 CLINTON-1 3-108 Rev 5-2/89 l
l t
TABLE : . 5-23 (continued) I GOAT FILK PATHWAY FACTORS - RC !
aij(TEEN) ,
2 (m mrem /yr per 4Ci/sec) [
l ORCAt M LIVER T.P,0DY TinTOID VIDNEY Id!hG GI-LLI l t
I I-135 2.75E+04 7.08E+04 2.62E+04 4.56E+06 1.12E+05 NO DATA 7.85E+04 !
CS 134 2.94E+10 6.91E+10 3.21E+10 NO DATA P. 20E+10 8.39E+09 8.60E+08 i CS-136 1.34E+09 5.27E+09 3.54E+09 NO DATA 2.87E+09 4.52E+08 4.24E+08 l
~
f CS-137 4.01E+10 5.33E+10 1.86E+10 NO DATA 1.82E+10 7.05E+09 7.59E+08 l CS 138 4.73E-23 9.08E-23 4.54E 23 NO DATA 6.70E-23 7.80E-24 4.12E-26 ;
BA-139 9.84E 09 6.92E 12 2.87E-10 NO DATA 6.53E-12 4.77E-12 8.78E-08 BA-140 5.82E+06 7.13E+03 3.75E+05 NO DATA 2.42E+03 4.30E+03 8.98E+06 BA-141 9.53E-47 7.11E-50 3.18E-48 NO DATA 6.60E 50 4.87E-50 2.03E-52 i SA 142 5.44E-81 5,44E 84 3.35E-82 NO DATA 4.60E-84 3.62E-84 1.67E-92 I r
LA 140 9.67E-01 4.75E-01 1.26E-01 NO DATA NO DATA NO DATA 2.73E+04 1A 142 4.08E 12 1.81E-12 4.51E-13 NO DATA NO DATA NO DATA 5.52E-OS I CE-141 1.07E+03 7.12E+02 8.17E+01 NO DATA 3.35E+02 NO DATA 2.04E+06
.gs.. l I
CE-143 9.14E+00 '6.65E+03 7.43E NO DATA 2.98E+00 NO DATA 2.00E+05 !
CE 144 7.86E+04 3.25E+04 4.23E+03 NO DATA 1.94E+04 NO DATA 1.98E+07 !
PR-143 3.47E+01 1.39E+01 1.73E+00 NO DATA 8,06E+00 NO DATA 1.14E+05 I PR-144 1.42E-54 5.81E-55 7.19E-56 NO DATA 3.33E-55 NO DATA 1.56E 57 ND-147 2.17E+01 2.36E+01 l 1.41E+00 NO DATA 1.38E+01 NO DATA 8.50E+04 U-187 1.43E+03 1.16E+03 4.08E+02 .NO DATA NO DATA NO DATA 3.15E+05 ;
NP 239 8.3BE-01 7.90E-02 4.39E-02 NO DATA 2.48E-01 NO DATA 1.27E+04 ;
i l
- mrem /yr per #Ci/m 3
- 5.15 x 105 s I i
i f
CLINTON-1 3-109 Rev.5-2/89 [
I i
TABLE 3.5-24 GOAT MILK PATHWAY FACTORS - R C ,,(ADULT) a ,t]
2 (m mrom/vr por gCi/sec)
ORGAN
- EQHE LIVER T. BODY THYROID EIDNEY -1219, GI-LLI ISOTOPE H 'l NO DATA 1.55E+03* 1.55E403* 1.55E+03* 1.55E+03* 1.55E+03* 1.55E+03*
C 14 3.63E+05* 7.26E+04* 7.26E+04* 7.26E+04* 7.26E+04* 7.26E+04* 7.26E+04*
NA-24 2.95E+0$** 2.95E+05 2.95E+05 2.95E+05 2.95E+05 2.95E+05 2.95E+05 l P-32 2.05E+10 1.27E+09 7.91E+08 NO DATA NO DATA NO DATA 2.30E+09 CR-51 NO DATA NO DATA 3.43E+03 2.05E+03 7.56E+02 4.55E+0S 8.63E+05
!CI-54 NO DATA 1.01E+06 1.92E+05 NO DATA 2.99E+05 NO DATA 3.08E+06 MN-56 NO DATA 4.96E-04 8.79E-05 NO DATA 6.29E-04 NO DATA 1.58E-02 FE-55 3.27E+05 2.26E+05 5~.27E+04 NO DATA NO DATA 1.26E+05 1.30E+05 FE 59 3.85E+05 9.06E+05 3.47E+05 NO DATA 2.53E+05 NO DATA 3.02E+06 CO 58 NO DATA 5.62E+05- 1.26E+06 NO DATA NO DATA NO DATA 1.14 E+07 CO 60 NO DATA 1.96E+06 4.33E+06 NO DATA NO DATA NO DATA 3.69E+07 NI 63 8.05E+08 5.58E+07 2.70E+07 NO DATA NO DATA NO DATA 1.16E+07 NI-65 4.43E 02 5.76E 03 2.63E-03 CU-64 NO DATA NO DATA NO DATA- 1.46E 01 NO DATA 2.62E+03 1.23E+03- NO DATA 6.6'2E+03 NO DATA 2.24E+05 !
ZN-65 1.64E+08 5.22E+08 2.36E+08 NO DATA 3.49E+08 NO DATA 5.29E+08 d 69 2.41E-13 _4.61E-13 3.21E-14 NO DATA 3.00E-13 BR-83 No DATA 6.93E-14 NO DATA NO DATA NO DATA NO DATA NO DATA NO DATA NO DATA BR-84 NO DATA NO DATA NO DATA NO DATA NO DATA -NO DATA NO DATA BR 85 NO DATA NO DATA NO DATA NO DATA NO DATA NO DATA NO DATA RB-86 NO DATA- 3.10E+08 1.45E+08 NO DATA NO DATA NO DATA 6.12E+07 RB 88 NO DATA 2.57E-46 1.36E-46 NO DATA NO DATA ~NO DATA 3.55E RB-89 NO DATA 5.37E 54 3.78E-54 NO DATA NO DATA NO DATA 3.12E-67 SR 89 3.04E+09 NO DATA 8.73E+07 NO DATA NO DATA NO DATA 4.88E+08 SR 90 9.78E+10 NO DATA 2.40E+10 NO DATA --NO DATA NO DATA 2.83E+09 SR-91 6.01E+04 NO DATA 2.43E+03 NO DATA NO DATA NO DATA 2.86E+05 SR-92 1.03E+00 NO DATA 4.45E-02 NO DATA NO DATA NO DATA 2.04E+01 Y-90_ 8.48E+00 NO DATA 2.28E-01 NO DATA NO DATA NO DATA 9.00E+04 CLINTON-1 3-110 Rev.5-2/89
i TABLE 3.5-24 (continued)
GOAT MILK PATHWAY FACTORS - RC (ADULT)
- 2 (m mrem /yr per 4Ci/sec)
ORGAN
- 0
}_0EE LIVER LigI6 THYROID FIDNEY lye GI-LLI ISOTOPE
.Y-91m 7.69E-21 NO DATA 2.98E-22 NO DATA NO DATA NO DATA 2.26E 20 Y 91 1.03E+03 NO DATA 2.75E+01 NO DATA NO DATA NO DATA 5.66E+05 Y-92 6.68E-06 NO DATA 1.95E 07 NO DATA NO DATA NO DATA 1.17E 01 Y-93 2.65E-02 NO DATA 7.32E-04 NO DATA NO DATA NO DATA 8.41E+02 2R-95 1.13E+02 3.63E+01 2.46E+01 NO DATA 5.69E+01 NO DATA 1.15E+05 2R 97 5.17E-02 1.04E-02 4.77E 03 NO DATA 1.58E 02 NO DATA 3.23E+03 NB-95 9.90E+03 5.51E+03 2.96E+03 NO DATA 5.45E+03 NO DATA 3.34E+07 MO 99 NO DATA 2.96E+06 5.63E+05 NO DATA 6.71E+06 NO DATA 6.86E+06 TC-99m 3.95E-01 1.12E+00 1.42E+01 NO DATA 1.70E+01 5.47E-01 6.61E+02 TC-101 3.43E-61 4.94E 61 4.84E-60 NO DATA 8.89E 60 2.52E 61 1.48E-72 RU-103 1.22E+02 NO DATA 5.24E+01 NO DATA 4.64E+02 NO DATA 1.42E+04 RU-105 1.02E 04 NO DATA 4.02E 05 NO DATA 1.32E-03 NO DATA 6.23E-02 RU-106 2.44E+03 NO DATA 3.09E+02 NO DATA 4.72E+03 NO DATA 1.58E+05 AG-110m 6.96E+06 -6.44E+06 3.82E+06 NO DATA 1.27E+07 NO DATA 2.63E+09 TE-125m 1.95E+06 7.07E+05 2.61E+05 5.87E+05 7.94E+06 NO DATA 7.79E+06 TE-127m 5.46E+06 1.95E+06 6.66E+05 1.40E+06 2.22E+07 NO DATA 1.83E+07 TE 127 7.82E+01 2.81E+01 1.69E+01 5.80E+01 3.19E+02 NO DATA 6.17E+03 TE-129m 7.21E+06 2.69E+06 1.14E+06 2.48E+06 3.01E+07 NO DATA 3.63E+07 TE-129 3.83E-11 1.27E-11 8.23E-12 2.59E-11 1.42E-10 NO DATA 2.55E-11 TE-131m 4.53E+04 2.12E+04 1.76E+04 3.35E+04 2.14E+05 NO DATA. 2.10E+06 TE 131 4.37E-34 1.83E-34 1.38E-34 3.60E 34 1.92E-33 NO DATA 6.19E 35 TE-132 2.87E+05 1;86E+05 1.74E+05 2.05E+05 1.79E+06 NO DATA 8.79E+06 I-130 5.00E+05 1.47E+06 5.82E+05 1.25E+08 2.30E+06 NO DATA 1.27E+06 I-131 3.54E+08 5.06E+08 2.90E+08~ 1.66E+11 8.68E+08 NO DATA 1.34E+08 I-132 1.98E-01 5.29E-01 1.85E-01 1.85E+01 8.43E-01 NO DATt. 9.93E-02 1-133 4.62E+06 8.03E+06 2.45E+06 1.18E+09 1.40E+07 NO DATA 7.22E+06 I-134 2.27E-12 6.16E-12 2.20E-12 1.07E-10 9.80E-12 NO DATA 5.37E 15 CLINTON-1 3-111 Rev.5-2/89
. . _ . .. _. _- - . . _ . _ _ _ __ __m. _. ____ _. . . . _ , _ . _ . _ - . _ _.
l TABLE 3.5-24 (continued) l GOAT MILK PATHWAY FACTORS -R C (ADULT) 2 (m mrem /yr per pCi/sec)
ORGAN: fQJ!E LIVER T. BODY THYROID KIDNEY El!EG GI-LLI ISOTOPE I 135 1.55E+04 4.06E+04 1.50E+04 2.68E+06 6.51E+04 NO DATA 4.59E+04 CS 134 .1.69E+10 4.03E+10 3.29E+10 NO DATA 1.30E+10 4.32E+09 7.04E+08 CS-136 7.88E+08 3.11E+09 2.24E+09 NO DATA 1.73E+09 2.37E+08 3.53E+08 CS-137 2.21E+10 3.03E+10 1.98E+10 NO DATA 1.02E+10 3.41E+09 5.84E+08 CS-138 2.61E 23 5.15E 23 2.55E-23 NO DATA 3.78E-23 3.73E-24 2.20E-28 BA-139 5.32E 09 3.79E 12 1.56E 10 NO DATA 3.54E 12 2.15E-12 9.44E-09 BA-140 3.23E+06 4.05E+03 2.11E+05 NO DATA 1.38E+03 2.32E+03 6.65E+06 BA 141 5.18E-47 3.92E-50 1.75E-48 NO DATA 3.64E 50 2.22E-50 2.44E 56 BA 142 3.00E-81 3.09E-84 1.89E-82 2.61E 84 1.75E-84 NO DATA 4.23E 99 1A-140 5.40E 01 2.72E 01 7.19E-02 NO DATA NO DATA NO DATA 2.00E+04 1A 142 2.27E-12 1.03E 12 2.57E-13 NO DATA NO DATA NO DATA 7.52E-09 CE 141 5.80E+02 3.92E+02 4.45E+01 NO DATA 1.82E+02 NO DATA 1.50E+06 CE 143 5.00E+00 3.70E+03 4.09E-01 NO DATA 1.63E+00 NO DATA 1.38E+05 CE-144 4.29E+04 1.79E+04 2.30E+03 NO DATA 1.06E+04 NO DATA 1.45E+07 PR-143 1.89E+01 7.56E+00 9.35E-01 NO DATA 4.37E+00 NO DATA 8.26E+04 PR 144 7.71E-55 3.20E-55 3.92E-56 NO DATA 1.80E-55 NO DATA 1.11E-61 ND-147 1.13E+01 1.30E+01 7.79E 01 NO DATA 7.64E+00 NO DATA 6.2SE+04 W 187 7.78E+02 6.50E+02 2.27E+02 NO DATA NO DATA NO DATA 2.13E+05 NP-239 4.39E-01 4.32E-02 2.38E-02 NO DATA 1.35E-01 NO DATA 8.86E+03 mrem /yr per pCi/m 3
- 2.95 x 10 5 CLINTON-1 3-112 Rev 5-2/89
_ _ - -- _ - _ _ _ ~ - . . - . - - - _ _ _ _ ~ _ . - . _ _ . . _ . - - .
TABLE 3.5-25 4
MEAT PATHWAY FACTORS - RM alj(CHILD) i 2
(m mrem /yr per pCi/sec) {
ORG @ HOf;E LIVER T. BODY THYROID KIDNEY GI LLI LELQ l ISOTOPE l
H3 NO DATA 2.32E+02* 2.33E+02* 2.33E+02* 2.33E+02* 2.33E+02* 2.33E+02* l C 14 5.29E+05* 1.06E+05* 1.06E+05* 1.06E+05* 1.06E+05* 1.06E+05 1.06E+05* i NA 24 1.84E-03** 1.84E-03 1.84E-03 1.84E-03 1.84Et03 1.84E-03 1.84E-03 i
P 32 7.43E+09 3.47E+08 2.86E+08 NO DATA NO DATA NO DATA 2.05E+08 a CR 51 NO DATA NO DATA 8.78E+03 4.88E+03 1.33E+03 8.90E+03 4.66E+05 MN-54 NO DATA 8.03E+06 2.14E+06 NO DATA 2.25E+06 NO DATA 6.74E+06 [
MN-56 NO DATA 1.56E-53 3.52E-54 NO DATA 1.89E 53 NO DATA 2.26E-51 !
FE-55 4.58E+08
^
2.43E+08 7.52E+07 NO DATA NO DATA 1.37E+08. 4.50E+07 -
FE-59 3.76E+08 6.09E+08 3.03E+08 NO DATA NO DATA 1.76E+08 6.34E+08 ,
L co 58 NO DATA 1.64E+07 5.03E+07 NO DATA NO DATA NO DATA 9.58E+07 ?
CO 60 '
NO DATA 6.93E+07 2.04E+08 NO DATA NO DATA NO DATA 3.84E+08 NI-63 2.91E+10 1.56E+09 9.90E+08 NO DATA NO DATA NO DATA 1.05E+08 !
NI-65 3.55E-52 3.34E-53_ 1.92E-53 NO DATA NO DATA NO DATA 4.10E-51 !
CU-64 NO DATA 2.77E-07 1.67E-07 NO DATA 6.69E-07 NO DATA 1.30E-05 ;
.ZN 65 3.75E+08 1.00E+09 6.22E+08 NO DATA 6.30E+08 NO DATA 1.76E+08 !
ZN-69 0.00E+00 0.00E+00 0.00E+00 NO DATA 0.00E+00 NO DATA 0,00E+00 L BR-83 NO DATA NO DATA NO DATA NO DATA NO DATA .NO DATA NO DATA BR-84 NO DATA NO DATA NO DATA NO DATA NO DATA NO DATA NO DATA BR-85 NO DATA NO DATA NO DATA NO DATA NO DATA NO DATA NO DATA .
R.B 86 NO DATA 5.76E+08- 3.54E+08 NO DATA- NO DATA NO DATA 3.71E+07 j RB-88 UO DATA 0.00E+00 0.00E+00 NO DATA NO DATA NO DATA 0.00E+00 .
f RB-89 NO DATA -0.00E+00 0.00E+00 NO DATA NO DATA NO DATA 0.00E+00 SR-89 4.80E+08 NO DATA 1.37E+07 NO DATA NO DATA NO DATA 1.86E+07 SR-90 1.04E+10 NO DATA 2.64E+09 NO DATA NO DATA NO DATA 1.40E+0B 7
i SR-91 2.26E 210 NO DATA 8.53E-12 NO DATA NO DATA NO DATA 4.99E-10 SR-92 2.00E-49 NO DATA 8.04E-51 NO DATA NO DATA NO DATA 3.80E-48 :
Y-90 1 73E+02 NO DATA 4.62E+00 NO DATA NO DATA NO DATA 4.91E+05 CLINTON-1 3-113 Rev.5-2/89 ;
h I
s
?
TABLE 3.5-25 (continued) .
MEAT PATHWAY FACTORS - RM ..
a.13 ( CHILD) !
2 (m mrem /yr per pCi/sec) i i
ORGAN AQEE LIVER T. BODY THYROID KIDNEY LIMG, GI-LLI -l ISOTOPE Y-91m 0.00E+00 NO DATA 0.00E+00 NO DATA NO DATA !!O DATA 0.00E+00 Y-91 1.80E+06 D DATA 4.81E+04 NO DATA NO DATA NO DATA 2.40E+08 !
Y-92 2.37E-39 NO DATA 6.78E-41 NO DATA NO DATA No DATA 6.84E-35 ,
Y-93 NO DATA 1.92E-13
- 6. 9 8 E - 12_- NO DATA NO DATA NO DATA 1.04E-07 !
ZR-95 2.67E+06 5.87E+05 5.22E+05 NO DATA 8.40E+05 NO DATA 6 . '.2 E+0 8 ,
ZR-97 3.16E-05 4.57E-06 2.69E-06 6.55E 06 NO DATA NO DATA 6.5'E-01 -
i NB-95 3.10E+06 1.21E+06 8.61E+05 NO DATA 1.13E+06 NO DATA 2.23E+09 f MO 99 NO DATA 1.14E+05 2.83E+04 NO DATA 2.44E+05 NO DATA 9.45E+04 ;
TC-99m 6.01E-21 1.18E-20 1.95E-19 NO DATA 1.71E-19 5,98E-21 6.71E 18 I i
TC-101 0.00E+00 0.00E+00 0.00E+00 NO DATA 0.00E+00 0.00E+00 0.00E+00 f RU 103 1.55E+08 NO DATA 5.96E+07 NO DATA 3.90E+08 NO DATA 4.01E+09 i RU-105 8,48E-28 NO DATA 3.08E-28 7.45E-27
~ NO DATA NO DATA 5.54E-25 i 5
RU 106 4.43E+09 NO-DATA 5.53E+08 NO DATA 5.99E+09 NO DATA 6.90E+10 {
AG 110m 8.41E+06 5.68E+06 4.54E+06 NO DATA 1.06E+07 NO DATA 6.75E+08 :
TE-125m 5.69E+08 1.54E+08 7.58E+07 1.60E+08 NO DATA NO DATA 5.49E+08 !
TE-127m 1.77E+09 4.78E+08 2.11E+08 4.24E+08 5.06E+09 NO DATA 1.44E+09 !
TE-127 3.34E-10 9.01E-11 7,17E-11 2.31E-10 9.51E-10 NO DATA 1.31E-08 !
TE-129m 1.79E+09 4.99E+08 2.77E+08 5.76E+08 5.25E+09 NO DATA 2.18E+09 l TE 129 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 NO DATA 0.00E+00 TE-131m -6.97E+02 2.41E+02 2.57E+02 4.96E+02 2.33E+03 NO DATA 9.78E+03 i TE-131 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 PO DATA 0.00E+00 I TE-132 2.13E+06 9.43E+05 1.14E+06 1.37E+06 8.76E+06 NO DATA 9.50E+06 2; I-130 2.91E-06 5.89E-06 3.03E-06 6.49E-04 8.80E-06 I-131 NO DATA 2.75E-06 i 1.65E+07 1.66E+07 9.46E+06 5.50E+09 2.73E+07 NO DATA 1.48E+06 l I-132 1.05E-58 1.93E 58 8.86E-59 8.93E 57 2.95E-58 I-133 NO DATA 2.27E-58 5.75E-01 7.10E-01 2.69E-01 1.32E+02 1.18E+00 NO DATA 2.86E-01 I-134 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 NO DATA 0.00E+00 !
q i
CLINTON-1 3-114 Rev.5-2/89 -
i
TABLE 3.5-25 (continued)
MEAT PATHWAY FACTORS - RM ..
ar) (CHILD)
(m2 mrem /yr per pCi/sec)
, QLQ6N1 EQE LIVER T. BODY THYROID FIDNEY llT.GQ GI-LLI ISOTOPE I 135 6.86E-17 1.23E 16 5.83E-17 1.09E-14 1.89E-16 NO DATA 9.38E-17 CS-134 9.20E+08 1.51E+09 3.18E+08 NO DATA 4.68E+08 1.68E+08 8.14E+06 CS-136 1.62E+07 4.45E+07 2.88E+07 NO DATA 2.37E+07 3.53E+06 1.56E+06
. CS-137 1.33E+09 1.27E+09 1.88E+08 NO DATA 4.15E+08 1.49E+08 7.98E+06 CS-138 0.00E+00 0.00E+00 0.00E+00 NO DATA 0.00E+00 0.00E+00 0.00E+00 BA 139 0.00E+00 0.00E+00 0.00E+00 NO DATA 0.00E+00 0.00E+00 0.00E+00 BA 140 4.38E+07 3.84E+04 2.56E+06 NO DATA 1.25E+04 2.29E+04 2.22E+07 BA-141 0.00E+00 0.00E+00 0.00E+00 NO DATA 0.00E+00 0.00E+00 0.00E+00 BA-142 0.00E+00 0.00E+00 0.00E+00 NO DATA 0.00E+00 0.00E+00 0.00E+00 1A-140 5.56E 02 1.94E-02 6.05E 03 NO DATA NO DATA NO DATA 5.41E+02 LA-142 6.18E-92 1.97E-92 6.17E-93 NO DATA NO DATA NO DATA 3.91E 87 CE-141 2.22E+04 1.11E+04 1.64E+03 NO DATA 4.85E+03 NO DATA 1.38E+07 CE-143 3.20E-02 1.74E+01 2.51E-03 NO DATA 7.28E-03 NO DATA 2.54E+02 CE-144 2.31E+06 7.24E+05 1.23E+05 NO DATA 4.01E+05 NO DATA 1.89E+08 PR 143 3.34E+04 1.00E+04 1.66E+03 NO DATA 5.43E+03 NO DATA 3.60E+07 PR-144 0.00E+00 0.00E+00 0.00E+00 NO DATA 0,00E+00 NO DATA 0.00E+00 ND-147 1.17E+04 9.47E+03 7.33E+02 NO DATA 5.20E+03 NO DATA 1.50E+07 W-187 3.21E-02 1.90E-02 8.53E 03 NO DATA NO DATA NO DATA 2.67E+00 NP-239 -4.23E-01 3.04E-02 2.14E-02 NO DATA 8.79E-02 NO DATA 2.25E+03
- mren/yr per pCi/m 3
- 1.84 x 10-3 CLINTON-1 3-115 Rev.6-12/89
CPS-0DCM TADLE 3. 5-2 6 MEAT PATHWAY FACTORS - RM (TEEN) 2 (m mrem /yr per pCi/sec)
ORGAN: EQHE LIVER T. BODY THYROID KIDNEY 1,13G GI-LLI ISOTOPE H-3 NO DATA 1.93E+02* 1.93E+02* 1.93E+02* 1.93E+02* 1.93E+02* 1.93+02*
C-14 2.81E+05* 5.62E+04* 5.62E+04* 5,62E+04* 5.62E+04* 5.62E+04* 5.62E+04*
NA-24 1.16E-03** 1.16E-03 1.16E-03 1.16E 03 1.16E-03 1.16E-03 1.16E-03 P-32 3.95E+09 2.45E+08 1.53E+08 NO DATA NO DATA NO DATA 3 . ? ':E+08 CR-51 NO DATA NO DATA 5.65E+03 3.14E+03 1.24E+03 8.07E+03 9.50E+05 MN-54 NO DATA 7.02E+06 1.39E+06 NO DATA 2.09E+06 NO DATA l.44E+07 dN 56 NO DATA 1.17E-53 2.09E 54 NO DATA 1.48E-53 NO DATA 7.72E 52 FE-55 2.38E+08 1.69E+08 3.94E+07 NO DATA NO DATA 1.07E+08 7.31E+07 FE-59 2.12E+08 4.95E+08 1.91E+08 NO DATA NO DATA 1.56E+08 1.17E+09 Co-58 NO DATA 1.41E+07 3.25E+07 NO DATA NO DATA NO DATA 1.94E+08 CO-60 NO DATA 5.84E+07- 1.32E+08 NO DATA
,, NO DATA NO DATA 7.61E+08 NI-63 1.52E+10 '1.07E+09 5.15E+08 NO DATA NO DATA NO DATA 1.71E+08 NI 65 1.90E-52 2.43E-5't 1.11E-53 NO DATA CU 64 NO DATA NO DATA 1.32E-51 NO DATA 2.06E-07 9.68E-08 NO DATA 5.21E-07 NO DATA 1.60E-05 2N-65 2.50E+08 8.69E+08 4.05E+08 No DATA 5.56E+08 NO DATA 3.68E+08 ZN-69 0.00E+00 0.00E+00 0.00E+00 NO DATA 0.00E+00 NO DATA 0.00E+00 BR-83 NO DATA NO DATA NO DATA NO DATA NO DATA NO DATA NO DATA BR-84 NO DATA NO DATA NO DATA NO DATA NO DATA NO DATA NO DATA BR-85 NO DATA NO DATA NO DATA NO DATA NO DATA NO DATA NO DATA RB-86 -NO DATA 4.05E+08 1.90E+0S NO DATA NO DATA NO DATA 6.00E+07 RB-88 NO DATA 0.00E+00 0.00E+00 NO DATA NO DATA NO DATA 0.00E+00 RB-89 NO DATA 0.00E+00 0.00E+00 NO DATA NO DATA NO DATA 0.00E+00 SR-89 2.54E+08 NO DATA 7.27E+06 NO DATA NO DATA NO DATA 3.02E+07 SR-90 8.04E+09 NO DATA 1.99E+09 NO DATA NO DATA NO DATA 2.26E+08 SR-91 1.20E-10 NO DATA 4.78E-12 NO DATA SR-92 NO DATA NO DATA 5.45E-10 1.08E-49 NO DATA 4.59E-51 NO DATA NO DATA NO DATA 2.74E-48 Y-90 9.11E+01 NO DATA 2.45E400 NO DATA NO DATA NO DATA 7.51E+05 CLIIGON-1 3-116 Rev. 5-2/g g
CPS-0DCM TABLE 3.5-26 (continued) '
MEAT PATHWAY FACTORS - R M aij (TEEN) 2 (m mrom/yr per pCi/sec)
ORGAN: DCLN1 LIVER T.P0DY THYROID };IDNEY Ll!EG GI-LLI ISOTOPE Y-91m 0.00E+00 NO DATA 0.00E+00 NO DATA NO DATA NO DATA 0.00E+00 Y 91 9.55E+05 NO DATA 2.56E+04 NO DATA NO DATA NO DATA 3.91E+08 Y-92 1.26E-39 NO DATA 3.64E 41 NO DATA NO DATA NO DATA 3.45E-35 Y-93 3.70E 12 NO DATA 1.01E 13 NO DATA NO DATA NO DATA 1.13E-07 ZR-95 1.50E+06 4.74E+05 3.25E+05 NO DATA 6.93E+05 NO DATA 1.09E+09 ZR-97 1.70E 05 3.36E-06 1.55E-06 NO DATA 5.10E-06 NO DATA 9.11E-01 NS-95 1.79E+06 9.94E+05 5.47E+05 NO DATA 9.64E+05 NO DATA 4.25E+09 MO-99 NO DATA 8.20E+04 1.56E+04 NO DATA 1.88E+05 NO DATA 1.47E+05 TC-99m 3.42E 21 9.54E-21 1.24E-19 NO DATA 1.42E 19 5.29E 21 6.26E-18 TC-101 0.00E+00 0.00E+00 0.00E+00 NO DATA 0.00E+00 0.00E+00 0.00E+00 RU-103 8.57E+07 NO DATA 3.66E+07 NO DATA 3.02E+08 NO DATA 7.16E+09 RU-105 4.56E-28 NO DATA 1.77E-28 NO DATA 5.75E-27 NO DATA 3.68E 25 RU-106 2,36E+09 NO DATA 2.97E+08 NO DATA 4.54E+09 NO DATA 1.13E+11 AC-110m 5.04E+06 4.77E+06 2,90E+06 NO DATA 9.10E+06 NO DATA 1.34E+09 TE-125m -3.03E+08 1.09E+08 4.06E+07 8.47E+07- NO DATA NO DATA 8.95E+08 TE-127m 9.40E+08 3.33E+08 1.12E+08 2.24E+08 3.81E+09 NO DATA 2.34E+09 TE-127 :1.78E-10 6.30E-11 3.82E-11 1.23E 10 7.20E-10 NO DATA 1.37E 08 TE-129m 9.49E+08 3.52E+08 1.50E+08 3.06E+08 3.97E+09 NO DATA 3.56E+09 TE-129 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 NO DATA 0.00E+00 TE-131m 3.73E+02 1.79E+02 1.49E+02 2.69E+02 1.87E+03 NO DATA 1.44E+04 TE-131 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 NO DATA 0.00E+00 TE-132 1.17E+06 7.38E+05 6.95E+05 7.78E+05 7.08E+06 NO DATA 2.34E+07 I-130- 1.63E 06 -4.71E-06 1.88E-06 3.84E-04 7.25E-06 NO DATA 3.62E-06 I-131 8.89E+06 1.24E+07 6.69E+06 3.63E+09 2.14E+07 NO DATA 2.46E+06 ,
1 I-132 5.78E-59 1.51E-58 5.42E-59 5.09E-57 2.38E-58 NO DATA 6.58E-59 I-133 3.09E-01 5.25E-01 1.60E-01' 7.32E+01 9.20E+01 NO DATA 3.97E-01 I-134 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 NO DATA 0.00E+00 CLINTON-1 3-117 Rev.5-2/89
CPS-0DCM I
l
~
}
TABLE 3.5-26 (continued) !
MEAT PAI'INAY FACTORS - RM aij (TEEN) ,
2 (m mrem /yr per yCi/sec) s QRCA@; M LIVER T. BODY THYROID KIDNEY M GI-LLI ISOTOPE '
I-135 3.79E-17 9.75E 17 3.61E-17 6.27E 15 1.54E-16 CS-134 NO DATA 1.08E.16 5.22E+08 1.23E+09 5.70E+08 No DATA 3.91E+08 1.49E+08 CS-136 1.53E+07 ;
9.36E+06 3.68E+07 2.47E+07 NO DATA 2.01E+07 3,16E+06 2.96E+06 i v
CS-137 7.24E+08 9.63E+08 3.35E+08 NO DATA 3.28E+08 1.27E+08 1.37E+07 '
CS 138 0.00E+00 0.00E+00 0.00E+00 NO DATA 0.00E+00 0.00E+00 0.00E+00 I BA 139 0.00E+00 0.00E+00 0.00E+00 NO DATA 0'.00E+00 0.00E+00 0.00E+00
{
3A-140 2.37E+07 2.91E+04 1.53E+06 1,96E+04 NO DATA 9.86E+03 3.66E+07 (
BA-141 0,00E+00 0.00E+00 0.00E+00 NO DATA 0.00E+00 0.00E+00 0.00E+00 ?
BA-142 0.00E+00 0.00E+00 0.00E+00 NO DATA 0.00E+00 0.00E+00 0.00E+00 ,
LA-140 3,03E-02 1.49E 02 3.97E-03 NO DATA NO DATA NO DATA 8.56E+02 LA-142 3.37E-92 1.49E-92 3.72E-93 NO DATA no DATA NO DATA 4.55E 88 i CE-141 1.17E+04 7.83E+03 9.00E+02 NO DATA 3.69E+03 NCi DATA 2.24E+07 CE 143 1.70E 02 !
1.24E+01 1.38E-03 NO DATA 5.SSE-03 NO DATA 3.72E+02 :
CE-144 1.23E+06 5.10E+05 6. ME+04 NO DATA 3.04E+05 NO DATA 3.10E+08 !
PR 143 1.77E+04 7.06E+03 8. 2+02 NO DATA 4.10E+03 NO DATA 5.82E+07 PR-144 0.00E+00 0.00E+00 0.00E+00 NO DATA 0.00E+00 NO DATA 0.00E+00 ND-147 6.22E+03 6.76E+03 4.05E+02 NO DATA 3.97E+03 NO DATA 2.44E+07 V-187 1.74E-02 1.42E-02 4.96E-03 NO DATA NO DATA NO DATA 3.83E+00 i
N?-239 2.25E-01 2.12E-02 1.18E-02 NO DATA 6.67E-02 NO DATA 3.42E+03 '
- mrem /yr per 4Ci/m 3 l
l ** 1.16 x 10-3 1 j l
t l-l I i-I CLINTON-1 3-118 Rev.5-2/89 i
CPS.0DCM TA DLE 3 . 5 ,*' */
MEAT PA'1HWAY FACTORS - RM ( ADULT,'
(m2 mrem /yr por NCi/ Sac)
OEGim fEL LIVER 'LISD,y THYROID IMG 131Q G I . LLI_
Is9 TOPE H.3 NO DATA 3.24E+02* 3.24E+02* 3.24E+02* 3.24E+02* 3.24E+02* 3.24E402*
C.14 3.33E+05* 6.66E+04* 6.66E+04* 6.66E+04* 6.66E+04* 6.66E+04* 6.66E+04*
NA.24 1.45E.03** 1.45%.03 1.45E 03 1.4$E 03 1.45E.03 1.45E 03 1.45E.03 P 32 4.65E+09 2.89E+08 1.80E+08 NO DATA NO DATA NO DATA 5.23E+0B CR 51 NO DATA NO DATA 7.05E+03 4.21E+03 1.55E+03 9.35E+03 1.77t+06 MN.54 NO DATA 9.19E+06 1.75E+06 NO DATA 2.73Er06 110 DATA 2.81E+07 M!i.56 N0 DATA 1.45E.53 2.57E.54 !!O DATA 1.84E.53 NO DATA 4.62E.52 TE.55 2.94E+08 2.03E+08 4.74E+07 (10 DATA NO DATA 1.13E+08 1.17E+08 EE.59 2.66E+08 6.24E+08 2.39E408 NO DATA NO DATA 1.74E+08 2.08E+09 o C0 + ',8 NO DATA 1.83E+07 4 V.+C 'NO DATA NO DATA NO DATA 3.70E+08 C0 60 110 DATA 7.51E+07 1.66. '8 HO DA**. No DATA NO DATA 1.41E+09 NI 63 1.89E+10. 1.51E+09 6.32E4 48 NO DATA NO DATA NO DATA 2.73E+08 5 4:a ~
NI.65 2.27E.? 2.94E.53 1.34E.53 NO DATA NO DATA NO DATA 7.46E.52 CU.64 NO DATA 2.52E.07 1.18E.07 NO DATA 6.36E.07 HO DATA 2.15E.05 ZN.65 3. 56 E &Os. 1.13E+09 5.12E+08 NO DATA 7.57E+08 NO DATA 7.13E+08 ZN 69 0.00E+00 0.00E+00 0.00E+00 NO DATA 0. 00E+N NO DATA 0.00E+00 BR.83 NO DATA NO DATA 110 DATA NO DATA NO DATA NO DATA NO DATA BR 84 NO DATA NO DATA NO DATA NO DATA NO DATA NO DATA NO DATA ER.65 NO DATA NO DATA NO DATA NO DATA NO DATA NO DATA NO DATA RB.86 NO DATA 4.87E+08 2.27E+08 NO DATA NO DATA NO DATA 9.61E+07 RS.88 NO DATA 0.00E+00 0.00E+00 NO DATA NO DATA NO DATA 0.00E+00 RB 89 NO DATA 0.00E+00 0.00E400 NO DATA NO DATA NO DATA 0.00E+00 SR.89 3.01E+08 UO DATA 8.64E406 NO DATA NO DATA NO DATA 4.83E+07 SR 90 1.24E+10 NO DATA 3.0$E+09 NO DATA NO DATA NO DATA 3.59E+08 1 91 1.43E.10 NO DATA 5.79E.12 NO DATA NO DATA -NO DATA 6.83E.10-3 92 1.28E.49 NO DATA 5.54E.51 NO DATA NO DATA NO DATA 2.54E.48
, MO 1.09E+02 NO DATA 2.92E+00 NO DATA NO DATA No DATA 1.15E+06 CLINTON 1 3 119 Rev.5 2/89
CPS 0DCM TABLE . C-27 (continded)
MEAT PAT!!WAY FACTORS - R (ADULT)
(m2 mrem /yr por 4Ci/sec)
ORGAff: E LIVER T. BODY TIPIROID KIDNEY g 01.LLI ISOTOPE Y 91m 0.00E+00 NO DATA 0.00E+00 NO DATA NO DATA NO DATA 0.00E+00 Y 91 1.13E+06 NO DATA 3.03E+04 NO DATA NO DATA NO DATA 6.23E+08 Y 92 1.49E 39 No DATA 4.36E 41 NO DATA NO DATA NO DATA 2.61E.35 Y.93 4.40E.12 NO DATA 1.21E.13 NO DATA NO DATA NO DATA 1.39E.07 ZR 95 1.87E+06 6.00E+05 4.06E+05 110 DATA 9.41E+05 NO DATA 1.90E+09 ZR 97 2.03E 05 4.10E 06 1.88E.06 NO DATA 6.17E 06 NO DATA 1.27E+00 NB 95 2.30E+06 1.28E+06 6.86E+05 NO DATA 1.26E+06 NO DATA 7.75E+09 M0 99 NO DATA 9.91E+04 1.8?E+04 NO DATA 2.24E+05 NO DATA 2.30E+05 TC 99m 4.32E 21 1.22E.20 1.56E 19 HO DATA 1.86E.19 5.99E 21 7.23E.18 TC.101 0.00E+00 0.00E+00 0.00E+00 NO DATA 0.00E+00 0.00E+00 0.00E+00 .
, ., r RU.103 1.0$E+08 No DATA 4.53E+07 NO DAIA 4.02E+08 NO DATA 1.23E+10 RU 105 S.42E.28 NO DATA 2.14E.28 NO DATA 7.00E.27 NO DATA 3.32E-25 RU 106 2.81E+09 NO DATA 3.55E+08 NO DATA 5.42E+09 NO DATA 1.82E+11 AG.110m 6.67E+06 6.17E406 3.67E+06 NO DATA 1.21E+07 NO DATA 2.52E+09 TE.125m 3.59E+08 1.30E+08 4.81E+07 1.08E+08 1.46E+09 NO DATA 1.43E+09 TE.127m 1.12E+09 3.99E+08 1.36E+08 2.85E+08 4.54E409 NO DATA 3.75E+09 TE 127 2.09E.10 7.52E 11 4.53E 11 1.55E.10 8.53E 10 NO DATA 1.65E 08 TE.129m 1.13E+09 4.22E+08 1.79E+08 3.89E+08 4.73E+09 NO DATA 5.70E+09 TE.129 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 NO DATA 0.00E+00 TE 131m 4.50E+02 2.20E+02 1.83E+02 3.48E+02 2.23E+03 NO DATA 2.18E+04 TE.131 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 NO DATA 0.00E+00 TE 132 1.42E+06 9.21E+05 8.64E+05 1.02E+06 6.87E+06 NO DATA 4.36E+07 1 130 2.03E.06 5.98E 06 2.36E.06 5.07E.04 9.33E 06 NO DATA 5.15E.06 1 131 1.07E+07 1.54E+07 3.80E+06 5.03E+09 2.63E+07 No DATA 4.05E+06 I-132 7.13E.59 1.91E.58 6.67E-59 6.67E~57 3.04E.58 NO DATA 3.58E 59 1 133 3.70E 01 6.43E 01 1.96E 01 9.45E+01 1.12E+00 NO DATA 5.78E.01 I 134 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 NO DATA 0.00E+00 CLINTON 1 3 120 Rev.5 2/89 l
CPS 0DeM TAELE 3.5-27 (continued)
MEAT PATHWAY TACTORS - R (ADULT)
(m2 mrem /yr per pCi/sec)
ORGAN: EQUS LIVER T.. BODY THYPotD GQ!{Ey
- LUS,G G1, ,LLI ISOTOPE 1-135 4.65E 17 1.22f,16 4.49E 17 8.03E 15 1.95E.16 NO DATA 1.38E 16 CS-134 6.53E+08 1.55E+09 1.27E+09 NO DATA 5.03E+08 1.67E408 2.72E+07 CS 136 1.20E+07 4.75E+07 3.42E+07 No DATA 2.65E,07 3.63E+06 5.40E+06 CS 137 8.69E+08 1.19E+09 7.78E+08 NO DATA 4.03E+08 1.34E+08 2.30E+07 CS 138 0.00E+00 0.00E+00 0.00E+00 NO DATA 0.00E+00 0.00E+00 0.00E+00 BA-139 0.00E+00 0.00E+00 0.00E+00 No DATA 0.00E+00 0.00E+00 0.00E+00 BA-140 2.88E+07 3.62E+04 1.89E+06 NO DATA 1.23E+04 2.07E+04 5.94E+07 BA 141 0,00E+00 0.00E+00 0.00E+00 NO DATA 0.00E+00 0.00E+00 0.00E+00 BA 142 0.00E400 0.00E+00 0.00E4 00 NO DATA 0.00E+00 0 .00E+00 0.00E+00 1A 140 3.68E 02 1.85E 02 4.90E 13 NO DATA NO DATA NO DATA 1.36E403 LA 142 4.07E 92 1.85E 92 4.61E 93 NO DATA NO DATA NO DATA 1.35E 88 CE 141 1.39E+04 9.43E+03 1.07E+03 NO DATA 4.3SE+03 NO DATA 3.61E+07 CE 143 2.03E 02 ^1.$0E+01 1.66E 03 NO DATA 6.61E 03 NO DATA 5.61E402 CE 144 1.46E+06 6.10E+05 7.83E+04 NO DATA 3.62E+05 NO DATA 4.93E+08 PR 143 2.09E+04 8.40E+03 1.04E+03 NO DATA 4.85E+03 NO DATA 9.17E+07 PR 144 0.00E+00 0.00E+00 0.00E+00 NO DATA 0.00E+00 NO DATA 0,00E400 ND 147 7.04E+03 8.14E+03 4.87E+02 NO DATA 4.76E+03 No DATA 3.91E407 W 187 2.06E 02 1.72E 02 6.02E 03 NO DATA NO DATA NO DATA 5.64E+00 NP 239 2.57E 01 2.53E 02 1.39E 02 NO DATA 7.88E 02 NO DATA 5.18E+03
- mrem /yr per 4Ci/m 3
- 1.45 x 10'3 i-i CLINTON-1 3 121 Rev.5 2/89
\
, , . . . . _ - - , , . - . , - - . ~ - - - - - - - -
. T CPS.0DCM TABLE 3.5-28 VEGETATIOli PATHWAY FACTORS - R (CHILD)
(m2 nrem/yr por NCi/coc) t ORGAN: ff!!.E LIVER THYROID T.. BODY }ilitiff 11!11g a1.LLI If0 TOPE .
a H.3 !!O DATA 4.01E+03* 4.01E+03* 4.01E+03* 4.01E+03* 4.01E403* 4.01E+03* i C 14 3.51E+06* 7.01E405* 7.01E+0$* 7.01E+05* 7.01E+05* 7.01E405* 7.01E40$*
NA 24 3.75E+0$** 3.75F,+0$ 3.75E+05 3.75E+05 3.75E405 3.75E+05 3.75E+05 .
P 32 3.37E+09 1.57E408 1.30E+08 NO DATA NO DATA NO DATA 9.30E+07 CR.51 NO DATA NO DATA 1.17E+05 6.49E404 1.77E+04 1.18E+05 6.20E+06 MN 54 NO DATA 6.64E+08 1.77E+08 NO DATA 1.86E+08 NO DATA 5.58E+08 MN.56 NO DATA 1.87E+01 4.22E+00 No DATA 2.26E+01 NO DATA 2.71E+03 FE.55 8.02E+08 4.25E+08 1.32E+08 NO DATA NO DATA 2.4 0 E+08 7.88E407 FE.59 3.98E+08 6.43E408 3.21E+08 NO DATA NO DATA 1.87E+08 6.70E+08 co.58 NO DATA 6.44E+07 1.97E+08 Nu DATA NO DATA NO DATA 3.76E408 CO 60 NO DATA 3.79E+08 1.12E+09 NO DATA NO DATA NO DATA 2.10E+09 NI.63 3.95E+10 2.11E+09 1.34E+09 NO DATA NO DATA 110 DATA 1.42E408 t
NI 65 1.05E+02 9.89E+00 5.77E+00 NO DATA NO DATA NO DATA 1.21E+03 CU.64 !!O DATA 1.09E+04 6.59E+03 NO DATA 2.64E+04 NO DA"'A. 5.12E405 ZN.65 8.11E+08 2.16E+09 1.34E+09 !!O DATA 1.36E+09 NO DATA 3.79E+08 '
ZN.69 9.29E.06 1.34E.05 1.24E 06 8.14E.06 NO DATA NO DATA 8.46E.04 BR.83 NO DATA NO DATA 5.40E+00 NO DATA NO DATA NO DATA NO DATA BR 84 NO DATA NO DATA 3.92E.11 NO DATA NO DATA NO DATA NO DATA 1 BR 85 NO DATA NO DATA NO DATA NO DATA NO DATA NO DATA NO DATA Rb 86 NO DATA 4.53E+08 2.79E+08 NO DATA NO DATA NO DATA 2.91E+07 RB.88 110 DATA 4.38E.22 3.04E.22 NO DATA !!O DATA !!O DATA 2.15E.23 L R2 89 NO DATA 4.69E.26 4.17 E. 26 NO DATA !!O DATA NO DATA 4.09E.28
- SR 89 3.59E+10 110 DATA 1.03E+09 NO DATA NO DATA NO DATA 1.39E+09 SR.90 1.24E+12 NO DATA 3.14E+11 NO DATA NO DATA NO DATA 1.67E+10 SR 91 5.21505 NO DATA 1.97E+04 NO DATA !!O DATA NO DATA 1.15E+06 ;
SR.92 7.29E+02 NO DATA 2.92E+01 !!O DATA NO DATA NO DATA 1.38E+04 Y.90 i' 2.31E+04 NO DATA 6.18E+02 NO DATA NO DATA NO DATA 6.58E+07 i
I l
CLINTON.1 3 122 Rev.5 2/89
CPS 0DCM TABLE 3.5-28 (continued)
VEGETATION PATHWAY TACTORS - R (CilILD)
(m2 mrom/yr per 4Ci/coc)
ORCMU h.Q.HI LIVER T.PODY THYROID MIDNEY LQG GI LL1 if0TOPP Y 91m 9.24E 09 NO DATA 3.36E 10 NO DATA NO DATA NO DATA 1.81E 05 Y 91 1.86E+07 NO DATA 4.97E+05 NO DATA NO DATA NO DATA 2.48E+09 Y 92 1.56E+00 NO DATA 4.52E 02 NO DATA NO DATA NO DATA 4.57E+04 Y 93 2.92E+02 NO DATA 8.01E+00 N6 DATA !!O DATA NO DATA 4.35E+06 ZR 95 3.86E+06 8.49E+05 7.56E+05 NO DATA 1.22E+06 NO DATA 8.86E+08 ZR 97 5.66E+02 8.18E+01 4.83E+01 NO DATA 1.17E+02 NO DATA 1.24E+07
-NB 95 4.10E405 1.60E+05 1.14E405 NO DATA 1.50E+05 NO DATA 2.95E+08 MO 99 NO DATA 7.67E+06 1.90E+06 NO DATA 1.64E+07 NO DATA 6.35E+06 TC 99m 4.70E+00 9.21E+00 1.53E402 NO DATA 1.34E+02 4.68E+00 5.24E+03 70 101- 1.48E 30 1.54E 30 1.96E 29 NO DATA 2.63E 29 8.16E 31 4.91E 30 RU 103 1.54E+07 NO DATA 5.90E+06 NO DATA 3.86E+07 NO DATA 3.97E+08 RU 105 9.16E+01 NO DATA 3.32E401 No DATA 8.05E+02 NO DATA 5.98E+04
, RU 106 7.45E+08 NO DATA 9.30E+07 NO DATA 1.01E+09 NO DATA 1.16E+10 l
AG 110m 3.21E+07 2.17E+07 1.73E+07 NO DATA 4.04E+07 NO DATA 2.58E+09
( TE 125m 3.51E+08 9.52E+07 4.68t+07 9.86E+07 NO DATA NO DATA 3.39E+08 TE 127m 1.32E+09 3.56E+08 1.57E+08 3.16E+08 3 .- 7 7 E+ 09 NO DATA 1.07E+09 TE 127 9.84E+03 2.65E+03 2,11E+03 6.81E403 2.80E+04 NO DATA 3.84E+05 TE 129m 8.43E+08 2.35E+08 1.31E+08 2.72E+08 2.47E+09 NO DATA 1.03E+09 TE 129 1.-32E 03 3.68E 04 3.13E 04 9 42E 04 3.86E 03 NO DATA 8.21E 02 TE 131m 1.54E+06 5.33E+05 5.67E+05 1.10E+06 5.16E+06 NO DATA 2.16E+07 TE 131 2.59E 15 7.89E 16 7.71E 16 1.98E 15 7.83E 15 NO DATA 1.36E 14 l
l l TE-132 7.00E+06 3.10E+06 3.74E+06 4.51E+06 2.88E+07 NO DATA 3.12E+07 i
1 130 6.10E+05 1.23E+06 6.35E+05- 1.36E+08 1.84E+06 NO DATA 5.77E+05 i 1-131 1.43E+08 1.44E+08 8.16E+07 4.75E+10 2.36E+08 NO DATA 1.28E+07 I-132 9.20E+01 1.69E+02 7.77E401 7.84E+03 2.59E+02 NO DATA 1.99E+02 1-133 3.53E+06 4.36E+06 1.65E+06 8.11E+08 7.27E+06 NO DATA 1.76E+06 I 134 1.50E 04 2.79E 04 1.28E 04 6.41E 03 4.26E 04 NO DATA 1.85E 04 .
CLINTON 1 3 123 Rev.5 2/89
CPS 0DCil TABLE 3.5-28 (continued)
VEGETATION PATHWAY FACTOPS - RY aij(CHILD) 2 (m mrom/yr per pC1/ cec)
- w s iX1il ORGAN! - -fg25 LIVER LBODY 'rHYR010 CplM 11!1El C1 LLI ISOTOPE
. *tu+3ed.S *tu+ds't.s *(0+3ec.s * ( O hi + l I 135 22 6.2BDtileIE 4.1*3@0M 9 % . JbMdl.f 9. % .00DC7 1.73E+05 NO DATA 8.61E+04 i CS 134 1. 60DWA * % . 63DW A % . 55DOVd. h0 DXTA" 8.15E+09 2.92E+09 1.42E+08 l CS 136 -8 23E+07 9 -26E*nn 1 Alig4ng nQ DATA 1.20E+08 1.80E407 7.95E+06 L I
n mi Vrl ATAU Url ATAU OH +
CS 137 2.39EMOU'%.29 6 9 U 4 .3&$ 0VA NO DATA 7.46E+09 2.68E+09 1.43E+08 CS 138 6.44EM 0% 9569C h.68EkT1Y 6.30E 11 6.78E 12 NO DATA 4.12E 11 BA 139 4. 9 7E 02.-- 2 4SE o % i A4E 03 No DATA 2.32E 05 1.56E 05 2.87E+00
. , . . ~ . .; . v .m . .
j BA 140 2.7fE+0I8 % ,'2.42EO 5' 1.62E+07 NO DATA 7.89E+04 1.45E+05 1.40E+08 i BA 141 2.04E 21d*'i.14E 24 6.64E 23 9.88E 25 6.71E 24 NO DATA 1.16E 21 !
BA 142 9.70E 39 6.98E 42 5.42E 40 5.6$E 42 4.11E 42 NO DATA 1.27E 40 [
i 1A 140 3.24E+03 1.13E+03 3.53E+02 NO DA NO DATA NO DATA 3.16E+0?
1A 142 3.39E 04 1.08E 04 3.38E 05 !
_,,.y NO DA . NO DATA NO DATA 2.14E+01 CE 141 -6 . 5 6 E+05 3.2/E+05 4.85E+04 NO DA*1A 1.43E+05 ' NO DATA 4.08E+08 r
CE 143 1.71E+03 9.29E+05 1.35E+02 3.90E+02 NO DATA NO DATA 1.36E+07 :
CE 144 1.27E+08 3.99E+07 6,79E+06 2.21E+07 NO DATA NO DATA 1.04E+10 PR 143 1.45E+05 4.37E+04 7.22E+03 NO DATA 2.36E+04 NO DATA 1.57E+08 l PR 144 ' d5.64E-26 1.74E 26 2.84E 27 NO DATA 9.22E 27 NO DATA 3.75E 23 ND 147 7.16E+04 5.80E+04 4.49E+03 NO DATA 3.18E+04 '
NO DATA 9.18E+07 V-187 -6 A4E+04- 3. 81E+04 1.71E+04 NO DATA NO DATA NO DATA 5.36E+06 ,
- n. m v.. '
NP 239 2.56 N0f 0"L.84E+02 1.29E+02 F
ATA0 011 NO DATA 5.31E+02 NO DATA 1.36E+07 I Nl i
- nrem/yr por pCi/m 3
- 3 75x105 t
I CLINTON 1 3-124 Rev. 6-12/89 l
CPS 0DCM i
I 1
TABLE 3.5-29 i
VEGETATION PATHWAY FACTORS -RY aij (TEEN) i j
2 (m mrem /yr per NCi/ cec)
DL%': EQllI LIVER T.P.0DY TIM 01D l'IDNEY llTG GI LLI I gvt . . . .n .
H3 NO DATA 2.59E+03* 2.59E703* 2.59E403* 2.59E40* 27DE+03* 2'.59E+03*
C 14 NA 24 1.45E+06* 2.91E+0$*
2.40E+0$** 2.40E+05
- 2. 91E4.0M . J2. 94$ 0M , f . 91E+ 0$*I , ,2 . 9 4+Dk*., p 2. 91 E+05
- 2.40E+0$j 0$.40R$0A c,$.40Ef0A 3.J.40E,+q$33, j 2.40E+05 l
l me pn m t on. w c .n ,er ?
P 32 1.61E409 9.97E+07 6.24E+07 NO~UATA 80 VAT F* N0' DATA 1.35E+08 i CR 51 NO DATA NO DATA 6.12E404 3. 40Ef 0Je c , (1. 34 0,4D4n .8. 74 E+04 1.03E+07 MN 54 NO DATA 4.54E+08 9.01E+07 NO DATAjgg ,(1.36,E31o 0 NO DATA 9.32E408 !
m t n - > -
MN 56 NO DATA 1.43E+01 2,54E+00 NO DATA 1781I401 NO DATA ~-~'9.41E402 !
FE 55 3.26E+08 2.31E+08 5.39E+07 NO DATA NO DATA,, 1.46E+08- 1.00E+08 FE 59 1.79E+08 4.18E408 1.61E+08 NO DATA NO DATA 9.88E+08 l
,1. 3 2 E+ 08, j I
CO 58 NO DATA 4.36E407 1.01E408 NO DATA NO DATA NO DATA 6.02E+08 !
CO 60 NO DATA 2.49E+08 5.60E+08 NO DATA NO DATA No DATA 3.24E+09 .
NI 63 1.61E+10 1.14E+09 5.46E+0B NO DATA NO DATA NO DATA , 1.81E408 !
NI 65 5.73E+01 ~7.32E+00 3.34E400 NO DATA NO DATA NO DATA ~3.97E+02 :
CU 64 NO DATA 8.28E+03 3.90E+03 NO DATA 2.10E+04 NO DATA 6.42E405 ,
ZN 65 4.23E+08 1.47E+09 6.86E+08 NO DATA 9.41E+08 NO DATA 6.23E+08 :
. (
ZN 69 5.04E 06 9.60E 06 6.72E 07 NO DATA 6.28E 06 NO DATA 1;77E 05 I BR 83 NO DATA NO DATA 2.93E+00 NO DATA NO DATA NO DATA,9,g NO DATA !
BR 84 NO DATA NO DATA 2.31E 11 NO DATA NO DATA NO DATAgy,7 NO DATA i
BR 85 NO DATA NO DATA NO DATA NO DATA NO DATA 'NO DATA NO DATA ;
RB 86 NO DATA 2.72E+08 1.28E+08 NO DATA NO DATA ,,,)10 DATA g ,; 4.02E+07 i RB 88 NO DATA 3.17E 22 1.69E-22 NO DATA NO DATA NO DATA 2.72E 29 i
RB-89 NO DATA 3.56E 26 2.52E 26 NO DATA NO DATA NO DATA 5.45E 35 SR 89 1.51E+10 NO DATA 4. 32E4 08 NO DATA NO DATA NO DATA 1.80E+09 i SR 90 7.50E+11 NO DATA 1.85E+11 NO DATA NO DATA NO DATA 2.11E+10 ;
SR 91 2.82E+05 NO DATA 1.12E+04 NO DATA NO DATA NO DATA 1.28E+06 }
SR 92- 4.00E+02 NO DATA 1.70E+01 NO DATA NO DATA NO DATA 1.02E+04 !
Y 90 1.2SE+04 NO DATA 3.37E402 NO DATA NO DATA NO DATA 1.03E+08 I
CLINTON 1 3 US Rev.5-2/89 f
f
CPS 0DCM TAntI 3.5-29 (continued)
VEGETATION PATHWAV FACTORS -R (TEEN)
(m2 mrom/yr per #Ci/sec)
ORGAN! fd E LIVER T. BODY THYROID }1DEX 1, lei GI LLI l ISOTOPE Y 91m 5.04E 09 NO DATA 1.93E 10 NO DATA NO DATA NO DATA 2.38E 07 i Y 91 7.84E+06 NO DATA 2.10E605 NO DATA NO DATA NO DATA 3. 21E4 09 Y 92 8.60E 01 NO DATA 2.49E 02 NO DATA NO DATA NO DATA 2.36E+04 Y 93 1.58E+02 NO DATA 4.34E+00 NO DATA NO DATA NO DATA 4.83E406 ZR 95 1.73E+06 5.46E+05 3.75E+05 No DATA 8.02E+05 NO DATA 1.26E+09 ZR 97 3.10E+02 6.14E+01 2.83E+01 tio DATA 9.31E+01 No DATA 1,66E+07 13B 95 1.92E+05 1.07E+05 5.86E+04 NO DATA 1.03E+05 NO DATA 4.56E+08 HO 99 110 DATA 5.64E+06 1.08E+06 NO DATA 1.29E+07 110 DATA 1.01E+07 TC 99m 2.73E+00 7.61E+00 9.86E+01 No DATA 1.13E+02 4.23E+00 5.00E+03 TC 101 8.02E 31 1.14E 30 1.12E 29 No DATA 2.06E 29 6.95E 31 1.95E 37 RU 103 6.81E+06 NO DATA 2.91E+06 NO DATA 2,40E+07 NO DATA 5.69E+08 RU 105 4.97E+01 NO DATA 1.93E+01 NO DATA 6.27E+02 NO DATA 4.01E+04 RU 106 3.09E+08 NO DATA 3.89E+07 NO DATA 5.95E+08 NO DATA 1.48E+10 A0-110m 1.$1E+07 1.43E+07 S 72E+06 NO DATA 2.73E+07 NO DATA 4.03E+09 TE 125m 1.49E+08 5.35E+07 1.99E+07 4.15E+07 NO DATA NO DATA 4.38E+08 TE 127m 5.52E+08 l'. 96 E+08 6.57E+07 1.31E+08 2.24E+09- NO DATA 1,38E+09 TE 127 5. 40 E,-03 1.92E+03 1.16E+03 3.73E+03 2.19E+04 NO DATA 4.17E+05 TE 129m 3.60E+08 1.34E+08 5.70E+07 1.16E+08 1.51E+09 No DATA 1.35E+09 TE 129 7.13E 04 2.66E-04 1.73E 04 5.09E 04 2.99E 03 NO DATA 3.90E 03 TE-131m 8.44E+05 4.05E+05 3.38E+05 6.09E+05 4.22E+06 NO DATA 3.25E+07 TE 131 1.41E 15 5.80E 16 4.39E 16 1.08E 15 6.15E 15- NO DATA 1.15E 16 TE 132 3.91E+06 2.48E+06 2.33E+06 2.61E+06 2.37E+07 UO DATA 7. 07 '
I 130 3.50E+05 1.01E+06 4.0$E+05 8.26E+07 1.56E+06 NO DATA 7. c.+0 5 I 131 7.66E+07 1.07E+08 5.76E+07 3.13E+10 1.85E+08 NO DATA 2.12E+07 1 132 5.19E+01 1.36E+02 4.87E+01 4.58E+03 2.14E+02 NO DATA 5.91E+01 1-133 1.93E+06 3.28E+06 1.00E+06 4.58E+08 5.75E+06 NO DATA 2.48E+06 1-134 8.44E 05 2.24E 04 8.03E 05 3.73E 03 3.53E 04 NO DATA 2.95E 06 vLINTON 1 3 126 Rev.5-2/89
. ~ _ _ _ - _ . _ . _ _ _ . _ . . . . _ _ . _ . - _ _ . . . _ . _ . , . . _ _ . . . _ _ _ _ _ _ _ _ _ _--_ -,.._, _ .- _
- ,._ __ . . _ _______ _ _ ____ _ __ _ _.._ _________m.____ __ ,
CPS ODCri -
TABLE 3.5-29 (continued)
VEGETATION PATINAY FACTORS - R (TEEli)
(m2 mrem /yr per 4Ci/sec)
ORGAth M LIVER T.PODY THYROID FIDNEY IM 01-LLI ISOTOPE 1-135 3.53E+04 9.09E+04 3.37E+04 5.85E+06 1.44E+05 NO DATA 1.01E+05 CS 134 7.10E+09 1.67E+10 7.75E+09 NO DATA 5.31E+09 2.03E+09 2.08E+08 CS 136 4.37E+07 1.72E+08 1.16E+08 NO DATA 9.37E+07 1.48E+07 1.3BE+07 CS 137 1.01E+10 1.35E+10 4.70E+09 NO DATA 4.59E+09 1.78E+09 1.92E+08 CS 138 3.54E-11 6,80E 11 3.40E 1 NO DATA 5.02E 11 5.84E 12 3.08E-14 BA 139 2 70E*02 1.90E 05 7.86E. NO DATA 1.79E 05 1.31E 05 2.41E 01
~
EA 140 1.38E408 1.61Lrva o.89E+06 NO DATA 5.73E+04 1.14E+05 2.13E+08 BA-141 1.11E-21 8.27E 25 3.70E 23 NO DATA 7.67E 25 5.66E 25 2.36E 27 BA 142 5.35E 39 5.35E-42 3.29E 40 NO DATA 4.53E 42 3.56E 42 1.64E 50 LA 140 1.80E+03 8.86E+02 2.36E+02 NO DATA NO DATA !!O DATA 5.09E+07 1A 142 -1.88E 04 8.35E 05 2.08E-05 NO DATA NO DATA NO DATA 2.54E+00 CE 141 2.83E+05 1.89E+05 2.17E+04 No DATA 8.90E+04 NO DATA 5.41E+08 CE 143 9.33E+02 6.79E+05 7.58E+01 NO DATA 3.04E+02 NO DATA 2.04E+07 CE 144 5.29E+07 -2.19E+07 2.84E406 NO DATA 1.31E+07 NO DATA 1.33E+10 PR 143 7.00E+04 2.79E+04 3.4SE+03 NO DATA 1.62E+04 NO PR 143 7.00E+0 PR 144 3.04E 26 1.24E 26 1.54E 27 NO DATA 7.14E 27 NO DATA 3.35E 29 ND 147 3.62E+04 3.94E+04 2.36E+03 NO DATA 2.31E+04 NO DATA 1.42E+08-U 187 3.53E+04 2.88E+04 1.01E+04 NO DATA NO DATA NO DATA 7.79E+06 NP 239 1.39E+03 1.31E+02 7.26E+01 NO DATA 4.10E+02 NO DATA 2.10E+07
- mrom/yr per pCi f.a 3
- 2.40x105 CLINTON-1 3-127 Rev.5 2/89 l
-__ __- . . -.- ~._ _ - - -. _ _ _ .- -.._...~ - . - - .~ .
CPS 0DCM l
TABLE 3.5-30 VEGETATION PATHWAY FACTORS - RV alj (ADULT) 2 (m mrom/yr per 4Ci/sec)
ORGANt EQtiE LIVER T. BODY THYROID KIDNEY Lpl{G Gl LL1 ISOTOPE H3 NO DATA 2.26E+03* 2.26E+03* 2.26E+03* 2.26E+03* 2.26E+03* 2.26E+03*
C-14 8.97E+05* 1.79E+05* 1.79E+05* 1.79E+05* 1.79E+0$* 1.79E+05* 1.79E+05*
NA 24 2.71E+05** 2.71E+0S 2,71Ff05 2.71E+05 2.71E+05 2.71E+05 2.71E+05 P 32 1.40E+09 8.70E+07 5.41E+07 NO DATA NO DATA NO DATA 1.57E+08 CR 51 NO DATA NO DATA 4.60E+04 2.75E+04 1.01E+04 6.11E+04 1.16E+07 MN 54 NO DATA 3.13E+08 5.96E+07 NO DATA 9.30E+07 NO DATA 9,58E+08 MN 56 NO DATA 1.59E+01 2.82E+00 NO DATA 2.01E+01 NO DATA 5.06E+02 FE 55 2.10E+08 1.45E+08 3.38E+07 No DATA NO DATA 8.10E+07 8.33E+07 FE 59 1.26E+08 2.96E+08 1.13E+08 NO DATA lio DATA 8.27E+07 9.86E+08 CO-58 NO DATA 3.08E+07 6.90E+07 NO DATA NO DATA NO DATA 6.24E+08 CO 60 NO DATA 1.67E+08 3.69E+08 NO DATA NO DATA NO DATA 3.14E+09
, . NI 63. 1.04E+10 7.21E+08 L49E+08 NO DATA NO DATA NO DATA 1.50E+0F NI 65 6.18E+01 8.03E+00 3.66E+00 NO DATA NO DATA NO DATA 2.04E+02 CU 64 NO DATA 9.16E+03 4 .- 3 0 E+03 NO DATA 2.11E+04 NO DATA 7.81E+05 ZN-65 3.18E+08 1.01E+09 4.57E+08 NO DATA 6.76E+08 NO DATA 6.36E+08
-ZN 69 5.39E 06 1.03E 05 7.17E 07 NO DATA 6.69E-06 NO-DATA 1.55E 06 BR-83 NO DATA NO DATA 3.13E+00 NO DATA NO DATA NO DATA 4.50E+00 BR 84 NO DATA NO DATA 2.54E 11 NO DATA NO DATA NO DATA 1.99E 16 BR 85 NO DATA NO DATA NO DATA NO DATA NO DATA NO DATA NO DATA RB 86 NO DATA 2.19E+08 1.02E+08 NO DATA NO DATA NO DATA 4.33E+07 RB 88 NO DATA 3.43E-22 1.82E 22 NO DATA NO DATA- NO DATA 4.74E 33 <
RB-89 NO DATA 3.96E-26 2.79E 26 NO DATA NO DATA NO DATA 2.30E 39 ;
SR-89 9.95E+09 NO DATA 2.86E+08 NO DATA NO DATA NO DATA 1,60E+09 *
, SR 90 6,04E+11 NO-DATA 1.48E+11 NO DATA -NO DATA- -NO DATA 1.75E+10 i SR 91 3.02E+05 NO DATA 1.22E+04 NO DATA NO DATA NO DATA 1.44E+06 SR 92- 4.28E+02 NO DATA 1.85E+01 NO DATA NO DATA NO DATA 8.48E+03 Y-90 1.33E+04 NO DATA 3.56E+02 NO DATA NO DATA NO DATA 1.41E+08 e
CLINTON-1_ 3 128 Rev.5-2/89 i
....m--__-....- - - . - -1,~ . - - - _ - , . _ _ . . . _ __ _ , _ ,
m.___________.____ _ _ . . _ _ _ _
CPS 0DCM TACLE 3.5-30 (cortinued) ,
VEGETATION PATHWAY FACTORS -R Y (ADULT)
(m2 = rem /yr per pci/sec)
OPGMh f.EE LIVER T. BODY THYROID 1:IDNEY ILiq fd.1L1 ISOTOPE Y 91m 5.42E 09 NO DATA 2.10E 10 NO DATA NO DATA NO DATA 1.59E 38 Y-91 5.12E+06 NO DATA 1.37E+05 NO DATA NO DATA NO DATA 2.82E+09 Y 92 9.13E 01 NO DATA 2.67E 02 NO DATA NO DATA NO DATA 1.60E+04 '
Y 93 1.69E+02 NO DATA 4.65E+00 NO DATA NO DATA NO DATA 5.35E+06 ZR 95 1.18E+06 3.79E+0) 2.56E+05 NO DATA 5.94E+05 NO DATA 1.20E+09 j ZR 97 3.36E+02 6.78E+01 3.10E+01 NO DATA 1.02E+02 NO DATA 2.10E+07 ;
. NB 95 1.42E+05 7.91E+04 4.25E+04 NO DATA 7.82E+04 NO DATA 4.80E+0S MO 99 NO DATA 6.12E+06 1.16E+06 NO DATA 1.39E+07 NO DATA 1.42E+07 TC 99m 3.09E+00 8,73E+00 1.11E+02 NO DATA 1.33E+02 4.28E+00 5.16E+03 ,
I TC 101 8.62E 31 1.24E 30 1.22E 29 NO DATA 2.24E-29 6.35E 31 3.73E 42 l RU 103 4.77E+06 NO DATA 2.06E+06 NO DATA 1.82E+07 NO DATA 5.57E+08 :
RU 105 5.36E+01 NO DATA 2.12E+01 NO DATA 6.93E+02 NO DATA 3.28E+04 c ..# ,
RU 106 1.93E+08 NO DATA 2.44E+07 HO DATA 3.73E+08 NO DATA 1.25E+10 AC 110m 1.05E+07 9.75E+06 5.79E+06 1.92E+07 i NO DATA NO DATA 3.9CE+09 TE 125m 9.67E+07 3.51E+07 1.30E+07 2.91E+07 3.93E+08 No DATA 3.86E+08
(
TE-127m 3.49E+08 1.25E+08 4.26E+07 8.93E+07 1.42E+09 NO DATA 1.17E+09 i TE-127 5.65E+03 2.03E+03 1.22E+03 4.19E+03- 2.30E+04 NO DATA 4.46E+05 TE 129m 2.51E+08 9.35E+07 3.97E+07 8.61E+07 1.05E409 NO DATA 1.26E+09 t TE 129 7.61E 04 2.86E 04 1.85E-04 5.84E 04 3.20E 03 NO DATA 5.75E 04 TE 131m' 9.12E+05 .4.46E+05 3.72E+05 7.06E+05 4.52E+06 NO DATA 4.43E+07 i TE 131 1.51E 15 6.32E 16 4.78E 16 1.24E 15 6.63E 15 NO DATA 2.14E-16 '
TE 132 4. 31E< 06 2.79E+06 2.62E+06 3.0SE+06 2.68E+07 NO DATA 1.32E+08 j I-130 3.01E+05 1,15E+06 4.55E+05 9.77E+07 1.80E+06 NO DATA '9.93E+05 :
I 131 8.07E+07 1.15E+08 6.62E+07 3.78E+10 1.98E+08 NO DATA 3.0$E+07-I 132 . 5. 7 7 E4 01 1.54E+02 5.40E+01 5.40E+03 2.46E+02 NO DATA 2.90E+01 l I-133 2.09E+06 3.63E+06 1.11E+06 5 34E+08 6.34E+06 NO DATA 3.26E+06 I 134- 9.33E 05 2.53E 04 9.06E 05 4.39E 03 4.03E 04 NO DATA 2.21E 07 i
CLINTON 1 3 129 Rev.5-2/89
7 ,
CPS ODCM TABLE 3.5-30 (continued)
VEGETATIOli PATINAY FACTORS - RYaij( ADULT) l (m2 mrom/yr por yCi/sec) l ORGAN
- LIVER T.P00Y EOFE THYROID }'IDNEY 1&lig GI-LL1 ISOTOPE I 135 3.91E+04 1.02E+05 3.77E+04 6.75E+06 1.64E+05 NO DATA 1.16E+05 j CS 134 4.67E+09 1.11E+10 9.08E+09 P') DATA 3.59E+09 1.19E+09 1.94E+08 ;
CS-136 4.26E+07 1.68E+08 1.21E+08 NO DATA 9.35E+07 1.28E+07 1.91E+07 l I
CS-137 6.36E+09 8.70E+09 5.70E+09 NO DATA 2.95E+09 9.82E+08 1.68E+08 !
CS 138 3.84E 11 7.5 E 11 3.75r. 11 NO DATA 5.57E 11 5.50E-12 3.23E 16 I BA 139 2.86E 02 2.04E 05 8.38E 04 NO DATA 1.91E 05 1 16E 05 5.07E 02 BA 140 1.29E+08 1.62E+05 8.43E+06 NO DATA 5.50E+04 9.26E+04 2.65E+08 BA 141 1.18E 21 8.90E-25 3.98E 23 NO DATA 8.28E 25 5.05E-25 5.55E-31 BA-142 5.79E 39 5.96E 42 3.64E 40 NO DATA 5.03E 42 3.37E 42 8.16E 57 i
1A 140 1.98E+03 9.95E+02 2,63E+02 NO DATA NO DATA NO DATA 7.31E+07 1A-142 2.04E 04 9.2SE 05 2.31E 05 NO DAh NO DATA NO DATA 6.76E-01 CE-141 1.97E+05 1.33E+05 1.51E+04 NO DATA 6.19E+04 NO DATA 5.09E+08
.is.
l l
CE 143 9.98E+02 7.38E+05 8.17E+01 NO DATA 3.25E+02 NO DATA 2.76E+07 l
CE-144 3.28E+07 1.37E+07 1.76E+06 NO DATA 8.14E+06 NO DATA 1.11E+10 l
PR 143 6.26E+04 2.51E+04 3.10E+03 NO DATA 1.45E+04 NO DATA 2.74E+08 i
, PR-144 3.25E 26 1.35E 26 1.65E 27 NO DATA 7.61E 27 NO DATA 4.68E 33 l ND-147 3.33E+04 3.85E+04 2.31E+03 No DATA 2.25E+04 NO DATA 1.85E+08 W 187 3.80E+04 3.18E+04 1.11E+04 NO DATA NO DATA NO DATA 1.40E+07 l
i NP-239 1.43E+03 1.40E+02 7.74E+01 NO DATA 4.38E+02 NO DATA 2.88E+07
(
- mren/yr por pCi/m 3
- 2.71x10 6 l
l CLINTON-1 3 130 Rev.5-2/89 l
{
CPS 0DCM f
i TABLE 3.5-31 l i
GROUND PLANE PATHWAY FACTORS - RO 1
2 (m mrem /yr por 4Ci/ soc)
Total Total Total l JJotone Body Shin I t:o tone Body Skin Isotone L Jv Shin l li 3 0.00E+00 0.00E+00 Y 91 1.07E+06 1.21E+06 CS 136 1.51E+0B 1.71E+00 }
C 14 0.00E+00 0.00E400 Y 92 1.80E+05 2.14E+05 CS 137 1.30E+10 1.52E410 !
NA 24 1.20E+07* 1.39E+07 Y 93 1.83E+05 2.50E+05 CS 138 3.59E+05 4.10E405 l P 32 0.00E+00 0.00E+00 ZR 95 2.45E+08 2.85E+08 BA 139 1.06E+05 1.19E+05 '
CR-51 4.65E+06 5.50E+06 2.R 97 2.96E+06 3.44E+06 BA 140 2.0$E+07 2.35E+07 I MN 54 1.38E+09 1.62E+09 NB 95 1.37E+08 1.61E+08 BA 141 4.17E+04 4.75t+04 MN 56 9.03E+05 1.07E+06 MO 99 3.99E+06 4.62E+06 BA 142 4.49E+04 5.11E+04 f TE 55 0.00E+00 0.00E+00 TC-99m 1.84E+05 2.11E+05 LA 140 1,92E+07 2.18E+07 !
TE 59 2.73E+08 3.20E+08 TC 101 2.03E+04 2.26E+04 LA 142 7.60E+05 9.12E+05 CO 58 3.80E+08 4.45E+08 RU 103 1.0BE+08 1.26E+0B CE 141 1.37E+07 1.54E+07 !
CO-60 2.32E+10 2.73E+10 RU 105 6.36E+05 7.21E+05 CE 143 2.31E+06 2.63E+06 !
NI 63 0.00E+00 0.00E+00 RU 106 4.22E+08 5.06E+08 CE 144 6.96E+07 8.05E+07 i
~# NI-65 2.97E+05 3.45E+05 AG-110m 3.44E+09 4.01E+09 PR 143 0.00E+00 0.00E+00 CU 64 6.05E+05 6.86E+05 TE 125m 1.56E+06 2.13E+06 PR 144 1.84E+03 2.11E+03 ,
ZN 65 7.48E+08 8.60E+08 TE-127m 9.16E+04 1.08E+05 ND 147 8.39E+06 1.01E+07 {
t ZN 69 0.00E+00 0.00E+00 TE 127 2.99E+03 3.29E+03 W-187 2.35E+06 2.73E+06 (
BR 83 4.87E403 7.07E+03 TE-129m 1.98E+07 2.31E+07 NF 239 1.71E+06 1.98E+06 [
BR 84 2.03E+05 2.36E+05 TE 129 2.64E+04 3.12E+04 l;
[
BR-85 0.00E+00 0.00E+00 TE 131m 8.02E+06 9.46E+06 l RB-86 8.98E+06 1.03E+07 TE-131 2.92E+04- 3.45E+04 :
RB 88 3.31E+04 3.78E+04 TE 132 4.24E+06 4.99E+06
[
RB 89 f 1.23E+05 1.48E+05 I 130 5.50E+06 6.68E+06 SR 89 2.16E+04 2.50E+04 1 131 1.72E+07 2.09E+07 SR 90 NO DATA NO DATA I 132 1.25E+06 1.47E+06 SR-91 2.14E+06 2.51E+06 I-133 2.45E+06 2.98E+06 i SR-92 7.77E+05 8.64E+05 1-134 4.46E+05 -5.30E+05 !
3- Y 90 4.50E+03 5.31E+03 I-135 2.53E+06 2.95E+06 !
i 7
Y-91m 1.00E+05 1.16E+05 CS-134 6.87E+09 8.01E+09 *1.20 x 10 [
i CLINTON 1 3-131 Rev.5 2/89 [
i
CPS-ODCM I
4.0 COMPLIANCE WITH 40CFR190 4.1 Total Dose - Operation and Surveillance Requirements OPERATION REQUIPEMENT The annual (calendar year) dose or dose commitment to any MEMBER OF THE PUBLIC due to releases of radioactivity and to radiation from f uranium fuel cycle sources shall be limited to less than or equal to i 25 mrem to the total body or any organ, except the thyroid, which l shall be limited to less than or equal to 75 mrem. This requirement is applicable at all times. !
REMEDIAL REOUTREMENT: l
- a. With the calculated doses from the release of radioactive i materials in liquid or gaseous effluents exceeding twice the limits of S ctions 2. 4.1(a) , 2.4.1(b), 3.5.l(a), 3.5.1(b), ,
3.5.2(a), and 3.5.2(b), calculations shall be made including l direct radiation contributions from the reactor unit and from l outside storage tanks to determine whether the above limits of '
Section 4.1 have been exceeded. If such is the case, prepare and submit to the Regional Administrator of the Regional Office of the NRC within 30 day's a Special Report that defines the corrective action to be taken to reduce subsequent releases to prevent recurrence of exceeding the above limits ;
m and includes the schedule for achieving conformance with the '
above limits. This Special Report, as defined in 10 CFR Part 20.405c, shall include the following information: 1 l
l l 1. A determination of which uranium fuel cycle facilities or operations, in addition to CPS, contribute to the annual dose to the maximum exposed individual. Fuel cycle facilities I located beyond the 5-mile radius from CPS need not be l considered in this determination.
1
- 2. A determination of the maximum exposed individual.
- 3. A determination of the total annual dose to the maximum exposed individual from all existing pathways and sources of radioactivity and radiation (including direct radiation from N-16, the plant and storage facilities) using methodologies described in this manual. The direct radiation dose may be either calculated using UUREG-0133 methodolgy or measured.#
- The total body and organ doses resulting from liquid effluents will be summed with tue doses resulting from gaseous effluents (including non-noble gases) and the doses to the maximum exposed individual from other operations of the uranium fuel cycle. The effluent doses will be based l
upon releases from CPS during the previous three quarters and from the quarter in which the Section 4.1 OPERATION REQUIREMENT was exceeded.
l CT.TNTON-1 4-1 Rev.6-12/89 1
CPS-oDCM 1
- 4. It shall doccribe the levels of radiation and concentrations of radioactive material involved, and the cauce of the exposure levels or concentrations.
If the estimated dose (c) cxceeds the above limits, and if the releace condition resulting in Violation of 40 CFR Part 190 has not already been corrected, the Special Report chall include a request for a variance in accordance with the
- provisions of 40 CTR Part 190. fiubmittal of the report is considered a timely request, and a variance is granted until staff action on the request is cceplete.
SUPVET3LANcr nrOUTnrMENTS __
4.1.1 Cumulativo doce contributions from liquid and gaseous effluents chall be determined in accordance with Sections 2.4.1.1, 3.5.1.1, and 3.5.2.1, and in accordance with the methodology and parameters described or specified in this manual.
. 4.1.2 Cumulativo dose contributions from direct radiation from the reactor and from radwaste storage tanks shall be determined in accordance with the methodology and paramotors described or specified in thic manual. This requirement is applicable only under conditions set forth in the Remedial Requirement specified above (Section 4.1) .
CLINTON-1 4-2 Rev.G-12/89
r CPS-ODCM ;
5.0 RADIOLOGICAL EliVIROliME11TAL MOf1ITORIf1G PROGRAM The primary requirements for the Clinton Power St^ tion Radiological Environmental Monitoring Program (REMP) are set forth in Section 5.1 of this manual.
Supplemental REMP samples required by commitment 6 in the Environmental Report - Operating License Stage (ER-OLS) are described in Table 5.1-4 and Figures 5.0-1, 5.0-2, 5.0-3, and 5.0-4.
In addition to the required sampling program, CPS will perform supplemental periodic and long term sampling and analyses in order to better monitor the environmental exposure pathways. These ,
samples will not be listed in this manual, however, full sample 1 descriptions and results will be included in the Annual Radiological Environmental Operating Report.
Surface and drinking water samples are composited by collecting aliquots of fixed volume at fixed time intervals. This method of sampling is considered consistent with note (g) in Table 5.1 l.
l i
f i
l
~l l
I l
l l
mmm-1 5-1 Rev.6-12/89
- - . - _ . _ . . - . _ _ , . - _ . _ . _ _ _ _ ... - . _ . - _ __i
CPS-ODCM r
5.1 Monitoring Program - Operation and Surveillance Requirements OPERATION REOUIREMENT l The Radiological Environmental Monitoring Program shall be conducted j as specified in Table 5.1-1. This requirement applies at all times, ,
. REMEDIAL REOUIREMEET. ;
t
- a. With the radiological environmental monitoring program not being conducted as specified in Table 5.1-1 prepare and submit ;
to the Commission, in the Annual Radiological Environmental !
Operating Report required by Technical Specification 6.9.1.6, !
a description of the reasons for not conducting the program as !
required and the plans for preventing a recurrence. !
- b. With the level of radioactivity as the result of plant effluents in an environmental sampling medium at a specified l
. location exceeding the report levels of Tabic 5.1-2 when j averaged over any calendar quarter prepare and submit to the ;
Regional Administrator of the Regional Office of the NRC i within 30 days a Special Report that identifies the cause(s) !
for exceeding the limit (s) and defines the corrective actions l to be taken to reduce, radioactive effluents so that the ;
potential annual dose to a MEM3ER OF THE PUBLIC is less than !
the calendar year limits of Section 2.4.1, 3.5.1, and 3.5.2.
When more than one of the radionuclides in Tabic 5.1-2 are detected in the sampling medium, this report shall be submitted if. t concentration (1) + concentration (2) + .. 21.0 [
reporting level (1) reporting level (2) i dhen radionuclides other than those in Table 5.1-2 arc !
detected.and the result of plant effluents this report shall ;
be submitted if the potential annual dose *,to a MEMBER OF THE PUBLIC is equal to or greater-than the calendar year limits of Section 2.4.1, 3.5.1, and 3.5.2. This report is not required !
if the measured level of radioactivity was not the result of -
plant effluents; however, in such an event, the condition .
shall be reported and described in the Annual Radiological Environmental Operating Report.
- c. With milk or fresh leafy vegetation samples unavailable from one or more of the sample locations required by Table 5.1-1, !
identify locations for obtaining replacement samples and add <
them to the radiological environmental monitoring program j s ;
- The methodology and parameters used to estimate the potential annual l dose to a MEMBER OF THE PUBLIC shall be indicated in this report. ;
l 4 i
, CLINTON-1 5-2 Rev.6-12/89 [
i l . . _ _ _ _ _ _ __ , ~ . . _ . __ __ _ .
9 CPS-ODCM OPERATION REQUTRFMEliT fMonitorina Procraml (continued 5.1 REMEDIAL REOUTREle"5' (Continued)t '
within * .f s . The specific locations from which samplos vero .lable may then be deleted from the monitoring progt Pursuant to Technical Specification 6.9.1.7, identify the cause of the unavailability of samples and identify the now location (s) for obtaining replacement samplos in the next Somiannual Radioactive Effluent Releasc Report and ,
also include in the report a revised figuro(s) and table for this manual reflecting the new location (s). .
~
SURVETLIANCE REOUTREMENTS _
5.1.1. The radiological environmental monitoring samples shall be collected pursuant to Table 5.1-1 from-the specific locations given in Table 5.1-1 and Figures 5.0-1, 5.0-2, 5.0-3, and 5.0-4 and shall be analyzed pursuant to the requirements of Tablo 5.1-1 and the detection capabilities required by Table 5.1-3.
4 CLINTON-1= 5-3 Rev.6-12/89
M r
CPS-ODCM l
j' TABLE S.1-1 i 5' :
RADIOIDGICAL ENVIROITMENTAL liOllITORIllG PROGRAM t
j EXPOSURE PATHWAY NUlfBER OF REPRESENTATIVE SAMPLING AND AND/OR SAMPLE a TYPE AfiD FREQUENCY SAMPLES AND SAMPLE LOCATIONS COLLECTION FREOUENCY OF ANALYSIS l t
- 1. DIRECT RADIATIOlib 40 routine monitoring stations Quarterly Gamma dose either with two or more dosi- quarterly.
meters or with one instrument 3 for measuring and recording dose rate continuously, placed '
as follows:
j (1) an inner ring of stations, one in each meteorological j sector in the general area t-of the SITE BOUNDARY; SECTOR CODE- DISTANCE from station (miles) 1 i N CL-36 0.6 ,
j NNE CL-S 0.7 '
NE CL-22 0.6 ENE CL-23 0.5 i E CL-24 0.5 4- ESE CL-42 2.8 ;
SE CL-43 2.8 !
SSE CL-44 2.3 S CL-45 2.8 SSW CI,-4 6 2.8 -
SW CL-47 3.3 WSW CL-48 2.3 W CL-1 1.8 !
!" WNW CL-34 0.8
) NW CL-35 0.7 j NNW CL-63 1.3 1
i !
l r i
I CLINTON-1 5-4 l Rev.6-12/89 i
.w....- w -+,m. ...-w,_ w. ., ,-,- , , , ,, ,w-,, .. y . . - - , . , , , , , , . . - , . .--w-,, m-.,., ,m 4,,--,.r, . .-. ..-,v.., .- . .,. . , . . , , . ,_......--,,,-,,,,.,m- -,,,-...,,,,,--%,e,-,
+ 1 i
CPS-ODCM '
TABLE 5.1-1 (Continued)
RADIOLOGICAL ENVIRONMEfiTAL MONITORIfiG PROGRAM i
- . EXPOSURE PATHWAY ' NUMBER OF REPRESENTATIVE SAMPLING AND AND/OR SAMPLE a TYPE AND FREQUENCY SAMPLES AND SAMPLE LOCATIONS COLLECTION FREQUEllCY OF AtTALYSIS
- 1. DIRECT RADIATION b (2) an outer ring of stations, **,.
(Continued) one in each meteorological sector in the 6 to 8 km l (3.7 miles to.5.0 miles) l range from the sitei '
SECTOR CODE DISTAfiCE fron station (miles) i
)
i- N CL-76 4.6 i l NNE CL-77 4.5 '
NE CL-78 4.8 ENE CL-79 4.5
- E CL-53 4.3 ESE CL-54 4.6 SE CL-55 4.1
- SSE CL-56 4.1 S CL-57 4.6
} SSW CL-58 4.3 i SW CL-60 4.5
- l WSW CL-61 4.5 l W CL-80 , 4.1 WNW CL-81 4.5 :
j NW CL-51 4.4 t NNW CL-52 4.3 i !
l 4
I .
, .L , 3 l' ' I i CLINTON-1 ,' -
5-5 j 4 . .
Rev.6-12/89
e CPS-ODCM TABLE 5.1-1 (Continued)
RADIOLOGICAL EITVIROfiMEfiTAL MOfiITORIfiG PROGRAM EXPOSURE PATHWAY NUMBER OF REPRESEllTATIVE SAf1PLI!!G AllD TYPE Af1D FREQUEliCY a
AfiD/OR SAMPLE SAMPLES AllD SAMPLE LOCATIOfiS COLLECTIO!i FREOUEfiCY OF AllALYSIS
- 1. DIRECT RADIATIOliD'(3) the balance of the stations ','
(Continued) to be placed in special in-terest areas such as popu-lation centers, nearby resi-dences, schools, and in 1 or 2 areas to serve as control stations.
SECTOR CODE DISTAliCE from station (miles)
N CL-37 3.4 N CL-75 0.9 EllE CL-65 2.6 E CL-41 2.4 S (control) CL-11 16 W CL-49 3.5 W CL-74 1.9 WNW CL-64 2.1 4
s..
, .L . 'm t
CL111 TON-1 ." .
S-6 Rev.6-12/89
e 6
CPS-ODCH TABLE 5.1-1 (Continued)
RADIOLOGICAL ENVIRONMENTAL MOfiITORITIG PROGRAM EXPOSURE PATHWAY NUMBER OF REPRESEllTATIVE AND/OR SAffPLE a SAMPLING AND TYPE ATID FREQUEliCY SAMPLES AfiD SAMPLE LOCATIONS COLLECTIOff FRFOUEfiCY OF AfiALYS'S
- 2. AIRBORIIE !
i I
Radioiodine and Samples from 5 locations: !
Particulates Continuous sampler Radiolodine Canister:
- a. 3 samples from close to the operation with sample I-131 analysis weekly.
collection weekly, or 3 SITE BOUNDARY locations more frequently.if !
in different sectors of the required by dust Particulate Sampler:
j highest calculated annual loading.
average ground-level D/Q. Gross beta radioactivity
, analysis follgw;ing filter change Gamma i
isotopic analysis" of composite (by location) j quarterly. !
SECTOR CODE I
- DISTANCE from station (miles) [
NNE CL-2 !
NE 0.7 ;
CL-3 0.7 N CL-15 0.9
- b. 1 sample from the vicinity s
of a community having the highest calculated annual average ground-level D/Q.
SECTOR CODE DISTANCE from station (miles) 4 E CL-8 a 2.2 l i l
i ,
/
[
u f
CLINTON-1 5-7 !
Rev.7-2/91 ,
r 1
CPS-ODCM .
TABLE 5.1-1 (Continued) '
t RADIOLOGICAL EtiVIRONMENTAL MO!!ITORING PROGRAM i
i EXPOSURE PATHWAY NUMBER OF REPRESENTATIVE a SAMPLING AIID TYPE AtID FREQUENCY AND/OR SAMPLE SAMPLES AND SAMPLE LOCATIONS COLLECTIO!i FREOUEtiCY OF AllALYSIS j
- 2. AIRBORNE ' '
(Continued) i
- c. 1 sample from a control !
location, as for example i J 15-30 km (9.3 miles to '
18.6 miles) distant and I in the least prevalent '
wind direction C.
SECTOR CODE _DISTAriCE from station (miles)
S (control) CL-11 16
- 3. WATERBOR!iE l
- a. Surface f t
1 sample upstream Composite sample over Gamma isotopic analysis * [
1 sample downstrean 1 month period 9 monthly. Composite for tritium analysis j quarterly. :
s SECTOR CODE DISTAliCE from station (miles) ,
i- ENE (upstream) CL-91 6.1 f i SE (downstream) CL-90 0.4 I t
t i
1 CLItiTOri-1 5-8 Rev.6-12/89 [
i
CPS-ODCM I
TABLE 5.1-1 (Continued)
I EADIOLOGICAL ENVIRO!! MENTAL MONITORIliG PROGRAM _ .-
EXPOSURE PATHWAY NUMBER OF REPRESENTATIVE SAMPLING AND AND/OR SAMPLE a TYPE AND FREQUENCY SAMPLES AND SAMPLC LOCATIONS COLLECTION FREOUENCY OF ANALYSIS
- 3. WATERBORNE (Continued) '. '
- b. Ground Samples from 1 or 2 sources, Quarterly Gamma isotopic e and only if likely to be affectedh. tritium analysis I quarterly.
SECTOR CODE DISTAliCE from station (miles)
E CL-12 1.6*
ESE CL-7D 2.3 ,
- Sample location is in pump station distant from well. Well located 1.0 mile S of plant on the edge of the lake.
t
- c. Drinking 1 sample of each of 1 to 3 of Composite sample I-131 analysis on each the nearest water supplies over 2-week period 9 composite when the dose j that could be affected by its when I-131 analysis calculated for the con- L discharge.* is performed, monthly sumption of the water is composite otherwise greater than 1 mrem per year.1 Composite for
- No municipal or public drinking water st-pplies gross beta and gamma are taken from Clinton Lake or downstream for isotopic analyses" 200 miles. Drinking water for Clinton Power monthly. Composite for Station is supplied by Clinton Lake. Samples tritium analysis 3
t for this drinking water source are required by quarterly.
Table 5.1-4, item 3.
1 sample from a control location **
- No control',' location necessary.
.L , ,$
CLINTON-1 -
. , 5 - 9 .,. Rev.6-12/89
~.
6
~
CPS-ODCN >
TABLE 5.1-l'(Continued)
- RADIOLOGICAL E13VIRONMEliTAL MO!!ITORITIG PROGRAM EXPOSURE PATHWAY liUMBER OF REPRESENTATIVE a SAMPLIt3G AND TYPE A!Ib rREQUEliCY AllD/OR SAMPLE _ SAMPLES AND SAMPLE LOCATIO!!S COLLECTION FREOUEliCY OF ANALYSIS
- 3. WATERBORNE (Continued) 1 sample from downstream area Semiannually Gamma isotopic analysise
- d. Sediment semiannually.
' from with existing or potential shoreline recreational value.
SECTOR CODE DISTAtiCE from station (miles)
SE CL-7 B 2.1
- 4. IliGESTION ,
- a. Milk Samples from milking animals Semimonthly when Gamma isotopic" and in 3 locations within 5-km animals are on I-131 analysis semi-distance having the highest pasture, monthly monthly when animals dose potential. If,there are at other times are on pasture; none, then, 1 sample from monthly at other milking animals in each of 3 times.
areas between 5 to 8 km i distant from doses are -
calculated to be in greater than 1 mrem per yr. * .
i
- No milking animals within 8 km of the site were identified in the most recent annual land use survey.
a es '
, .L. , es 5-10 Rev.6-12/89 CLIITTON-1 . ,
__ -,. . . . _ . . _ _ . . . . . . , ... _ _ . _ _ _ _ _ . _ . . . . . . , _ . , , _ . _ . . _ . _ . _ _ . _ _ _ . . . _ _ _ . . . _ . . . ~ . . . . _ . _ . _ . . . _ ... _.. _ . -- . . . _ _ _
CPS-ODCM TABLE 5.1-1 (Continued)
RADIOLOGICAL ENVIRONMEliTAL MONITORIlfG PROGRAM '
EXPOSURE PATIiWAY NUMBER OF REPRESENTATIVE AND/OR SAMPLE a SAMPLING AND i SAMPLES AND SAMPLE LOCATIONS TYPE AND FREQUENCY ;
COLLECTIori FREOUENCY OF ANALYSIS !
- 4. INGESTION -
(Continued) !
i i
- a. Milk I sample from milking animals -
i (continued) at a control location, 15-30 km !
.! (9.3 miles to 18.6 miles) distant and in the least )
prevalent wind direction. .
l SECTOR CODS DISTANCE from station (miles) l USU'(control) CL-116 14 Fish and b.
I sample each of 3 important
+
Inverte- Sample in season, or Gamma isotopic analysis" brates species (such as bass, semiannually if they crappie, carp, or bluegill) are not seasonal on edible portions. '
in vicinity of plant dis- !
charge area.
SECTOR CODE !
DISTANCE from station (miles)
E CL-19 3.4 I 1, sample of same species in I areas not influenced by plant discharge. l SECTOR CODE DISTANCE from station (miles) !
i S (control) CL-105 50 -
i I
i CLINTON-1 I 5-11 Rev.6-12/89 !
,, . - - , - - ~s- .-w- ,-~.. - r -,-v - , - - ,-
4 i CPS-ODCM '
~
TABLE 5.1-1 (Continued)
RADIOLOGICAL EfiVIRONMENTAL MONITORING PROGRAM i
EXPOSURE PATHWAY NUMBER OF REPRESENTATIVE SAMPLING AfiD AND/OR SAMPLE a TYPE AND FRt.QUENCY SAMPLES AND SAMPLE LOCATIONS _ COLLECTION FREOUENCY OF ANALYSIS
\
- 4. INGESTION .
(Continued)
- i 1 c. Food 1 sample of each principal
- Products class of food products from At time of harvest 3 Gamma isotopic analysis E
! on edible portion. i any area that is irrigated t
by water in which liquid i plant t 'stes have been discharged.*
- No known usage of Salt Creek water for irrigation in DeWitt, Logan, Menard, or Cass Counties. This information is checked annually as part of the land use survey.
. Samples of 3 different kinds Monthly during Gamma isotopice and ,
i of broad leaf vegetation growing season I-131 analysis.
(such as lettuce, cabbage, and swiss chard) grown ,
nearest each of two different i offsite locations of highest predicted annual average ground-level D/Q if milk.
sampling is not performed.
SECTOR CODE DISTANCE from station (miles)
NE CL-115 0.7 N CL-117 0.9 i
1 -
i t
Rev.7-2/91 l
l CLINTON-1 5-12
. - , _ _ . . . . , . . _ . - ~ _ - ~ _ , . _ . , . _ _ . _ . . _ . - . . _ . . . . _ _ . , . . _ , . _ . - - , - _ _ _ . . . . . _ . _ - - . _ _ _ _ . _ . _ _ - - _ _ . _ . . _ . , - _ . _ , _ _n
CPS-ODCM l
' I TABLE 5.1-1 (Continued)
RADIOLOGICAL ENVIRONMENTAL MoraITORING PROGRAM i
EXPOSURE. PATHWAY IMMBER OF REPRESENTATIVE SAMPLING AND AND/OR SAMPLE a TYPE AND FREQUENCY SAMPLES AND SAMPLE LOCATIONS COLLECTION FREOUENCY OF ANALYSIS
] 4. INGESTION ~'
- (Continued)
I
- c. Food Products 1 sample of each of the similar Monthly during Gamma isotopic" and [
broad leaf vegetation grown growing season I-131 (continued) 15-30 km (9.3 miles to 18.6 -
t miles) distant in the least prevalent wind direction if i
milk sampling is not performed.
SECTOR CODE DISTANCE from station (miles)
SSE (Control) CL-114 12.5 t
. i e* j
.L A t t
CLINTott-1 *
- I
CPS-ODCM i TABLE 5.1-1 (Continued)
BAnioLoGICAL ENVIRONMENTAL MONITORING PROGRAM TABLE NOTATIONS a
Refer to NUBEG-0133, " Preparation of Radiological Effluent Tcchnical Specifications for Nuclear Power Plants," October 1978, and to Radiological Assessment Branch Technical Position, Revicion 1, November 1979. Deviations are parmitted from the required sampling i schedule if specimens are unobttinable due to hazardous conditions, seasonal unavailability, malfunction of automatic sampling equipment and other legitimate reasons. If specimens are unobtainable due
- to sanpling equ'ipment malfunction, every effort shall be made to--
complete corrective action prioi* to the end of the next sampling '
period. All deviations from the samplir.7 schedule shall be documented in the Annual Radiological Environmental Operating Report pursuant to Technical Specification 6.9.1.6. It is recognized that, at times, it may not be possible or practicable to continue to obtain samples of the media of choice at the most desired location or time. In these instances suitable alternative media and locations may be chosen for tho' particular pathway in question and apprcpriate substitutions made within 30 days in the radiological environmental monitoring program. Pursuant to Technical specification 6.9.1.7, identify the cause of the unavailability of samples for that pathway and identify the new S 's location (s) for obts.ining replacement samples in the next Semiannual .
Radioactive Effluent Release Report and also include in the report a '
revised figure (s) and table for the ODCM, reflecting the new location (s).
~
b Or: or more instruments, such as a pressurized ion chamber, for measuring and recording dose rate continuously mey be used in place of, or in addition to, integrating dor'teters. For the purposes of this .
table,_a thermoluminescent dosimeuir '.CD) is considered to be one phosphor; two or more phosphors in a packet are considered as two ort morn dosimeters. Film badges shall not be used as dosimeters for -
measuring direct radiation. The 40 stations is not an absolute .
number. The number-of direct radiation monitoring stations may be reduced according to geographical limitations; e.g., at an ocean site,
=some sectors will be over water so that the number of dosimeters may be reduced accordingly. The frequency of analysis or readout for TLD systems will depend upon the characteristics of the specific system used and should be selected to obtain optimur dose information with minimal fading. -
cThe purpose of this sample is to obtain background information. If it is not practical to establish control locations in accordance with the ..
distance and wind direction criteria, other sites that provide valid.
s background dat a may be substituted. .
4 CLINTON-1 5-14 Rev.6-12/85
CPS-ODCM TABLE S.1.1 (Continued)
- c. EADIOLOGICAlf ENVIPONMENTAL MONITORING PROGRAM TABLE NOTATIONS (Continued) d Airborne particulate sample filters shall be analyzed for gross beta radioactivity 24 hours2.777778e-4 days <br />0.00667 hours <br />3.968254e-5 weeks <br />9.132e-6 months <br /> or more after sampling to allow for radon and thoron daughter decay. If gross beta activity in air particulate samples is greater than ten times the yearly mean of control samples, gar.ma isotopic analysis shall be performed on the individual samples.
' Gamma isotopic aralysis means the identificat' .. and quantification of gamma-emitting radionuclide that may be attr uc ale to the effluents from the facility. : ,
f The " upstream sample" shall be taken at a distance beyond significant influence of the discharge. The " downstream" sample sbo.11 be taken in an area beyond but near the mixing zone. " Upstream" samples in an estuary must be taken far enough upstream to be beyond the plant influence. Salt water shall be sampled only when the receiving water is utilized for recreational activities.
9 A composite sample is one in which the quantity (aliquot) of liquid sampled is proportional to the quantity of flowing liquid (or time)
~ and in which the method of sampling employed results in a specimen that is representative of the liquid flow. In this program composite -
sample aliquots shall be collected at time intervals that are very short (e.g., hourly) relative to the compositing period (e.g.,
monthly) in order to assure obtaining a representative cample.
h Groundwater samples shall be taken when this source is tapped for .
drinking or irrigation purposes _.; areas where the hyqraulic gradient or recharge properties are suitable for atamination.
i The dose shall be calculated for the maximum organ and age group, -
using the methodology and parameters in section 2.4.2. -
I If harvest occurs more than once a year, sampling shall be performed during each discrete harvest. If harvest occurs continuously, sampling chall be monthly. Attention shall be paid to including samples of tuborous and root food products.
CTTUTnN-1 9-15 Rev.6-12/89 k
i CPS-ODCM TABLE 5.1-2 REPORTIliG LEVELS FOR RADIOACTIVITY COliCE!!TRATIOll3 Ifi EtiVIROffME!!TAL SAMPLES WATER AIRBORfiE PARTICULATE FISH MILK FOOD PRODUCTS 3
AffALYSIS (DCi/l) OR GASES (DCi/m ) (pC1/kq, wet) < ,(DCl/l) fpCi/kq, wet) l 11 - 3 20,000*
Mn-54 1,000 30,000 Fe-59 400 10,000 Co-58 1,000 30,000 Co-60 300 10,000 Zn-65 300 20,000 l Zr-iib-95 400***
I-131 2** 0.9 3 100 Cs-134 30 10 1,000 60 1,000 Cs-137 50 20 2,000 70 2,000 Ba-La-140 200*** 300 I,
- For drinking water samples. This is 40 CFR Part 141 talue. If not drinking water pathway exists, a value of 30,000 pCi/l may be used.
o*If no drinking water' pathway exists, a value of 20 pCL/1 may be used.
o** Total for parent and daughter .
,.i. '5 CLIllTOli-1 .' '
9-16 no" ^ 17 'c 0
CPS-ODCM TABLE 5.1-3 (Continued) f DETECTION FOR ENVIRONMENTAL SAMPLE ANALYSISa,b f
t TABLE NOTATIONS ,
aThis list does not mean that only these nuclides are to be considered. (
Other-peaks that are identifiable, together with those of the above nuclides, shall-also be analyzed and reported in the Annual Radiological Environmental Operating Report pursuant to Technical Specification ;
6.9.1.6. !
D Required detecbion capabilities for thermoluminescent dosimeters used f for environmental measurements shall be in accordance with the ' -
i recommendations of Regulatory Guide 4.13, Rev. 1, July 1977. ;
cThe LLD is defined, for purposes of these specifications, as the !
(
smallest concentration of radioactive material in a sample that will r yield a not count, above system background, that will be detected l with 95% probability with only 5% probability of falsely concluding >
that a blank observation represet.tu a "real" signal. .
For a particular measurement system, which may include radiochemical !
separation: -4 4.66sb -
LLD = -
~ !
E V -
2.22 Y a exp (- Aat) .
Where: i LLD is the "a priori" lower limit of detectien as defined above, as-picoeuries per unit mass or volume, ,
e sb.is the standard deviation of the background counting rate or of the counting rate of a blank sample as appropriate, as counts per ;
minute, E is the counting efficiency, as counts per disintegration, f V is the sample size in units of mass or volume, 2.22 is the number of disintegrations per minute per picocurie, -
Y is the fractional radiochemical yield, when applicable,- ..
A is (sec-}he ), and radioactive decay constant for the particular radionuclide -
t at for environmental samples is the elapsed time between sample '
collection, or end of the cumple collection period, and time of )
counting (sec).
CLINTON-1 5-18 Rev.6-12/89 '
, , , , _ . . - . _ _ _ . _ _ . - ~ - - - _ . _ . _
CPS-ODCM TABLE 5.1-3 DETECTION CAPABILITIES FOR EITVIRONMEllTAL SAMPLE ANALYSISa,b c
LOWER LIMIT OF DETECTION (LLD)
WATER AIRBORNE PARTICULATE FISII MILK FOOD PRODUCTS SECIMENT 3
ANALYSIS (DC1/1) OR GAS (DCi/m ) (pCi/ka. wet) _(pCi/l) DCi/ko. wet) (pCi/ko . d ry) '
Gross beta 4 0.01 11 - 3 2000*
Hn-54 15 130 Fe-59 30 260 Co-58,60 15 130 Zn-65 30 260 Zr-95 30 Hb-95 15 '
I-131 1** 0.07 1 60 Cs-134 15 0.05 130 15 60 150 C.4-13 7 18 0.06 150 18 80 180 Ba-140 '60 60-La-140 15 15
- If no drinking water pathway ex{sts, a value of 3000 pCi/1 may be used.
- If no dr. inking water pathway exists a value of 15 pCi/1 may be osed.
CLINTOfi-1 5-17 Rev.6-12/89
)
CPS-ODCM i
TABLE 5.1-3 (Continued)
DETECTION CAPABILITIES FOR ENVIRONMENTAL SAMPLE ANALYSISa,b TADLE NOTATIONS (Continued)
Typical values of E, V, Y, and At should be used in the calculation.
It should be recognized that the LLD is-defined as an a priori (before the fact) limit representing the capability of a measurement system and not as an a nosteriori (after the fact) limit for a particular measurement. Analyses shall be performed in such a manner that the stated LLDs will be achieved under routine conditions. Occasionally background fluctuations, unavoidable small sample sizes, the presence of interfering nuclides, or other uncontrollable circumstances may render these LLDs unachievable. In such cases, the contributing fcctors shall be identified and described in the Annual Radiological Environmental Operating Report pursuant to Technical Specification 6.9.1.6.
cam CLINTON-1 5-19 Rev.6-12/89 I
CPS-ODCM i
Table 5.1-4 ENVIRONMENTAL REPORT (OPERATING LICENSE STAGE)
TABLE 6.1-8 REOUIREMENTS i i
e REQUIRED SAMPLING REQUIRED TYPES _i EXPOSURE PATHWAY AND COLLECTION AND FREQUENCY and/or SAMPLE TYPE FREOUENCY OF ANALYSIS i 5
- 1. Direct Radiation -
Quarterly Gamma dose, quarterly :
FECTOR CODE ANCE from station (miles) ;
NNE CL-2 0.7 !
NE CL-3 0.7 :
SW CL-4 0.8 WSW CL-6 0.8 SE CL-7 2.3 E CL-8 2.2
- 2. Airborne Continuous sampler Radiciodine '
operation with Cannister:
sample collection I-131 analysis ;
weekly, composite weekly.
quarterly, i Particulate Samoler: (
Gross beta >
radioactivity ,
analysis following !
filter changes.
Gamma isotopic '
analysis of composite (by location, quarterly). -
SECTOR CODE DISTANCE from station (miles)
W CL-1 1.8 SW CL-4 0.8 WSW CL-6 0.8 ,
l SE CL-7 2.3 CLINTON-1 5-20 Rev.7-2/91
CP9-ODCM Table 5.1-4 (continued)
ENVIRONMENTAL REPORT (OPERATING LICENSE STAGE)
TABLE 6.1-8 REOUIREMENTS REQUIRED SAMPLING REQUIRED TYPES EXPOSURE PATHWAY AND COLLECTION AND FREQUENCY and/or SAMPLE TYPE FREOUENCY OF ANALYSIS
- 3. Surface Drinking Composite sample I-131 analysis Water over 2-week period on each composite when I-131 analysis for the dose is performed calculated for monthly composite the consumption otherwise, of the water if greater than 1-mrem per year.
Composite for gross beta and gamma isotopic analysis monthly.
Composite for tritium analysis quarterly.
,, SECTOR CODE DISTANCE from station (miles)
WNW CL-14 within service building
- 4. Surface Water Monthly grab Gamma isotopic sample composited analysis. Tritium quarterly by analysis on location. quarterly composite.
SECTOR CODE DISTANCE from station (miles)
ESE CL-9 2.7 ENE CL-10 5.0 SW CL-13 3.6
- 5. Bottom Sediment Semiannual grab Gamma isotopic sample. analysis.
SECTOR CODE DISTANCE from station (milesi SE CL-7C 1.3 ENE CL-10 5.0 .
i l
CLINTON-1 i 5-21 Rev.7-2/91 i l
i
CPS-ODCM Table 5.1-4 (continued)
ENVIRONMENTAL REPORT (OPERATING LICENSE STAGE)
TABLE 6.1-8 REOUIREMENTS REO" IRED SAMPLING REQUIRED TYPES EXPOSURE PATHWAY AND COLLECTION AND FREQUENCY and/or SAMPLE TYPE FREOUENCY OF ANALYSIS
- 6. Shoreline Sediment Semiannual grab Gamma isotopic sample. analysis.
SECTOR CODE DISTANCE from station (miles)
ENE CL-10 5.0
- 7. Slime or aquatic Semiannual grab Gamma isotopic vegetation sample. analysis.
(periphyton)
SECTOR CODE DISTANCE from station (miles)
SE CL-7C 1.3 ENE CL-10 5.0
- 8. Soil Every three years Gamma isotopic grab sample, analysis.
SECTOR QODE DISTANCE from station (miles)
W CL-1 1.8 NNE CL-2 0.7 NE CL-3 0.7 SW CL-4 0.8 WSW CL-6 0.8 i l' SE CL-7 2.3 E CL-8 2.2 S CL-11 16 E CL-94 0.6 >
t t
lCLINTON-1 5-22 Rev.7-2/91
CPS-ODCM Table 5.1-4 (continued)
ENVIRONMENTAL REPORT (OPERATING LICENSE STAGE)
IABLE 6.1-8 REOUTREMENTS REQUIRED SAMPLING REQUIRED TYPES EXPOSURE PATHWAY AND COLLECTION AND FREQUENCY and/or SAMPLE TYPE FREOUENCY OF ANALYSIS
- 9. Ground Water Biweekly I-131 - biweekly Grab Gamma isotopic analysis and Gross beta analysis -
monthly.
Tritium analpsis -
quarterly composite of monthly.
SECTOR CODE DISTANCE from station (miles)
E CL-12 1.6*
ESE CL-7D 2.3 Sample location is in pump station distant from well. Well located
, _ 1.0 mile S of plant on edge of lake.
CLINTON-1 5-23 Rev.6-12/89
- CPS-ODCM 1
-t t
5.2- Land'Use Census - Operation and Surveillance Requirements !
OPERATION REOUIREMENT !
1 A land-use census shall be conducted and shall identify within a j distance of 8 km-(5 miles) the location.in each of-the 16. !
meteorological sectors of the nearest milk animal,-the nearest i residence and the nearest garden" of greater than 50 m2 (500 ft )
2 q
producing' broad leaf vegetation. For elevated or mixed-mode i releases as defined _in Regulatory Guide 1.111, Revision 1, July l 1977, the land use consas shall also identify within a' distance of 5 j km (3 miles) the location in each of the 16 meteorological sectors j of all milk animals and all gardens of greater than 50 m d producing j broad leaf vegetation. This requirement applies at all times.
REMEDIAL REOUTREMENT: . .. 3 l
- a. With a land use census identifying a location (s) that yields a j calculated dose or dose commitment greater than the values y currently being calculabad in Section 3.5.2.1, identify the =!
now location (s) in the next Semiannual Radioactive Effluent -i Release Report, pursuant to Technical Specification 6.9.1.7. !
5
- b. With a land-use census identifying a location (s) that yields a j
, calculated dose or dose commitment (via the same exposure l pathway) 20 percent greater than at a location from which !
samples are currently being obtained in accordance with !
Section 5.1, add the new location (s) to the radiological i n -, environmental monitoring program within'30. days. The sampling .'l location (s), _ excluding the control station location, having .,
the lowest calculated dose or dose commitment (s), via the same -l exposure pathway, may be deleted from this monitoring-program- l after_ October 31 of the year in which this land use census was ,1 conducted. Pursuant to Technical Specification 6.9.1.7, identify the new location (s) in the next Semiannual i Radioactive Effluent Release Report and also include in the report a revised figure (s) and table for this manual .C reflecting the new location (s). ,
?
- Broad Icaf vegetation sampling of1at least'three different1 kinds of vegetation may-be. performed at the site boundary in eacn of two-different direction sectors with the highest predicted D/Qs'in lieu !
of the-garden census._ Specifications for broad leaf vegetation -
sampling in Table 5.1-1.4c shall be followed, including analysis of. }
control samples. .,
s 7
~
l l-p '
i I
i
, CLINTON-1 5-24 Rev.6-12/89 i t
f
-. . _. - . . - . = . . _ _ .
CPS-ODCM SURVEILLANCE REOUIREMENTS 5.2.1 'The-land use census shall be-conducted during the growing season at least once per 12 months using that information that will provide the best results, such as by a door-to-door survey, aerial survey, or by consulting local agriculture authorities. The results of the land use census shall be included in the Annual Radiological
, Environmental Operating Report pursuant to Technical Specification 6.9.1.6.
- 4
'R-k M .T N'T'N- 1 1 5-25 Rev.6-12/89 l l
l
' CPS-ODCM
- 5. 3' INTERLABORATORY COMPARISON-PROGRAM All' analyses'for CPS Radiological Environmental ~ Monitoring Program are performed by Teledyne Isotopes Midwest Laboratories (TIML) located in Northbrook, Illinois.
_ TeledyneLIsotopes Midwest Laboratory (formerly Hazleton
~ Environmental Sciences).has participated'in interlaboratory '
comparison-(crosscheck) programs since the formulation of_its quality control program in December 1971. These programs have been operated by agencies which supply environmental-type samples (e.g.,
milk or water) containing concentrations of radionuclides known to
-the-issuing agency but not to the participant laboratories. The purpose of such a program is to-provide an independent check on the laboratory's analytical. procedures and to alert it to any possible -
problems.
g
^
Participant laboratories measure the concentrations of specifie'd radionuclides and report them to the issuing. agency. Several~ months later, the agency reports the known values to the participant laboratories ~and specifies the range the results should fall within.
Results consistently higher or lower than the known values and results outside the specified ranges indicate a need to check the instruments or procedures used.
If_the results of a determination in the EPA-crosscheck program.are outside the control-limits specified by the-EPA, CPS will require
- P" TIML to investigate the cause of the problem and take steps to .
correct 11t. The results of this investigation and corrective action shall.be includsd in-the Annual Radiological Environmental Operating Report.
Operation 1and Surveillance Requirements for the Interlaboratory .
Comparison Program are prescribed _in Section 5.3.1 (which follows).
- 7
.~
i
.CLINTON-1 5-26 Rev.6-12/89.
s
- - - - . . , . . , , , . . - ~ _ . . , m, , _ . _ . - . . _ , , -- ,
CPS-ODCM 5.3.1 Interlaboratory Comparison Program - Operation and Surveillance Requirements OPERATION REOUIREMENT Analyses shall be performed on all radioactive materials, supplied as part of an Interlaboratory Comparison Program that has been approved by the Commission, that correspond to samples required by Table 5.1-1. This requirement applies at all times.
REMEDIAL REOUIREMENT:
- a. With analyses not being performed as required above, report the corrective actions taken to prevent a recurrence to the Commission in the Annual Radiological Environmental Operating Report pursuant to Technical Specification 6.9.1.6.
SURVEILLANCE REQUIREMENTS 5.3.1.3 The Interlaboratory Comparison Program is described in Section 5.3. A summary of the results obtained as part of the above required Interlaboratory Comparison Program shall be included in the Annual Radiological Environmental Operating Report pursuant to Technical Specification 6.9.1.6.
l l
l i
CLINTON-1 5-27 Rev.6-12/89 j l
O.- O k- 4x~ s A w , . ~ - 6 4m- .,, L. m be-e.e 4*6 L e -*21 W 4 A& n CPS-ODCM-TIGURE 5.0 REMP LOCATIONS WITHIN 1 MILE OF CPS f
N 117 15 s
75 ,
21
$ t, 36 %
'. /] 1gv @ 5
$1 115 l 35 - gg I 'v / -
N s4 Sj 23 CLINTON E
- . 1 LMe ,
oo )
920 (b
)
i l 93
, as . 16 as i :'
30 Ito 29 28 27 Y\ '
. . 87 k7 .,.
i e q%. , ,,
1 r=#
[ #
- 1. _
~
- l. 1 CLINTON-1 5-28 Rev.7-2/91 1.
F l CPS-ODCM j FIGURE 5.0-2 REMP-LOCATIONS 1-2 MILES FROM CPS N
62 G3 ILL'RT 54 f I CLINTON 74 LAKE p la i '
/
vp CuINTON 7C LAKE g l '
CLINTON-1 5-29 Rev.6-12/89
.___, .. . . . . . . . ~ . . . -. . . - . . . . - . , . . _ _ . _ - . . . _ - _ - _ . . . - - . _ .
CPS-CDCM.
-FIGURE 5.0-3 REMP LOCATIONS 2-5 MILES PROM CPS N
76 eg 52 ,
/
51
%)as 39
, 78 (2) g 3 40 l
81 j ,
50 05 y1 ,
{0, .
f BIRF BECK
, s.
65 7
t
/4l r<
,} %
.u bp[
- j
/
I ' 53 54
[ /' 54 y.7 7 u- [ )g htflM ' . rf, "g.a[-?. 'QI 61 A7 -i' '
3 6 Y4 4I d) j
.AN=, . / 55 ,
60 SALT
^
/ 59 @ LANE
'D WELDON M-7
- 56 -
N /
CLINTON-1 S-30 Rev.7-2/91
.. .m . . . . . _ . . _ _ . _ . . .
CPS-ODCM FIGURE 5.0-4 REMP LOCATIONS GREATER THAN 5 MILES FROM CPS
-s 8 .
l <<h Acu p.4L y - kh Tm 55 i
'J .I -
cij 5t #4 g
MORTONj ,' EVER E: N g
/ ~
\ 2 NORMA 47 4 r' 6, i
l l l t
, LOCMINGT0r s a 57
/-> .- _
g f,- .- 1 4 Q '#
Q ANTOI ."
( s -
' 55 -
~
' r y
__ 73 2 f
_ INCL N CLINTON / .
) f*? .- 'e ct2NTON 1 _ _ _,
/ - . 3 g HAMPAIGN D I ~~ ~
, gg .
-~ #
l E
oc'cYTun g.N E* y DECATUR SPRIWIELD cuen
M3
~p V L.D> _
45 0' l _s'
\ '~'
W1rvittr' y - f --
i 105 '-
l %. N_3 -
l I
CLINTON-1 5-31 Rev.7-2/91
. . ._ . _-. _ = _ - _ . ___ _ ___ _. _ _ .-_ _ _ _ .. - _ . _
CPS-ODCM !
t t
6.0 -BASEA FOR OPERATION AND SURVEILLANCE REOUIREMENTS 6.1 General Operation and Surveillance Recuirements j
The requirements of Sections 1.2-and 1.3 provide general :
requirements applicable-to each of the. Operation Requirements and .{
Surveillance Requirements specified within Sections 2.0 through 5.0. j 1.2.1 This requirement is provided to emphasize when each Operation l Requiremert is applicable and when the associated REMEDIAL {
REQUIREMENT should be met.
l 1.2.2 This requirement defines those conditions necessary to j constitute compliance with the terms of an individual Operation '
-Requirement an'd associated REMEDIAL REQUIREMENT.
1.3.1 This requirement provides that surveillance activities, j necessary to ensure the-Operation Requirements are met, will be !
-performed-during the_ conditions for which the Operation Requirements l are applicable. Some surveillance activities may be required to be i performed without regard.to the applicable conditions specified in i
.the-associated Operation Requirement. l
)
1.3.2 The provisions of this requirement provide allowable l tolerances for performing surveillance activities beyond those !
specified in- the nominal surveillance interval. These tolerances i are necessary to provide operational flexibility because of j scheduling and performance considerations. The phrase "at least" j associated with a surveillance frequency does not negate this ;
allowable tolerance; instead, it permits the more frequent !
performance of surveillance activities, j t
The tolerance values,-taken either individually or consecutively -l over three test intervals,'are sufficiently restrictive to-ensure j that the reliability associated with the surveillance activity--is !
.not:significantly degraded beyond that obtained from the nominal specified interval.
1.3.3 .The-provisions of this require ant set forth.the criteria for j determination of compliance with thes 'ERABILITY requirements of the s Operation Requirements. - Under these criteria, equipment,. systems' ,
-or: components are assumed to be OPERABLE if the associated-survaillance activities have been satisfactorily performed within the specified time interval. Nothing in this provision is to be.
construed ' as- defining equipment, systems or components OPERABLI, j
when such. items are found or known to be inoperable although still meeting -the Surveillance Requirements, j i
l l
i i
i CLINTON-1 6-1 Rev.6-12/89 !
t
CPS-ODCM !
1.3.4 This requirement ensures that surveillance activities i associated with a Operation Requirement have been performed within the specified time interval prior to entry into a specified system i operating mode. The intent of this provision is to ensure that !
surveillance activities have been ' satisfactorily demonstrated on a l current basis as required to meet the OPERABILITY requirements of the Operation Requirement.
Under the terms of this requirement, for example, during initial I plant startup or following extended plant outage, the applicable surveillance activities must be performed within the stated surveillance interval prior to placing or returning the system or equipment into OPERABLE status. ;
)
6.2 Monitorine' Instrumentation '
Section 2.7: Radicabtive Licuid Effluent Monitorina Instrumentation i The radioactive liquid effluent instrumentation is provided to monitor and control, as applicable, the releases of radioactive materials in liquid effluents during actual or potential releases of l
liquid effluents. The alarm / trip setpoints for these instruments ,
shall be calculated and adjusted in accordance with the methodology #
and parameters in this manual to ensure that the alarm / trip will occur prior to exceeding the limits of 10 CFR Part 20. The -
OPERABILITY and use of this instrumentation is consistent with the requirements of General Design Criteria 60, 63 and 64 of Appendix A to 20 CFR Part 50.
'i Section 3,9,1: Offcas Radiation Monitorina Instrumentation The OPERABILITY of the radiation monitoring instrumentation ensures that; (1) the-radiation levels are continually measured in the areas , '
served by the individual channels; (2) the alarm or automatic action is initiated when the radiation level t2ip setpoint is exceededt and ;
(3) sufficient information is available on selected plant parameters '
to monitor and assess these variables following an accident. .This capability is consistent with 10 CFR Part 50, Appendix A, General Design Criteria 19, 60, 61, 63 and 64. ,
r CLINTON-1 6-2 Rev.6-12/89 .
CPS-ODCH j l
l Seccion 3.9.2: Radioactive Gaseous Effluent Monitorina Instrumentation i i
The radioactive gaseous effluent instrumentation is provided to monitor and control, as applicable, the release of radioactive materials in gaseous effluents during actual or potential releases of gaseous effluents. The alarm / trip setpoints for these instruments shall be calculated and adjusted in accordance with the methodology and parameters in this manual to ensure that the alarm / trip will occur prior to exceeding the limits of 10 CFR Part
- 20. The OPERABILITY and use of this instrumentation is consistent with the requirements of General Design Criteria 60, 63 and 64 of Appendix A to 10 CFR Part 50. The sensitivity of any noble gas activity monitors used to show compliance with the gaseous effluent release requirements of Section 3 5.1 shall be such that r concentrations as low as 1 x 10-6 pCi/ml are measurable. '
l 6.3 Radioactive Effluents 6.3.1 Licuid Effluents l
Section 2.3.1: Licuid Effluent Concentration l
This requirement is provided to ensure that the concentration of l radioactive materials released in liquid waste effluents to UNRESTRICTED AREAS will be less than the concentration levels specified in 10 CFR Part 20, Appendix B, Table II, Column 2. This ,
limitation provides additional assurance that the levels of
. radioactive materials in bodies of water in UNRESTRICTED AREAS will result in exposures within (1) the Section II.A design objectives of Appendix 1, 10 CFR Part 50, to a MEMBER OF THE PUBLIC.and (2) the limits of 10 CFR Part 20.106(e) to the population.- The
- concentration limit for dissolved or entrained noble gases is based upon the assumption that Xe-135 is the controlling radioisotope and its MPC in air (submersion) was converted to an equivalent
- 5-concentration in water using the methods described in International j Commission on Radiological Protection (ICRP) publication 2.
This requirement applies to the release of radioactive materials in liquid offluents from the site.
The required detection capabilities for radioactive materials in liquid waste samples are tabulated in terms of the lower limits of l detection (LLDs). Detailed discussion of the LLD, and other -
detection limits can be found in Currie, L. A., " Lower Limit of Detection: Definition and Elaboration of a Proposed Position for Radiological Effluent and Environmental Measurements," NUREG/CR-4007 (September 1984), and in the HASL Procedures Manual, HASL-300
_(revised annually). -
CLINTON-1 6-3 Rev.6-12/89
CPS-ODCM Section 2.4.1: 10CFR50, Annendix I Release Rate Limits This requirement is provided to implement the requirements of Sections II.A, III.A and IV.A of Appendix I, 10 CFR Part 50. She Limiting Condition for Operation implements the guides set forth in Section II.A of Appendix I. The ACTION statements provide the required operating flexibility and at the same time implement the guides set forth in Section IV. A of Appendix I to assure that the releases of radioactive material in liquid effluents to UNRESTRICTED AREAS will be kept "as low as is reasonably achievable." Also, for fresh water sites with drinking wate supplies that can be potentially affected by plant operat.vns, there is reasonable assurance that the operation of the facility will not result in radionucli_de concentrations in the finished drinking water that are in excess of the requirements of 40 CFR Part 141. The dose-.
calculation methodology and parameters in this manual implement the requirements in Section III.A of Appendix I that conformance with.
the guides of Appendix I be shown by calculational procedures based-on models and data, such that the actual exposure of a MEMBER OF THE PUBLIC through appropriate pathways is unlikely to be substantially underastimated. The equations specified in this manual for calculating the doses due to the actual release rates of radioactive-materials in liquid effluents are consistent with the methodology '
provided in Regulatory Guide' 1.109, "CElculation of Annual Doses to Man from Routine Releases of Reactor Effluents for the Purpose of
, Evaluating Compliance with 10 CFR Part 50, Appendix I," Revision 1, October 1977 and Regulatory Guide 1.113, " Estimating Aquatic .
Dispersion of Effluents from Accidental and Routine Reactor Releases "'
for the Purpose of Implementing Appendix I," April 1977.
This requirement applies to the release of radioactive materials in liquid effluents from the one reactor unit on the site.
Section 2.5.1: Licuid Radwaste Treatment System The OPERABILITY of the liquid radwaste treatment system ensures that this system will be available for use whenever liquid effluents require treatment prior to release to the environment. The requirements that the appropriate portions of this system be used -
when specified provides assurance that the releases of radioactive materials in liquid effluents will be kept "as low as is reasonably achievable." This specification implements the requirements of 10 CFR Part 50.36a, General Design Criterion 60 of Appendix A to 10 CFR Part 50 and the design objective given in Section II.D of Appendix I -
to 10 CFR Part 50.- The specified limits governing the use.of .- w appropriate portions of the liquid radwaste treatment system were .,
specified as a suitable fraction of the dose design objectives set forth in Section II.A of Appendix I, 10 CFR Part 50, for liquid effluents. .
i This requirement' applies to the release of radioactive materials ~i~n liquid effluents from the one reactor unit on the site.
CLINTON-1 6-4 Rev.6-12/89
, CPS-ODCM 4
~!
6.3.2 Gaseous Effluents ;
i Section"3,4.1;-10CFR20 Release Rate Limits I This requirement is provided to ensure that the dose at any time at l and beyond-the SITE BOUNDARY from gaseous effluents from all units I on the site will be within the annual dose limits of 10 CFR Part 20 !
to UNRESTRICTED AREAS. The annual dose limits are the doses '
associated'with the concentrations of 10 CFR Part 20, Appendix B, ;
Table II, Column 1. These limits provide reasonable assurance that ;
radioactive material discharged in gaseous effluents will not result {
in the exposure of a MEMBER OF THE PUBLIC in an UNRESTRICTED-AREA, ;
either within or outside the SITE BOUNDARY, to annual average i concentrat$bns exceeding the limits specified in Appendix B, Table ;
"' II-of 10 CFR Part 20 (10 CFR Part 20.106(b)). For MEMBERS OF THE l' PUBLIC Ubo may at times be within the SITE BOUNDARY, the occupancy of: that MEMBER OF THE PUBLIC will usually be sufficiently low to compensate for any increase in the atmospheric diffusion factor ;
above that for the SITE-BOUNDARY.
PUBLIC, with the appropriate occupancy factors, shall be given in Examples of such MEMBERS OF THE j this manual. Doses for such MEMBERS OF THE PUBLIC are provided in t the Semiannual Radioactive Effluent Release Report. The specified - -;
release rate limits restrict, at all times, the corresponding gamma ;
and beta dose rates above background to a MEMBER OF THE PUBLIC at or 3 beyond-the-SITE BOUNDARY to less v.han or equal to 500 mrem / year to !
the whole body or to less than or squal to 3000 mrem / year to the ;
skin. These release rate limits a..so restrict, at all times, the .t corresponding-thyrcid dose rate above background.to a child via the "1 inhalation pathway-to less than or equal to 1500 mrem / year. l t
This requirement applies to the release of radioactive materials in !
gaseous effluents-from the one reactor unit on the site.
The required detection capabilities for radioactive material in gaseous-waste samples-are tabulated in terms of the lower _ limits of- ,
detection (LLDs).- Detailed discussion of the LLD, and other. ;
detection limits can be found in Currie, L. A., " Lower Limit of Detection: Definition and Elaboration of a Proposed Position for i Radiological Effluent and Environmental Measurements," NUREG/CR-4007 !
(September 1984), and in the HASL-Procedures Manual, HASL-300 - *
(revised annually). ~
t Section 3.5.1: Noble Gas Dose -t This requirement is provided to implement the requirements.of. ,
-s '
-Sections II.B, III.A and IV.A of Appendix I, 10 CFR Part 50. The- ..!
Limiting Condition.for Operation implements the guides set.forth in' !
Section II.B of Appendix I. The ACTION statements provide the !
required operating flexibility and at the same time implement th'e i guides set forth in Section IV.A of Appendix I to assure that the ,
I CLINTON-1 6-5 Rev.6-12/89 L
l CPS-ODCM i
t releases of radioactive material in gaseous effluents to UNRESTRICTED AREAS will be kept "as low as is reasonably i achievable." The Surveillance Requirements implement the !
requirements in Section III.A of Appendix I that conformance with the guides of Appendix I be shown by calculational procedures based i on models and data such that the actual exposure of a MEMBER OF THE '
PUBLIC through appropriate pathways is unlikely to be substantially underestimated. The dose calculation methodology and parameters _
established in this manual for calculating the doses due to the !
actual release rates for radioactive noble gases in gaseous effluents are consistent with the methodology provided in Regulatory !
Guide 1.109, " Calculation of Annual Dosos to Man frcm Routine '
Releases of Reactor Effluents for the Purpose of Evaluating Compliance with 10 CFR Part 50, Appendix I," Revision 1, October t 1977 and Regulatory Guide 1.111, " Methods for Estimating Atmospheric ;
Transport and Dispersion of Gaseous Effluents in Routine Rel. eases ;
from Light-Water Cooled Reactors," Revision 1, July 1977. The i equations in this manual for determining the air doses at and beyond ;
the SITE BOUNDARY are based upon real time atmospheric conditions.
This requirement applies to the release of radioactive materials in gaseous effluents from the site. ,
Section 3.5.2: Todine-131. Iodine-133. Tritium, and Radionuclides in-Particulate Form ,
uJ This requirement is provided to implement the requirements of '
Sections II.C, III.A and IV.A of Appendix I, 10 CFR Part 50. The Limiting Conditions for Operation are the guides, set forth in :.e .
Section II.C of Appendix I. The ACTION statements provide the required operating flexibility and a't the same time implement the guides set forth in Section IV.A of Appendix I to-assure that the >
releases of radioactive materials in gaseous effluents to UNRESTRICTED AREAS will be kept "as low as is reasonably achievable." The calculational methods specified in the Surveillance Requirements implement the requirements in Section, III.A of Appendix I that conformance with the guides of Appendix I be shown by calculational procedures based on models and data,.such-r that the actual exposure of a MEMBER OF THE PUBLIC through appropriate pathways is unlikely to be substantially underestimated.
The calculational methodology and parameters for calculating the doses due to the actual release rates of the subject materials are .
consistent with the methodology provided in Regulatory Guide 1.109,
" Calculation of Annual Doses to Man from Routine Releases of Reactor Effluents for the Purpose of Evaluating Compliance with 10 CFR Part _ l 50, Appendix I," Revision 1, October 1977 and Regulatory G_uide ~ .
1.111, " Methods for Estimating Atmospheric Transport and Dispersion '- '
of Gaseous Effluents in Routine Releases from Light-Water-Cooled Reactors," Revision 1, July 1977. These equations also provide for determining the actual doses based upon the real time atmospheric :
conditions. The release rate specifications for iodine-131,, 3 tritium, and radionuclides in particulate form with half lives .
etTUTn"-1 6-6 Rev.6-12/89 >
CPS-ODCM i
greater than 8 days are dependent upon the existing radionuclide pathways to man in the areas at and beyond the SITE BOUNDARY. The pathways that were examined in the development of these calculations -
were: 1) individual inhalation of airborne radionuclides, 2) deposition of radionuclides onto green leafy vegetation with I subsequent consumption by man, 3) deposition onto grassy areas where milk animals and meat producing animals graze with consumption of-the milk and meat by man, and 4) deposition on the ground with subsequent exposure of man.
This requirement applies to the release of radioactive materials in gaseous effluents from one reactor unit on the site.
Sections 3.6 and 3.7: Gaseous Radwaste (Offcas) Treatment and Ventilation-Exhaust Treatment System -
The OPERABILITY of the WASTE GAS HOLDUP SYSTEM and the VENTkkATION EXHAUST TREATMENT SYSTEM ensures that the systems will be available for use whenever gaseous effluents require treatment prior to .
release to the environment. The requirement that the appropriate portions of these systems be used, when specified, provides '
reasonable assurance that the releases of radioactive materials in gaseous effluents will be kept "as low as is reasonably achievable."-
This requirement implements the requirements of 10 CFR Part 50.36a, General Design Criterion 60 of Appendix A to 10 CFR Part 50 and the design objectives given in Section II.D of Appendix I to 10 CFR Part '
- 50. The specified limits governing the use of appropriate portions of the systems were specified as a suitable fraction of the dose Sw- design objectives set forth in Section II.B and II.C of Appendix I, ..
10 CFP. Part 50, for gaseous effluent.s. .
This requirement applies to the release of radioactive materials in gaseous effluents from the one reactor unit on the site.
~
6.3.3 Total Dose
~ -
Section 4.1: Total Dose .
This requirement is provided to meet the dose limitations of do CFR Part 190 that have been incorporated into 10 CFR Part 20 by 46 FR -
1a525. The requirement requires the preparation and submittal of a Special Report whenever the calculated doses from plant generated '
radioactive effluents and direct radiation exceed 25 mrems to the s total body or any organ, except the thyroid, which shall be limited to less than or equal to 75 mrems. For sites containing up to 4 -
reactors, it is highly unlikely that the resultant dose to.a MEMBER v )
OF THE PUBLIC Will exceed the dose limits of 40 CFR Part 190 if'the -
individual reactors remain within twice the dose design objectives -
l of Appendix I, and if direct radiation doses from the reactor' units ~
and outside storage tanks are kept small. The Special Report will describe a course of action that should result in the limitation of the annual dose to a MEMBER OF THE PUBLIC to within the 40 CFR Part 190 limits. For the purposes of the Special Report, it may be CLINTON-1 6-7 Rev.C-12/89
CPS-ODCM assumed that the dose commitment to the MEMBER OF THE PUBLIC from other uranium fuel cycles sources is negligible, with the exception that dose centributions from other nuclear fuel cycle facilities at the same site or within a radius of 8 km must be considered. If the dose to any MEMBER OF THE PUBLIC is estimated to exceed the requirements of 40 CFR Part 190, the Special Report with a request for a variance (provided the release conditions resulting in violation of 40 CFR Part 190 have not already been corrected), in accordance with the provisions of 40 CFR Part 190.11 and 10 CFR Part 20.405c, is considered to be a timely request and fulfills the requirements of 40 CFR Part 190 until NRC staff action is completed.
The variance only relates to the limits of 40 CFR.Part 190, and does not apply in any way to the other requirements for dose limitation of 10 CFR Part 20, as addressed in Sections 2.3 and 3.4. An individutl.is not considered a MEMBER OF THE PUBLIC during any-period in 'which he/she is engaged in carrying out any operation that is part of the nuclear fuel cycle. ;
6.4 Radiolouical Environmental Monitorina Section 5.1: Monitorine Procram The radiological environmental monitoring program required by this -
requ3rement provides representative measurements of radiation and of radioactive materials in those exposure pathways and for those radionuclides that lead to the highest potential radiation exposures
", of MEMBERS OF THE PUBLIC resulting from the station operation. This monitoring program implementsSection IV.B.2 of Appendix I to 10 CFR ,
Part 50 and thereby supplements the radiological. effluent monitoring "
program by verifying that the measurable conc.entrations of radioactive materials and levels of radiation are not higher than expected on the basis of the effluent measurements and the modeling of the environmental exposure pathways. Guidance for this monitoring program is provided by the Radiological Assessment Branch Technical Position on Environmental Monitoring, Revision 1, November 1979. The initially specified monitoring program will be effect,1ve for at least the first three years of commercial operation. .
Following this period, program changes may be initiated based ,cn1 operational experience.
The required detection capabilities for environmental sample analyses are tabulated in terms of the lower limits of detection (LLDs). The LLDs required by Table 5.1-3 are considered optimum for routine environmental measurements in industrial laboratories. It should be recognized that the LLD is defined as an a oriori (before -
the fact) limit representing the capability of a measurement system a and not as an a nosteriori (after the fact) limit for a particular ,,
measurement.
CLINTON-1 6-8 Rev.6-12/89
. CPS-ODCM I Detailed discussion of the LLD, and other detection limits, can be [
found in Currie, L. A., " Lower Limit of Detection: Definition and '
Elaboration of a Proposed Position for Radiological Effluent and Environmental-Measurements," NUREG/CR-4007 (September 1984), and in the HASL Procedures Manual, HASL-300 (revised annua'ly). ,
Section 5.2: Land Use Census ;
This requirement is provided to ensure that changes in the use of ;
areas at and beyond the SITE BOUNDARY are identified and that :
modifications to the radiological environmental monitoring program '
are made if required by the results of this census. The land use census shall be performed using the best information available (e.g., a door-to-door survey, from aerial surveys, questionaire, or i from consulting with local agricultural authorities). This census satisfies the requirements of Section IV.B.3 of Appendix I to 10 CFR Part 50. Restricting the census to gardens of greater than 50 m ,
provides assurance that significant exposure pathways via leafy -
vegetables will be identified and monitsred since a garden of this ,
size is the minimum required to produce the quantity (26 kg/ year) of '
leafy vegetables assumed in Regulatory Guide 1.109 for consumption by a child. To determine this minimum garden size, the following -
assumptions were made: (1) 20% of the garden was used for growing broad leaf vegetation (i.e., similar to lettuce and cabbage) and (2) j a vegetation yield of 2 kg/m '
Section 5.3.1: Interl aboratory Comparison Procram ,
The requirement for participation in,an approved Interlaboratory i comparison Program is'provided to ensure that independent checks on ,
the precision and accuracy of the measurements of radioactive material in environmental sample matrices are performed as part of the quality assurance program for environmental monitoring in order to demonstrate that the results are valid for the purposes of Section IV.B.2 of Appendix I to 10 CFR Part 50. '
y .
i h
.h
, .j
- *. f CLINTON-1 6-9 Rev.6-12/89
- m. . . ~ . - . . __ . _ _ _ _ _ _ . _ . . _ _ . _ . . . _ _ . _ ~ _ . _ _ , _ , . . . . . _ . - . _ . . _ _
CPS-ODCM 7.0" Reoortino-Recuirements 7.1 Annual Radiolocical-Environmental Operatino Report Routine RadiologicaliEnvironmental Operating Reports covering the operationfof the~ unit during the previous calendar year shall be
-submitted pri.or to May 1 of each year pursuant to Technical Specification 6.9.1.6.
The Annual: Radiological Environmental Operating Reports shall include the-following information:
- 1. Summaries, interpretations, and an analysis of trends of the results of the radiological environaental surveillance activities for the report period, including a comparison'with preoperational studies, with operational controls as :
appropriate, and with previous environmental surveilladce-reports, and'an assessment of the observed impacts of the' plant operation on the environment.
- 2. The results'of land use censuses required by Section--5.2..
- 3. . Results of analysis of all radiological environmental samples'-
2nd of all environmental radiation measurements taken during tha period pursuant to the locations specified in the Tables-and Figures in this manual, as well as summarized and w .s - tabulated results of these analyses and measurements in the format of the table in the Radiological Assessment Branch ..
Technical Position, Revision - 1, November 19-79. In the event that some-individual-results are not available for inclusion with the report, the report.shall be submitted
- noting and explaining the reasons for the missing results.. The missing-data shall be submitted as soon,as possible in a supplementary report. ,
- 4.,
-A summary description of the radiological environmentaI
- monitoring program. -
-5. At least two legible maps
- covering all sample locations keyed ~
-tofa. table giving distances and. directions from the HVAC-stack. -
- 6. - The results of licensec participation in the Interlaboratory Comparison Program, required by Section-5.3.1. -
- 7. Discussion of all deviations from the sampling schedule of; -d Table 5.1-1. -.
i
- j 4
- 0ne map shall cover stations near the site boundary and a second map' ~ .
shall-include the more distant-stations.
]
I cf.TMTnN-1 7-1 Rev.6-12/89
- . _ . _ . . , . . _ . _ . _ _ _ . , _ - ,._._ . . _ ,. . ..._._ . _.. , _ . _ ._ . . _ _,~ . , .
j CPS-0DCM O. Discussion of all analysis in which the LLD reqaired by Table 5.1-3 was not achievabic.
7.2 EcrianniuiLindicardlye Ef fluent Polqnr.e PermIl Routine Rad 4cactive Effluent Release Reports covering the operation of the unic during the previous 6 months of operation shall be submitted within 60 days af ter January 1 and July 1 of each year pursuant to Technical Specification 6.9.1.7.
The Somiannual Radioactive Releano Report shall include the fe' v'ing information:
- 1. A summary of the quantities of radioactivo liquid and gaseous effluents and solid waste released from the unit as outlined in Rigulatory Guide 1.21, "headuring, Evaluating, and -
Repor ting Radioectivity in Solid Wastes and Releases of Radioact!.va Mat wials in Liquid and Gascous Ef fluents from Light-Water Cor.ed Nuclear Power Plants, Revision 1, June 1974, with dab. summarized on a quarterly bacr1 following the format of Appendix B thoroof. For solid wa.r,- the format for Table 3 in Appendix B shall be supplemer /. tith 3 additional catogories: class of solid was.:a (ac defincd by 10-CFR Part 61), type of container (e.g., LSA, Type A, Type B, Large Quantity) , and SOLIDIFICATION agent or absorbent (e.g.,
coment, uren formaldehyde).
- 2. The following information for cach : lass of solid waste (as defined by 10 CFR Part 61) chipped offaire.during the report period:
- e. Container volume,
- b. Total curio quantity (specify whether determined by measurement or estimate),
- c. Principal radionuclides (specify whether determinch by measurement or estimate), .
- d. Source of wasto and proccasing employed (e.g.,
downtored spent resin, compacted dry waste, evaporator bottoms),
- 3. A list and descrip' tion of' unplanned releases from the site to UNRESTRICTED AREAS of radioactive materials in gaceous and -
liquid effluents mado during the reporti'.1g period. .
4 CLIN 70N-1 7-2 Rev.6-12/89 l
CPS-ODCM
- 4. A listing of now locations for dose calculations and/or environmental monitoring identiflod by the land uso censuo pursuant to Section 5.2.
L
- 5. Changes to tho ODCM pursuant to technical Specification 6.14.
6 Major changes to gadioactivo liquid, gaseous, and solid waste treatment systems .
The discussion of each chango shall 7 contain:**
- a. A summary of the ovaluation that led to the determinttion that the change could be mado in accordance with 10 CFR Part 59.59.
- b. ' - Sufficient detailed information to totally support the reason for the chango without bonofit of additional or supplomontal information; '
- c. A detailed doccription of the equipment, components and i procosaco involved and the interfaces with other plant systems;
- d. An ovaluation of the chango, which shows the predicted -
relonnes of radioactivo materialc in liquid and gaseous of flunnts and/or quantity of solid wasto that dif fer from those previously predicted in the licenso application and amendments thereto;
- o. An evaluation of the chango, which shows the expected '
minimum exposures to a MEMBER OF. THE PUBLIC in the UNRESTRICTED AREA and to the general population that differ from th' = previously estimated in the 31conse application ant sendments thereto;
- f. A comparison of the predicted releason of radioactive materials, in liquid and gaseous offluents and in s.olid wanto, to the actual releases for the period prior to when the changos are to be mado; .
- g. An estimato of the exposure to plant operating personnel as a result of the change; and
- h. Documentation of the fact that the chango was reviewed and found acceptable by the FRG.
- Licensees may choono to submit the information called for in this '
requiremont as part t ' its annual USAR updato.
- Changes doccribed by this requircmont shall becono offecti've upon -
review by the FRG. 4 C LT NTON-1 7-1 Rev.6-12/89
}
CPS-CDCM '
i l
The Semiannual Radioactive Effluent Release Report to be submitted within 60 days after January 1 of each year shall also include the follewing information:
- 1. An annual summary of hourly meteorological data collected over the previous year. This annual summary may be either in the form of an hour-by-hour listing on magnetic tape of wind speed, wind direction, atmospheric stability, and '
precipitation (if measured), or in the form of joint frequoney distributions of wind speed, wind direction, and atmosphoric stability.**
- 2. As acrossment of the radiation dosos due to the radioactive liquid and gaseous offluents released from the unit or station during the previous calendar year. -
- 3. Anassessmentoftheradiationdosesfromradioactivebiquid '
and gaseous offluents to MEMBERS OF THE PUBLIC due to their.
activities inside the SITE BOUNDARY (Figures 2.1-1 and 3.1-1)-
during the report period.
All assumptions used in making these assessments, i.e., specific activity, exposure time and location, shall be included in these -
reports. The meteorological conditions concurrent with the time of release of radioactive materials in gaseous offluents, as determined by sampling frequency and measurements, shall be used for datormining the gaseous pathway dosos. The assessment of r:tdiation doses shall be performed in accordance with the methodology and ..
, , . - paramotors in this manua.'..
- 4. An assessment of radiation doses to the' likely most exposed MEMBER OF THE PUBLIC from reactor releases and other nearby uranium fuel cycle sources, including doses from primary offluent pathways and direct radiatic.t, for the provicus calendar year to show conformance with 40 CTR Part 190, Environmental Radiation protection Standards for Nuclear Power '
Operation.
Acceptabic methods for calculating the dose contribution from liquid and gaseous effluents are given in Regulatory Guido 1.109, Rev. 1, -
October 1977.
l --
- In lieu of submission h tne first ha f year Radioactive Effluent -
Release Report, the licensco has the option of retaining this. summary s o of required meteorological data on site in a file that shall be '
l provided to the NRC upon request.
l l
CLINTON-1 7-4 Rev.6-12/89
CPS-0DCM i 8.0 ADJUSTMEffT OF Tile CPS ODCM fiETjiODOLOGY }
l Consistent with the llRC Commissioners' opinion on 10CFR50 Appendix I !
dated April 30, 1975, CPS Will use environs monitoring data to t improva doso calculational models and to request CPS 00CM changes on i the basis of such operating experienco data. Such adjustments are l recognized as being especially important for the radiciodine-milk i pathway where conservativo regulatory guido assumptions have boon j mado. By using environs monitoring data,. uncertaintion associated !
with plume-behavior, rndioiodino chemical form, deposition and j rotontion of foragos,.and milk consumption patterns may be i circumvented or reduced. j
,c- . j
.. i J
t i
. l i
i i
w ., ;
. I
. i 5
)
i e
- i 6
\
f l,
i r
- I
.; r
. . )
CLINTON-1 8-1 Rev.5-12/89. f a.= . . . . - . . . - . - . . , - , . . , . . . .
CPS-ODCM 9.0 ATMOEEHERIC TRANSPORT AND DISPERSION MODEL
-9.1 Introductipn The atmospheric transport and dispersion model used by Illinois Power company is a straight-line, sector-averaged Gaussian model designed to estimate average relative concentrations at various receptor points. The model was developed in accordance with routino release analysis proceduros specified by Regulatory Guido 1.111 (Revision 1 July 1977), Section C.1.c " Constant Meun Wind Direction dodels". .
All meteorological and dose calculations prescribed in this manual are based on noteorological data concurrent with tho time'of release. Near-real time meteorological data ..
proccasing is described in Section 9.2 e 9.2 Concurrent Meteoroloaical Data Processina Meteorological data is acquired and processed through a model which utilizes bi-level hourly meteorclogical tower data or single _ level joint frequency esta to r trform the required 4 analysis. Throo distinct release moded are treated: elevated, ground and mixed. A set of five output arrays are generated for oach dose receptor location as follows:
Relativo undecayed, undepleted plume concentration (X/Q) ,
7.-
Relativo decayed and depleted ra'dioiodine and particulate concentration (D2D?XQ)
Relative decayed noble gas concentration (D1XQ)
Relativo particulate and radiciodine deposition-(D/p)
Standard deviations of the undecayed, undopleted plume concentrations Since the Regulatory Guide 1.111 depletion and deposition curves are defined only within the range encompassing 100 to 200,000 meters, analysis results are r.ot considered valid outside this range. The following sections describe the l calculations performed by the transport and dispersion model - l for a one hour time interval. . v- :
. . i 4
CLINTON-1 9-1 Rev.6-12/89
l CPS-0DCM l
9.2.1 D,etermination of Pascuill Stability Class The Pasquill Stability Class is determined by categorizing the temperaturo gradient, AT, into one of several ranges betwoon ~0.900 and 0.900 *C/ meter according to the following equation:
AT = Tu -TL , 'C/ motor (1)
Hg -HL ,
where Tu = Motoorological (mot) toWor upper lovel
,- temperature, 'C T L=Motocrologicaltowerlowerloveltemperatuhe, *C Hg = Motoorological tower upper lovel instrumentation height
= 60 motors HL = Motoorological tower level instrumentation -
height
= 10 motors
.,,,, AT is then classified according to the following schemos -
Eagguill stability Definino condition A (Extremely Unstable) -0. 9 0 0 < AT S-0. 019 B
C
-0. 019 < AT $~0. 017
-0. 017 < AT I-0. 015 D (Noutral) -0. 015 < AT d-0. 005 E
F
-0. 005 < AT $ 0. 015
- 0. 015 < AT s 0 94 0 G (Extremely Stable) 0. 04 0 < AT d 0. 900 Invalid AT $-0.900 or AT> Os900 9.2.2 Calculation of Stack Heicht Wind Sneed -
The wind spood at the release point (HVAC Exhaust Stack or Standby Gas Treatment System Exhaust Stack) height, STACWS, is calculated using the expressions:
STACWS = WSPU (STACKH/Hg)P, motor /sec (2). ,
P = log (WSPL/WSPU ) , dimensionless (3) log (Ht/H U) ~
~
4 CLINTON-1 9-2 Rev.6-12/89
CPS-CDCM where WSPp = Upper met tower level wind speed, meterface
~
WSPL = Lower met tower icvel wind speed, meter /sec
~
.STACKH = Physical release point s*.ack height P = Wind power law exponent, dimensionless All other parameters are as defined for equation (1) .
9.2.>'-
Determination of Release Mode and the Entrainment-Coefficient .-
The mede of release can be clavated, ground or mixed; the latter being a combination of the first two. The mode of releane, as well as an entrainment coefficient, TCORR, are determined-from the stack height, STACH, building height, BLDGHT, stack exit velocity, EXITV, and the wind speed at the stack hoAght, STACUS. -
For offluents exhausted from release points that are higher than twice the height of adjacent solid structures, I~
~~
STACKH > 2 (BLDGHT) , TCORR = 0.0 (4) the releane is considered completely elevated and the entrainment coefficient is zero. For offluents released from points less than the height of adjacent solid structures, a ground-level release is assumed STACKH < BLDGHT , TCORR = 1.0 (5) -
and the entrainment coefficient is unity. For ,
effluents released from points or vents at the level .
I of, or above, adjacent sclid structures, but lower than clovated release points,
- 2 (BLDGHT) > STACKH > BLDGHT (6) the release is treated as elevated, ground or mixed -
according to the following relationships: . v ELEVATED: TCORR = 0. 00 if EXITV >5 (STACWS) (7)
GROUND: TCORR = 1.0 if EXITV < STACWS (8) ;
i l
CLINTON-1 9-3 Rev.6-12/89
_ - ~ . . _ . _ _ - . _ . _ _ .. _.--. _ - ,
CPS-ODCM MIXED: TCORR = 0.30-0.06(EXITV/STACWS) if (9) l 5 (STACWS) 2 EXITV > 1. 5 (STACWS)
TCORR = 2.58-1.58(EXITV/STACWS) if (10) 1.5(STACWS) 2 EXITV 2 (STACWS)
In the mixed modo, the release is considered to occur '
as an elevated release 100(1-TCORR) porcont of the timo '
and as a ground releaso 100(TCORR) percent of the timo. s Each of thoso casos are than ovaluated separately and the concentration X/Q calculated according to the fraction of the time each roloase occurs.
9.2.4 calculation of Vertical Standard Deviation The vertical plume spread (vertical standard deviation), ag, is a function of the distance i from the release point to the rocoption point for a given Pasquill stability class. The numerical value of ,
og if obtained by a polynominal fitting equation which simulates Figure 1 of Regulatory Guide 1.111 og = 10(A + B log (X) + C (log (x)) 23 , tutor (11) where X = Distance to a specific receptor, kilometer A,B,C = Empirical factors which vary by stability class, determined by fitting polynominal equations to the Regulatory Guide 1.111 Figure 1 curves, dimensionless Emoirical Factors Used in Ecuation (11)
Pasquill Class & D g A 2.79166 2.69043 1.07483 B 2.11394 1.47930 0.40676 C 1.81954 0.88317 -0.06101 D 1.51851 0.74130 -0.08699 E 1.36173 0.68570 -0.11956
{
F 1.14613 0.66066 -0.12363 G 1.14613 0.66066 -0.12363 Additionally, an optional value called the " mixing height lid" may be specified which limits the value of an to be no greater than this value.
CLINTON-1 9-4 Rev.7-2/91
CPS-ODCM !
9.2.5 Calculation of the Buildina Wake correction l
For ground-based and mixed-mode releases, an adjustment !
is made in the calculation of X/Q that takes into l consideration initial mixing of the affluent plume l within the building wake. This adjustment is an !
additional factor added in quadrature to the vertical !
plume spread equation (11): :
E: = (og + 0.5(BLDGHT)2/w ] (12) f with the requirement that Eg is restricted to values f Ez $ (3) (az) .
9.2.6 Calculation of Momentum Plume Rise i
For elevated or nixed-mode releases only, the amount of ,
plume rise due to the initial vartical momentum of the !
exhausted effluent, AH, is calculated. For Pasquill j stability classes A,B,C and D, AH is calculated per i section 9.2.6.1; for classes E,F and G, section 9.2.6.2 is used.
9.2.6.1 AH For Pasnuill Class A B.C and_D -
AH is calculated using both equations. (13) !
A and (14) and the minimum value is selected {
for use. In addition, when the vertical L exit velocity, EXITV, is less than 1.5 I times the horizontal windspeed, STACWS, a t downwash correction is subtracted from :
equation (13) per equation (15).
l AH1 = 1. 4 4 (STACD) (EXITV/STACWS) 2/3 (13) f i
.(X/STACD)1/3-DOWNWASH, meter f
AH2 = 3.0 (STACD) (EXITV/STACWS) , meter (14)
DOWNWASH = 3. 0 (STACD) (1. 5-EXITV/GTACWS) , meter (15) I where STACD = Internal release point stack diameter }
= 3.*,7 meters (HVAC Exhaust Stack)
= 0.44 meters (SGTS Exhaust Stack) .(
EXITV = Stack exil velocity, meter /second j All other parameters are as defined previously. !
l s
CLINTON-1 9-5 Rev.6-12/89
--n.- , - -- ,, - . , - , . . . , - - - . - - - - - - , - . . , . . . -
CPS-ODCM +
i 9.2.6.2 MI For Pasculli Class E. F and G AH is datormined by colecting the minimum value calculated by equations (13) and (14) above and equations (16) and (17) below:
AH3 = 4.0 ( (0. 5 (EXITV) (STACD) ) 2fg)h, motor (16) aH4 = 1.5 ( (0. 5 (EXITV) (STACD) ) 2/STACWS)1/3(S)-1/6, (17) motor where
' S = Rostoring accoloration por unit vertical-2
,. - displacement for adiabatic motion, soc .
= 8.70E-04 (E stability) --
= 1.75E-03 (F stability) '
w 2.45E-03 (G stability)
All other parameters are as defined in section 9.2.6.1..
9.2.7 Calculg_tdon of the Ef fective Plume fleicht The offactive plumo height,.H, is datormined using section 9.2.6 results for the momentum plume riso, aH, and the terrain height, TERAIN:
H = STACKH + AH - TERAIN , motor (18) ..
whero TERAIN = Difference betwoon the plant baco hoight above mean ,
saa lovel (MSL) and the receptor point height above .
MSL, metar 20.0 l
1 I
i I
CLINTON-1 9-6 Rev.6-12/89
CPS-ODCM 9.2.8 Determination of Affected Sectors The wind direction for the hour determined which sector will be affected. Sectors are 22.5' arcs and are classified according to the following scheme:
Sector Compass Wind Direction (WD)
Upmber Direction 1 N 0.0* < WD < 11.25' or 348.75' s WD < 350.00*
2 NNE 11.25* 5 WD < 33.75' 3 NE 33.75' s WD < 56.25' 4 ENE 56.25' S WD < 78.25' 5 E 78.75' s WD < 101.25' 6 -
ESE 101.25' s WD < 123.75' -
7 SE 123.75' s WD < 146.25*..
8 SSE 146.25' S WD < 168.'/5' -
9 S 168.25' s WD < 191'.25' 10 SSW 191.25' s WD < 213.75' 11 SW 213.75' s WD < 236.25*
12 WSW 236.25' $ WD < 258.75' 13 W 258.75' $ WD < 281.25' 14 WNW 281.75* 5 WD < 303.75' -
15 UW 303.75' s WD < 326.25' 16 NNW 326.25' s WD < 348.75' For clovated releases, the wind direction at the upper met tower level is used; ground releases follow the direction of ..
Au the wind at the lower met tower level. For mixed-mode ""
releases, two X/Q calculations,are performed: one for_each of the two met tower levels. If the wind direction is the same at both levels, the resulting X/O will be summed into the same sector; otherwise, the X/Q will be summed into the appropriate ,
sectors. During periods of calm wind, the wind speed is set at one-half the anemometer threshold value and assigned the direction of the previous hour. ~
9.2.9 Calculation of Denletion and Deposition Pa.ctors .-
The depletion, DPF, and deposition, DPSF, factors are calculated using the curves provided by Rege.latory Guide 1.111. Actual values are calculated using polynomial equations developed to simulate the Regulatory Guide curves.
Both the DPF and DPSF calculations depend on the effective ;
plume height, H, the stability class, S, and the distance, X, - '
to the receptor. .
m- 1 1
4 CLINTON-1 9-7 Rev.6-12/89
.~ -- .
CPS-ODCM 4
The Regulatory Guide 1.111 curves represent plumes that are 100, 60, 30, and 0 (ground-level) meters above the ground.
For plumes between 0 and 15 meters above the ground, the model uses the ground-level release graphs; for those between 15 and 45 meters, it uses the 30 meter curves; between 45 and 80 meters above the ground, it uses the 60 meter curves; and for those greater than 80 meters above the ground, it uses the 100 meter curves. The model assumes that, after full plume rise is achieved, the plume cannot get higher from the ground. The derivation of these curves assumed no change in terrain height with downwind distance. Since topography does change with distance, and likewise the vertical distance between the plume centerline and the ground, it is necessary to read from more than one depletion or deposition curve of Regulatory Guide 1.117-as the plume travels with distance. -
9.2.9.1 DPF Calculation l The effectiva plume height, H, is categorized into one-of four J-ranges according to the following scheme:
Plume Heicht (meters) J Valug 0 5 H $ 15 - 5 15 < H s 45 6 45 < H $ 80 7 g, H > 80 8 Similarly, the stability class is categorized into one 3 of three S-ranges as follows: .
Stability Class S Value A, B, C 1 D 2 E, F, G 3 e i
. CT.T NTON-1 9-8 Rev.6-12/89 i
-- -. .. .- . - - - . - - - - - - . - - .- l
CPS-ODCM The (SJ) product is then .t. .ted and an (A) value determined at the receptor lococion X according to the following scheme (where no A value in given, DPF=1.0):
S*J Value X A DPP 5 X < 100 1.0 X 2 100 A=1 calculated 6 X < 200 1.0 X 2 200 A=5 calculated 7 X < 300 1.0
- X 2 300 A = 17 calculated 8 X < GOO 1.0 0 X 1 600 A = 29 calculated -
10 all X 1.0
~~"
12 '
X < 400 1.0 X 1400 A=9 calculated 14 X < 1000 1.0 X 2 1000 A = 21 calculated 15 all X 1.0 16 X < 1700 1.0 X 2 1700 A = 33 calculated -
,~
18 X < 6000 1.0 X 2 6000 A = 13 calculatoC 21 X < 60,000 1.0 X 1 60,000 A = 25 calculated 24 all X 1.0 .,
,es. ,
DPF is calculated using.the value for A and equations (19) and (20):
DPF = B(A) + B(A + 1)d + B(A + 2)d2 + b(A + 3)d3 (19) ,
d = log (X)
(20) t
~
4 l
CLINTON-1 9-9 Rev.6-12/89
CPS-ODCM !
i The corresponding values for the B(A), B(A + 1), B(A + f
- 2) and B(A + 3) terms are as follows ,
t B(1) = .788234 B(19) = .426473 !
B(2) = .207198 B(20) = -0.0471767 B(3) = .0563034 B(21) = .615442 '~
B(4) = .0 B(22) = .317258' '
B(5) = 2.59508 B(23) = .0631839 B(6) = -1.43610 B(24) = .O ;
B(7) = .433300 B(25) = -6.89581 !
B(8) = .0466221 B(26) = 3.37961 B(9) = 1.507264 B(27) = .361582 ,
B(10) = .2745668 B(28) = .0 [
B(11) = .0556577 B(29) = 3.58532
, - B (12 )
= .007670194 j B(30) = -2.21101 -
B(13) = -18.01858857 B(31) = .642613 ; ;
B(14) = 12.755137 B(32) = .0651465 ' i B(15) = -2.7658938 B(33) = .234274 [
B(16) = .19103896 B(34) = .512656 j B(17) = 2.47756 B(35) = .0857995 [
B(18) = 1.36010 B(36) m .0
\
9.2.9.2 DPSF Calculations * ;
1 Using the same (SJ) and X values determined in section !
9.2.9.1, a corresponding C value is defined according
[
3, , to the following scheme (where no C value is given, i DPSF = 0): .: s S*J .
Value X C DPSF ,
i 5 X < 100 0 ,
l X 2 100 C=1 calculated ;
6 X < 100 0 ;
X 2 100 C=8 calculated -
5 ;
7 X < 100 0 .
[
X 2 100 C = 29 calculated .- l 8 X < 100 0 ;
X 2 100 C = 50 calculated -
i 10 all X 0 l 12 X < 100 0 -
t X 2 100 C = 15 calculated !
14 X < 120 0 i X 2 120 C = 36 calculated -l 15 all X 0 v i 16 X < 210 0 X 2 210 C = 57 calculated 18 X < 2900 0 ,
X 2 2900 C = 22 calculated '
. I 21 X < 26,000 0 . 4 .
~
X 2 26,000 C = 43 calculated l 24 all X 0 !
E CLINTON-1 9-10 Rev.6-12/89 !
- . . . - - - - ... _ .. - - . - - . - .. . . - . - . . . -. , ,.--. - - . ,-, ,_l
-CPS-ODCM DPSF in calculated using the value for C and equations (20), (21), and (22):
- Y DPSF = 10 / (0. 392699X) (21)
, Y = A(C) + A (C+1)d + A(C+2) d2 + A(C+3)d3 (22)
+ A(C+4)d 4 + A(C+5)d5 + A(C+6)d6 The corresponding values for the A(C), A(C+1), A(C+2),
A(C+3), A(C+4), A(C+5) and A(C+6) terms are as follows:
A(1) = -3.17821 A(33) = 7.552876 {
A(2) = .353463 A(34) = .82569984 l A(3) =. .0759066 A(35) = .036134823
,' A(4)
= 0. A(36) = -53.7335 --
A(5) = 0. A(37) = 45.3671 ' ;
A(6) = 0. A(38) = -15.3282 '
A(7) = 0. A(39) = 2.24735 '
A(8) = -25.7331 A(40) = .122674 A(9) = 26.2738 A (41) = 0.
A(10) = -11.3014 A(42) = 0. :
A (11) = 2.04278 A(43) = -674.351 -
A(12) = .134412 A(44) = 384.531 _!
A (13) = 0. A(45) = -73.7766 i A(14) = 0. A(46) = 4.72041 '
A(15) = -47.5827 A(47) = 0. !
a" A (16) = 43.8050 A(48) = 0. .. l A (17) = -16.0781 A(49) = .O. ""
A (18) = 2.53726 , A(50) =. -55.5622 A(19) = .148044 A(51) = 53.6534 t A(20) = 0. A(52) = -20.6300 .
A (21) = 0. A(53) = 3.44177 .
t A(22) = -128.5278 A(54) = .212314 .
A(23) = 77.28943 A(55) = 0. ;
A(24) = -15.90284 A(56) =- O. *
- j
. A(25) = 1.071885 A(57) = 436.987302 -
A(26) = 0. A(58) = -755.860224 .
A(27) = 0. A(59) = 515.64145 -
A(28) = 0. A(60) = -181.713295 -
l A(29) = 41.024767 A(61) = 35.153579 !
A (3 0) = -103.969677 A(62) = -3.558356 !
A (31) = 86.215344 A(63) = .14774 i A(32) = -35.1021096
- i u i e
- l i
CLINTON-1 9-11 Rev.6-12/89 h
CPS-ODCM 9.2.10 Ground Level X/0, D2DPXO, D1XO, D/O Analysin 9.2.10.1 Undecayed, Undepleted Plume Relative Concentration, X/O The atmospheric concentration of effluent at ground level, normalized by the source term Q, is given by the following equation:
X/Q = 2.032(TCORR) , sec/m 3 (23)
WSPL(X) Amin where Amin = The lesser of the two values obtained by c'~ equations (24) and (25), meter
- A1= (a2 g
,gz)\, meter (24)
A2" (3) 8z , meter (25) 2.032 = The constant (2/n)b divided by the width in radians of a 22.5' '
sector (i.e., w/8), dimensionless X = Distance between release point to receptor, meter 9.2.10.2 Decayed, Denleted Radiciodine and Particulate Relative Concentration, D2DPXO .
The decayed, depleted radiciodine concentration, D2DPXQ, is calculated in accordance with the following .
equation:
D2DPXQ = DPF (DC2) X/Q , sec/m 3 (26) ;
where .
DPF = The depletion factor calculated per -
section 9.2.9, dimensionless !
DC2 = The radiciodine decay factor, !
dimensionless .,
~'~
a exp (-0. 693 (X)/tg (WSPL) ) .
= exp [-0.693 (X)/ (8 day) (24 hr/ day)
(3600 3cc/hr) (WSPL )] ,
4 '
= exp (-1.00E-06 (X/WSP L)) ,
i I
ctTumnu_,
4-17 Rev.6-12/89 l
CPS-ODCM 9.2.10.3 Decayed Noble Gas Plume Relative Concentration, D1XO The decayed noble gas plume relative concentration, D1XQ, is calculated in accordance with the following equation:
D1XQ = DC1 (X/Q) , sec/m 3 (27) shore DC1 = The noble gas decay factor, dimension 1 css
= exp (-0.693(X)/tg(WSPL )]
= exp (-0.693 (X)/(2.26 day) (24 hr/ day) ..
(3600 sec/hr) (WSPL ))
= exp (-3.55E-06 (X/WSP L))
9.2.10.4 Radiciodine and Particulate Relative Deposition, D/O The relative deposition for radiciodines and -
particulates, D/Q is calcu.'ated in accordance with the following equation:
D/Q = DPSF(DC2) (TCORR) , m -2 (28)
(2n/16) X ,
.a .,
where ,
DPSF = The deposition factor calculated per section 9.2.9, m -1 ,
9.2.11 Elevated X/0, D2DPXO, D1XO, D/O Analysis 9.2.11.1 Undecayed. Undenleted Plume Relative Concentration, X/O The atmospheric concentration of effluent at grou'nd ,
level, normalized by the source term Q, is given by the following equation:
X/Q = 2.032(1-TCORR)exp(-0.5(H/az)2), sec/m 3 (29)
STACWS (X) a: -
where all parameters are as previously defined. -
L l
a .
CLINTON-1 9-13 Rev.6-12/89
CPS-ODCM 9.2.11.2 Decaved, Denleted Radiciodine and Particulate Relative Concentration, D2DPXO The calculation of D2DPXQ for elevated releases follows
' section 9.2.10.2 methodology with the exception that the WSP L value used in the calculation of DC2 in equation (26) is replaced by the STACWS value and the equation (29) X/Q is used.
9.2.11.3 pgqaved Noble Gas Plume Relative Concentration, D1XO The calculatiots of D1XQ for elevated' releases follows section 9.2.10.3 methodology by substituting the
~ equation (29) X/Q value into equation (27) and STACWS
,- for WSPL in the calculation of DC1. -
9.2.11.4 Radio' iodine and Particulate Relative Donositionf D/O The calculation-of D/Q for elevated' releases follows section 9.2.10.4 methodology by substituting (1-TCORR)-
for the TCORR term in equation (28) and STACWS for WSP L in the calculation of DC2.
. ::e L
9 4
- LINTON-1 9-14 Rev.6-12/89
CPS-ODCM Table 9.2-1 GASEOUS EFTLUENT RELEASE POINT CHARACTERISTICS tva u rsuaon aw u. suw uvu.sT:ue
- w. m.w m:o.a j
. an c.rsiv l/
/._ / ,.
" " 8M 7 cowrns, amu.
Ksm m 7 ,
my .
W commanvr ec.c. n. en e f'
- u.
- 1 l- --\% ,- gn V (
1 d e-V e-v e "**
N, f3 { / / mou c.nov ov.s *
/! ' h' ,f
, $h b t C
gg,~,;;,. / I //j/ #
/ EEEE.95=.2 K,', ' . . . n. ,,,,. w l oca.cm ac = mana
/f wso n esamn.tsevi m w ie
--- L- -/
JfVAC Exhaust Stack SGTS Exhaust' Stack Release Point Height (m) 61 61 -
Building Height (m) 58 58 -
Release Point Geometry Duct Pipe Release Point Area (m2) 11.15 0.15 i
Release Point Diameter (r) 3.77* 0.44
- Annual Average Flow Rate (m3 /sec) 111.73 1.89 ,
Vertical Exit Velocity (m/sec) 10.02 12.49 .;
- Ef f octive 2 ( A/r) 5 diareter CLINTON-1 9-15 Rev.6-12/89
_ _ _ _ - - _ - - .